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Abstract 2 
 
Abstract 
Synthesis of a photoactivated uncoupler I was completed and subsequently used by collaborators 
to demonstrate mitochondria uptake. 
 
The synthesis of a ratiometric, targetable calcium sensor was completed up to intermediate II (9 
steps), alongside a thiohydantoin heterocycle III synthesised in 5 steps. A co-worker has 
subsequently completed the probe synthesis based on this route, with the resulting probe 
showing good binding and optical responses in testing. 
 
Numerous routes to 5,6-disubstituted phenanthridinium salts were investigated towards the 
synthesis of a mitochondrially targeted superoxide probe and hydroxylated standards. In the 
course of this work a novel cyclisation was developed based on intramolecular SNAr giving access 
to 9-benzyloxyphenanthridinium salt V.  
 
Rapid and high-yielding access to 5,6-disubstituted phenanthridinium salts IX was then achieved 
through forming benzophenones VIII via Suzuki coupling and converting these to imines with the 
alkylamine. The nitrogen atom of the imine then undergoes cyclisation onto the aryl fluoride in an 
intramolecular SNAr upon heating. This transformation was shown to have good steric and 
electronic tolerance in the synthesis of 13 phenanthridinium analogues with 6 structural 
diversification points. Subsequent DFT calculations by a colleague showed this reaction proceeds 
in a concerted fashion and as such represents a considerable mechanistic novelty. 
 3 
 
 
Efforts towards a new probe for mitochondrial superoxide led to the synthesis of 3-tertbutyl-
dihydrophenanthridine X, which does not intercalate into DNA upon oxidation. This concept was 
refined and lead to the development of neopentyl ethidium XI and the targeted analogue 
MitoBNH XII and its deuterated analogue XIII.  
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Abbreviations 
(aq) 
 
aqueous solution 
(l) 
 
liquid 
(vac) 
 
in vacuum 
°C 
 
degrees Celsius 
µL 
 
microlitre 
Ȧ 
 
angstrom 
Ac 
 
acetyl 
Acetyl CoA 
 
Acetyl coenzyme A 
ADP 
 
adenosine diphosphate 
AMP 
 
adenosine monophosphate 
APCI 
 
atmospheric pressure chemical ionisation 
ATP 
 
adenosine triphosphate 
APTRA 
 
o-aminophenol-N,N,O-triacetic acid 
BAPTA 
 
1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid  
BHT 
 
butylated hydroxytoluene 
Bn 
 
benzyl 
Boc 
 
tert-butyloxycarbonyl 
br  Broad (NMR signal) 
Bu 
 
butyl 
cAMP 
 
cyclic adenosine monophosphate 
CCCP 
 
Carbonyl cyanide m-chlorophenylhydrazone  
cGMP 
 
cyclic guanosine monophosphate 
CICR 
 
calcium induced calcium release 
COSY 
 
correlation spectroscopy 
CRET 
 
chemiluminescence resonance energy transfer 
DCM 
 
dichloromethane 
DEPT 
 
distortionless enhancement by polarisation transfer 
DFT 
 
density functional theory 
DHP 
 
dihydropyran 
DIBALH 
 
diisobutylaluminium hydride 
DIPEA 
 
N,N-diisopropylethylamine 
DME 
 
dimethylether 
DMF 
 
dimethylformamide 
DMNPE 
 
 1-(4,5-dimethoxy-2-nitrophenyl)ethyl  
DMSO 
 
dimethylsulfoxide 
DNA 
 
deoxyribonucleic acid 
DNP 
 
2,4-dinitrophenol 
dppf 
 
1,1'-bis(diphenylphosphino)ferrocene 
EDCI 
 
1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide 
EI 
 
electron impact 
Eq 
 
equatorial 
eq 
 
equivalent 
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ESI 
 
electrospray ionisation 
Et 
 
ethyl 
ETFQOR 
 
electron transferring flavoprotein ubiquinone oxidoreductase 
EWG 
 
electron withdrawing group 
FAB 
 
fast atom bombardment 
FADH2 
 
flavin adenine dinucleotide 
FCCP 
 
carbonylcyanide-p-trifluoromethoxyphenylhydrazone 
FRET 
 
fluorescence resonance energy transfer 
FRTA 
 
free radical theory of ageing 
g 
 
grams 
GPDH 
 
glycerol 3-phosphate dehydrogenase  
HMBC 
 
heteronuclear multiple-bond correlation spectroscopy 
HOMO 
 
highest occupied molecular orbital 
HPLC 
 
high performance liquid chromatography 
HRMS 
 
high resolution mass spectroscopy 
HSQC 
 
heteronuclear single-quantum correlation spectroscopy 
IF 
 
complex I NADH binding site  
InsP3 
 
inositol triphosphate 
IP3R 
 
inositol trisphosphate receptor 
IPA 
 
isopropyl alcohol 
iPr 
 
isopropyl 
IQ 
 
complex I ubiquinone binding site  
IRA 
 
anionic ion exchange resin 
J 
 
joule 
K 
 
Kelvin 
L 
 
litre 
LC-MS 
 
liquid chromatography-mass specrometry 
LiHMDS 
 
lithium hexamethyldisilazide 
M 
 
Mole(s) per litre 
Me 
 
methyl 
MeCN 
 
acetonitrile 
mg 
 
milligram(s) 
MHz 
 
megahertz 
mL 
 
millilitre(s) 
mmol 
 
millimole(s) 
Mol 
 
mole(s) 
MP 
 
melting point 
MRC 
 
mitochondrial research centre 
Ms 
 
mesyl 
MS 
 
mass spectrometry 
mtDNA 
 
mitochondrial deoxyribonucleic acid 
NADH 
 
Nictoinamide adenine dinucleotide 
NHC 
 
N-heterocyclic carbene 
NMDA 
 
N-methyl-D-aspartate receptor 
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NMR 
 
nuclear magnetic resonance 
NOESY 
 
nuclear Overhauser effect spectroscopy 
NSI 
 
nanospray ionisation 
Nu 
 
nucleophile 
o- 
 
ortho 
OGDH 
 
2-oxo-glutarate dehydrogenase  
p- 
 
para 
Pd/C 
 
palladium on carbon 
PDH 
 
pyruvate dehydrogenase 
PEPPSI 
 
pyridine-enhanced precatalyst preparation stabilization and initiation 
PET 
 
photoinduced electron transfer 
PG 
 
protecting group 
Ph 
 
phenyl 
PMCA 
 
Plasma membrane Ca2+ ATPase 
Pt/C 
 
platinum on carbon 
RET 
 
reverse electron transfer 
Rf 
 
retention factor 
RNA 
 
ribonucleic acid 
ROS 
 
reactive oxygen species 
RT 
 
room temperature 
RyR 
 
Ryanodine receptor 
SERCA 
 
 sarco/endoplasmic reticulum Ca2+-ATPase 
SET 
 
single electron transfer 
SM 
 
starting material 
SN1 
 
monomolecular nucleophilic substitution 
SN2 
 
bimolecular nucleophilic substitution 
SNAr 
 
nucleophilic aromatic substitution 
SOD 
 
superoxide dismutase 
T 
 
temperature 
tBu 
 
tertiary butyl 
TEMPO 
 
(2,2,6,6-tetramethylpiperidin-1-yl)oxidanyl 
Tf 
 
triflyl 
TFA 
 
trifluoroacetic acid 
THF 
 
tetrahydrofuran 
TLC 
 
thin layer chromatoagraphy 
TMRE 
 
tetramethyl rhodamine ester 
TMS 
 
trimethylsilyl 
TMSCl 
 
trimethylsilyl chloride 
TPP 
 
triphenylphosphonium 
TS 
 
transition state 
UCP 
 
uncoupling protein 
UV 
 
ultraviolet (wavelength) 
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Chapter 1: Metabolism and the mitochondria 
1.1 Introduction to metabolism 
The etymology of the word ‘metabolism’ seems initially ironic; coming from the Greek ‘metabole’, 
meaning ‘to change’, the term encompasses the chemical reactions which sustain living 
organisms, allowing our cells and bodies to function consistently. In reality, however, the story of 
life is one of continuous chemical change; the order which characterises our construction is 
actively maintained through a constant balance of competing and intertwined processes. 
Ultimately we rely on the transformation of raw materials (food, air) to replenish our supply of 
chemical building blocks, and provide the energy to utilise these.1 Life fundamentally relies upon 
increasing entropy2,3 and avoiding equilibrium,4,5,6 and metabolism is the continuous process 
which makes this possible.7,8,9,10,11 
 
The complexity, interconnectedness and dynamism of cellular chemistry makes interrogating and 
understanding metabolic systems tremendously challenging. Some simplifying classifications can 
be used, however. Metabolic processes can be broken into subdivisions (Figure 1). ‘Catabolism’ 
refers to the conversion of organic molecules into lower energy products and capturing the 
energy liberated. ‘Anabolism’ refers to processes which use this energy to construct complex 
molecules from simpler building blocks, such as in protein construction in the endoplasmic 
reticulum. Collections of enzymes and other active biomolecules can also be assigned to 
‘pathways’, referring to their consecutive application to an initial substrate. 
 
Figure 1 - The linking of catabolic and anabolic processes. 
 
In order for the process of metabolism to work, an effective means of releasing and capturing 
energy and transporting it between these types of pathway must exist. In humans and other large 
organisms relatively diverse, complex chemical fuels such as proteins and lipids are broken down 
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into their subunits, supplying amino acids, fatty acids, mononucleotides and sugars.12 These are 
then transported to cells, where further metabolism occurs. 
1.2 The cellular organelles 
 
Figure 2 - Simplified schematic of a cell.13 
 
Each cell contains a large number of specialised compartments (Figure 2), or organelles, which 
segregate metabolic pathways and chemical environments. Anabolic processes such as the 
synthesis of DNA (Nucleus) and proteins (Ribosomes) occur at a variety of specific sites, allowing 
regulation of their chemical environment. The major catabolic processes occur within the 
mitochondria (Figure 3). 
1.3 Mitochondria 
 
Figure 3 - Basic mitochondrial anatomy, with the electron transport chain located in the inner 
membrane walls.14 
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Mitochondria are unusual organelles, and probably evolved from prokaryotic symbionts.15 They 
have their own DNA and RNA, along with the machinery required to produce some of their own 
proteins. On average typical animal cells have 1000 mitochondria, with up to 2000 found in some 
cells. They resemble bacteria in size and shape, and can be very mobile.16 The outer membrane 
contains a protein called porin, and is consequently permeable to molecules up to about 5000 
daltons in mass.17 The inner membrane by contrast is impermeable except where specific 
transport proteins are involved. This membrane has a highly convoluted structure made up of 
cristae, providing a large surface area. The surface area can vary between cells; a cardiac muscle 
cell mitochondrion has triple the cristae of an equivalent mitochondrion in a liver cell.16 Within 
the inner membrane is the matrix, a dense gel composed of up to 50% protein.18  
 
It is within the mitochondrial matrix that many of the major metabolic cycles found in animals 
occur, including the catabolism by which energy is acquired to sustain the chemical and physical 
processes carried out within eukaryotic cells. There are many complexities, variations and 
interlinked processes,19 but the key processes are remarkably conserved between organisms,20 
and can be simplified as described below (Figure 4). Carbohydrates and sugars are ultimately 
broken down to glucose and then further to pyruvate via glycolysis21 in the cytosol, producing 
adenosine triphosphate (ATP). ATP acts as an energy ‘currency’22 within the body by releasing 
energy via controlled degradation to either adenosine diphosphate (ADP) or adenosine 
monophosphate (AMP). Glycolysis also produces nicotinamide adenine dinucleotide (NADH), a 
redox active molecule which can transport high energy electrons. Within the mitochondria more 
ATP and NADH result from the oxidation of pyruvate to CO2, first through the pyruvate 
dehydrogenase complex to Acetyl CoA, then the Krebs cycle, with the electrons liberated being 
‘stored’ in NADH and FADH2 (flavin adenine dinucleotide). 
 
Figure 4 - The link between glucose and ATP.23 
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1.4 The electron transport chain 
The electron transport chain is the series of complexes in which enzymes allow electron transfer 
from NADH and FADH2 to carriers of successively lower energy, ending in reduction of cytochrome 
c. This complex is then re-oxidised by molecular oxygen to generate water.18 The energy liberated 
in these transfers is used to expel protons from the mitochondrial matrix, generating an 
increasing charge gradient (chemiosmotic potential) across the membrane until the energy 
required to expel protons against this gradient exceeds that produced by the reduction of oxygen 
with NADH (Figure 5).24 
 
 
Figure 5 - The electron transfer chain, with the green ‘water level’ showing the relative electron 
free energy.25 Adapted by permission from Macmillan Publishers Ltd: Nature reviews. Molecular 
cell biology Moncada, S.; Erusalimsky, J. D. 3, 214–20. Copyright 2002.  
 
The complexes of the electron transport chain are all embedded within the impermeable inner 
mitochondrial membrane, and allow electrons to move via a mixture of redox active mobile 
electron carriers such as ubiquinone and cytochrome c and quantum tunnelling between metal 
centres.26 The physical barrier is vital, preventing the proton concentration equilibrating across 
the membrane and so allowing different environments to be established in the intermembrane 
space and the mitochondrial matrix. The charge and concentration difference across the 
membrane acts as potential energy store. This proton motive force is comprised of a membrane 
potential of 160 mV a pH difference of approximately half a unit.27 This electrochemical gradient 
couples the catabolic electron transport chain to the anabolic process of regenerating ATP from 
ADP and AMP when it is used to drive ATP synthase in a process termed ‘oxidative 
phosphorylation’. 
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1.5 Oxidative phosphorylation 
Oxidative phosphorylation is catalysed by ATP synthase. This complex is highly conserved and very 
similar in form and function in all organisms in which oxidative phosphorylation occurs.28 The 
membrane bound F0 portion is associated with proton translocation, and the kinetic energy 
generated causes rotation of the F1 subunit in a clockwise manner, catalysing ATP synthesis 
(Figure 6, a).29 It is estimated that each molecule of ATP synthesised correlates to the 
translocation of 3-4 protons.30 The reversible action of ATP synthase allows it to pump protons 
back out of the mitochondria (Fig. 6, b) when the membrane potential has been disrupted. 
 
Figure 6 - The catalytic function of ATP synthase.31 
1.6 Mitochondria in ageing and disease: the importance of reactive oxygen species 
(ROS) 
Given the crucial nature of respiration and the important role played by mitochondria in signalling 
and homeostasis, it is unsurprising that mitochondrial dysfunction is implicated in many 
important medical conditions, including cancer,32 diabetes33 and mitochondrial myopathies such 
as ragged red fibre disease.34 However, many of the most important effects of mitochondrial 
dysfunction arise indirectly from the generation of reactive oxygen species (ROS). 
 
For many years it has been known that oxygen is both essential for life and toxic,35 for the same 
reasons. As a powerful oxidant it plays a fundamental role in being the final destination for 
electrons from the electron transport chain. Inevitably such a powerful oxidant is also capable of 
doing considerable damage within the cell. Oxygen levels within tissue are much lower than 
atmospheric concentrations, and the sites where it is reduced are highly evolved to contain 
dangerous radical by-products. Even so high concentrations reduce the lifespan of many species 
and oxidative damage in response to normal atmospheric concentrations is measurable. 
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 Oxidative damage is a major topic in biomedical fields, often implicated in degenerative diseases 
and illnesses associated with ageing,36 in addition to various cardiovascular illnesses.37 
Mitochondria are known to be a major source of reactive oxygen species (ROS), with many redox 
active centres and electron transfer components. Among the most common ROS are superoxide 
and hydrogen peroxide. Although among the less reactive oxidative species generated, both can 
be converted by redox active centres to the hydroxyl radical, which reacts with biomolecules at a 
nearly diffusion limited pace.38 
1.7 Free radical theory of ageing 
Proposed by Denham Harman in 1954, the free radical theory of ageing proposes that the gradual 
damage which constitutes the ageing process arises ultimately from oxidative damage. Harman 
extended this in 1972 to suggest that superoxide radicals generated in metabolism are 
responsible for the most damage, and that maximum lifespan is ultimately determined by the rate 
of damage to the mitochondrial DNA.39 The theory is difficult to prove or disprove conclusively 
and remains a matter of considerable debate, with attempts to provide definitive answers 
hampered by the complexities of the system studied and the limitations of the tools available to 
do so. 
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Chapter 2: Mitochondrial uncoupling and MitoPhotoDNP 
2.1 Mitochondrial uncouplers 
2.1.1 Endogenous uncouplers 
The term ‘mitochondrial uncoupling’ describes a mechanism which allows protons to leak across 
the membrane without passing through ATP synthase (therefore uncoupling proton influx from 
ATP synthesis, Figure 7). The transfer of a proton across the electrochemical gradient is 
accompanied by a loss of potential energy, and where this is not used to drive ATP synthesis such 
energy is released as heat.  
 
Figure 7 - The electron transport chain with (b) and without (a) uncoupling protein (UCP2) which 
allows protons to leak across the membrane.40 Adapted by permission from Macmillan Publishers 
Ltd: Nat. Rev. Neurosci. Andrews, Z. B.; Diano, S.; Horvath, T. L., 6, 829-40, 2005. Copyright 2005.  
 
Uncoupling is a naturally occurring phenomenon, and generating heat (hence maintaining 
homeostasis) is one important role. Another is to reduce the electrochemical gradient, and this 
impacts a range of other variables. The class of proteins involved (UCPs) have also been shown to 
be involved in fatty acid metabolism, insulin production and neuron function40 and are believed to 
have other roles.41 The uncoupling proteins have a specific role in regulation of the influx of 
calcium ions (an important signalling species within cells, Chapter 11) into mitochondria, via their 
ability to regulate membrane potential. By reducing mitochondrial membrane potential calcium 
influx is retarded or reversed and resulting cell death can be prevented.42 
 
Reduction of the membrane potential is also important in limiting generation of ROS. These are 
caused by electron leakage from the electron transport chain to nearby molecular oxygen, 
generating the superoxide radical (O2
.-) which is catalytically converted to a mix of molecular 
oxygen and hydrogen peroxide (H2O2). Superoxide (and hence hydrogen peroxide) formation is 
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dependent on membrane potential.43 Limited uncoupling as provided by the UCP proteins can 
therefore protect against oxidative damage (Figure 8). 
 
Figure 844 - Photomicrographs comparing tyrosine hydrolase neurons (green) wild type (a) and 
without UCP2 (b). ROS shown by red staining (ethidium, b). Higher exposure to the dye (c, d) 
compares wild type (c) with a transgenic cell containing human UCP2 (d). Republished with 
permission of the Society of Neuroscience from “Neurobiology of Disease Uncoupling Protein-2 Is 
Critical for Nigral Dopamine Cell Survival in a Mouse Model of Parkinson’s Disease”, Zane B. 
Andrews, Balazs Horvath, Colin J. Barnstable, John Elseworth, Lichuan Yang, M. Flynt Beal, Robert 
H. Roth, Russell T. Matthews, and Tamas L. Horvath, 25, 1, 2005. Permission conveyed through 
Copyright Clearance Center, Inc. 
  
A B 
C D 
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2.1.2 Synthetic uncouplers 
Uncoupling proteins are vastly complex proteins with very specific functions, but it is possible to 
reproduce the mitochondrial uncoupling with much simpler molecules. There are several 
mechanisms by which this can be done, and the simplest is direct proton cycling. The 
requirements are simple; the uncoupler must have a protonated form and a non-protonated form 
with a Pka close enough to 7 for a significant amount to be in the protonated form in the 
intermembrane space and the non-protonated form in the matrix. Any prospective uncoupler 
must also be able to cross the inner mitochondrial membrane in both its protonated and non-
protonated forms (so the non-protonated form should be uncharged or heavily delocalised) and 
prove resilient enough to have a sustained effect. Several of the most commonly used uncouplers 
are shown below (Fig. 9) 
 
Figure 9 - A selection of common mitochondrial uncouplers. 
 
Of the compounds shown (Fig. 9), 2,4-dinitrophenol 1 (DNP) is perhaps the best known. The 
compound itself is a weak lipophillic acid (pKa = 3.96),45 and is partially protonated in the space 
between the inner and outer mitochondrial membranes. Upon crossing into the matrix (resting 
pH ~ 8)46 the DNP is deprotonated, leaving a DNP anion 5 (Fig. 10). Aromaticity and conjugation 
with the nitro groups make the negative charge delocalised and diffuse, so it does not prevent the 
anion crossing the membrane. DNP uncouples directly via proton cycling and has a narrow 
therapeutic window, causing hyperthermia in the case of a large dose. 
 
Figure 10 - DNP uncoupling of mitochondria by proton translocation. 
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Carbonyl cyanide m-chlorophenylhydrazone (CCCP) 2 and carbonylcyanide-p-
trifluoromethoxyphenylhydrazone (FCCP) 3 are similar in both structure and function, with pKa of 
~ 6.0 and 6.2 respectively.47,48 In each case the acidic proton is the secondary amine attached to 
the aryl group. The deprotonation of CCCP 2 brings the entire molecule into conjugation, 
delocalising the charge over a large electronic surface and resulting in only a diffuse charge 
(Scheme 1). This allows CCCP- 6 to cross membranes.  
  
Scheme 1 - Charge delocalisation upon deprotonation of CCCP 2 to give CCCP- 6.49 
 
Butylated hydroxytoluene (BHT) 4, works somewhat differently from DNP and FCCP. At low 
concentrations BHT induced uncoupling is through interaction with adenine nucleotide 
translocase (ANT)50 through an unknown mechanism to uncouple the mitochondria. This pathway 
has a limited capacity, and produces weak uncoupling even when fully activated. This ANT 
dependent mechanism is not unique to BHT 4; benzoic acid uncouples only through this 
mechanism. DNP 1 and CCCP 2 appear also to activate this pathway but this is overshadowed by 
their proton cycling properties, which are far better than BHT 4 and mask the effects of the ANT 
pathway. At higher concentrations BHT produces additional uncoupling through the proton 
cycling mechanism used by DNP 1, CCCP 2 and FCCP 3. The effect of combining a poor proton 
cycler such as BHT with the ANT mechanism is to give concentration dependent uncoupling over a 
much wider range of concentrations.44 
 
Although the criteria for an effective uncoupler appear specific, some of these requirements 
(membrane permeability for polar molecules) are requirements of drugs in general, and 
compounds designed for other uses can act as uncouplers. DNP itself was not used for this 
purpose until many years after discovery,51 and nimesulfide,52 a non-steroidal anti-inflammatory 
drug, is another example. There are some possibilities for uncoupler design which better take 
advantage of the peculiar properties of mitochondria; in particular the membrane potential which 
drives ATP synthesis.  
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2.2 Targeted photoactivated uncoupler design 
Our aim was to use the membrane potential to target a caged uncoupler to the mitochondria and 
then release it by irradiation with light. Thus, combining mitochondria targeting and a photolinker 
could allow selective mitochondrial accumulation and photorelease of an uncoupler. This would 
allow a small dose of inactive caged uncoupler to accumulate at the mitochondrial membrane and 
then be selectively activated. The caged uncoupler could be useful for temporal and spatially 
resolved studies on the mitochondria with imaging techniques. DNP 1 was chosen as the 
uncoupler in the caged uncoupler MitoPhotoDNP 7 (Scheme 2); its advantages include its 
properties being well characterised, the compound stable and the uncoupling kinetics relatively 
simple. Targeting would be achieved using a lipophilic cation, and alkyltriphenylphosphonium 
group (TPP). Photoactivated release of a phenol from an o-nitrobenzyl linker is quite well known 
and efficient and the synthesis not intrinsically difficult. Therefore this photolinker was chosen on 
the basis that it should be easy to link with the other components of the molecule and o-
nitrobenzylic group is tolerant of a wide range of groups and substituents. An added advantage 
for both DNP and o-nitrobenzyl is that both have been used heavily in the past, potentially 
providing a lot of directly comparable data for both uncoupling studies and photocleavage. The 
TPP targeting group and the photolinker will now be discussed in detail. 
 
Scheme 2 - MitophotoDNP target 7. The caged uncoupler, o-nitrobenzyl linker and the TPP 
targeting group are colour coded. 
2.3 Lipophillic cations 
Cell membranes are composed of lipids, with polar groups on the surface interacting with water 
molecules and long saturated alkyl chains within the membrane. Simple membranes self-
assemble, as water-alkyl interactions are weaker than those between water molecules and 
charged groups or other water molecules, and so the molecules assemble in order to give the 
arrangement with minimal contact between water and lipophilic groups. Compounds added to 
the system will be found in equilibrium between the aqueous cytoplasm and hydrophobic 
membranes, with the position of this equilibrium determined by the properties of the compound. 
The equilibrium constant is expressed as a partition coefficient. A drug or probe will generally 
have to diffuse through several layers of each environment, so a compound which splits 
reasonably evenly between the two media is usually preferred for these. Because the probe 
molecules are diffusing in this manner they will generally be found in places other than their 
target, and this dispersion is accounted for in dosing.  
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If the drug or probe target is within the mitochondrial matrix or inner mitochondrial membranes 
then the charge gradient across the inner mitochondrial membrane provides an opportunity to 
concentrate compounds in the inner mitochondrial membrane or matrix.53 Cations that are able 
to diffuse across the inner membrane will accumulate in accordance with the Nernst equation.54 
The primary difficulty with such an approach is that highly charged or polar compounds often 
struggle to get through membranes, and molecules targeted at inner mitochondrial processes 
need to diffuse through a number of these. As such, a very hydrophilic compound is unlikely to 
reach its target. Fortunately charged groups with diffuse charges stabilised by resonance or 
induction have less favourable interactions with water and are therefore more lipophilic. 
Alternatively, cations could be attached to otherwise very hydrophobic groups or molecules in 
order to balance out the effect of the cation. These effects can be modelled as giving the ion a 
large hydrophobic surface.55 
 
Organophosphonium cations, particularly those with large lipophilic groups insulating the charge, 
are a good choice for targeting groups and there is literature precedence for use of 
alkyltriphenylphosphonium (TPP) groups for this purpose.56 Previous studies have shown that the 
phosphonium group itself integrates into the membrane surface, but is also able to travel through 
it (Fig 11).53 
 
Figure 11 - Potential energy diagram for a lipophillic cation crossing a membrane.53 Republished 
with permission of Annual Reviews, Inc, from “Targeting Antioxidants to Mitochondria by 
Conjugation to Lipophilic Cations”, Murphy, M. P., & Smith, 47, 2006 permission conveyed 
through Copyright Clearance Center, Inc. 
 
As a result concentrations on membranes surfaces are high but within the membrane the 
concentration is much lower, although a long alkyl chain between the charged head group and an 
attached drug may allow the active part of the drug to accumulate deeper in the membrane.53 
Bioactive organic molecules bearing TPP groups accumulate several hundred-fold in the 
mitochondrial matrix. Furthermore, one such compound, MitoQ, has been taken orally by 
patients in Phase II clinical studies for up to 1 year without problems, so TPP is well validated for 
biological use. 
2.4 Photolinkers 
The difficulty with such a targeting strategy is that the TPP ions will inhibit the proton cycling if 
attached to an uncoupler. This was an issue with MitoDNP 9 (Figure 12).50 One way to overcome 
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this problem is to use a connection between the two components which can be broken by specific 
stimuli. 
 
Figure 12 - MitoDNP50 
 
Selecting the stimulus in question is challenging; the mitochondria is integrated with the 
biochemical pathways of the cell in a vastly complex manner not yet fully understood and as such 
it is difficult to find a stimulus which will break up a linker without impacting surrounding systems. 
One strategy is to use a photolinker, which can be cleaved on application of relatively intense light 
of specific wavelength. A laser beam can provide the correct energy to a small area of the cell 
where the targeted uncoupler is present. The wavelength specific nature of photoexcitation 
means that cellular components caught within the beam are unlikely to be very badly damaged if 
the photolinker is designed to cleave at a wavelength different from those which excite groups in 
proteins, lipids and sugars. 
 
Design considerations for photolinkers are outlined by Adams and Tsein,57 for whom the following 
properties are vital: the attached molecule should be unreactive when linked (or ‘caged’), the 
molecule should be released in high yield and sufficiently quickly by wavelengths of light non-
detrimental to the biological system used, and any side products generated should be both 
unreactive and unable to interact with the biological system. A small selection of photolinkers 
extensively used are shown below (Fig. 13).  
 
Figure 13 - A large range of photolinkers are used.57,58,59,60 The selection presented is comprised of 
ortho-nitrobenzyl derivatives 10, the related DMNPE analogues 11, phenacyl ethers 12 and 
coumarins 13. 
 
Some common features are apparent; all have highly conjugated and mostly rigid structures. 
Either of these properties could be coincidental as rigid structures tend to be highly conjugated 
and vice versa, but in reality both are important. UV absorption (usually the wavelength region 
used for ease of handling) is typically high among conjugated, aromatic compounds, and a 
molecule with a rigid excited state will relax to ground state less easily due to Condon’s rule (the 
limited geometries available restrict transitions available into lower energy levels). Many of the 
molecules are polar and some have highly polar excited states. Most are incapable of acting as 
acids or bases under physiological conditions. This is good as pH dependence would greatly 
complicate calculations of quantum yield and effective use. 
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Probably the most commonly used photocleavable linker is the o-nitrobenzyl group, which is 
optimally excited at 265 nm. A number of variants exist with a benzylic proton replaced. A general 
scheme for the photocleavage of such compounds is outlined below (Scheme 3). 
 
Scheme 3 – General photocleavage of o-nitrobenzyl compounds.61 
 
The photoreaction starts with proton transfer to the nitro group in the excited state, at this point 
generating 2 geometrical isomers of the intermediate 15 if R and X are not identical. A proton is 
then transferred between the oxygens on the nitro group, giving E or Z aci-nitro intermediates 17 
which can be observed and distinguished from one another, before forming a cyclic 
benzisoxazoline 18. Both isomers then decay through cyclic state 18 into nitroso compound 19 
which loses X to form the carbonyl 20. 
 
o-Nitrobenzyl groups have several advantages, such as being compatible with the functional 
groups for which photolinker are commonly used,64 including primary amines which work poorly 
with other linkers. They are relatively easy to make and have reasonable photochemical 
properties,62 which are unfortunately influenced by substituent, pH, solvent polarity and a host of 
other environmental factors.55 A major advantage of these compounds is that their kinetic 
behaviour is relatively well understood and characterised. The disadvantage of o-nitrobenzyl 
derivatives is the undesirable reactivity of the nitrosobenzaldehyde products 20.63 DMNPE (11, R = 
Me) is an ortho-nitrobenzyl analogue with a longer photocleavage wavelength (365 nm), 
highlighting the impact of the methoxy groups adding electrons to the ring system. The release 
mechanism is analogous to that of other o-nitrobenzyl compounds. 
 
Phenacyl ester derivatives such as 12 (Fig. 13) are used specifically where a carboxylic acid 
cleavage product is desired, and produce these in good yield and purity with a range of 
substrates.64 These groups can also be used on phosphates65 to good effect. They display high 
solubility in water and have been used as a photolinker in biotin/avidin systems.66 4-
Methoxyphenacyl 12 is optimally excited at 280 nm, but can be excited at higher wavelengths.50 
High quantum yields are achieved for suitable substrates, and cleavage can be very fast.64  
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The final group listed in Figure 13 are coumarin based. Low quantum yields are observed for 
carboxylic acids, but results are reasonable for uncaging cAMP and cGMP,67 and amines can also 
be caged. Coumaryls can also be used to release sulfates,67 alcohols and diols. The advantages of 
coumaryl chromophores is the high wavelength absorption maxima which are very substituent 
dependent, but can extend into the visible region. The group also gives rise to a fluorescent by-
product, and gives fast release with the potential for two-photon excitation.  
2.5 Iodo MitoPhotoDNP 7-I synthesis 
 
Scheme 4 - Overview of the route to MitoPhotoDNP. 
 
The planned synthetic route to MitoPhotoDNP 7-I uses a convergent synthesis following previous 
work within the group (Scheme 4).68 The ortho nitrobenyl photocleavable group 22 (green) and 
the mitochondria targeting triphenylphosphonium salt 24 (blue) are prepared and linked to form 
phosphonium iodide salt 25-I prior to addition of the DNP uncoupling moiety to form 
MitoPhotoDNP iodide 7-I. Caroline Quin had previously prepared MitoPhotoDNP by the same 
route except that an alkyl bromide had been used instead of alkyl iodide 24.68 Her last two steps 
had suffered from low yields and more compound was required for testing. 
 
In my hands, the commercially available benzaldehyde 21 was reduced to benzylic alcohol 22 
using NaBH4 in MeOH in high yield (Scheme 5). 
 
Scheme 5 - Reduction of benzaldehyde 21. 
 
The TPP iodide targeting group and linker was synthesised by substituting an iodide from 1,4-
diodobutane 23 with triphenylphosphine, taking advantage of the poor solubility of charged 
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groups in PhMe to precipitate the TPP salt and give only the monosubstitution product 24 
(Scheme 6).  
 
Scheme 6 - Targeting group synthesis 
The phenol 22 and targeting group 24 were then coupled under basic conditions (Scheme 7) to 
give phosphonium salt 25-I. Initially coupling in MeOH was problematic, with the difficulty of 
separating multiple phosphonium salt products exacerbated by the product proving unstable on 
silica. Switching the reaction solvent to dry MeCN and increasing the number of equivalents of 
phenol 22 from 1 to 1.7 resulted in near quantitative coupling.  
 
Scheme 7 - Coupling of the photoactivated and targeting groups 
 
The final step of the synthesis was an SNAr comprising attack by the benzylic alcohol 25-I onto 1-
fluoro-2,4-dinitrobenzene 26 under mild conditions (Scheme 8).  
 
Scheme 8 - Addition of DNP uncoupling moiety. 
 
The 1-fluoro-2,4-dinitrobenzene substrate 26 is ideal for this reaction as the ortho and para nitro 
groups stabilise the transition state leading to the Meisenheimer complex intermediate. Since the 
initial nucleophilic addition to generate this intermediate is usually the rate determining step, the 
highly electronegative fluorine also stabilises the transition state leading to this formal carbanion. 
Three solvents were tested for this transformation, with acetone proving the most effective, 
giving high conversion. The low solubility of phosphonium salt 25-I hindering reaction in Et2O, and 
MeCN gave a complex mixture of side products. Chromatographic purification proved challenging, 
with the MitoPhotoDNP iodide 7-I eventually isolated in low yield. 
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2.6 MitoPhotoDNP Tetraphenylborate Salt synthesis 
Following the difficulties experienced with the iodide salt 7-I, the more crystalline 
tetraphenylborate salt was synthesised as an alternative (Scheme 9).  
 
Scheme 9 - Tetraphenylborate synthesis. 
 
The first two steps gave the same products as previously isolated by Caroline Quin. Using 
dibromobutane 27 substitution is significantly slower than using diiodide 23 due to the poorer 
leaving group but also higher yielding. The bromide 28 was coupled to phenol 22 to give alcohol 
25-Br then converted to the tetraphenylborate salt 25-BPh4 prior to DNP addition to give 
MitoPhotoDNP tetraphenyl borate salt 7-BPh4, which crystallised following column 
chromatography. Unfortunately Dr Murphy’s group in Cambridge showed that with this 
counterion MitoPhotoDNP is too hydrophobic and insoluble for uptake testing. 
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2.7 Alternate routes and variant compounds 
Several alternate routes were investigated to circumvent the purification difficulties experienced 
in the synthesis of MitoPhotoDNP iodide 7-I. The p-xylyl linker was considered on the assumption 
that the more rigid final product would prove easier to purify, and substitution at the benzyilc 
sites would be facile. Consequently, xylyl bromide 29 was converted into phosphonium salt 30. 
However a complex mixture resulted from the attempted coupling to the o-nitrobenzyl group to 
give triphenylphosphonium bromide 31 (Scheme 10). 
 
Scheme 10 - Attempted synthesis of more rigid p-xylyl derivative. 
2.8 Uptake Testing 
MitoPhotoDNP iodide 7-I was tested for mitochondrial uptake by the group of Dr Michael P. 
Murphy (MRC, Cambridge), with the results shown below (Figure 14). 
 
Figure 14 - Electrode response to the uptake of MitoPhotoDNP.  
 
The response of an electrode selective for the triphenylphosphonium cation69 is shown on the y-
axis. Using an appropriately buffered solution at pH 7.2 and 37 ˚C, five sequential additions of 
MitoPhotoDNP allowed calibration of a linear response. Next Complex I of the electron transport 
chain was inhibited by addition the of pesticide rotenone,70 which prevents development of a 
membrane potential in the rat liver mitochondria subsequently added. This means the decrease in 
electrode response can be attributed solely to MitoPhotoDNP accumulating by diffusion and 
partitioning into the membranes of the mitochondria. Succinate is then added to stimulate 
Complex II (succinate dehydrogenase), which is part of both the Krebs cycle and the electron 
Electrode Response (A.U.) 
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transport chain. This and bypasses the blockage of Complex I by rotenone. The electron transport 
chain begins to function and the electrode response then drops as most of the remaining free 
MitoPhotoDNP partitions into the mitochondrial matrix. The final addition of FCCP 3 (Fig. 3) 
uncouples the mitochondria eliminating the membrane potential, causing free MitoPhotoDNP 
concentrations to return towards the previous equilibrium position. The process is only semi-
quantitative and drift means that the minimum prior to addition of FCCP 3 and the restored levels 
following FCCP 3 addition are lower than expected. 
2.9 Effectiveness in cells 
Following the successful demonstrations of mitochondrial uptake a post-doc in the group, Dr 
Stuart Caldwell, developed an efficient route to the MitoPhotoDNP bromide. Susan Chalmers 
from the group of Prof. John G. McCarron then tested MitoPhotoDNP bromide salt 7-Br in colonic 
smooth muscle cells (Fig. 15). 
 
Figure 1571 - Photolytic uncoupling of mitochondria in a whole cell - colours are artificial. 
 
The cells were loaded with tetramethyl rhodamine ester (TMRE), a fluorescent dye which is 
dependent on membrane potential.72 Panel i shows the effect of brief UV laser irradiation (355 nm 
for 85 ms) in the absence of MitoPhotoDNP 7. 200 nM of MitoPhotoDNP 7-Br was added and 
allowed to equilibrate. The same irradiation protocol was then applied (panel ii), with a loss of 
TMRE fluorescence shown in red at the site of photolysis. Rotenone and oligomycin were added 
resulting in total depolarisation (panel iii). The cell without colouring is also shown (panel iv). 
These results (in conjuction with appropriate controls) proved the effectiveness of the probe, and 
the work was subsequently published.71  
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Chapter 3: Design of a selective, quantitative superoxide probe 
3.1 Types of small molecules probes used to study metabolism 
3.1.1 Introduction to different types of probe 
Limited information can be acquired from looking at the anatomy of cells, and the native chemical 
species are often engaged in multiple different pathways. The difficulties are exacerbated by the 
necessity of studying transient species and situations where a single species may engage in many 
processes dependent on timescale and concentration.73 The obvious solution to understanding a 
complex system is to break it down into smaller parts, such as single pathways or cascades. One 
way to do this is to induce effects via mechanisms alien to normal cellular chemistry, or to 
measure an artificial species known to behave in a particular way. In essence, this is the role of 
the small molecule probe. 
 
Various elaborate designs abound,74 and ‘chemical probe’ is a descriptive rather than prescriptive 
term so over definition must be avoided, but some categorisation is possible. In particular, the 
distinction should be made between probes used to validate drug targets75,76 and those used to 
interrogate cellular chemistry.74,77,78 The latter are the focus of the following discussion. It should 
be noted that the term ‘small molecule probe’ can apply to any species significantly below the 
masses of biological polymers such as protein and RNA strands, including some molecules which 
are very large by the usual standards of a synthetic chemist, and covers any conceivable sensing 
or reporting mechanism. Some general points can be made relating to their design nonetheless.  
 
There are two essential functions any such probe must display. These are sensing, the interaction 
which allows the species or phenomena being studied to be recognised by the probe, and 
reporting, any process by which a sensing event can be recognised by the investigator. 
Additionally, with the occasional exception79 the response of probes to stimuli can be described as 
reversible, as in the case of ion chelators, or irreversible, usually where a chemical bond is 
formed.  
 
Some of the same considerations applied in medicinal chemistry are important in probe design. 
Any probe intended to diffuse through the cytosol must have appropriate solubility, for example. 
Fortunately the requirements with respect to these properties are much less stringent than for 
drugs. Many probes are applied to cells or small fragments of organisms, and with techniques 
such as patch clamping not even membrane permeability is required. Toxicity is only a concern in 
so far as it occurs during the time course of the measurement. In order to reach the desired 
species on which it is to report a probe must have appropriate stability. Stability is contextual; a 
probe need only survive long enough to be useful. Often stability is related to selectivity for 
reaction with a particular species, especially in the case of irreversible reaction. However, 
selectivity might also be used to refer to different binding affinities for different ions. Kinetics is 
important and restricts the ability of the probe to report on dynamic and transient events. 
Sensitivity needs to be appropriate to the concentration of the species measured. Finally, in many 
cases it is desirable to localise probe distribution, to a particular compartment within the cell. To 
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better illustrate the interplay of these factors examples are described in the following sections 
(3.1.3 - 3.1.6). First, a brief explanation of fluorescence and associated phenomena is required. 
3.1.2 FRET, PET and fluorescence94,80 
Many probes use fluorescence as a reporting mechanism. Excitation is caused by absorption of a 
photon corresponding to the difference between ground and excited state energies, leading to 
the promotion of an electron between levels corresponding to molecular orbitals (Figure 16). 
Within these energy levels numerous rotational and vibrational levels exist. The ‘S’ and ‘T’ 
markers refer to ‘singlet’ and ‘triplet’, the spin states of the system, which are maintained on 
initial excitation. UV absorption results in the S0  Sx transition, with excitation to S2 or higher not 
forbidden. Fluorescence refers to a spin allowed relaxation to a lower energy state by emission of 
a photon through the lowest vibrational level of S1 to S0. This is because fluorescence is slow 
compared to relaxation through vibration or internal conversion. As the rate of stimulated 
emission is proportional to the cube of emission frequency, only relatively high energy transitions 
occur in this fashion, and so S2  S1 is less likely to be fluorescent. 
 
Figure 16 - Jablonski diagram. Reprinted by permission from Macmillan Publishers Ltd: Nature 
Methods, Lichtman and Conchello 2005, copyright 2005.80 
 
Figure 17 - The origin of absorption and emission ranges. Reprinted by permission from Macmillan 
Publishers Ltd: Nature Methods, Lichtman and Conchello 2005, copyright 2005.80 
 
Although fluorescent relaxation is from the lowest energy S1 level, higher vibrational or rotational 
energy levels may receive the electron prior to further non-radiative relaxation. Likewise, 
excitation can be to any rotational or vibrational level, and so a range of wavelengths are 
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absorbed and emitted, although each individual event corresponds to a transition of precise 
energy (Figure 17). 
 
Many of the same considerations relevant to photo uncaging groups (Section 2.4) apply also to 
fluorophore design. In particular, UV absorption energies usually correspond to π  π* 
transitions and so conjugated systems have the correct energies. Particularly in extended systems, 
the conjugation of multiple bonds allows absorption across more of the molecules’ surface. These 
traits lend rigidity, limiting both the overlap of other energy levels which might allow non-
radiative and limiting the excited state geometry available for such relaxation (see Section 2.4). 
 
Because relaxation can also occur rapidly through interactions with neighbouring molecules, 
fluorescence has extraordinary environmental sensitivity. This has both positive and negative 
impacts on its use for detection. In Figure 18 excitation of an electron from S0 32 to S1 transfers 
electron density to the nitrogen, delocalising the charge over 33. This excited species then forms 
hydrogen bonds with methanol giving a vibrational relaxation pathway which competes with, and 
quenches, fluorescence. The outcome of this competition, and hence the fluorescence quantum 
yield, is determined by the acidity of the solvent hydrogen bond. However, the emission 
wavelength is equally dependent on solvent hydrogen bond acidity and the dipolarity of the 
system. As a result both variables can be defined from the fluorescence spectra of the 
compound.94 
 
Figure 18 - Excitation of a fluorophore in a polar, acidic environment. Reproduced from de Silva et 
al.94 
 
Fluorescence resonance energy transfer (FRET) is a non-radiative energy transfer mechanism by 
which excitation can be passed from one chromophore to another in close proximity, so long as 
the emission spectra of the excited donor overlaps with the absorption spectra of the acceptor 
(Figure 19).81 The distance dependency is r-6, so such mechanisms can be activated by a stimulus 
which changes the conformation of the molecule, giving a dramatic ‘turn on’ effect. They can also 
be used to modulate the wavelength of eventual emission. The first fluorophore can be common 
among a set of probes, allowing all to be excited simultaneously but with different subsequent 
emission wavelengths.82 
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Figure 19 - A typical FRET system, with the required overlap marked by the arrow. Reproduced 
with permission from Sapsford et al.83 
 
Photoinduced electron transfer (PET) is a common quenching mechanism utilised in probe design 
(Figure 20).94 Excitation promotes an electron from the fluorophore HOMO into the fluorophore 
LUMO. An electron can then be transferred into the fluorophore HOMO from the PET donor 
HOMO, preventing radiative relaxation into the fluorophore HOMO. Changing the energy levels in 
such a way as to either make transfer from the donor HOMO geometrically impossible or reducing 
the energy of this level to make transfer unfavourable will remove the quenching mechanism and 
allow fluorescence. 
 
Figure 20 - PET mechanism. Adapted from de Silva et al.94 
 
For a successful probe the fluorescence emission must change upon the sensor portion 
interacting with the target species. There are 2 changes likely, change in emission wavelength and 
change in brightness, and ideally both are desirable. A change in emission or excitation 
wavelength allows activated and unactivated forms to be separately imaged, and so be observed 
more accurately, a process referred to as ratiometric imaging. An increase in brightness on 
binding is preferred: a decrease in brightness also works in principle but in practice the sensitivity 
of such probes is more limited. Increased brightness helps maximise spatial resolution with light 
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microscopy, and is also important in order to minimise the quantity of dye required (and hence 
any disruption it may cause). 
3.1.3 Reversible sensing of an abundant endogenous species: Calcium green 
FlAsH88 
The first example of a chemical probe involves sensing a vital and abundant species in living cells. 
The pivotal role of Ca2+ ions within and between cells is detailed later (Chapter 11), but for the 
present it is sufficient to understand that it is among the most vital of signalling species, and that 
transient, localised variations in [Ca2+] are crucial cellular events. Numerous probes exist for the 
purpose of calcium imaging,84,85 and green flash (Figure 21) was designed specifically to report on 
transient microdomains of high calcium concentration.86,88 The arsenic groups allow selective 
binding to a tetracysteine sequence expressed in specific proteins known to occur close to the 
phenomenon studied. The soft Lewis acid arsenic atoms bind strongly to the soft Lewis base sulfur 
atoms of cysteine, and strong binding and selectivity are achieved through the chelate effect, 
resulting in nearly all expressed tetra cysteine moieties binding fluorophore. Prior to binding the 
free arsenic groups quench fluorescence through either vibrational relaxation or photoinduced 
electron transfer (PET),87 and so the restriction on movement and orbital geometry provided by 
tethering results in a four-fold increase in fluorescent emission, allowing successful tethering to 
be confirmed. Binding to Ca2+ then causes a further ten-fold increase in fluorescence, presumably 
restricting one or both of the aforementioned quenching mechanisms in the upper, ion chelating 
portion of the molecule. Lastly, excitation (488 nm) and emission (approx. 540 nm) are at 
wavelengths where few biomolecules absorb.  
 
Figure 21 - The bound, active form of the calcium green FlAsH probe.88 The coordination sites are 
shown in green (APTRA) and red (modified).  
 
The calcium ion sensor component is based on the APTRA pentacoordinate magnesium chelator,89 
known to have low calcium affinity. A carboxylate was replaced with a morpholine amide, 
reducing the Lewis basicity of the coordination site to improve selectivity over Zn2+ (Kd = > 10 
mM). Low affinity (Kd = 100 µM) means a greater range of [Ca
2+] can be distinguished prior to 
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saturation, and fast dissociation kinetics allows resolution of multiple events within a short time 
frame (Figure 22).  
 
Figure 22 - The dynamic response range (A) and response times (B) demonstrate how low binding 
affinity produces ideal properties for measuring rapid concentration variations in an abundant 
species such as Ca2+. Adapted by permission from Macmillan Publishers Ltd: Nature Chemical 
Biology, Tour, O.; Adams, S. R.; Kerr, R. A.; Meijer, R. M.; Sejnowski, T. J.; Tsien, R. W.; Tsien, R. Y. 
3, 423–431, copyright 2007. 
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3.1.4 Irreversible sensing of a toxic species at low concentration: Rhodamine based 
mercury probe 
Quite different properties are desirable in a mercury probe. Where Ca2+ is ubiquitous and vital, 
Hg2+ is scarce and deadly. When looking for a rare species, an irreversible sensing approach is 
often desirable, allowing the reacted form concentration to build up over time and so improve 
detection. This is especially true in the case of an ion like mercury which does not perform a 
useful role; generally the role of a probe is to confirm the presence of Hg2+, rather than 
investigate its interactions. Fine tuning kinetics and providing mechanisms to localise the probe is 
not especially important; selectivity and sensitivity become much more so, and stability and 
toxicity concerns may be greater if longer observation periods are required. Several rhodamine 
based probes90,91 utilise cyclisation of thiosemicarbazide groups driven by the affinity of mercury 
for sulfur (Scheme 11). Mercury preferentially bonds with the thiocarbonyl following coordination 
in 36, increasing reactivity towards the favoured 5-exo-trig cyclisation from the amide, which is 
activated by the α effect. Desulfurisation is then driven by the aromaticity of the furan product 
38. 
 
Scheme 11 - The mechanism of the Hg2+ sensing desulfurisation reaction. 
 
Figure 23 - Fluorescence of zebrafish before (left) and after (right) addition of HgCl2. Adapted from 
Ko et al, J. Am. Chem. Soc., 128, 43, 2006.90 
  
The applications of the probe are reflected in design elements; the non-fluorescent to fluorescent 
transition limits quantification accuracy but improves contrast, and the rhodamine dye has strong 
absorbance and high quantum yield (φf = 0.52),
 making rhodamine 38 detectable at 2 ppb.74 With 
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an emission maximum of 577 nm biomolecule absorbance of the emission is negligible. Figure 23 
also demonstrates that the probe equilibrates through the organism, and as xanthene 35 is stable 
from pH 4-14, it should be active in virtually all cellular environments. The cyclisation used is 
selective for Hg2+, and the probe gave minimal responses in the presence of other metal ions. 
3.1.5 Irreversible sensing of a low abundance species: Dicarbonyl hydrogen 
peroxide probe 
H2O2 is less ubiquitous than Ca
2+ but of more subtle effect than Hg2+. The most obvious reactivity 
of H2O2 is as an oxidising agent, a property shared by other ROS. Another property is used to 
distinguish it from other ROS. Many ROS are radicals, and less nucleophilic than the conjugate 
base of H2O2. The combination of high nucleophilicity and the presence of a hydroxide leaving 
group in H2O2 is exploited for selective detection. One fluorescein probe
93 uses the rapid Baeyer-
Villiger reaction of benzil moieties92 followed by hydrolysis to generate a fluorescein with a high 
quantum yield (φf = 0.8), and long excitation (495 nm) and emission (525 nm) wavelengths 
(Scheme 12). The standout feature of this probe is a 150-fold increase in brightness from benzil 39 
to fluorescein 40. While fluorescence and quenching observation is often serendipitous, in this 
case some rationale is given for the design: the reduction potential of the benzil group suggests a 
LUMO low enough to undergo donor PET quenching (Section 3.1.2) from the excited 
fluorophore.93  
 
Scheme 12 - Activation of the fluorophore by H2O2.
93 The benzil moiety is marked in red. 
 
Figure 24 - Selectivity of probe 39 for hydrogen peroxide over other common ROS. Reproduced 
from Abo, M.; Urano, Y.; Hanaoka, K.; Terai, T.; Komatsu, T.; Nagano, T. J. Am. Chem. Soc. 2011, 
133, 10629–10637. 
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Reasonable kinetics are also required as H2O2 is created and destroyed both regularly and in a 
localised fashion, and a moderate rate (k = 4.2 x 10-3s-1, pseudo-1st order with 1000 fold excess of 
H2O2) was ideal as it does not disturb the steady state H2O2 concentration by competing with 
endogenous processes. The probe also reacts with alkylhydroperoxides and peroxynitrite (Figure 
24), although the latter is a product of H2O2 and NO, and so the reaction could be considered an 
indirect measurement of H2O2. Fortunately, H2O2 is far more abundant than these species so the 
error induced by these side reactions is insignificant. 
3.1.6 A targeted, quantitative and non-fluorescent hydrogen peroxide probe 
The three previous examples provided all report by means of fluorescence. There are major 
advantages to this approach; numerous fluorophores are well characterised and often 
synthetically easy to obtain, it is non-invasive and extremely sensitive, simple experiments are 
(relatively) easy to do, and the output is visual, intuitively understandable, and gives dynamic 
responses and spatial distributions. For all these reasons and others most biological probes rely 
on fluorescence. As demonstrated previously however, the ideal properties of a probe are 
dependent on the measurement required, and fluorescence has drawbacks. In particular, it is 
extraordinarily sensitive to environmental factors,94 and the cell is an extremely complex 
environment. Basic fluorescent measurements do not therefore allow quantification. Ratiometric 
probes can ameliorate some of the difficulties (Chapter 11), but a truly ratiometric probe is a non-
trivial undertaking, and not a complete solution. Additionally, isolated mitochondria are known to 
be of limited comparative value when seeking to understand physiological systems (see Section 
3.2). It is therefore necessary to examine the whole organism at once, which is not usually 
possible with optical techniques due to limited penetration. Where accurate quantification rather 
than spatial information is the goal alternatives to fluorescence should be considered. 
 
 One technique offering better quantification is LC/MS/MS, which was utilised for H2O2 
quantification using MitoB, a probe developed and synthesised by the Hartley group and tested 
by the Murphy group at the MRC in Cambridge. The use of this probe is summarised in Figure 25. 
The arylboronic acid is attached to a triphenylphosphonium targeting moiety, which increases 
mitochondrial accumulation as described in Section 2.3. In drosophila calculations suggested 90% 
of the probe was within cells, and 98% of the cellular probe was within mitochondria.95 The 
boronic acid from MitoB is then selectively attacked by the hydroperoxide anion,96 which reacts 
substantially faster than H2O2, and is more prevalent within the mitochondrial matrix due to its 
higher pH in this environment. This results in four-fold faster conversion within the mitochondrial 
matrix versus the cytosol at the same concentration. Between the accumulation and preferential 
reaction of MitoB 41 the resulting MitoP/MitoB ratio is substantially indicative of mitochondrial 
H2O2 concentrations, with an error comparable with those inherent in such experiments 
regardless of detection method. 
 
MitoB 41 and mitoP 42 diffuse freely across membranes95 and so can be administered to whole 
organisms and the MitoB/MitoP ratio determined by extraction and extrapolated to quantitative 
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data, with deuterated analogues of both added to the homogenised organism to correct for 
detection variations. The cationic nature of the probes improves mass spectrometry detection. 
 
 
Figure 25 - The application and quantification of MitoB, reproduced with minor modifications 
from Cochemé, H. M.; Quin, C.; McQuaker, S. J.; Cabreiro, F.; Logan, A.; Prime, T. a; Abakumova, I.; 
Patel, J. V; Fearnley, I. M.; James, A. M.; Porteous, C. M.; Smith, R. a J.; Saeed, S.; Carré, J. E.; 
Singer, M.; Gems, D.; Hartley, R. C.; Partridge, L.; Murphy, M. P. Cell metabolism 2011, 13, 340–50. 
3.2 Reactive oxygen species 
3.2.1 What to measure? 
Following the success of MitoB, my research involved using the same approach to measure 
another ROS, superoxide. Before describing the design of the probe it is necessary to consider the 
context, specifically to look in more detail at the generation and role of ROS. 
 
The term ROS originally referred to a handful of oxygen-containing radicals, but the list of 
chemical species included has lengthened as it has become apparent that the sequences of 
biological reactions related to these radical species is very complex and often interlinked. The 
greater understanding of the cellular chemistry has resulted in a broadening of the definition to 
the point where both non-radicals and non-oxygen containing species are regularly described as 
ROS.97 Many researchers working in the area are now suggesting that, if the term itself has not 
outlived its usefulness as a descriptor it is not specific enough to describe a target of study.98 
There are several reasons for this; one is that the term has now expanded to cover a range of very 
distinct chemical species with different specificity, different levels of reactivity and sometimes 
generated in different places. Therefore attributing an outcome to ROS is a poor description of 
A 
B 
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the likely actual pathway. Secondly, some ROS are now known to be useful or indeed essential, 
such as nitric oxide or H2O2, for signalling.
99 
 
Broadly the term ROS covers species that are capable either of causing oxidative damage or being 
converted by redox chemistry to a species which can do so. The majority of these species come 
from chain reactions initiated by superoxide,100 and the radical chain generated from a single 
superoxide radical may span thousands of events.106 The full details of the interactions of the 
myriad of ROS are both extremely complex and a matter of ongoing study but for the purposes of 
this summary the basics may be shown diagrammatically (Figure 26). 
 
 
Figure 26101 - This image was originally published in Biochemical Journal. Murphy, M. P. 2009. 
How mitochondria produce reactive oxygen species; Biochemical Journal, 417, 1-13 © Portland 
Press Ltd. 
 
A rough summary is as follows. The respiratory chain generates various ROS through initial 
production of superoxide. These ROS can then damage lipids, DNA and enzymes and cause cell or 
tissue death, being implicated in over 100 human or animal diseases.106 However, some of these 
species also play an important role in cellular signalling pathways. Some 90% of ROS originate in 
the mitochondria,102 and many are too short lived to diffuse significantly (Figure 27). 
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Figure 27 - Maximum diffusion distances estimated for various ROS within the cell.103 
 
Ideally biomarkers could be used to observe the effects of oxidation, and this is a common 
approach. Increasingly, however, it has been realised that the role of some ROS is considerably 
more complex than initially surmised, and may in fact signal stress and mobilise protective 
responses in some cases.104 Furthermore, some common biomarkers have been specifically shown 
to be problematic. For example, lipid peroxidation may be as much a measure of the antioxidant 
defence as anything else,106 and similarly protein carbonylation represents protein turnover 
rates.104 
 
An alternative would be to quantify the species causing individual types of oxidative damage 
events, but in many cases the terminal oxidant is the extremely reactive hydroxyl radical, which 
has the highest reduction potential of any known oxygen-centred radical (+2.31 V). This has an 
extremely low steady-state concentration owing to its ability to react at essentially diffusion 
limited pace with virtually any biomolecule,105 meaning there is almost nothing to measure and 
the terminal oxidation is hardly selective anyway. Other species such as hydroperoxyl and 
alkylperoxyl radicals are also capable of causing damage by lipid peroxidation, but these are 
difficult to distinguish from each other and transient themselves.106 Instead, the precursor to 
these reactive species, superoxide, was considered. This can lead directly to the hydroxyl radical 
via iron catalysed Haber-Weiss and Fenton chemistry (Scheme 13). 
 
 
 
 
 
 
While still difficult, it may be possible to measure superoxide. Superoxide is the product of one 
electron reduction of the diradical107 O2, which has two partially filled degenerate orbitals and 
correspondingly accepts only one electron at a time,101 into an antibonding orbital.106 Although the 
standard reduction potential for this process is negative, superoxide formation is favourable 
under physiological conditions due to the relative concentrations of O2 and O2
.- within the matrix, 
where tentative estimates suggest a superoxide concentration of 10-200 pM.101 Superoxide is 
relatively unreactive, (although capable of damaging some Fe-S clusters),38 but matrix O2
.- is 
Scheme 13 - Haber-Weiss and Fenton iron catalysed hydroxyl radical formation from H2O2 and O2
.- 
(a) Fe3+ + O2
.-  Fe2+ + O2 
(b) Fe2+ + H2O2  Fe
3+ + .OH + -OH 
(c) Overall reaction: H2O2 + O2
.-
  
.OH + -OH + O2 
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limited by superoxide dismutase, an enzyme which converts the radical into H2O2 extremely 
rapidly (k is approx. 2.3 x 109 M-1 s-1), a consideration not factored into the diffusion radius shown 
in Figure 27. When the effect of SOD, antioxidants and other defense mechanisms are considered 
alongside the difficulty of anionic superoxide crossing the inner mitochondrial membrane, 
multiple recent reviews have concluded that significant O2
.- efflux from the matrix is 
improbable.108,106 Since oxidative damage to mitochondrial DNA is postulated to be the limiting 
factor on human longevity according to the free radical theory of ageing, investigations can be 
limited to superoxide in the mitochondrial matrix. There is not currently any way of measuring 
matrix superoxide production or accurately determining its steady state concentration in the 
matrix of living organisms.101 
3.2.2 How is superoxide produced? 
Several sources of superoxide are known to exist within the mitochondrial matrix (Figure 28), 
although the mechanisms and extent of their activity under physiological conditions is poorly 
understood.109,110 
 
Figure 28111 - The maximal rates of superoxide production at different sites in the mitochondria. It 
is not clear to what extent all of these are active in vivo. Superoxide production sites are pyruvate 
dehydrogenase (PDH), 2-oxo-glutarate dehydrogenase (OGDH), complex I NADH binding site (IF), 
complex I ubiquinone binding site (IQ), electron transferring flavoprotein ubiquinone 
oxidoreductase (ETFQOR), glycerol 3-phosphate dehydrogenase (GPDH) and complex III outer 
ubiquinone binding site (IIIQo). 
 
The best understood of these are within the electron transport chain (see Section 1.4). Complex II 
produces superoxide in specific experimental conditions but is not believed to produce significant 
quantities in vivo, while the affinity of complex IV for partially reduced oxygen prevents escape of 
superoxide.108 Complexes I and III are capable of superoxide production. An exhaustive description 
of these complexes is unnecessary, but as superoxide formation by complex I has been discussed 
in detailed reviews,101,112 a brief outline of the process is provided for illustrative purposes. 
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Figure 29 - The structure of mitochondrial complex I. The lower portion containing the antiporters 
is within the inner mitochondrial membrane. A hydrophilic arm points into the matrix. This 
contains the seven Fe-S clusters which compose the internal electron transport chain of Complex 
I. The NADH oxidation site (IF) has a flavin cofactor and is furthest from the membrane, while 
terminal ubiquinone reduction site N2 (IQ) is only 20 Å from the membrane. Republished with 
minor alterations with permission of Annual Reviews, Inc, from “Mitochondrial Complex I”, Hirst, 
J. 82, 2012 permission conveyed through Copyright Clearance Center, Inc. 
 
The reduction of oxygen to superoxide is believed to occur through an outer sphere mechanism, 
and so proximity is required. Only the entry (IF) and exit (IQ) of the complex I electron transport 
chain are accessible, as the Fe-S clusters are protected by the complex proteins (Figure 29).  
 
The binding of NADH to the flavin (IF) at the peak of the complex I electron chain as drawn results 
in hydride transfer between the two, giving NAD+. Binding and transfer is extremely rapid and 
reversible, with electron transfer by quantum tunnelling also extremely quick, and the rate 
limiting step is reduction of the ubiquinone at the lower energy site (IQ). It is possible to treat 
NADH/NAD+ binding and hydride transfer as a pre-equilibrium, with the ratio essentially setting 
the relative levels of oxidised and reduced flavin. Superoxide production is favoured by a high 
NADH/NAD+ ratio, as a greater proportion of IF sites are reduced and so able to reduce oxygen in 
turn. Interestingly, increasing the absolute NADH concentration rather than changing the 
NADH/NAD+ ratio inhibits superoxide production by preventing access to the flavin site (oxygen 
reduction is very slow compared to NADH hydride transfer).  
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Scheme 14 - Reduction of ubiquinone at site IQ. The reverse oxidation process occurs under 
reverse electron transfer (RET) conditions.  
 
Until recently it was suspected that IQ was also a significant superoxide source, as shown in Figure 
28. This was considered to be particularly relevant during Reverse Electron Transfer (RET), where 
the mitochondrial chemiosmotic potential is sufficiently high to drive reverse transfer from a pool 
of ubiquinol (the reduced form of ubiquinone, Scheme 14) up the complex I electron transport 
chain. The absence of ubiquinone to react with the reduced N2 cluster would allow oxygen to do 
so instead. Underlining the developing nature of our knowledge of this area, recent evidence113 
appears to discount IQ as a superoxide source, showing superoxide reduction even under RET 
conditions occurs via the IF flavin. 
 
The above description gives only a very simplified outline of the current understanding pertaining 
to complex I superoxide production. As the literature related to superoxide production is 
extremely extensive and the topic only tangentially related to the work undertaken no further 
description of superoxide production is attempted here, but may be found in both the recent 
reviews referenced throughout this section and in several others.114,115 
3.3 Designing a probe for matrix superoxide quantification in whole organisms 
3.3.1 What tools are available? 
Several of the previously cited reviews explicitly emphasise the need for more information on 
superoxide, in fact our ability to quantify this species in the matrix under physiological conditions 
is very limited.101 Most studies purporting to measure superoxide do so indirectly by measuring 
another species, usually H2O2. In many cases this is likely sufficient, but several assumptions are 
required. These include assuming that effectively all superoxide is converted to H2O2, and that all 
H2O2 comes from superoxide within the matrix (or at least that we can accurately correct for side 
reactions), and that no significant H2O2 degradation occurs prior to measurement.
101 We know 
that all three of these assumptions are certainly incorrect at least some of the time.116,117,118 This 
does not of course mean that measuring H2O2 as an indicator of superoxide levels is invalid; in 
many cases it will likely give accurate data, but given our limited understanding of the 
mitochondrial matrix under physiological conditions it would be beneficial to measure the species 
of interest directly. In this respect many tools relying on specific damage markers are similarly 
limited by our understanding of their native roles and interactions. For example, when using 
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aconitase oxidation as a marker it should be noted that the iron released will take part in Fenton 
chemistry and modify the ROS balance present.119 
 
Some tools for the direct measurement of superoxide do exist, and understanding the limitations 
of these is important in identifying new approaches to the problem. Many of the approaches have 
been reviewed120 and the good and bad points of various detection schemes detailed. It is 
sufficient to note here that generally these approaches either display low selectivity or are very 
obviously unsuitable for in vivo application. A small selection of alternative superoxide probes are 
listed in a more recent review.121 All rely on optical approaches, which limits the tissues in which 
they can be utilised. As mentioned earlier (Section 3.1.5), use of fluorescence as a quantification 
tool is limited by environmental sensitivity. In addition, the possibility of reabsorption of emitted 
photons by nearby probe molecules is relevant where selective uptake strategies could result in 
high local probe concentrations. Because of the limitations of the reporting technique, the 
compounds described in the following section are unsuitable for quantification of superoxide 
levels in a whole organism in vivo. However, the details of their function, and particularly their 
sensing moieties, can be used to design an alternative probe to do so. 
3.3.2 A selective, oxidation resistant, ‘turn on’ fluorophore: Hydrocyanine dyes 
The hydrocyanine probes developed by Murthy and coworkers122 (Scheme 15) feature an 
extended conjugated system in the oxidised cyanine form 44, which can be disrupted by 
reduction. The reduced form 45 is able to diffuse through membranes as it is uncharged. 
Subsequent oxidation by ROS results in a strongly fluorescent, membrane-impermeable probe.  
 
Scheme 15 - Interconversion of cyanine 44 (oxidised) and hydrocyanine 45 (reduced) by NaBH4 or 
superoxide respectively. 122  
 
Cyanines 44 have several advantages as fluorophores. The extended conjugated system in the 
more fluorescent form 44 gives a long wavelength, low energy excitation (535-750 nm) and 
emission (560-830 nm), with the exact values dependent on the analogue used. The hydrocyanine 
form 45 is only weakly fluorescent, with oxidation producing a 100-fold increase in fluorescence 
intensity. The reduced moiety is quite resilient to auto-oxidation in aqueous environments, which 
is attributed to a lower driving force for oxidation compared to ethidium based probes (Section 
3.3.4), for which this can be a limitation. Reasonably good selectivity for superoxide is reported 
(Figure 30) and believed to arise from two consecutive one electron oxidations. Importantly low 
reactivity with H2O2 is observed. Significant side reactions have been reported with 
indiscriminately reactive species such as the hydroxyl radical, but this is present only in 
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vanishingly low concentration (see Section 3.2.1). These probes are sensitive to nanomolar levels 
of radical oxidants. 
 
Figure 30 - The selectivity of Hydro-Cy3122 for various ROS. Republished with permission from 
Kundu et al.122 ©2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 
3.3.3 A ROS sensitive chemiluminescent probe: KEIO-BODIPY-KBI 
An alternative to fluorescence as an optical reporting tool is showcased in Suzuki and 
coworkers’123 chemiluminescent probe 46 for ROS. The energy emitted in this case is liberated by 
oxidation of the probe itself,124 so no external stimulation is required. The chemiluminescent 
group was linked to an additional BODIPY fluorophore, with the idea of allowing transfer of 
excitation through chemiluminescence resonance energy transfer (CRET), which is functionally 
identical to FRET (see Section 3.1.2). Longer wavelength emission from the fluorophore is then 
less likely to be absorbed by biomolecules. This was the strategy originally pursued, but the probe 
synthesised emitted at a higher wavelength (545 nm) than the BODIPY fluorophore used, and so 
the emission was attributed to the whole probe acting as a single chromophore, exhibiting a 
strong response under superoxide generating conditions.  
 
Scheme 16 - The chemiluminescent reaction of KEIO-BODIPY-KBI probe 46. 
 
High specificity is claimed but not fully demonstrated for this probe. The reported response to 
H2O2 was relatively strong, although this was attributed to the higher concentration of this oxidant 
under test conditions. A lower response was observed in the presence of catalase, which destroys 
H2O2, suggesting a 30:1 selectivity for superoxide over H2O2 assuming direct comparison is 
possible.  
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3.3.4 Unusual product selectivity and a targeted probe: MitoSOX 
The use of hydrophenanthridines as probes is not an especially recent development. The parent 
phenanthridinium salts had long been used for a variety of purposes (see Section 8.1.1), and 
ethidium was known to undergo metabolic interactions in vivo in the 1970s.125 By the mid 1980s 
oxidation of hydroethidine 48 (Scheme 17) was being used to infer the redox conditions in 
different areas of the cell.126 This oxidation was attributed to ROS in 1990, with sensitivity to both 
H2O2 and O2
.- observed.127 In 2003 Kalyanaraman and coworkers observed during a study on redox 
sensitive dyes that superoxide addition appeared to lead to a different product to that produced 
from reaction with H2O2, hydroxyl radicals, peroxynitrite, cytochrome c and nitric oxide, although 
the actual structure was unknown.128 Later work clarified the structure129 and suggested a 
possible mechanism for this oxidation,130,131 shown in Scheme 17 and described below. 
 
Scheme 17 - Oxidation of hydroethidine 48 makes both ethidium 51 and 2-OH-E+ 55.130,131 
 
One electron oxidation of hydroethidine 48 gives aminyl radical 49 or radical cation 50, which can 
interconvert via gain or loss of a proton. This rate of this initial step varies with oxidant and may 
be very fast, but is usually rate determining. Further one electron oxidation gives the parent 
ethidium 51. Alternatively, in the presence of O2
.- extremely rapid (k approx. 2 x 109 M-1s-1)131 
reaction with another O2
.- produces peroxy adduct 52, with water subsequently lost to form 
iminyl-quinone 53. Tautomerisation, possibly via a reaction with a hydride donor or acceptor130 
gives phenoxide 54, which is strongly favoured by the formation of an extended aromatic system. 
The conjugated, electron poor phenoxide 54 has a pKa of 7.4 and the protonated 2-
hydroxyethidium (2-OH-E+) 55 and deprotonated form 54 are roughly equal in concentration 
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within the cell. Two equivalents of oxidant are required in this pathway, however as many species 
can perform the original oxidation and O2
.- is present at low concentrations, it is reasonable to 
assume that one superoxide radical gives one molecule of 2-OH-E+ 55 under physiological 
conditions. 
 
The key advantage of this mechanism is that extensive testing suggests that oxidation of 
hydroethidine 48 produces the 2-OH phenanthridinium product (2-OH-E+) 55 only in the presence 
of O2
.-.132,133 This selectivity is vital in detecting a species present only at low concentration. The 
Kalyanaraman group went on to suggest the red-shifted fluorescence of 2-OH-E+ 55 relative to 
ethidium 51 could be used to distinguish the two,130 and add a TPP cation to the end of a hexyl 
analogue to give MitoSOX 56 and ensure targeting to the mitochondria (Fig. 27). They abandoned 
this position on fluorescent quantification when it became clear that numerous fluorescent 
oxidation products were generated and interfered with quantification, and that the 
hydroethidium moiety was light sensitive, instead embracing HPLC quantification approaches.134 
Various other detection methods exist,132,134 some of which may give sensitivity down to the atto 
molar level.135 
 
Scheme 18 – The reaction of MitoSOX with superoxide gives rise to a product variously identified 
as the 2-OH phenanthridinium 57 or the 9-OH phenanthridinium 58. 
 
Beckman and coworkers attempted to use lower wavelength excitation to measure selectively 
superoxide formation in the mitochondrial matrix with MitoSOX.136 Uptake and release in 
accordance with the membrane potential was demonstrated and the identity of the superoxide 
addition adduct was disputed. Beckman and co-workers claim the 9-OH analogue is produced, 
although it is labelled as the 2-OH compound, perhaps due to confusion surrounding the naming 
convention on phenanthridines. The different regioisomers have both recurred in the literature 
since, probably obscured by the related misnaming, and this uncertainty is further addressed in 
Chapter 10. Later work by the Beckman group uses MitoSOX for live cell imaging.137 
 
When the creation of a mass spectrometry probe analogous to MitoB was investigated it was 
therefore considered that the creation of a deuterated analogue of MitoSOX 56 to correct for 
variations in uptake would allow quantification by mass spectrometry of superoxide production 
within the mitochondrial matrix of whole organisms. Unfortunately, no synthesis of MitoSOX had 
previously been published. In planning a route, the various literature approaches to 5,6-
disubstituted dihydrophenanthridines were therefore considered and will be discussed in the next 
chapter. 
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Chapter 4: Making 5,6-disubstituted dihydrophenanthridines and 
phenanthridinium salts 
4.1 Introduction to the synthesis of 5,6-disubstituted dihydrophenanthridines 
Electron-rich 5,6-disubstituted dihydrophenanthridines like MitoSOX 56 are susceptible to 
oxidation and are generally prepared by reduction of the more stable 5,6-disubstituted 
phenanthridinium salts 60 or less commonly, the 6-substituent is introduced by addition of a 
formal carbanion or equivalent reagent to an N-alkylphenanthridinium 62 that is not substituted 
at C-6. These two disconnections are shown in Scheme 19 and will be further discussed within the 
sections marked. 
 
Scheme 19 - The initial disconnections used for the synthesis of a 5,6-disubstituted 
phenanthridinium salt 59. 
4.2 Disconnection one: the ubiquitous N-alkylation 
Hydrogenation and most hydride reducing agents will reduce phenanthridiniums to 
dihydrophenanthridines, so the main challenge is accessing the parent 5,6-disubstituted 
phenanthridinium salt 60. Given the many uses of 5,6-disubstituted phenanthridinium derivatives 
60 (see Section 8.1.1), and the large number which have been synthesised, it is striking that N-
alkylation of a 6-substituted phenanthridine is almost invariably the final step. Phenanthridines 61 
are poor nucleophiles, so the early examples of N-alkylation and preparation of 
phenanthridiniums 60 bearing simple short N-alkyl chain used excess alkyl tosylates, bromides 
and iodides at elevated temperatures.138,139,140 More recent syntheses mostly use triflates.141,142 
Synthetic approaches to the phenanthridine precursors 61 are much more varied, and a brief 
discussion of literature examples is organised in sections according to the retrosynthesis shown 
below (Scheme 20). Probably the most common disconnection is between C6 and C7a (red, 4.2.2). 
Addition of a nucleophile to the C6 unsubstituted phenanthridine is also possible (green, 4.2.3), as 
is intramolecular imine formation from a C6 ketone and a C4a amine (pink, 4.2.4). A few recent 
methods use the more unusual N5-C4a disconnection (blue, 4.2.5), with the C1a-C10a strategy 
most commonly applied to the synthesis of benzophenanthridine natural products (orange, 4.2.6). 
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Scheme 20 - Common disconnections used in the synthesis of phenanthridines. 
4.2.1 Forming the C6-C7a bond: intramolecular nucleophilic attack from an arene 
The C6-C7a disconnection to give imine 63 is by far the most common retrosynthesis of 6-
substituted phenanthridines 60. In the forward direction this is nucleophilic addition to a 
polarised C=N which is an extremely common transformation and compatible with several classic 
heterocycle synthesis strategies. These include the Bischler-Napieralski reaction, sometimes 
called the Hubert-Pictet reaction (ZnCl2, 250-300 °C) or Morgan-Walls cyclisation (POCl3, 80-200 
°C) depending on conditions (Scheme 21). Nucleophilic attack from the aromatic ring on an 
iminium chloride generated in-situ from amide 69 gives phenanthridine 70, and is mechanistically 
similar to the Vilsmeier-Haack formylation (see Section 11.4.1).  
 
Scheme 21 - An example of the Morgan-Walls reaction from Lion et al.143 
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Another common way of forming phenanthridines is the Pictet-Spengler reaction (Scheme 22), 
e.g. imine (or iminium) formation from amine 71 and aldehyde 72 is followed by intramolecular 
nucleophilic attack in a 6-endo-trig cyclisation to give a dihydrophenanthridine. The 
dihydrophenanthridine oxidises under reaction conditions to give phenanthridine 73. 
 
Scheme 22 - Phenanthridine synthesis by Pictet-Spengler reaction. 
  
The Pictet-Spengler reaction is slightly different from the Bischler-Napieralski in that the C=N 
bond is formed in the same reaction as the C6-C7a bond. This is a relatively common theme 
among phenanthridine synthesis protocols. Intramolecular addition of an iminyl radical to an 
aromatic ring has also recently been used to effect the same transformation (Scheme 23) in a 
reaction between an aryl boronic or alkyl boronic acid 74 and a biaryl isocyanate 76.144 According 
to the mechanism proposed by Chatani and coworkers, reaction of boronic acid 74 with a one 
electron oxidant [Mn(III)] gave radical 75 which was trapped with isocyanobiphenyl 76 to give the 
carbon-centred radical 77, which reacts to form the better stabilised phenyl radical 78. Further 
oxidation to cation 79 followed by proton loss gives phenanthridine 80.  
 
Scheme 23 - Mechanism proposed by Chatani and coworkers for the cyclisation of 
isocyanobiphenyl 76 to phenanthridine 80.144 
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4.2.2 Addition of R3 to C6: nucleophilic attack on a phenanthridine 
Nucleophilic addition to C6 is a common strategy for adding a range of R3 groups. This is not a 
phenanthridine synthesis strategy so much as a functionalization, as the starting material 64 is a 
phenanthridine. Treating phenanthridine 81 which has no R2 group with phenyllithium gives the 
6-phenylphenanthridine 82, following oxidation in the work up, which can be further substituted 
to 6,6 disubstituted hydrophenanthridine 83 (Scheme 24) under harsh conditions.145 Addition to 
give the C6 phenyl derivative 82 can alternatively be achieved quantitatively under relatively mild 
conditions using a nickel catalysed arylzinc addition.146 
 
Scheme 24 - C6 funtionalisation of phenanthridine 81. 
 
Organometallic nucleophiles are not required, enolate addition also works well.147 Surprisingly, C6 
addition of an amine occurs in preference to reaction with an alkyl bromide, as evidenced by the 
formation of phenanthridinium 87a by Cronin and coworkers.148 This mechanism was proven by 
opening the five-membered ring, with the failure of the subsequent product to re-cyclise ruling 
out the Baldwin disallowed 5-endo-trig cyclisation. An interesting disproportionation was 
observed, presumably from intermediate 86, which is reminiscent of the Cannizzaro reaction. 
 
Scheme 25 - Unexpected C6 addition of an amine to phenanthridine. 
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4.2.3 N5-C6 condensation: cyclisation through imine formation 
Compounds 92 closely related to phenanthridines can be made from biphenyls 91 with final 
intramolecular condensation of an amine onto a suitable ketone.149 Imine formation is preceded 
by C1a-C10a bond formation via Suzuki coupling between aryl halides 89 and boronic acids 90, 
while an acid sensitive amine protecting group allows deprotection and cyclisation to target 92 in 
one step (Scheme 26). 
 
Scheme 26 - Suzuki coupling to form C1a-C10a followed by combined deprotection and 
cyclisation.149 
 
Transition metal catalysed C-H activation followed by carboamination allows addition of more 
varied and complex C6 substituents and has been demonstrated with both free150 (Scheme 27) 
and protected amines.151 
 
Scheme 27 - C-H activation and carboamination on unprotected biphenyl-2-ylamine 93.150 
 
An alternative formation of the imine is showcased in the work of Gallo and co-workers,152 who 
use azides 95 as amino surrogates and a combination of a ruthenium catalyst, white light and 
heating to achieve a C-H amination and oxidation tandem reaction with the release of N2 to give 
phenanthridines 96 (Scheme 28). Yields were variable and may reflect the difficulty of removing 
the side products reported. 
 
Scheme 28 - A ruthenium catalysed benzylic C-H amination and oxidation process.152 
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4.2.4 N5-C4a cyclisation: transition metal and radical induced cyclisation 
Unlike the analogous C6-C7a bond formation on the other side of the heterocyclic B ring, N5-C4a 
cyclisation is comparatively rare. Presumably this reflects the ability of unsubstituted phenyl ring 
systems to undergo electrophilic substitution reactions, while leaving groups are generally 
required for the equivalent nucleophilic aromatic substitution. As a particularly electronegative 
element, nucleophilic attack on nitrogen is unusual and so formation of N5-C4a is rarely used to 
complete phenanthridine synthesis. Lautens and coworkers synthesise phenanthridines via an 
olefination-cyclisation cascade (Scheme 29), and propose formation of this bond by reaction of an 
imine with an aryl palladium (IV) species derived from the aryl triflate 97.153 A radical reaction not 
dissimilar to that used for C6-C7a bond formation has also been demonstrated as one outcome 
from photolysis of oxime carbamates.154 
 
Scheme 29 - Olefination-cyclisation, from Blanchot et al.153 Bonds formed shown in red. 
4.2.5 C1a-C10a: benzyne cyclisation and C-H activation 
An unusual strategy for forming the C1a-C10a bond has been used to synthesise phenanthridine 
natural products lacking the C6 substituent. The phenanthridine moiety is found in numerous 
alkaloids,155 and among these many are N-alkylated,156 although not necessarily found in the 
quaternary salt form.157 Naturally occurring benzophenanthridines are usually structurally and 
electronically different from ethidium-like phenanthridinium salts, and so different synthetic 
approaches are preferred. In particular, a benzyne cyclisation has been used in the synthesis of 
multiple benzophenanthridines alkaloids.158,159 One example is the conversion of aryl halide 100 
into benzophenanthridine 101 (Scheme 30).  
 
Scheme 30 - Synthesis of a benzophenanthridine through benzyne cyclisation.160 
 
The mechanistic steps of this type of cyclisation are shown in Scheme 31. First the amine 102 is 
deprotonated, then deprotonation of the CH of aryl halide 103 gives benzyne 104. Nucleophilic 
attack from C1a (ortho to the amino group) onto the benzyne forms the C1a-C10a bond, in 
carbanion 105. Protonation of anion 105 during the work up then gives the 
dihydrophenanthridine 106, which is then oxidised to give phenanthridine 106. Deprotonation of 
the amine 102 is required to activate ring A sufficiently to cyclise onto the benzyne.  
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Scheme 31 - Benzyne cyclisation to a phenanthridine. The proton abstracted is shown on 
precursor 105. 
 
Subsequent investigation produced some mechanistic details: N-methylation prevented an 
analogous cyclisation, and deprotonation of only the amine alone did not produce cyclisation, 
showing that benzyne formation is necessary.161 Substitution in the 7 position shown improves 
yield by favouring a conformation where the carbons of the A ring ortho to the nitrogen anion are 
close in space to the benzyne generated. The presence of alkoxy groups on the C ring are noted to 
favour side reactions because inductively withdrawing groups increase benzyne electrophilicity.162 
Changing conditions to LDA in THF at −78 °C improved the yield dramatically in some cases, and 
this was attributed to the bulkier base being prevented by steric hindrance from reacting further 
with the benzyne generated.163 An alternative cyclisation of similar substrates was demonstrated 
by Nakanishi et al in the synthesis of drug candidate NK109, where the phenanthridine was closed 
by radical cyclisation instead.164 More recently Peng et al165 report cyclisation by a C-H activation 
mechanism (Scheme 32). Takeda et al have demonstrated this transformation occurring in 
tandem with prior N-arylation, however low to moderate yields resulted.166 
 
Scheme 32 - C-H activation and intramolecular cyclisation to form C1a-C10a. 
4.3 Disconnection two: addition of a nucleophile to an N-alkylphenanthridinium 
Preparation of 6-substituted phenanthridines 61 and N-alkylation to give 5,6-disubstituted 
phenanthridinium 60 is the most common way of accessing these compounds (Scheme 19). 
However, addition of carbanion equivalents to N-alkylphenanthridinium salts 62 also works. The 
practical difficulty of separating multiple N-alkylphenanthridinium salts in any mixture reduces the 
appeal of this approach. Furthermore the solubility of N-alkylphenanthridinium salts is usually low 
in the types of non-polar solvent often used for organometallic reagents. However, a range of 
benzophenanthridines have been synthesised by Nakanishi et al in this fashion (Scheme 33).167 
The methoxy adduct 111 (a pseudobase) forms the phenanthridinium 112 reversibly in solution, 
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avoiding solubility problems and allowing reaction with the Grignard nucleophile to form 
dihydrophenanthridine 113. Even so, the authors note synthetic difficulties in preparing 
analogues in this way. 
 
Scheme 33 - Grignard addition to a phenanthridinium salt.  
 
The potential reversibility of nucleophilic additions to C6 can be utilised in sensor systems. Cronin 
and co-workers168 developed a pH sensor based on cyclisations from groups such as malononitrile 
(pKa approx. 11)169 which may or may not be nucleophiles in aqueous solution, depending on pH 
(Scheme 34). If the malononitrile is protonated the aromatic open form 114 is favoured. However, 
when the pH is reduced the neutral C6 adduct 115 is preferred despite the loss of aromaticity. 
This results in a fluorescent pH sensor, with change in absorbance and fluorescent properties 
upon acidification. 
 
Scheme 34 - A pH dependent photoswitch based on reversible addition to the C6 position of the 
phenanthridinium. 
 
Chen et al170 take advantage of reversible addition to phenanthridinium salts in a combined 
coumarin-phenanthridinium heterocycle 116 which displays thermochromic properties upon 
cooling in MeOH. 
 
Scheme 35 - Coumarin-phenanthridinium combination 116 displays thermochromic properties.170
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4.4 Direct access to 5,6-disubstituted dihydrophenanthridines 
As previously discussed, according to the literature it is almost invariably necessary to N-alkylate a 
phenanthridine in order to make the corresponding 5,6-disubstituted phenanthridinium. Two 
recent exceptions exist: a single N-methyl hydrophenanthridine analogue 118 has been made via 
the Pictet-Spengler reaction, but the electronics of the precursor biphenyl 117 have been 
optimised and it is unclear that this strategy would be more generally applicable (Scheme 36).171  
 
Scheme 36 - Synthesis of an N-methyl hydrophenanthridine 118 by Pictet Spengler reaction. 
 
Direct synthesis of dihydrophenanthridines with bulkier R groups has also been reported with 
what the authors describe as ‘a hydride transfer/cyclisation/Dötz benzannulation cascade’ 
(Scheme 37), but this requires R2 and R3 to be identical, and the starting material would likely 
prove challenging and sensitive. Additionally, while technically impressive the mechanistic 
complexity of this process would likely make optimisation very difficult.172  
 
Scheme 37 - Dihydrophenanthridine synthesis via cascade reaction.172 
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Chapter 5: Synthesis of 3,8-Diamino-6-phenylphenanthridinium salts 
5.1 Preparation of 9-Hydroxyphenanthridine for N-alkylation 
Utilisation of MitoSOX 56 as a mass spectrometry superoxide probe required both deuterated and 
non-deuterated standards for the reaction product, believed to be the 9-OH compound 58 (See 
Chapter 10). Late addition of the TPP component would allow a late common synthetic 
intermediate. Conveniently, N-alkylation is by far the most common way of making these salts 
anyway, so a synthetic route to a protected 9-hydroxy phenanthridine precursor 126 was 
designed. 
 
Scheme 38 - Synthesis of a precursor to 9-hydroxyphenanthridinium 126. 
 
The route (Scheme 38) is based on one originally attempted by Susan MacIntyre,173 who had 
prepared benzophenones 123 and 124 starting with nitration of dihydroxybenzophenone 122, 
benzyl protection of both phenols and then attempted selective deprotection. Disappointing 
yields resulting from low selectivity in nitration and deprotection steps were addressed by 
rearranging the synthesis. 
 
The literature174 and experience within the group suggested mono protection of 2,4- 
dihydroxybenzophenone 122 should be possible due to the low acidity of the phenolic hydroxyl 
group ortho to the ketone. Hydrogen bonding between 2-OH and C=O allows the 4-OH to be 
preferentially deprotonated. A single deprotonation increases the ring electron density and 
consequently disfavours diphenoxide formation, allowing the more acidic phenol to be protected 
selectively. This allowed near quantitative conversion of diol 122 into para-benzyloxy protected 
compound 123. The same procedure cannot be used if C5 nitration precedes protection as the 
presence of the nitro group makes both phenols sufficiently acidic that either could be 
deprotonated, and like the ketone, the nitro group hydrogen bonds with an ortho phenol. 
Nitration of phenol 123 under mild conditions resulted in complete conversion of starting 
material 124 into a mixture of nitrobenzophenone 124 and an alternative nitrated side product in 
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a ratio of 4.2:1. The yield of the pure phenol 124 from the recrystallisation was limited due to the 
similarity of the side product. 
 
Conversion of phenol 124 into aryl tosylate 125 was achieved overnight in pyridine. We reasoned 
that ketone 125 would react with 1,3-diaminobenzene to give phenanthridinium salt 126 when 
treated with acid. An initial attempt utilising Amberlyst 15 failed. When the mixture was heated 
under reflux with p-toluene sulfonic acid for 5 days under Dean-Stark conditions, a red solid with 
low solubility precipitated, the identity of which was eventually confirmed by washing with strong 
aqueous base, so that the 1H NMR spectrum was not complicated by signals from p-toluene 
sulfonate (Scheme 39). This revealed the 7.30 ppm doublet (H1), which correlated with peaks for 
H2 and H4 in the COSY spectrum confirming the identity of phenanthridine 127. 
 
Scheme 39 - Neutralisation of phenanthridinium tosylate 126. 
 
The mechanism of this transformation is believed to involve the formation of both imine isomers 
128 and 129 by removing water. The sterically less favoured isomer 129 then cyclises by 
nucleophilic attack from the para position of the dianiline ring on the aryl tosylate, with the 
resulting Meisenheimer complex 130 stabilised by the electron withdrawing properties of the 
para nitro group. Aromaticity is restored by loss of the tosylate from this. Restoration of 
aromaticity across the ring system then provides a strong driving force for deprotonation of 131. 
Formation of phenanthridinines by this type of cyclisation is unprecedented (Scheme 40). The 
absence of a strong base rules out cyclisation via a benzyne163 as used in the synthesis of 
Fagaronine158 and recent analogues (see Section 4.2.5).159 Attempts to use a higher boiling 
solvent, chlorobenzene, in the hope that higher temperatures would encourage isomerisation of 
the imine 128 and drive the reaction to completion were unsuccessful. 
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Scheme 40 - Postulated mechanism for cyclisation from benzophenone 125 to phenanthridinium 
126. 
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5.2 N-Alkylation of Phenanthridines 
5.2.1 Introduction and phenanthridines 
3,8-Diaminophenanthridine 133 is commercially available, so with 9-benzyloxy variant 127 in 
hand alkylation to give N-alkylphenanthridinium salts was attempted. Since the 3,8-
diaminoprecursor is commercially available this is an ideal approach to MitoSOX. Avoiding 
synthesis of the heterocycle results in a short synthesis, with only protection of the 3,8-amino 
functionality and alkylation required (Scheme 41). 
 
Scheme 41 - Alkylation strategy for synthesis of N-alkylphenanthridinium salts 135. 
 
Commercially available phenanthridine 133 was protected as a variety of carbamates according to 
literature procedures (Scheme 42).175 The Boc protected phenanthridine 137 was previously 
prepared by Stephen McQuaker, who attempted the alkylation with a variety of dihalides without 
success. Of the three additional carbamate-protected phenanthridines the methyl carbamate 139 
proved very insoluble but the benzyl and ethyl analogues 138 and 140 were tractable.  
 
Scheme 42 - Carbamate protection of phenanthridine 136 
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5.2.2 Alkylating agents 
 
Scheme 43 - Synthesis of a monophosphonium triflate salt 143. 
 
 Although there is literature precedent for use of alkyl dihalides,176 phenanthridines are very poor 
nucleophiles141 so triflate is the most commonly employed leaving group. Bis-triflate 142 was 
prepared according to a literature procedure from diol 141, with a distinctive 2H t at 4.5 ppm in 
the 1H NMR spectrum indicating success (Scheme 43).177 On treatment with triphenylphosphine 
the insolubility of phosphonium cations in Et2O allowed the mono-TPP salt 143 to be prepared 
exclusively. 1H NMR spectroscopy showed yields in excess of 90% based on characteristic CH2 
groups adjacent to phosphonium and triflate groups, and material was used directly rather than 
isolated due to moisture sensitivity. This compound proved hugely more moisture sensitive than 
the parent bis-triflate 142. This problem was independently experienced by the group of Robin 
Smith,178 and was attributed to the charge improving association with water molecules, making 
hydrolysis more probable. The sensitivity of phosphonium triflate 143 required fresh preparation 
and laborious handling conditions, so monobenzyl triflate 146 was synthesised instead (Scheme 
44). 
 
Scheme 44 - Synthesis of a monobenzyloxy alkyl triflate  146. 
 
One end of 1,6-hexanediol was benzylated, with the waxy solid being dried by azeotrope with 
PhMe prior to protection using a modified literature procedure.179 No selectivity is achieved in this 
reaction and the statistical mixture results. It was quickly realised that most of the diol could be 
washed out, and the remainder would stick to the SiO2 in the 1:1 petrol/Et2O mixture which 
eluted the desired monobenzyl alcohol 145. A sevenfold excess of 1,6-hexandiol was used with 
the excess removed by washing and filtration through SiO2. This avoids generation of the more 
difficult to remove dibenzylated side product, and the diol could be recovered and reused if 
desired. Triflate formation then gave monobenzyl triflate 146 in good yield.  
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5.2.3 Alkylation experiments 
Alkylation (Scheme 45) was attempted under various conditions, summarised in Table 1. 
 
Scheme 45 - General scheme for the alkylation of protected 3,8-diaminophenanthridines 
Table 1  
Entry Substrate Triflate T (˚C) t (h) Solv. Base 
I 137 142 RT - 120 20/3 PhNO2 - 
II 138 142 RT 1.5 THF - 
III 138 142 RT 72 THF - 
IV 138 143 RT 17 DCM - 
V 138 143 RT 17 PhNO2 NaHCO3(aq) 
VI 138 143 reflux 17 CD3CN Proton sponge 
VII 138 143 reflux 17 CD3CN - 
VIII 138 143 RT 17 CD3CN - 
IX 138 143 RT 17 d6-DMSO - 
X 138 146 RT 60 CD3CN - 
XI 138 146 RT - 100 60 d6-DMSO - 
XII 138 146 RT 60 PhMe - 
XIII 138 146 125 17 d6-DMSO - 
XIV 138 146 RT 21 PhNO2 - 
XV 139 146 RT 18.5 PhNO2 - 
XVI 140 146 RT 22 PhNO2 - 
XVII 140 146 RT 22 PhNO2 NaHCO3(aq) 
XVIII 140 143 RT 17 PhNO2 - 
XIX 140 143 35 21 PhNO2 - 
XXI 140 146 RT 72 PhNO2 [a] 
XXII 140 146 70 16 PhNO2 [a] 
 [a] 2,6-ditertbutyl-4-methylpyridine 
 
Nitrobenzene was the solvent of choice and is commonly used as the solvent for phenanthridine 
alkylation,138 being polar enough to solubilise starting materials, products and the SN2 transition 
state (which involves charge separation in this case) while being inert to most electrophiles due to 
electron deficiency. One indicator of alkylation is a t at around 4.5 ppm in the 1H NMR spectrum, 
distinguished from the CH2-1 peak at 4.5 ppm of triflates as a much broader signal. 
 
The Boc protected phenanthridine 137 did not react with triflate 142 at RT; heating to 120 ˚C 
followed by cooling and addition of Et2O resulted in precipitation of a mixture, possibly including 
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phenanthridinium 147 as a minor component (I). Similar results were achieved regardless of 
reaction time with benzylcarbamate 138 in THF (II and III). For the alkylation of TPP triflate 143 
DCM was tested (IV) as it is not very hygroscopic and phosphonium salts tend to be soluble in 
chlorinated solvents, but little or no reaction was observed. Since elimination was a plausible 
competing reaction a base was introduced to re-activate any subsequently protonated 
phenanthridine; NaHCO3(aq) was tested based on literature precedent (V).
142 Following reaction a 
precipitate was observed, but no product. To eliminate decomposition during work up reaction in 
CD3CN was followed by 
1H NMR spectroscopy. Heating to reflux caused decomposition (VI and 
VII), but entry VIII showed peaks at 4.5 and 4.1 ppm. These could be CH2-1’ and increase in size 
over 1 h, but heating overnight caused decomposition. Complicated mixtures uniformly resulted 
from these conditions at all time points. The procedure was repeated in d6-DMSO due to the 
availability of literature data, allowing alkylation to be judged by comparison with the ethidium 
analogue prepared and assigned by Luedtke180 - a shift to bring H7 upfield of H2/H9 would be 
considered characteristic of the phenanthridinium 148. DMSO also allows higher temperatures if 
needed and the dispersion of the 1H NMR peaks for the aromatic region in this solvent is helpful. 
No product was observed (IX).  
 
The moisture sensitivity of triflate 143 was considered to be impeding progress. Repeating 
previous tests with triflate 146 (X - XIII) showed complete consumption of triflate, but no product 
148. Room temperature alkylation with triflate 146 in PhNO2 did not result in reaction with benzyl 
carbamate 138 (XIV), but with methyl carbamate 139 gave a minor side product with an ortho d at 
10 ppm and a broad t at 4.7 ppm in the 1H NMR spectrum, suggesting phenanthridinium 
formation (XV). However, this was not successfully purified by chromatography or a Strata X-C ion 
exchange column.  
 
Repetition with ethyl carbamate 140 and alkyl triflate 146 followed by repeated chromatography 
with both SiO2 and C18 cartridges did give fractions which unambiguously contained an N-alkyl 
phenanthridinium 150 based on the characteristic broad t at 4.5 ppm (distinct in form from the 
sharp CH2-OTf from triflate 146), and amide broad singlets at 10 ppm in d6-DMSO in the 
1H NMR 
spectrum (XVI). These amide peaks were present in duplicate in approximately 1:1 ratio, which 
was initially attributed to slow rotation of the amide giving rotamers on the NMR timescale as the 
benzyl CH2 peak is present only once and integrates as if part of a single compound with the 
aromatic protons in the 1H NMR spectrum. Including NaHCO3(aq) (XVII) afforded a fraction in which 
phenanthridinium 150 was the major component. This allowed more precise development of a 
TLC system, which was important as PhNO2 is removed via initial chromatography of the reaction 
mixture. With evidence that the alkylation worked (if poorly), phosphonium triflate 143 was 
applied to the new conditions (XVIII - XIX). NaHCO3(aq) was omitted as experience had shown the 
moisture sensitivity of the alkylating agent by this point, with moderate conversion observed 
regardless of reaction time. On analysing fractions collected during chromatography of entries 
XVIII - XIX additional amide peaks were revealed to be an impurity rather than a rotamer when a 
trace sample from which they were absent was isolated. Faced with this purification problem 
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triflate 146 was again used, to avoid the complication of separating phosphonium salts from 
phenanthridinium salts. 
 
Although NaHCO3(aq) appeared to improve conversion a base soluble in anhydrous PhNO2 was 
considered preferable, with the caveat that very low nucleophilicity was required to prevent 
competition. 2,6-Ditert-butyl-4-methylpyridine was used, and after 72 h the desired product 150 
appeared favoured by approximately a 63:37 ratio over the side product (Scheme 46). Repeated 
chromatography gave a 7% yield at a purity estimated to be around > 90% if residual DCM is 
ignored (XXI). Increasing the equivalents of triflate 146 and the temperature caused a loss of 
selectivity and a 1:1 ratio of the phenanthridinium 150 to side product (XXII). 
 
Scheme 46 - Alkylation and intended route to the MitoSOX precursor 152. 
 
Mixtures of phenanthridinium 150 and the side product from alkylation were subjected to 
hydrogenolysis to remove the benzyl protecting group. Clean deprotection resulted, and 
subsequent chromatography gave a 17% yield of alcohol 151. Impure material was used for a 
small scale test of iodination (Appel reaction) and triphenylphosphine addition, confirming the 
conditions did not result in decomposition but unfortunately not that TPP salt 152 is formed. 
Small scale removal of ethyl carbamate by reflux in HBr(aq) gave better chromatographic 
separation, although unpredictable elution was still observed (see later). A single column yielded 
some fractions of approximately 90% purity, but the use of d6-DMSO as an NMR solvent hid the 
CH2 shift which would confirm the conversion from alcohol to bromide.  
 
Particular note was made during the course of the above work of the difficulty inherent in 
purifying these compounds, with considerable streaking contributing to a situation where elution 
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rarely mimicked TLC. Acetone/EtOAc systems worked well on TLC but proved hopeless on silica 
column. Even the various DCM/MeOH systems often required washing with high percentages of 
MeOH and/or NEt3 to recover the majority of material, which often adhered to the baseline but 
matched earlier fractions by NMR and TLC when recovered.  
 
Scheme 47 - Outline of a reduction-alkylation based synthesis of phenanthridinium iodide 154. 
 
When the difficulty of phenanthridine alkylation became apparent reduction of ethyl carbamate 
140 to an amine and subsequent alkylation of hydrophenanthridine 153 was investigated 
(Scheme 47). Hydrogenation over Pd/C in AcOH (allowing reduction through the reactive iminium) 
was unsuccessful, so LiBH4 was used. This is more reactive than NaBH4 due to the higher Lewis 
acidity of Li+,181,182 and is soluble in ethereal solvents, from which N-alkylphenanthridinium 154 
might be expected to precipitate were the steps combined. LiBH4 does not reduce carbamates in 
numerous literature examples.183 Reduction was confirmed by TLC and colour change. Additional 
aromatic peaks for the hydrophenanthridine 153 in the 1H NMR spectrum including those at 7.6 
ppm d (J = 9.2 Hz, H1/H10) and 6.64 ppm dd (J = 8.4, 2.1 Hz, H2/H9) are considerably upfield of 
where equivalent peaks are expected in the oxidised form 140. Re-oxidation is rapid; at best a 3:1 
ratio of 153:140 was observed by NMR spectroscopy (Scheme 31). 
 
Figure 31 - Comparison of 140 (top) and post reduction mixture (bottom) containing mostly 153 in 
CDCl3. The H1/H10 positions in each are highlighted, as is H2 in the reduced compound.  
 
Alkylation was attempted on the mixture using iodobutane, but even with long (72 h) reaction 
times no alkylation was observed. It was increasingly apparent that the synthesis of N-
alkylphenanthridinium salts was not trivial, so an alternative route was attempted.  
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5.3 Route to N-alkylphenanthridinium salts via Bischler-Napieralski cyclisation 
An alternative synthesis attempts to build on a literature report of cyclisation directly to a 
phenanthridinium alkaloid precursor 155 via Bischler-Napieralski type cyclisation (Scheme 48).184 
This is analogous to the classic Morgan-Walls cyclisation to give phenanthridines (see Section 
4.2.1). 
 
Scheme 48 - Literature example of a Bischler-Napieralski cyclisation to a phenanthridinium based 
alkaloid.184 
 
Scheme 49 - Synthesis of 3,8-diaminophenanthridinium salt 159 via Bischler-Napieralski reaction 
required access to key tertiary amide intermediate 158. 
 
Using the strategy outlined in Scheme 49 intermediate 158 is the key precursor for the cyclisation 
reaction. 4,4-Dinitrobiphen-2-ylamine 157 was prepared from biphenyl-2-ylamine 156, according 
to a literature procedure143 using KNO3 in H2SO4, which provides a powerful nitrating agent with 
lower water content than HNO3(aq)/H2SO4(aq).  
 
Scheme 50 - An amide formation and alkylation strategy did not allow access to intermediate 158. 
 
Using a large excess of KNO3 (8 eq.) resulted in a mixture of double and possible triple nitrated 
aromatic rings even at low temperature, but reducing the amount of KNO3 to 2.2 eq. gave clean 
conversion with no purification aside from an aqueous wash. The regiochemistry of nitration on 
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the aniline ring is consistent with the electron withdrawing effect of the aryl ammonium group 
generated in strongly acidic conditions. Amide formation by refluxing dinitrobiphen-2-ylamine 156 
with benzoyl chloride in chlorobenzene as in Lion et al resulted in a mixture of products.143 Mild 
alternative conditions185 gave good conversion (Scheme 50) to amide 160. 
 
Amide 160 dissolved well only in DMSO or hot DMF, complicating the recovery of material. 
Quenching into water gave a very fine precipitate which did not reliably filter out, or stay settled 
enough to separate from the solution after centrifugation. Many attempts were made at the 
subsequent alkylation with increasingly harsh conditions, including heating amide 160 to 170 ˚C 
with 3 eq. sodium hydride and excess 1,6-dichlorohexane for 90 min. Use of iodide catalysis was 
tested, as were various alkylating agents including triflate 142, 1,6-diiodohexane and an alkyl 
iodide bearing a THP-protected alcohol 162 synthesised via the Appel reaction (Scheme 51). 
 
Scheme 51 - Synthesis of a mono-THP protected iodohexyl compound 162.  
 
 Attempted alkylation of amide 160 resulted in various mixtures of numerous and diverse 
decomposition products under these conditions or indeed any more unusual procedures 
tested.186,187 The alkylation of amide 160 was expected to be problematic, being very electron 
poor and because the tertiary amide 158 would be sterically congested. However, it was not fully 
appreciated how strained the desired product would be until the atropisomerism displayed by a 
less hindered carbamate 245 (Scheme 77) was later identified. 
 
The original literature cyclisation184 required heating to reflux in MeCN even when decorated with 
multiple donating groups (Scheme 52), so it was anticipated that reduction of the nitro groups on 
amide 160 would prove necessary. Reduction via transfer hydrogenation (Scheme 52) was tested 
on the dinitroamide 160. 
 
Scheme 52 - Reduction of dinitrobiphenyl 160 to give more nucleophilic biphenyl 163. 
 
The diamino compound 163 was confirmed by a uniform upfield shift in the aromatic protons in 
the 1H NMR spectrum and the appearance of a 4H broad singlet at 3.8 ppm, but not purified or 
further characterised. To overcome alkylation difficulties the steps were rearranged, with benzoyl 
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protection following reductive amination. Aldehyde 164 was synthesised by Swern oxidation of 
alcohol 161 (Scheme 53). 
 
Scheme 53 - Swern oxidation to aldehyde 164. 
 
Attempts at reductive amination to convert primary amine 157 into secondary amine 165, both 
in-situ and via isolation of imine 166 and reduction proved unsuccessful, as did an unusual 
procedure using the direct alkylation of the amine 157 with alcohol 161 (Scheme 54).186 
 
Scheme 54 - Different reductive amination protocols failed to access secondary amine 165. 
 
The reactivity of the aniline was proving problematic, so the more circuitous route of reaction 
with an acid chloride and subsequent reduction was investigated, for which several acylating 
agents were prepared (Scheme 55). Synthesis and isolation of the 7-membered cyclic anhydride 
169 from a literature procedure188 starting with adipic acid 167 proved problematic. Double acid 
chloride 170 was synthesised by reaction with thionyl chloride and reacted immediately with 
aniline 157, resulting in a complex mixture of products. Mono methyl adipic acid was then used 
instead to generate acid chloride 171.  
 
Scheme 55 - Preparation of acylating agents 170 and 171. 
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Amine 157 was then reacted with acid chloride 171 to give amide 172 in good yield (Scheme 56). 
Ester 172 was hydrolysed to give acid 173. 
 
Scheme 56 - Secondary amine 175 was accessed by an acylation-reduction approach, but tertiary 
amide intermediate 158 remained elusive. 
 
The next step was reduction of the amide using the neutral and electrophilic THF-borane reagent. 
The borane coordinates to the more Lewis basic position prior to reduction, and in the case of 
carboxylic acids forms a triacyloxyborane (Scheme 57).189 Coordination to the acid generates 
complex 176, or a related structure,190 which decomposes to a structure 177 analogous to a mixed 
anhydride allowing rapid reduction. The expected result is that the aldehyde is generated then 
reduced in preference to the amide.191 A hydride such as DIBALH would preferentially reduce the 
amide, risking cyclisation from the amine when the aldehyde is produced. There is strong 
literature precedent for borane tolerating aromatic nitro groups,191,192 unlike reagents such as 
lithium aluminium hydride. 
 
Scheme 57 - Triacyloxyborane 176 decomposes to a mixed anhydride 177.189 
 
An initial test of reduction of acid 173 with 4 eq. of borane and overnight reflux showed reduction 
of one nitro group in addition to the expected reaction. Reflux with 2 eq. overnight gave reduction 
of the acid to the alcohol without reaction at the amide. Returning to 4 eq. of borane and 
monitoring by TLC allowed for good conversion to alcohol 174. Attempts to generate the amide 
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precursor 158 lead to benzoyl protection of the alcohol giving benzoate 175, and subsequent 
deprotonation of this with LiHMDS and reaction with benzoyl chloride proved ineffective. 
Conversion directly to phenanthridinium was attempted via procedures reminiscent of the Pictet 
Spengler reaction, initially combining TMSCl with benzaldehyde 72 and alcohol 174, before 
applying harsher literature Pictet-Spengler cyclisation and spontaneous oxidation conditions 
reported for the cyclisation of amine 156 to give phenanthridine 179193 using benzaldehyde in TFA 
at high temperature and in a sealed tube (Scheme 58).  
 
Scheme 58 - Literature Pictet-Spengler procedure.193 
 
Although this literature example does not form an N-alkylphenanthridinium, the reaction occurs 
in neat TFA so it is reasonable to assume the reaction proceeds through an iminium intermediate. 
In reality only a TFA ester (identified by a downfield shift in the adjacent CH2) was isolated 
(Scheme 59), probably due to the low reactivity of the aniline of dinitrobiphenyl derivative 33 
towards electrophiles. 
 
Scheme 59 - Pictet-Spengler attempt on secondary amine 174 gave only TFA ester 180. 
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5.4 Summary 
Having attempted multiple alkylation and cyclisation based routes, recurring difficulties were 
apparent. Alkylation of the consistently hindered and unreactive nitrogen was always 
problematic, exacerbated by the electron poor phenanthridines and biphenyl systems used. 
 
Concurrent preliminary work on commercially available 3,8-diamino-6-phenylphenanthridinium 
salts by Dr Murphy’s group at MRC in Cambridge suggested that the DNA intercalation observed 
made reproducible extraction challenging. On this basis the target was changed and required a 
bespoke phenanthridine heterocycle. Without the benefit of the commercially available 3,8-
Diaminophenanthridine as a starting material for the new route and in light of the considerable 
difficulties encountered the alkylation work was abandoned. Similarly the biphen-2-ylamine 
routes were deemed to be too dependent on difficult alkylations and to offer limited scope for 
analogue synthesis. Therefore, when considering a new target alternative synthetic routes were 
investigated instead. 
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Chapter 6: A new targeted superoxide sensor design 
6.1 Design and retrosynthesis 
6.1.1 Avoiding DNA intercalation 
In order to avoid DNA intercalation, it was necessary to modify the target probe. The structure 
was tweaked by exchanging the 3-amino group for a tert-butyl moiety, as shown in blue in 
superoxide probe target 181 (Figure 32). This should avert intercalation because the bulky 
substituent will make intercalation between DNA base pairs energetically unfavourable. 
 
Figure 32 - Target phenanthridinium showing A, B, C labels for rings, with the blocking tBu group 
in blue. 
6.1.2 Synthetic route towards superoxide probe 181 
The design of the new probe 181 imposed the requirement of selective substitution at the 3 and 8 
positions. In addition, based on the failure of previous approaches a few guiding principles were 
identified for application in evaluating routes: 
 Very electron poor aniline components should be avoided as they are unreactive, and 
sterically hindered versions even more so. 
 The N-alkyl group should be appended prior to construction of the heterocyclic B-ring as 
N-alkylation of phenanthridines is a poor reaction. 
 When constructing the B-ring, avoid loading one component of an intermolecular reaction 
with all the bulk of the C6- and N- substituents. 
 The reaction to make the N-alkylphenanthridinium should be simple, clean, high yielding 
and close to the end of the synthesis, because the separation of different 
phenanthridinium compounds is difficult and their solubility is problematic. 
 Demanding transformations that require extensive purification should occur prior to the 
construction of the N-alkylphenanthridinium for the same reasons. 
Working from these principles, a new route was devised concluding the synthesis of 
phenanthridinium core 182 with intramolecular imine formation. This is a 6-exo-trig cyclisation to 
make a polyaromatic system, and should be highly favoured. Additionally, the phenanthridinium 
salt 182 would likely precipitate from a non-polar solvent allowing easy isolation. The precursor 
ketone 183 could be prepared with robust and reliable cross coupling chemistry such as the 
Suzuki reaction which would be used to form the C1a-C10a bond. The cross coupling could use 
either the combination of a ortho-halobenzophenone 185 with ortho-aminoarylmetal 187 or a 2-
metalobenzophenone 184 with ortho-aminoaryl halide 186. This route avoids tertiary amine or 
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amide formation, which had torpedoed previous routes. The R group can be introduced early, 
with a variety of methods available to access secondary amine 186 from aniline 188. The 6-Ph 
substituent could be included by taking advantage of the commercial availability of 
benzophenones and the extensive literature on these substrates. 
 
Scheme 60 - Retrosynthesis for a proposed cross-coupling based synthesis. Unlike previous routes 
which relied upon C-N or C6-C7a bond formation for key steps, C1a-C10a is the critical 
transformation. 
6.2 Suzuki cross coupling 
6.2.1 Mechanism and ligand properties 
Following assembly of the desired aromatic components they were to be linked to form the biaryl 
systems via palladium cross coupling chemistry, ideally the Suzuki coupling. The reaction itself was 
an obvious choice due to its ubiquity, robustness and substrate tolerance. An array of catalysts 
and conditions exist and three common catalysts which will be important in later discussion are 
Pd(PPh3)4 (tetrakis) 189 and (dppf)PdCl2 190, which involve phosphine ligands, and PEPPSI-
iPr 191, 
which contains a N-heterocyclic carbene ligand (Figure 33). 
 
Figure 33 - A selection of common palladium cross coupling catalyst systems. 
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A discussion of the mechanism and the choice of conditions is appropriate (Scheme 61).  
 
Scheme 61 - A simplified catalytic cycle for Suzuki coupling. 
 
The precise nature of the catalytic Pd(0)Ln species varies and is a matter of debate, with Pd
(0)L2 193 
and Pd(0)L both possible. The cycle shown above (Scheme 61) and described below is based on the 
tetrakis system (L = PPh3). The metal has a full outer shell of d
10 electrons in Pd(0)L4 189 with 
repulsion reducing the bond strength and increasing ligand lability. Once one triphenylphosphine 
is lost the L2 193 and L3 192 forms equilibrate,
194 with L2 species 193 considered catalytically 
active. Bidentate ligands such as dppf 190 are conceptually similar but the active Pd(0) species is 
generated from the dihalide Pd(II) salt rather than dissociating an additional bidentate ligand.195 In 
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both cases the active species is usually a 14-electron complex which becomes 4 coordinate upon 
oxidative addition. 
 
It is currently believed the active Pd(0)L2 species 193 undergoes oxidative addition inserting itself 
into the C-X bond of the aryl halide 194 via a concerted process to give a cis Pd(II) species. A 
theoretical study suggests this process is favoured by kinetics compared to insertion into an alkyl 
halide due to back bonding in the transition state resulting from interaction of the aromatic π 
system with X.196 An exothermic isomerisation driven by the stability of the trans isomer197 and 
probably occurring via ligand addition to form a trigonal bipyramidal transition state200 leads to 
the observed trans198,199 Pd(II) species 195. This can be the rate determining step, especially for aryl 
chlorides. Substrate electronics influence the efficiency of this step, with electron poor aryl 
halides reacting more rapidly due to the electron rich nature of the neutral palladium species 193, 
particularly where ligands are strongly donating.200  
 
The halide is reversibly displaced by a nucleophilic ligand, usually hydroxide generated by a base 
reacting with water as shown in Scheme 61 but fluoride is also frequently used.201 This gives 
complex 196, which undergoes faster transmetallation.202,204 In the case of hydroxide the 
oxophillicity of the boron allows coordination prior to transmetallation in complex 200 and as a 
result the identity of the base counterion is important due to the potential competitive 
coordination of Pd-OH complex 196 by cations to form non-productive complex 197.203 
 
Due to the electron deficient nature of Pd(II) complexes transmetallation is a more facile process 
when an electron rich arylboronic acid is employed, and is disfavoured by donating ligands.200 The 
arylboronic acid 198 is necessarily in equilibrium with the unreactive trihydroxyborate 199, 
providing an upper limit to the acceleration provided by base.201,204 The trans complex formed 201 
is relatively stable199,205 in the absence of base, with recent literature suggesting further 
coordination with hydroxide to give a pentacoordinate compound 202 which bypasses the 
requirement for trans/cis isomerisation prior to reductive elimination.201,206 Analogous 
acceleration by a fifth ligand is precedented with a styrene promoter,207 and fluoride is believed to 
behave similarly. Reductive elimination then occurs to give the biaryl product 203, and this is 
most rapid when the electronic properties of the aryl groups are markedly different.208 Electron 
rich ligands disfavour reductive elimination, while wide bite angle bidentate ligands sterically 
favour elimination.209 
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6.2.2 Mono-ligated palladium species 
The previously shown catalytic cycle assumes Pd(0)L2 is the active catalyst. However, Pd
(0)L is also 
possible. Bulky monodentate ligands are believed to form tricoordinate210,211 intermediate 205 
upon oxidative addition. The pathway to these intermediates is dependent mostly on the halide 
used (Figure 34).212 
 
Figure 34 - The effect of ligand size on the generation of monoligated palladium species.213 
 
The reaction coordinate diagram shows the dissociation of bicoordinate complex 193 to give 
monocoordinate complex 204 and oxidative addition to ArX 194 giving tricoordinate complex 205. 
Increasing ligand bulk favours this dissociation by increasing the energy of the bicoordinate 
complex 193 more than the dissociated form 204, as do specific interactions found in some 
ligands.214 The nature of this process depends mostly on the halide used.212 
 
In the case of aryl chlorides prior ligand dissociation from complex 193 gives 204, a 12 electron 
species which undergoes rapid oxidative addition.215,216 Aryl iodides react via the PdL2 species, 
with one ligand then dissociating to form tricoordinate species 205, which may then dimerise 
depending on ligand sterics.217 Aryl bromides are variable; multiple mechanisms may occur in a 
substrate dependent fashion. Subsequent transmetallation may occur more easily to 
tricoordinate complexes,214,218 and calculations on C-C and related C-N systems suggest they 
undergo reductive elimination more readily.219,220,221 
6.2.3 N-Heterocyclic carbene catalysts 
N-Heterocyclic carbene (NHC) ligands may also generate monocoordinate species 204. NHC 
ligands represent an alternative to phosphine ligands. Originally believed to form PdL2 complexes, 
it is now established that PdL complexes are the active species.200,222 One example is the PEPPSI-
iPr catalyst 191 (Figure 33). The core of the ligands themselves is an aromatic,223 singlet,224 bent 
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carbene stabilised by σ withdrawing and π donating nitrogen atoms.225 While the reaction 
mechanism is broadly the same as when using phosphine ligands these complexes have important 
distinct properties. Bonding within NHC complexes varies depending on a range of subtleties.  
 
Figure 35 - The three major contributors to NHC-M bonding.226 
 
There are three major bonding contributions to NHC metal complexes (Figure 35). Strong σ 
donation from the lone pair is the largest feature, providing more electron donation than 
phosphine ligands.231 Of the remaining interactions metal  π* backdonation is more important 
for d10 metal complexes.227 A significant electrostatic component exists, particularly for cationic Pd 
species, but has proven difficult to quantify.227 In the case of the PEPPSI family of commercially 
available catalysts activation is believed to occur through double transmetallation of the Pd(II) salt, 
and elimination to give Pd(0), then pyridine dissociation and oxidative addition, which is favoured 
by substituents increasing σ donation. Moderately bulky ligands improve either transmetallation 
or reductive elimination steps, with the effect of the pyridine ligand on the rate suggesting 
reattachment by this point.228 NHC ligand based catalysts display high stability, allowing low 
catalyst loading.229 
 
For testing purposes three catalytic systems were selected; the heavily used and studied Pd(PPh3)4 
(tetrakis) 189, (dppf)PdCl2 190, selected as one of the more versatile bidentate catalysts,
230 and 
the most active231 of the available PEPPSI-NHC catalysts, PEPPSI-iPr 191 (Figure 33). 
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6.3 Methods of constructing arylboron reagents 
6.3.1 Miyaura Borylation: 
Organometallics 185 and 186 are required for the cross-coupling and as discussed above 
organoboron compounds are ideal for this. The Miyaura reaction283 is a way of converting aryl 
halides 194 to arylboronate esters 206 which uses a catalytic cycle mechanistically analogous to 
the Suzuki reaction to achieve borylation without the use of powerfully basic organometallic 
reagents (Scheme 62). 
 
Scheme 62 - The Miyaura reaction. 
 
Much of the prior discussion of the Suzuki mechanism is applicable here. The key difference is 
that these borylations go through a LnPd
(II)OAc complex. The hard Lewis base and soft Lewis acid 
combination may make this complex more reactive than the halide equivalent, with changes in 
geometry also implicated in some cases.232 Pinacolboron acetate is produced as a by product. The 
weak base used limits hydroxide formation when water is present suppressing Suzuki coupling, 
although dry conditions are often required for good conversion. Various related procedures exist 
using different metals, different boronic esters and in one case bis-boronic acid.233 
6.3.2 Lithium - halogen exchange followed by borylation 
Organolithium and Grignard type reagents can be used to make arylboronates (Scheme 63). Rapid 
metal-halogen exchange on aryl halide 194 generates a highly nucleophilic organometallic species 
207, which attacks a suitable boronic ester to give the arylboronate salt 199. Acidic workup then 
gives the boronic ester 198. Literature studies generally focus on one reagent, but in essence both 
share distinctive properties and observations made of one type of reagent is often extended to 
the other in literature. Here the general overview and more extreme chemical properties of 
organolithiates are described, followed by more specific discussion of ‘ate’ complex 
decomposition in organomagnesium species. 
 
Scheme 63 - Metal halogen exchange followed by borylation. 
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The lithium-halogen exchange is an equilibrium process, with the position determined by the 
relative stability of the carbanions formed (Figure 36).234 Increasing s character lowers the energy 
of the HOMO orbital so when exchanging an aryl halide with an alkyllithium species the transfer 
goes essentially to completion, because an aryllithium is more stable than an alkyllithium. 
 
Figure 36 - Relative stability of carbanions 
 
The mechanism of these exchanges is not completely understood. Complications include the 
aggregation of lithiated species, which is controlled by the sterics of the alkyl portion and varies 
with temperature, solvent and concentration.235 In the absence of a Lewis base hexamers and 
tetramers predominate. Lithium ions (bonding is predominantly ionic)236,237 form L3 triangles.
237 
Each lithium has at least four contacts, and is electron deficient in nature. The nbutyllithium often 
used forms discrete octahedrons.238 Addition of a Lewis base results in the positive lithium being 
stabilised by interaction with the base and reduces the aggregation, increasing reactivity.235,237 
The difference in reactivity is potentially enormous; Jones et al239 show that dimeric nbutyllithium 
is 8 orders of magnitude more reactive than tetrameric forms towards a terminal acetylene. In the 
same paper they estimate the monomer is at least 14 orders of magnitude more reactive than the 
tetramer towards the same substrate.239 Such differences in already rapid transformations make 
identifying the active species challenging. Depending on the nature of the arylhalide 194 either a 
radical mechanism (SET) through radical anion 209 then neutral radical 211, or an ‘ate’ complex 
such as 213 may be involved (Figure 37). 
 
Figure 37 - SET (radical) and ATE (nucleophilic) mechanisms 
 
Based on EPR spectroscopy,240 cyclic radical probe studies,241 and the isolation of characteristic 
products242 radical mechanisms are known to occur, particularly at higher temperatures and 
where an alkyl bromide is the substrate.243 Some ‘ate’ complexes have been isolated and are 
effective nucleophiles.244 Studies on the effects of substituent electronics245,246 and substrate 
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stoichiometry247 on the kinetics of aryl halide exchange suggest this is the dominant mechanism. 
Evidence for one mechanism does not necessarily preclude the other; detection of radicals does 
not disprove the involvement of an ‘ate’ complex. Some iodine ‘ate’ complexes generate radicals 
during decomposition.248  
 
Lithium - halogen exchange is a rapid process, occurring preferentially to deprotonation in some 
cases.249 Organolithium species are reactive and in particular very basic (the conjugate acid of 
C2H5Li has a pKa of around 50 relative to water).
250 As such, low temperatures and short reaction 
times are preferable, and the exclusion of oxygen and water is vital. 
 
Many of the mechanistic details pertaining to organolithium species are also relevant to 
magnesium halogen exchange processes; in particular an ‘ate’ complex is implicated. Some 
particular details have been elucidated by Hoffmann and co-workers.45,251,252 
 
Figure 38 - The proposed ‘ate’ complex route to the exchange product. Diagram and proposed 
structures amalgamated from Hoffmann et al.253 
 
If attached groups are sufficiently stabilising the ‘ate’ complex may take the form of an observable 
intermediate, either a solvent separated ion pair or dissociated ions 216 (Figure 38, Situation C). 
Otherwise a ‘contact ion pair’ 215 where the metal ion is more closely associated may be a 
transition state (Situation A). Alternatively, in Situation B ‘ate’ complex 215 is present only as a 
reactive intermediate and decomposes too rapidly to be observed. Situation C is also favoured by 
higher electron density at the magnesium centre, and hence by coordinating solvents.254 
However, even with very stable ‘ate’ complexes cationic species have a role in the final conversion 
to the Grignard reagent, with a bimolecular process 1st order with regard to total magnesium 
concentration observed.253 Introduction of an electrophile in the presence of an ‘ate’ complex of 
this type may catalyse a chain radical process leading to Grignard formation.  
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6.4 Synthesis of benzophenones components 
6.4.1 Synthesis of ortho-halobenzophenone component 
Availability of 2-aminobenzophenone amine 217 and precedent255 for synthesis of 2-
iodobenzophenone 218 (Scheme 64) contributed to the decision to utilise Suzuki coupling. 
 
Scheme 64 - Synthesis of benzophenone iodide 218. 
 
Diazotisation and quenching with potassium iodide gave near quantitative conversion with a 
procedure modified from literature.255 The viscosity of the mixture and the quantity of gas 
generated meant mechanical stirring, a large flask and careful additions were necessary. The weak 
C-I bond and electron deficient aryl ring make this substrate ideal for the aryl halide component of 
Pd cross coupling reactions. 
 
The synthetic plan was tested at this point by trial coupling reactions on iodobenzophenone 218, 
initially with 4-methoxyphenylboronic acid 219 which is electron rich and should undergo 
transmetallation readily, with reductive elimination also favoured due to the electronic 
complementarity with iodobenzophenone 218. The methoxybenzophenone 220 was isolated in 
an acceptable unoptimised yield (Scheme 65). 
 
Scheme 65 - Test Suzuki coupling of iodobenzophenone 218 with a methoxyarylboronic acid 219. 
 
In order to model the ortho substituent and establish the electronic of boronic acids or esters 
which could be used 2-nitrophenylboronic acid was coupled to benzophenone 218 (Scheme 66). 
 
Scheme 66 - Test Suzuki coupling of iodobenzophenone 218 with a nitroarylboronic acid 221. 
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The coupled benzophenone 222 was not isolated but inferred from the crude 1H NMR spectrum 
by observation of H4 and H6, which were clustered together downfield of both H3 and their 
equivalent iodobenzophenone 218 peaks, a pattern consistent with benzophenone 222 and 
observed repeatedly in other analogues (Chapter 8). 
 
Aryl bromide 223 was then used to test Negishi coupling conditions (Scheme 67). Successful 
lithiation of arylbromide 223 and transmetallation to Zn was followed by transfer into a reaction 
mixture with iodobenzophenone 218 and heating. A 64:36 ratio of starting iodobenzophenone 
218 to 2-arylbenzophenone 225 was identified by 1H NMR. No quenched arylzinc 224 was 
observed as a result of its volatility. Although optimisation would be required this demonstrated 
Negishi coupling to be possible with iodobenzophenone 218. 
 
Scheme 67 - Test Negishi coupling of iodobenzophenone 218 with aryl bromide 223. 
6.4.2 ortho-metalobenzophenones 
The alternative benzophenone-derived coupling partner would be an ortho-metalobenzophenone 
185. Some confusion surrounded the literature conditions255 for magnesiation of 
iodobenzophenone 218; the paper and the supporting information offer conflicting accounts of 
the reaction temperature. Testing first with iPrMgCl and PhMgCl at −40 ˚C (Scheme 68) a mixture 
of products was observed when either Grignard reagent was used followed by addition of borate 
226.  
 
Scheme 68 - Metallation and borylation of iodobenzophenone 218. 
 
Chromatography allowed some of these fractions to be investigated, and it was observed that the 
aromatics signals typically shift substantially upfield in the 1H NMR spectrum. This included a 
species with a d (J = 2.7 Hz, H6) and dd (J = 8.5, 2.7 Hz, H4) between 6.8 and 7.0 ppm, but the 
ortho d (H3) at 7.8 ppm. These peaks are close together in the iodobenzophenone 218, probably 
because the H4 and H6 positions are conjugated to electron withdrawing groups, and the H3 
position is ortho to iodine, which effects a downfield shift on the ortho position.256 The opposite 
change in shift pattern would therefore be expected for successful magnesiation-borylation, and 
Chapter 6: A new targeted superoxide sensor design 85 
 
this product appears more consistent with attack on a withdrawing group, to which both nitro 
and ketone groups are potentially susceptible. Broad singlets at 5.8 ppm and 4.9 ppm which 
exchanged upon D2O shake were also observed in these mixtures. No dehalogenation product 
was observed. 
 
Testing the more conservative SI conditions, exchange of iodine with iPrMgCl or PhMgCl at −78 ˚C 
followed by quenching with MeOH demonstrated that little or no exchange had occurred under 
these conditions (Scheme 69). 
 
Scheme 69 - Metallation test of iodobenzophenone 218. 
 
With low temperature Grignard formation ineffective and side products apparently favoured over 
the formation of boronate ester 227 at higher temperature, Miyaura borylation was attempted 
instead (Scheme 70). 
 
Scheme 70 - Product mixture from the attempted Miyaura borylation of iodobenzophenone 218. 
 
A complex mixture resulted from all attempts at these reactions, but the major products were 
identified. Using 1.1 eq. of bispinacolatodiboron, dehalogenated benzophenone 228 was 
identified as a minor component by comparison with literature data,257 and the major component 
isolated and characterised as dimer 229. This is believed to form through a Suzuki reaction 
between the iodide 218 and product 227, although dimer 229 was also observed in Scheme 107 
where no borylated derivative could be formed. In order to favour the boronate ester 227, the 
bispinaocolatodiboron equivalence was increased to 2 and the equivalence of KOAc reduced from 
5 to a more normal 3, the concentration doubled and the catalyst loading halved. This resulted in 
a mixture including fluorenone 230258 (major) and dimer 229 (minor). The probable mechanism of 
fluorenone 230 formation can be ventured based on a very similar cyclisation with a palladacycle 
catalyst and fluorenone products, which is believed to occur through oxidative addition to Pd(0) 
followed by C-H activation, and reductive elimination.259 The exact nature of such processes is a 
matter of ongoing debate, and a Heck-type mechanism is also conceivable.260,261,262 The isolation 
of small, pure crystals of the fluorenone cyclisation product 230, appeared to indicate that 
oxidative addition is followed by competing borylation and C-H activation based cyclisation of the 
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oxidative addition product. Rapid Suzuki coupling also competes once the arylboronate ester is 
present in significant quantities. Reduction of the temperature to 60 ˚C and reaction time to 3 h 
showed iodobenzophenone 218, dimer 229 and fluorenone 230, demonstrating that the Suzuki 
coupling is faster than the initial borylation and hence one of these side reactions will always be 
preferred, making Miyaura borylation unfeasible. 
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6.5 Synthesis of the tert-butylaryl component 
6.5.1 Synthesis of ortho-(N-alkylamino)aryl halides 
Ortho-(N-alkylamino)aryl halides were potential coupling partners and precursors to ortho-(N-
alkylamino)arylmetals 186 (Scheme 60). N-Alkylation of aniline 188 with an alkyl halide was 
considered so alkyl bromide 232 was prepared via the Appel reaction. Reductive amination also 
appeared to be a good approach to preparing N-alkylaniline derivatives, so previously prepared 
alcohol 145 was oxidised to give aldehyde 231. Numerous suitable procedures exist for oxidation 
of alcohol 145 to aldehyde 231; a TEMPO oxidation protocol263 was chosen as a mild, robust, 
cheap and quick approach (Scheme 71). The mechanism of this reaction is shown in Scheme 72. 
 
 
Scheme 71 - Synthesis of aldehyde 231 and bromide 232. 
 
Scheme 72 - Postulated TEMPO oxidation mechanism.264 
 
Oxidation of the TEMPO radical 233 generates a nitrosonium cation 235 which undergoes 
nucleophilic attack from the alcohol 234, with deprotonation forming complex 236. The resulting 
oxidation occurs by deprotonation to form the aldehyde 237 and eject the reduced cyclic 
hydroxylamine 238. Re-oxidation occurs first to nitroxyl radical 233 then nitrosonium 235. In the 
protocol NaOCl was added as the oxidant, but HOBr formed with KBr contributes significantly to 
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the oxidation rate.265 Oxygen can be used as the oxidant with the correct co-catalyst.266 Reaction 
is faster at pH 8.6 than at 12.7 (probably due to -OBr partitioning mostly into the aqueous phase) 
and faster at 0 ˚C than RT (due to nitrosonium stability).267 Benzyl ethers can oxidise to benzoates 
in systems containing NaOCl,268 and the benzyl ester was observed as a side product in the 1H 
NMR spectrum at levels of up to 15 - 20%, as identified by a 2H t at 4.35 ppm and 3 aromatic 
signals consistent is splitting and shift pattern to a phenyl group with an electron withdrawing 
substituent. Careful TLC monitoring and restricted reaction time and NaOCl(aq) equivalence 
eliminated this problem and allowed isolation in quantitative yield. 
 
With these in hand the necessary amine 240 was prepared (Scheme 73). Literature conditions 
allowed near quantitative nitration of tert-butyl aryl bromide 223 to give nitroaryl 239.269 
Dithionite reduction was attempted based on literature conditions.270 This was initially successful, 
but proved unreliable. Reduction with an iron acid mixture proved more robust, giving aniline 240 
in high yield.271  
 
Scheme 73 - Bromide tBu coupling partner 240 synthesis. 
 
Imine formation by stirring amine 240 and aldehyde 231 with Na2SO4 then reduction with LiBH4 
was ineffective, as was alkylation with alkyl bromide 232 at 80 ˚C in DMF with Cs2CO3, and at RT 
with NaH. Reductive amination with 2 eq. TFA produced a mixture of compounds.272 
NaBH(OAc)3/DCE
273 gave very slow conversion and side products. An alternative TFA based 
procedure utilising much higher equivalence of TFA and later addition of aldehyde 231 in DCM 
gave rapid conversion to 241 in good yield.  
6.5.2 Synthesis of ortho-(N-alkylamino)arylmetals 
Attempts were then made to use metal - halogen exchange and nucleophilic attack from the 
subsequent organometallic species to form a boronic ester Suzuki precursor 242 (Scheme 74). 
 
Scheme 74 - Borylation by metal halogen exchange on amine 241 was not successful. 
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Magnesium - halogen exchange ortho to a primary amine had previously been achieved by first 
deprotonating the amine.274 Metallation of secondary aniline 241 was first attempted both with a 
combination of Grignard reagents; PhMgCl is used to effect deprotonation to form a ‘magnesium 
amide’. The more reactive iPrMgCl is then used to transmetallate to give the aryl Grignard 
reagent274 which can then be used for nucleophilic attack on a borate to give the Suzuki 
precursor. Use of the literature conditions returned starting material and a small quantity of a 
side product. Allowing the mixture of aryl bromide and Grignard reagents to stir at RT for 3 h prior 
to cooling and quenching with a boronic ester gave a 63:37 ratio of aniline 241 to the side 
product. From the mixture the 1H NMR spectrum of this side product was observed to have an 
ABX coupling system shifted substantially downfield. Both the CH2 s of a benzyl group at 4.5 ppm 
and CH2 groups consistent with 1’ (at 3.3 ppm) and 6’ (at 3.5 ppm) positions were associated with 
this side product. The amino proton which is well defined and coupled to CH2-1’ in aniline 241 is 
missing however. Following chromatographic purification none of this side product was isolated. 
Both literature275 and the experience of colleagues confirm that chromatographic purification of 
pinacolboronic esters is possible. Indeed complete hydrolysis of a pinacolboronate ester is a 
difficult transformation.276 While it must be allowed that the electron-donation from the ortho 
group would accelerate protodeboronation, the coupling patterns observed in the reaction 
mixture and column fractions do not suggest this. On this basis, while the identity of the side 
product was not ascertained it was not believed to be the desired product.  
 
When lithium halogen exchange was attempted no reaction was observed at −78˚C with less than 
3 equivalents. It is possible that benzylic lithiation or directed lithiation occur. Warming a solution 
of aniline 241 and excess nbutyllithium from −78˚C to −55 ˚C was noted to produce a green colour. 
Subsequent addition of boronate ester produced the same impurity as previously noted and 
numerous others. At this point the metal - halogen exchange was abandoned, and the Miyaura 
borylation reaction attempted instead (Scheme 75). 
 
Scheme 75 - Miyaura borylation of secondary amine 241 gave dehalogenation product 243 among 
other side products. 
 
Miyaura borylation of aryl bromide 241 resulted in complete conversion giving two products. The 
major one was identified as dehalogenated amine 243 on the basis of an apparent t with an ortho 
coupling constant (J = 8.1 Hz) which would represent the position meta to the amine, and a meta 
apparent t (J = 1.8 Hz) consistent with the position between the amine and the tert-butyl group. 
11B NMR confirmed the absence of boron from either product, proving the reaction to be 
unsuccessful.  
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Deviating from the original synthetic plan, a reductive amination of iodobenzophenone 218 with 
aniline 241 was then attempted (Scheme 76). Successful transformation to tertiary aniline 244 
would give the desired trialkyl system which could then be linked, by Ullman coupling277 for 
example. 
 
Scheme 76 - Reductive amination to give substrate 244. 
 
No reaction was observed, with starting materials 241 and 218 isolated. Alternatives to aniline 
241 were then investigated. 
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6.5.3 Synthesis of N-alkyl-N-arylamides as precursors to the Suzuki Reaction 
 In order to simplify the transmetallation the aniline 241 was protected with Boc to give a 
carbamate (Scheme 77). this removes the most acidic hydrogen, and preventing formation of an 
anion at this position should improve the reactivity of the aryl bromide. Very hindered Suzuki 
couplings are well precedented.210  
 
Scheme 77 - Synthesis of tertiary amide 245. 
 
No reaction was observed when aniline 241 was heated to reflux with NEt3, DMAP and di-tert-
butyldicarbonate in DCM. Instead various strong bases were tested to deprotonate the aniline 
241 prior to dicarbonate addition. Using 1.05 eq. of PhMgCl produced no reaction, however the 
equivalent reaction with 1.12 eq. nbutyllithium gave good conversion, with some residual starting 
material but little decomposition. The procedure was refined by exchanging the nbutyllithium with 
LiHMDS.278 This allowed use of extra equivalents to drive the reaction to completion without 
lithiation giving rise to side products, and the isolation of the tertiary amide 245 in good yield. 
Minor side peaks were observed, alongside substantial broadening and inequivalent CH2-1’. It was 
unclear if these represented an impurity or NMR timescale inequivalence due to sterics, so 1H 
NMR at elevated temperature was compared to the RT data (Figure 39). 
 
Figure 39 - Temperature controlled 1H NMR spectra in CDCl3 of tertiary amide 245, showing RT 
(top) and 55 ˚C (bottom). 
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Two effects were identified. Axial chirality resulting in diastereotopic protons (green), which still 
do not interconvert at 55 ˚C, and geometrical isomers (red), which do. The origins of these effects 
are shown in Figure 40.  
 
Figure 40 - Two types of asymmetry are present on the NMR timescale; axial chirality (a) along the 
C2-N bond, and geometrical isomers (b) where rotation around the amide bond is observed. Note 
the amide C2-N bond and the N-C1’ bonds are out of the aryl ring plane (probably at 
approximately 90˚). 
 
The diastereotopic protons arise from axial chirality. The relation of protons H1‘A and H1‘B to the 
ring and bromide atom differ and the rotation is too slow for these to interconvert on the NMR 
timescale, remaining so even at 90 ˚C. H1‘A and H1‘B therefore represent protons on one species 
inequivalent due to differences in environment. Geometrical isomerism in the form of slow 
rotation around the amide bond is the origin of the side peaks mentioned, and in this case these 
signals are the same proton in different species. These geometrical isomers 246 and 247 
interconvert in a slow equilibrium process. Thus, unlike H1‘A and H1‘B the integrals of these signals 
are not required to be equal to one another. In this case one form is clearly favoured, but heating 
to 50 ˚C is sufficient to eliminate this effect, confirming one compound is present.  
 
Both effects will in principle be eliminated if sufficient energy is provided to increase rotation 
speed until interconversion occurs on the NMR timescale. In the case shown the coalescence 
temperatures (Tc) cannot be established from the data obtained. If this was possible the 
difference in chemical shift can be related to a rate constant for rotation through the Gutowsky 
equation and the energetic barrier to the given rotation further approximated through the Eyring 
equation.279 
 
Following confirmation that the tertiary amide 245 had been isolated pure, metal - halogen 
exchange of this substrate was investigated. Lithiation conditions were effective for amide 245 
and this was confirmed by quenching the aryllithium into MeOH, giving dehalogenated amide 248 
in good yield (Scheme 78). 
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Scheme 78 - Testing the metal-halogen exchange on tertiary amide 245. 
 
From the equivalent magnesiation with iPrMgCl at −30 ˚C only starting material was recovered. 
Repeat of the lithiation with nbutyllithium and quenching with a boronate ester (Scheme 79) gave 
mostly the dehalogenation product 248 rather than arylboronate 249, but chromatography 
showed several other side products, including one in which the 1H NMR spectrum combined a 
broad 2H t at 3.65 ppm for CH2N and a dd (1H, J = 8.5, 2.4 Hz) at 7.2 ppm suggesting a 1,2,4-
substitution pattern for the aromatic ring. The lack of a large methyl s for a pinacol ester and the 
equivalence of H1‘A and H1‘B ruled out the desired product however. Another product observed as 
part of the mixture showed an aromatic t at 7.8 ppm (J = 8.1 Hz), consistent with the position 
meta to the amine in a dehalogenated product, and diastereotopic protons for the CH2-1’ 
position. Repeat reactions with trimethylborate as the quenching agent resulted in 
dehalogenation product. 
 
Scheme 79 - Attempted borylation of tertiary amide 245. 
 
Although some precedent exists for crowded positions adjacent to Boc groups failing to lithiate at 
−78 ˚C,280 the dehalogenation product would appear to discount this possibility. Instead it was 
concluded that the reaction with borate esters is disfavoured by steric repulsion.
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It was decided that replacing the bromine with a zinc chloride would by comparison clash far less 
with the ortho substituents, so a Negishi coupling was attempted (Scheme 80). 
 
Scheme 80 - Unsuccessful transmetallation and Negishi coupling. 
 
Treating aryl bromide 245 with nbutyllithium then transmetallation to zinc and using the reaction 
mixture for a cross-coupling reaction with aryl iodide 218 gave only benzophenone starting 
material 218 and quenched amide 248. The possibility of instead using tertiary amide 245 as the 
halide component was then investigated (Scheme 81). This was treated with 2-nitrophenylboronic 
acid 221, in an attempt to synthesise biphenyl 252. No reaction was observed and amide 245 was 
consequently abandoned. 
 
Scheme 81 - Unsuccessful test of Suzuki coupling with tertiary amide 245. 
 
Instead of using an additional protecting group, a secondary amide would provide a less strained 
alternative. This would prevent the amine interfering with Miyaura borylation, and secondary 
amides are surprisingly effective at directing lithiation.281 Reduction could then be effected prior 
to cross-coupling, or if this proved problematic reasonable precedent exists for amide reduction 
in the presence of a ketone.282 First a suitable acid chloride 254 was prepared from acid 253 
(Scheme 82).  
 
Scheme 82 - Preparation of acid chloride 254. 
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Acid chloride 254 was used directly (Scheme 83) following preparation. 
 
Scheme 83 - Synthesis of phosphonium amide 256. 
 
Synthesis of amide 255 proceeded in disappointing yield. However, subsequent formation of 
phosphonium salt 256 proved efficient. Miyaura borylation283 then resulted in generation of side 
products; the most prominent appeared to lack the phosphonium salt as judged by the lack of the 
characteristic 2H m at 3.8 ppm in the 1H NMR spectrum resulting from the CH2 coupling to the 
adjacent 31P. The aryl peaks were all subsumed into a broad m and so no coupling pattern could 
be deduced, but the significant downfield shift is inconsistent with conversion from a bromide to 
a boronate ester substituent. A variant without the phosphonium present was investigated 
(Scheme 84). 
 
Scheme 84 - Alternate approaches to the synthesis of carboxylic acid 259 and unsuccessful 
formation of amide 260. 
 
The synthesis of amide 260 was approached by first producing carboxylic acid 259, originally by 
Jones’ oxidation284 of the alcohol 145 in good yield. This was improved upon by an alternative 2 
step procedure285 from caprolactone 258 with initial hydrolysis and benzyl protection of both acid 
and alcohol groups, followed by ester hydrolysis for selective deprotection to acid 259. 
Subsequent formation of an acid chloride and amide formation from amine 240 resulted in a 
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mixture. Later EDCI coupling conditions appeared to give slow reaction. A 1:1 mixture of starting 
material 240 and a side product was obtained. The side product gave a downfield shift of around 
0.3 ppm in the 1H NMR spectrum in the dd signal assigned para to the amine but a much smaller 
shift of 0.1 ppm in the d assigned meta to the amine. These integrated reasonably with peaks 
assigned as CH2-1’ and CH2-6’. This is consistent with the amide 260, although the material was 
not isolated or further pursued as this approach was abandoned in favour of SNAr, an alternative 
route which had been performed in parallel and which was felt to offer more novelty and 
versatility. This will be discussed in the next chapter. 
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Chapter 7: Phenanthridinium-based sensor by nucleophilic aromatic 
substitution 
7.1 New synthetic plan 
During the development of the Suzuki coupling an alternative approach was conceived (Scheme 
85). This retained nitro reduction of phenanthridinium 262 to give the aniline in the 8 position of 
probe 261 but envisaged an 6-exo-trig cyclisation by SNAr from a benzophenone derived imine 
(N5) to a halogen-substituted C4a. The electronics of imine 263 are appropriate as the rate-
determining step of SNAr is nucleophilic addition to form a carbanion, which is stabilised by 
electron withdrawing groups such as the 7a imine and especially the 8 nitro group, both of which 
are conjugated to the 4a position. Fluorine was used as the halide because the carbanion is 
inductively stabilised by the leaving group, and fluorine provides more effective stabilisation due 
to its greater electronegativity relative to the other halides.286 The alkylamine 264 is separately 
synthesised allowing the chain and triphenylphosphonium targeting group to be introduced by 
formation of imine 263 from biphenyl 265. The aryl-aryl bond of biphenyl 265, which becomes 
C1a-C10a in probe 261 would be formed by Suzuki coupling of benzophenone 218 with ortho-
fluoroarylboronate 266, previously formed by borylation of aryl fluoride 267. 
 
Scheme 85 – Retrosynthesis of SNAr route, atoms numbered as positioned in probe 261. 
 
The route outlined in Scheme 85 has several advantages. The late addition of alkylamine 264 
results in a more convergent synthesis, and imine formation is well precedented on a huge range 
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of substrates, various benzophenones included.287 The 2-fluoroarylboron component 266 is also a 
far less sterically demanding substrate than the previously synthesised alkyl anilines (Chapter 6). 
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7.2 Aryl fluoride synthesis 
Synthesis of the appropriate aryl halides 267 was required in order to test this route. Aryl 
fluorides are an obvious choice of electrophile for SNAr reactions. Aromatic fluorination is a 
relatively challenging transformation at a laboratory scale, due to harsh conditions and hazardous, 
difficult to manage reagents and side products. Taking advantage of the commercial availability of 
aryl fluorides a route using Friedel-Crafts alkylation of 2-fluorohalobenzenes 268 and 269 was 
investigated. Consideration of both Hammett parameters288 and the influence of the halides on 
13C NMR shifts289 suggested C5 is the more nucleophilic position, but the differences between C4 
and C5 are small. It was believed that steric interactions may favour formation of the C4 
substituted aryl fluoride 271. A variety of Friedel-Crafts alkylation conditions were used to probe 
the regiochemistry of the reaction (Scheme 86). 
 
Scheme 86 - Friedel-Crafts alkylation, possible regiochemistry. 
 
Rapid conversion was achieved with a 3% loading of AlCl3 in 
tBuCl at 0 ˚C. When applied to 1-
bromo-2-fluorobenzene 268 the C5 substituted arylbromide 272 was the major product, but the 
4-tert-butylaryl bromide product was observed as a minor product (Scheme 87). 
 
Scheme 87 - Friedel-Crafts alkylation on the bromoaryl substrate 268 gave mostly C5 selectivity. 
 
When repeated with the 1-iodo-2-fluorobenzene 269 the procedure gave near quantitative 
conversion to the C5 substituted aryliodide 273 (Scheme 88). 
 
Scheme 88 - Friedel-Crafts alkylation on the iodoaryl substrate 269 gave complete C5 selectivity. 
 
These results prove the desired regiochemistry to be the less favoured outcome for the Friedel-
Crafts alkylation, due to the influence of the fluoride group on electrophilic substitution. On this 
basis it was decided that the fluoride should be introduced after the tert-butyl group. Effective 
electrophilic fluorination protocols rely on the formation of organometallic nucleophiles,290 
difficult to do selectively in the presence of an aryl bromide. With the electron rich aryl bromide 
223 unsuitable for SNAr reactions and with regiocontrol of fluorination vital the Balz-Schiemann 
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reaction appeared to be the most viable approach. Aniline 240 was used to provide the desired 
regiochemistry (Scheme 89). 
 
Scheme 89 - Synthesis of the fluoroaryl substrate 275. 
 
The Balz-Schiemann reaction actually involves two steps, with diazonium tetrafluoroborate 274 
formed and then thermally decomposed. Initially a combination of HBF4(aq) and NaNO2 was 
reacted with aniline 240 to form the diazonium tetrafluoroborate 274 in 51% yield after washing 
with HBF4(aq) and Et2O. Due to the low solubility of diazonium salt 274 subsequent pyrolysis under 
reflux in PhMe gave only a low yield of aryl fluoride 275 (24%). DMSO was tested as a solvent for 
pyrolysis, giving clean conversion to a non-fluorinated product assumed to be the phenolic 
derivative. This is consistent with a literature study showing incorporation of the oxygen from 
DMSO, forming phenols due to a preassociation of the solvent molecule prior to generation of the 
aryl cation.291 
 
Although diazonium salt 274 had been isolated in reasonable yield, the combination of poor 
solubility in PhMe, toxic reagents and the potentially explosive intermediate made this procedure 
undesirable. Instead, the diazonium tetrafluoroborate salt 274 was formed with NOBF4 in DCM, 
then PhMe added and the DCM removed under vacuum before pyrolysis to give aryl fluoride 275 
in good yield.292,293 Scale up was carried out in batches for safety reasons. Various details of the 
reaction mechanism remain obscure. There are two alternate pathways for decomposition 
broadly accepted in the literature (Scheme 90).294 
 
Scheme 90 - Alternate dediazoniation pathways.295 D. is a radical donor, X = electrophile. 
 
Balz-Schiemann products arise from the heterolytic pathway (I), where the C-N bond of the 
diazonium tetrafluoroborate ion pair 276 is broken, resulting in an ion pair between nitrogen and 
the reactive phenyl cation296 277 which reacts with a nucleophile within a local solvation sphere 
to give aryl fluoride 278.297 The nucleophile has been shown to be BF4
-
 rather than F
-.298 
Heterolytic decomposition is favoured by electron donating substituents which destabilise the 
arenediazonium 276 and stabilise the cation 277. These reactions are favoured by oxygen rich 
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atmospheres which suppress the homolytic pathway (II), in which the aryldiazonium salt 276 
decomposes to the phenyl radical 279, which reacts with an electrophile and undergoes SET to 
give neutral species 280.299 Many reactions of this type exist, with some mechanistic variation.300 
The homolytic pathway can result from solvent acting as a nucleophile prior to decomposition to 
the phenyl radical 279. Since the homolytic pathway301 can result in protodediazoniation and aryl 
homocoupling in addition to formation of the desired product non-nucleophilic solvents are 
preferred, and basic conditions avoided.302 
 
Evidence for the Balz-Schiemann going through the heterolytic pathway (I) can be seen in the 
biaryl product composition seen when the reaction takes place in the presence of other aryl 
groups, with regiochemistry defined by ring electronics and influenced by substituents (Scheme 
91).303 The Gomberg - Bachmann reaction uses diazonium salts to produce biphenyls under 
neutral or basic conditions via a radical mechanism and correspondingly does not show the same 
selectivity in product composition.304 One study of diazonium tetrafluoroborate pyrolysis in the 
solid phase observed the Balz-Schiemann reaction accelerates in a fashion reminiscent of a chain 
reaction, leading the authors to propose a mechanism where radicals are generated following 
decomposition to an ion pair.305  
 
Scheme 91 - Products observed from pyrolysis of diazonium tetrafluoroborate 276 (top) and 
chloride 282 (bottom).303  
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7.3 Borylation of 2-fluoroarylhalides 
The aryl bromide 275 was to be converted to a boronate using a lithium-halogen exchange. 
Conditions for the lithiation and conversion to the potassium trifluoroborate salt were tested on 
1-bromo-2-fluorobenzene 268 (Scheme 92). 
 
Scheme 92 - Lithiation condition testing 
 
The aryllithium species is generated at low temperature from ortho arylbromide 268 to avoid side 
reactions, including solvent decomposition. Triisopropylborate was used as the boronate source, 
forming the arylboronate ester which was converted to the stable trifuoroborate salt 285 by 
stirring in KHF2(aq). Trifluoroborate salt 285 was crystallised from acetone. Formation of the 
aryltrifluoroborate 285 avoids the formation of boronate trimers sometimes seen in boronic acid 
synthesis.213 Although these react similarly to the monomers, analysis and yield calculation is less 
precise where multiple species are present. The trifluoroborate salts undergo slow hydrolysis to 
the boronic acid prior to cross-coupling, with side reactions suppressed by the low concentration 
of the boronic acid.306 The procedure was repeated with aryl bromide 275 (Scheme 93). Lithiating 
aryl bromide 275 and borylating then quenching into a KHF2 solution gave clean conversion to 
trifluoroborate salt 266 without the need for recrystallisation. 
 
Scheme 93 - Synthesis of the potassium trifluoroborate coupling partner 
7.4 Suzuki coupling to form ortho-arylbenzophenone 265 
The coupling of arylmetal 266 and benzophenone 218 was expected to be challenging due to both 
having ortho substituents, so time was spent identifying appropriate cross-coupling conditions. 
For testing purposes three catalytic systems were selected; the heavily used and studied Pd(PPh3)4 
(tetrakis) 189, one of the more versatile bidentate catalysts (dppf)PdCl2 190,
230 and the most 
active231 of the available PEPPSI-NHC catalysts, PEPPSI-iPr 191 (Figure 33). The need for alcoholic 
solvents was anticipated based on the solubility of the potassium trifluoroborate salts 266 and 
285. Since hydrolysis to the boronic acid precedes transmetallation low water content could 
inhibit reaction; use of a hygroscopic solvent also eliminated this concern. EtOH was used over 
MeOH allowing a greater thermal range without changing solvents. The temperature (78 ˚C) and 
catalyst loading (3%) are within the normal range for Suzuki coupling. DIPEA was used as the base 
with the exception of the PEPPSI iPr example where K2CO3 was initially used in line with the 
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PEPPSI use guide.307 The model potassium aryl trifluoroborate salt 285 was initially used as a test 
substrate and coupled to iodobenzophenone 218 with all three catalysts with the intention of 
making ketone 286 (Scheme 94).  
 
Scheme 94 - Cross coupling test reaction. 
 
Little reaction was observed using Pd(PPh3)4 189, and as this catalyst was also the least stable it 
was not further tested. Both dppf 190 and PEPPSI-iPr ligands 191 consumed the starting material, 
giving one spot by TLC. Subsequent 1H NMR spectra showed two compounds, one of which could 
be readily identified as benzophenone 286 due to 19F coupling on the fluorinated aromatic ring. 
These proved inseparable by flash chromatography. HPLC was used to isolate the other product as 
the dehalogenated compound 228. 
 
Isolation of the dehalogenated material suggested problems with the transmetallation or 
reductive elimination steps. Trifluoroboronate 266 is more electron rich (aiding transmetallation) 
and more electronically divergent from iodobenzophenone 218 (aiding reductive elimination) 
than the test substrate 285. It was decided that N,N-diisopropylethylamine (DIPEA) should be 
used as the base for both catalysts in the hope that β-hydride elimination would aid reduction of 
Pd(II) salts to Pd(0).308 DIPEA is also more soluble and less likely to reduce the available water 
content, and the conjugate acid is less likely to interact with Pd-OH prior to transmetallation. 
PEPPSI-iPr was tested in the coupling of iodobenzophenone 218 and trifluoroborate salt 266 and 
the biaryl 265 was isolated in good yield (Scheme 95). The dppf catalyst 190 also worked but the 
reaction was marginally less clean. 
 
Scheme 95 - The Suzuki coupling of iodobenzophenone 218 and potassium aryltrifluoroborate 
266. 
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7.5 Imine formation and SNAr to complete phenanthridinium core 
7.5.1 Imine formation 
With the key C1a-C10a bond made the remaining key transformations were the formation of the 
imine and intramolecular nucleophilic displacement of the fluoride ion to give the 
phenanthridinium core. The sequence was tested using benzophenone 265 and hexylamine to 
make imine 287, which could then be cyclised (Scheme 96). Heating in MeCN at 80 ˚C or at 150 ˚C 
in a sealed tube under microwave irradiation gave no reaction, and heating benzophenone 265 to 
90˚C in neat hexylamine also gave only starting material. However, using an excess of hexylamine 
with titanium tetrachloride converted benzophenone into imine 287 in acceptable yield following 
purification. 
  
Scheme 96 - Formation of imine 287 followed by heating gives cyclisation to phenanthridinium 
salt 288. 
 
The imine retained the dual 1,2,4-trisubstituted systems of benzophenone 265 in the 1H NMR 
spectrum (Figure 41). H4 and H6 showed a significant upfield shift, while H3 scarcely moved. This 
suggests a change in the electronics of the group at C1. 
 
Figure 41 - Benzophenone 265 (top) vs imine 287 (bottom), with key shifts highlighted. 
 
The difference in chemical shift between H4 and H6 in 1H NMR spectrum of the imine 287, but not 
in that of benzophenone 265, perhaps indicates that the hexyl chain forces the phenyl group into 
H4 & H6 H3, H2’, H6’ 
H4 H6 H3 
Benzophenone 
Imine 
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a different conformation relative to the other ring of the benzophenone. The H-F couplings in the 
1H NMR spectrum of the imine 287 were confirmed using 19F decoupled 1H NMR spectroscopy and 
showed that the fluoride had been retained in the same position as in the starting benzophenone 
265. Interestingly, the ortho F appears to couple with both C3 and H3 of the neighbouring C ring, 
demonstrated by the small additional C(H) - F coupling in the sp2 region of the 13C NMR spectrum 
and the loss of the smaller splitting of the dd assigned to H3 in the 19F decoupling experiment. 
Imine 287 shares structural features with literature compounds exhibiting this phenomenon, 
which in those cases was attributed to N lone pair - F repulsion locking the F in close proximity to 
C/H to which it couples.309 This is consistent with the observation of a pair of ddd at 3.0 - 3.5 ppm 
that were identified as diastereotopic protons at CH2N resulting from hindered rotation about the 
bond linking the two rings of the biaryl unit.  
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7.5.2 Cyclisation 
There are very few examples of imines displacing an aryl halide intramolecularly. However, an 
intramolecular SNAr was attempted by heating the crude imine 287 with 3 eq. TMSCl in CDCl3 at 
60 ˚C for 1 h prior to 1H NMR analysis. The resulting 1H NMR spectrum showed a few interesting 
features: 
 Additional methylsilane peaks were apparent in the 0.0 - 0.5 ppm region. 
 The aromatic region matched the pattern of the imine, but the benzophenone rings in 
particular showed strong downfield shifts. Also, peaks assumed to be H5’’ and H6’’ of the 
A-ring were separated. 
 The broad peak at 4.5 - 5.0 ppm characteristic of CH2N
+ in the phenanthridinium salts was 
not observed. 
These were considered consistent with TMS-iminium salt 289, although hardly conclusive 
evidence (Figure 42).  
 
Figure 42 - Possible TMS-iminium adduct 289. 
 
Following work up and short-path vacuum distillation of this reaction mixture in a kugelrohr 
apparatus, 1H NMR spectroscopy showed peaks characteristic of N-alkyl phenanthridinium salts, 
including a broad singlet at 5 ppm. Attempting to cyclise pure imine 287 at 200 ˚C in nitrobenzene 
resulted in isolation of phenanthridine 290 (a small amount of which was isolated for 
characterisation purposes) and no phenanthridinium 288 (Scheme 97). 
 
Scheme 97 - High temperature cyclisation of imine 287. 
 
Cyclisation of imine 287 (Scheme 97) was next investigated by heating the solid to 100 ˚C in a 
kugelrohr apparatus for 1 h, causing the material to discolour. Addition of CDCl3 followed by 
removal by distillation and heating for a further hour gave complete conversion of starting 
material to a mixture containing no 19F-1H coupling in the 1H NMR spectrum and no 19F according 
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to 19F decoupled 1H NMR spectroscopy (Figure 43). These clearer spectra resolved a peak 
corresponding to CH2N at 3.3 ppm as a 2H t. This was inconsistent with a phenanthridinium 288, 
but consistent with amine 292, which would result from hydroxide attack to give a pseudobase 
291 (see Section 4.3) and opening. COSY analysis shows H6’’ to be considerably downfield of H3’’ 
and H5’’ (Figure 43), which is as expected for this position, meta to both donating groups and 
conjugated to a stronger withdrawing group than before in the form of the ketone. Based on this 
evidence, these peaks were assigned to the hydrolysis product 292.  
 
Figure 43 - heating imine (top) results in a mixture containing predominantly amine 292 (middle), 
which then cyclises to the N-alkylphenanthridinium salt 288 on addition of TFA. 
 
Scheme 98 - The cyclisation of imine 287 and subsequent products. Protons are colour coded to 
the 1H NMR spectra shown above (Figure 43). 
 
As loss of fluorine had been observed, the eventual fate of the fluoride anion was of interest. It 
was considered that formation of fluorosilicates in the glass may drive the hydrolysis reaction, 
providing water and destabilising the salt. To test this theory the kugelrohr cyclisation experiment 
was repeated twice in the presence of chromatography grade SiO2. On both occasions the imine 
287 reacted somewhat more slowly, as expected in the presence of an acidic additive. Trace 
Imine 287 
Amine 292 
Phenanthiridinium 288 
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quantities of phenanthridinium 288 were formed alongside a greater range of side products. 
Comparison of the results with and without SiO2 (Figure 44) indicated that omission of SiO2 was 
preferable. 
 
Figure 44 - Comparison of cyclisation for 1 h from CHCl3, with and without SiO2. Green boxes 
indicate phenanthridinium peaks, red is the open form and blue the SM. 
 
It was expected that acidic conditions would push the equilibrium to favour phenanthridinium 
288 over pseudobase 291 and ketone 292 by favouring dehydration and limiting availability of 
hydroxide or neutral water for hydrolysis to the amine 292. Electron-rich phenanthridiniums 
would show greater hydrolytic stability as the electrophilicity of the iminium would decrease so it 
was decided to treat with acid after the cyclization and reduce the nitro group under acidic 
conditions.  
 
  
Without SiO2 
With SiO2 
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7.6 Scale up and completion of the probe 
The Suzuki coupling of trifluoroborate salt 266 and iodobenzophenone 218 was repeated on a 
large scale and benzophenone 265 isolated in a 95% crude yield (Scheme 99). This unpurified 
material was used to prepare imine 287, which was not purified following work-up, but was 
heated in a kugelrohr at 100 °C for 1 h. The resulting mixture was treated with TFA to ensure 
conversion to the phenanthridinium salt 288, and immediately hydrogenated over Pd/C using TFA 
as solvent. The mixture was neutralised and dried with K2CO3. An ion exchange procedure 
converted the material to mesylate. This gave the target aminophenanthridinium salt 293 in 47% 
yield from benzophenone 265 and a 45% overall yield from iodobenzophenone 218. 
 
Scheme 99 - The final synthesis of the tBu superoxide probe model 293. 
 
Phenanthridinium 293 was a precursor to a potential untargeted superoxide sensor 294, so 
reduction to the latter was tested and reacted rapidly with NaBH4. Re-oxidation proved very rapid 
and so isolation of the reduced form required development of a specific protocol (Scheme 100). 
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Scheme 100 - Reduction of superoxide probe precursor 293 to superoxide probe 294. 
 
The oxidised form 293 was added to a degassed biphasic system of H2O and Et2O through which 
argon is constantly bubbled. Excess NaBH4 was added and the bright orange colour of the 
aqueous phase was lost, then the system sealed and shaken for 10 min. Without opening the 
vessel, the Et2O layer is carefully syringed out into another vessel sealed and under argon, then 
additional degassed Et2O used to repeat the process. A high flow of argon was then used to 
evaporate the Et2O. When taken up and in degassed CDCl3 
1H NMR spectroscopy showed 
complete reduction, although rapid re-oxidation subsequently occurred. Since the 
dihydrophenanthridine 294 could be prepared from phenanthridinium 293, the phenanthridinium 
294 was submitted for testing by the group of Dr Michael P. Murphy at the MRC, Cambridge. The 
results of these tests will be discussed in Chapter 9. Since we had now developed a new route to 
N-alkylphenanthridiniums, we decided to exemplify this methodology, and this will be discussed 
in the next chapter.  
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Chapter 8: Methodology exemplification 
8.1 Why exemplify this methodology? 
8.1.1 The uses of N-alkylphenanthridinium salts 
N-Alkylphenanthridinium heterocycles have a considerable multitude of uses aside from their 
potential as superoxide probes, such as DNA intercalating132,180,310 dyes (such as ethidium 
bromide) and trypanocidal drugs311 e.g. Samorin. The combination of appropriate redox 
properties and intercalation allows phenanthridinium salts to be used in the study of the redox 
and electron transport properties of DNA.176,139 Phenanthridinium salts function as allosteric 
inhibitors of acetylcholine esterase.312 Related alkaloids display potential anti-tumour properties. 
These are reliant on the planar, cationic nature of the heterocycles,313 and can occur through 
Topoisomerase inhibition.314,315 They have also been shown to exhibit antibiotic properties.316,317 
8.1.2 Methodology scope and novelty 
In addition to the previously mentioned features, the route described in Chapter 7 also has 
considerable chemical novelty - SNAr reactions utilising an N-alkyl imine nucleophile are extremely 
rare, but a few examples do exist.318,319 The same reaction with an acyclic N-alkyl imine 
nucleophile, however, is almost unprecedented - only one literature example was found.320  
 
Despite their many applications, extant synthetic routes to phenanthridinium salts are limited, 
and rely on N-alkylation almost without exception (see Sections 4.1-4.3). A synthetic route to 
structural analogues without this often messy and slow transformation would allow the 
properties of phenanthridinium salts to be investigated and tuned more easily to meet the range 
of applications mentioned, and is therefore of considerable practical value. 
 
Following optimisation the imine cyclisation in Chapter 7 gave near quantitative conversion to the 
N-alkylphenanthridinium salt 288. The efficiency of this transformation was gratifying, and further 
work was undertaken to illustrate the electronic and steric tolerance of the cyclisation with a view 
towards providing a practical, general and convergent route to these important substrates. 
Scheme 101 outlines how our strategy allows access to a phenanthridinium salt 295 in just three 
steps from an arylboron 296, alkylamine 297 and benzophenone 298. Many analogues of each of 
these components are available commercially, and far more are identified in the literature. 
Furthermore, the chemistry used to access the precursor imines (Suzuki coupling, imine 
formation) is well understood, well precedented and generally robust. 
 
Scheme 101 - A generalised approach to the synthesis of 5,6-disubstituted N-
alkylphenanthridinium salts. 
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8.2 Target selection for methodology exemplification 
Subsequently targets were selected to exemplify the reaction and explicate its utility (Figure 45), 
focusing particularly on showing variation in electronics, sterics and substitution pattern while 
starting from a small palette of available or readily synthesised compounds.  
 
Figure 45 - Selected exemplification targets 
 
The 6 points of variation in the core structure give a diversity of objective compounds 
commensurate to the scope and utility to be demonstrated; compounds 299, 302, 303, 304, 305 
and 307 to probe the electronics of the system, 308 and 309 the steric tolerance, 306 and 311 the 
importance of the phenyl substituent. The remaining targets show either diversification routes 
(300 and 310) or in the case of 301 access to a novel structure which would require a convoluted 
synthetic route if constructed via alkylation protocols. 
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8.3 Precursor synthesis 
8.3.1 Synthesis of precursor arylboron 296 components 
Maximising the use of commercially available components such as the range of 2-
fluorophenylboronic acids and previously synthesised components such as iodobenzophenone 
218 was also considered during target selection. As such, the 2-haloaryl boronic acids used to 
couple with the precursor benzo and acetophenones 298 were mostly purchased from 
commercial sources (Figure 46). 
 
Figure 46 - The arylmetal components. With the exception of 266 and 315, these are 
commercially available. 
 
As potassium trifluoroborate salt 266 had already been synthesised, only pinacolborate 315 
required preparation. Grignard formation with PhMgBr then borylation was attempted according 
to a literature procedure321 but this gave a mixture of products (Scheme 102). 
 
Scheme 102 - Attempted synthesis of arylboronate 315 by Grignard formation and quenching 
with a boronate electrophile. 
 
Scheme 103 - Palladium catalysed borylation giving the 2-fluoro-4-nitroarylboronate ester 315. 
 
Instead pinacolboronate 315 was synthesised via Miyaura borylation (Scheme 103), using a 
modified literature procedure.322 0.15 eq. of NEt3 is added to activate the catalyst by β-hydride 
elimination.308 Quantitative conversion was observed; however repeated chromatography proved 
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necessary to remove the boronate byproducts. Recrystallisation of the pinacolboronate ester 
gave clean material in a lower yield.  
 
The potassium trifluoroborate salt 320 was also synthesised, by subjecting the crude reaction 
mixture from Miyuara borylation to KHF2(aq) and recrystallising from acetone (Scheme 104). 
Unfortunately this gave the salt 320 in low yield. 
 
Scheme 104 - Palladium catalysed borylation giving the potassium trifluoroborate salt 320. 
8.3.2 Synthesis of precursor arylhalide component 
For the most part 2-iodo-4-nitrobenzophenone 218 was used as the aryl halide component, 
supplemented by 2-bromoacetophenone 321, and 2-iodobenzophenone 322, and 2-bromo-4-
nitroacetophenone 323 (Figure 47). 
 
Figure 47 - Selected benzophenone precursors. 
 
The synthesis of 2-iodo-4-nitrobenzophenone 218 has been described already (see Chapter 5) and 
ketones 322 and 323 were purchased. 2-Bromonitroacetophenone 321 was synthesised by 
nitration of 2-bromoacetophenone 323. Three sets of conditions were tested: KNO3/H2SO4(aq), 
Ac2O/HNO3(aq) and AcOH/HNO3(aq). Acetophenone 323 proved too deactivated for the milder 
conditions so the H2SO4(aq)/KNO3 conditions were scaled up, and stopped at around 85-90% 
completion due to side product formation. Chromatography gave the desired compound in 
moderate yield (Scheme 105). 
 
Scheme 105 - Synthesis of 4-nitroacetophenone 321. 
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8.3.3 Suzuki cross coupling to give biaryl precursors 
A range of biaryls 324 - 333 (Figure 48) were then prepared by Suzuki coupling (Scheme 106 and 
Table 2), with conditions used initially based on those previously used for benzophenone 265 
(Section 7.4). Although the reagents are the same the conditions used varied (Table 2). These 
reactions can be divided into 2 categories: microwave and non-microwave reactions. The former 
was developed as a response to difficulties in getting particularly electron-poor arylboronates 
such as nitroarene 315 to cross couple, where higher temperatures are necessary. 
Transmetallation is usually the rate limiting step in the case of the NHC catalysts used, and 
electron poor arylboronates undergo this reaction less readily. The microwave is a fast and 
efficient way of achieving higher temperatures, and reaction was further aided by higher 
concentrations. More specific microwave effects have previously been claimed, but a recent 
review suggests there is no evidence of this.323 
 
Figure 48 - Cross coupling aryl halide and transmetallation partners. 
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Scheme 106 - Generalised Suzuki coupling outline. 
Table 2 - Summary of Suzuki reaction conditions and product yields. 
Target [ArX] t (h) ArBXn eq. cat. T (˚C) µwave Purification Yield 
265 0.12 4 1.12 6% 78 N Chromatography 78% 
324 0.41 0.17 1.03 5% 125 Y Chromatography 40% 
325 0.28 1 1.00 5% 125 Y Chromatography 53% 
326 0.10 22 1.11 3% 78 N Chromatography 55% 
327 0.25 16 1.00 3% 78 N Chromatography 76% 
328 0.19 0.5 1.03 5% 100 Y Chromatography 99% 
329 0.34 1 1.00 5% 125 Y Chromatography 84% 
330 0.28 0.16 1.00 5% 125 Y Chromatography 56% 
331 0.20 16 1.00 3% 78 N Precipitation 49% 
332 0.16 22 1.00 3% 78 N Crystallised 66% 
333 0.15 22 1.00 3% 78 N Crystallised 83% 
 
The conditions described for tbutyl benzophenone 265 were used as a starting point. The 6% 
catalyst loading appeared to give near quantitative conversion, but chromatography entailed 
substantial loses. Purification difficulties were observed with several substrates.  
 
Nitroacetophenone 321 reacted readily under microwave conditions, giving a 3 - 4:1 ratio of the 
3,8-Dinitroacetophenone 324 to an acetophenone derived impurity. Purification proved difficult, 
giving a moderate yield. Coupling to give heterocyclic benzophenone derivative 325 was 
attempted under thermal conditions, but only unreacted benzophenone 218 was recovered in 
large quantities. As the pyridylboronic acid 312 has a reported melting point of 172 ˚C324 and no 
aqueous wash was utilised in work up it was assumed that deboronation had destroyed the 
transmetallating component as pyridyl boronic acids are prone to decomposition.214 It is also 
possible that the pyridyl 312 competes with the weakly binding 3-chloropyridine ligand. Raising 
the reaction temperature with the microwave showed the Suzuki coupling to be faster than 
decomposition at 125 ˚C, allowing pyridylbenzophenone 325 to be isolated, although 
chromatography proved challenging. 
 
The coupling of bromoarylboronic acid 313 with 2-iodo-5-nitrobenzophenone 218 to give 
bromobenzophenone 326 posed a challenge; although electron poor 2-iodo-5-
nitrobenzophenone 218 was likely to undergo oxidative addition more rapidly than the bromide, 
the bromoarylbenzophenone 326 is also a good Suzuki coupling substrate and is present in higher 
concentrations as the reaction nears completion. Originally an excess of the iodobenzophenone 
218 was used, but it was established that this starting material was chromatographically 
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inseparable from the bromobenzophenone 326. Some success was achieved by sonicating the 
chromatographed mixture in an Et2O/Pet. ether mixture in which the product 326 was sparingly 
soluble, resulting in precipitation of the product as a fine white solid. Multiple failures to repeat 
this procedure with a later batch of material suggested that the conditions required are very 
precise and difficult to achieve reproducibly. Instead it proved necessary to use an excess of 
arylboronic acid 313 to consume fully the 2-iodo-5-nitrobenzophenone 218. This generated 
another impurity, identified as benzophenone dehalogenation product 228 (Scheme 70), which 
could be removed by chromatography. 
 
Coupling to give unsubstituted 2-arylbenzophenone 327 worked under thermal (76%) conditions. 
The equivalent acetophenone 329 required harsher conditions, producing a good yield only after 
extensive microwave heating. 
 
Since arylboronate 315 was synthesised by the Miyaura reaction, an attempt was made to 
combine Miyaura and Suzuki reactions to synthesise dinitrobenzophenone 328 by changing the 
Miyaura catalyst to PEPPSI-iPr and then adding the Suzuki reagents and a small amount of water 
after 16 h, but a complicated mixture containing little or no product resulted. Suzuki coupling of 
isolated arylboronate 315 with iodobenzophenone 218, under thermal conditions proved 
sluggish. Microwave irradiation of a 0.1 M solution of each component to 120 ˚C for 10 mins gave 
rapid conversion and mostly the dinitrobenzophenone 328. Dropping to 100 ˚C for 30 min 
reduced side product generation. Adjusting the conditions to 100˚C/30 min at 0.2 M 
concentration of iodobenzophenone 218 gave higher conversion and a yield of 99% after 
chromatography. 
 
Synthesis of aryl chloride 330 was problematic. The PEPPSI-iPr catalyst can affect oxidative 
addition on C - Cl bonds, and the electronics of the product 330 favour this and disfavour 
transmetallation from the arylboronate 316. Standard thermal conditions proved ineffective while 
microwave heating to 125 ˚C for 1 h with 1.1 eq. 2-chloro-5-nitrophenylboronic acid 316 gave side 
products in addition to chlorobenzophenone 330. Reducing the number of equivalents of 
chloroboronic acid 316 to 0.9 and reaction time to 10 min gave little purity change. A ratio of 3:1 
for product to homocoupled benzophenone 229 resulted (Scheme 107). This suggests 
transmetallation is sufficiently slow for competitive Pd(II) reduction. Increasing the number of 
equivalents substantially to counteract this would risk further cross coupling of the 
chlorobenzophenone 330 with arylboronic acid 316, so a moderate yield of 56% was accepted. 
 
Scheme 107 - Products of chloroarylboronic acid 316 and iodobenzophenone 218 cross coupling. 
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Synthesis of 2-arylbenzophenone 331 from iodobenzophenone 218 and 2-fluorophenylboronic 
acid 314 proved easier. Thermal conditions gave near quantitative conversion to 
mononitrobenzophenone 331 on a small scale. An unexpected shortage of 2-fluorophenylboronic 
acid 314 meant only 0.9 equivalents could be used, and subsequent Suzuki coupling resulted in a 
mixture of compounds. Separation proved challenging, with chromatography followed by 
precipitation as described for bromobenzophenone 326 giving a moderate yield of 
mononitrobenzophenone 331. Both methylbenzophenone 332 and methoxybenzophenone 333 
were synthesised by Suzuki coupling in a near quantitative fashion thermally, being recrystallised 
from CHCl3 to remove inorganic impurities prior to the methodology steps. 
8.3.4 Nitration of 2-(5’’-methoxy-2’’-fluorophenyl)-5-nitrobenzophenone 333 
To investigate the interplay of electron donating and withdrawing groups and to produce a 
precursor to the 2-hydroxyphenanthridinium MitoSOX standard desired for the superoxide probe 
project (Chapter 10) the dinitro compound 334 above was among the target precursors for the 
phenanthridiniums. Rather than modify the Suzuki precursor it was felt that the electronics of the 
ring systems might be distinct enough to allow regioselective nitration (Scheme 109). Although 
the major features of electrophilic aromatic substitutions and nitration in particular are 
understood, some details are recently discovered or disputed.325,326,327 Preassociation of the 
nitronium ion and the arene substrate occurs, through an ionic (π) complex or via SET to give two 
radicals, depending on the nature of the reactants. Either then give the σ-complex which precedes 
product.328 The ease of rearranging these associated states explains the observed high 
regioselectivity but low substrate selectivity.329 Various nitration conditions were attempted. 
 
Initial attempts to nitrate methoxyarene 333 with AcOH/HNO3(aq) proved this system to be 
insufficiently reactive, with no reaction observed after 1 h. Nitration in a biphasic mixture using 
H2SO4(aq)/KNO3 resulted in spontaneous decomposition to an insoluble black residue, believed to 
be composed of sulfonylation products. 
 
The nitronium salt NO2BF4 is a common, powerful nitrating agent. This was tested on the rationale 
that addition of 1 equivalent at –42 °C in MeCN followed by slow warming would result in 
preferential reaction at the more electron rich site and give dinitro compound 334. Practical and 
theoretical problems became apparent - NO2BF4 is sufficiently hygroscopic to be extremely 
difficult to weigh on a sub 50 mg scale, and sparingly soluble. The reaction with methoxyarene 
333 is rapid and exothermic, so the degree of local temperature control achieved with an external 
dry ice bath is debatable. The handling properties of NO2BF4 made using the correct equivalence 
challenging, and excesses resulted in further nitration and isolation of trinitro arene 335 showed it 
to have been formed in a 2:1 ratio (1H NMR) to the dinitrobenzophenone target 334, although the 
absence of methoxybenzophenone 333 from the mixture was considered encouraging. The 
regiochemistry of trinitrobenzophenone 335 was confirmed through analysis of C-F coupling in 
the 13C NMR spectra; in this case the C(H)-F coupling on the penta-substituted aryl ring was 28 
ppm, too large to be any position but adjacent to F.330 When addition in MeCN solution was 
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attempted fewer equivalents of the reagent were added due to the low solubility of NO2BF4; a 
mixture of methoxybenzophenone 333 and dinitrobenzophenone 334 resulted (Scheme 108). 
 
Scheme 108 - Trinitroaryl 335 was observed in a 2:1 ratio to desired dinitroaryl 334 when NO2BF4 
was used as the nitrating agent. 
 
These practical difficulties motivated the use of an Ac2O/HNO3(aq) system. Ac2O/HNO3(aq) is known 
to be a more powerful nitrating combination than AcOH/HNO3(aq).
331,332 Inclusion of DCM aided 
the solubility of methoxyarene 333 in acetic anhydride prior to HNO3(aq) and optimisation of the 
reaction time to 2 h at 0 °C allowed isolation of the dinitrobenzophenone 334 in 72% yield 
(Scheme 109). 
 
Scheme 109 - Selective nitration of lower benzophenone ring. 
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8.3.5 Alternate alkylating groups 
Having assembled a range of 2-arylbenzophenones for imine formation a number of amines and 
amine precursors were selected as condensation partners (Figure 49). 
 
Figure 49 - Alternative alkyl groups investigated. Compound 338 was provided by Stuart Caldwell. 
 
Compounds 336, 337 and 344 are commercially available. To produce the final superoxide probe 
target 261 either the +PPh3 or a surrogate should be substituted on the end of the alkyl chain. 
Unsurprisingly, therefore 4-aminobutylphosphonium iodide 339 was the first substrate 
investigated. Nucleophilic substitution using NH3(aq) in MeCN was performed on the 
iodobutylphosphonium iodide 24 synthesised previously (Section 2.5, Scheme 6). This gave a 
mixture, with a colleague having a similar result using condensed NH3(l). Instead using sodium 
azide as the nucleophile 4-azidophosphonium salt 345 was prepared quantitatively. Reduction of 
this alkyl azide proved difficult, with Staudinger reduction using PPh3 in DCM appearing to result 
in several products. Investigation showed iminophosphorane in the 1H NMR spectrum alongside 
side products when hydrolysis was omitted. When reduction with LiAlH4 in THF was tested 
azidoalkylphosphonium salt 345 was destroyed. Hydrogenation with Pd/C/H2(g) showed amine 339 
in the 1H NMR spectrum, but the initial choice of AcOH prevented precipitation and complicated 
isolation. Switching to MeOH and using a high catalyst loading (0.24 eq. of 10% Pd/C) with the 
azidobutylphosphonium salt 345 gave near quantitative conversion to the 
aminobutylphosphonium salt 339 (Scheme 110).  
 
Scheme 110 - Synthesis of aminobutylphosphonium salt 339. 
 
6-Azidohexylphosphonium iodide 340 was synthesised through the same nucleophilic substitution 
as used to synthesise phosphonium salt 345 from the iodoalkyl precursor 348 acquired from 
Stephen McQuaker (Scheme 52). The simple hexylazide 343 and 1,6-diazidohexane 349 were 
similarly prepared from the alkyl bromides 346 and 347. 
 
Scheme 111 - Synthesis of azidoalkyl compounds 340, 343 and 349. 6-Azidohexylphosphonium 
iodide 348 was provided by Stephen McQuaker. 
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The 1,6-azidohexane 349 was reduced (Scheme 53) with the two-phase Staudinger procedure 
which allows monoreduction as previously discussed in Section 11.4.3, Scheme 142. 
 
Scheme 112 - Monoreduction of 1,6-diazohexane 349. 
 
Difficulties were encountered in the synthesis of alkyne 341, where use of hydrazine produced 
alkene side products. An alternative procedure use AcOH and NaBH4 was successful,
333 but 
purification by ion exchange gave a poor yield (Scheme 113). 
 
Scheme 113 - Deprotection to yield alkyne 341 proved low yielding. 
 
With a range of simple amines in hand, imine formation was investigated. 
8.3.6 Imine formation 
Imine 287 had been prepared from benzphenone 265 using TiCl4 in DCM or PhMe. TiCl4 is a 
powerful dehydrating agent due to the oxophilicity of the Ti4+ ion and the favourability of TiO2 
formation. The high Lewis acidity of TiCl4 allows it to coordinate to carbonyls
334 activating these to 
nucleophilic attack. It has been suggested the active species in imine formation is an alkylamino 
complex of titanium (IV),335 certainly a colour change is observed on combination with hexylamine 
in PhMe or DCM. 
 
A series of N-hexylimine derivatives (Scheme 114, Figure 50) were synthesised under conditions 
similar to those used for the original benzophenone imine 287. Use of PhMe was convenient as 1 
M TiCl4 in PhMe is bright orange, so the quality of the reagent is easily assessed. The excess of 
amine, which was usually around 7 eq.,335 was reduced where the amine required synthesis. 
Between 1.5 and 2.0 eq. TiCl4 was used. The variation in TiCl4 and concentration were decided 
pragmatically: where problems with stirring were observed PhMe was added, incomplete 
conversion after approx. 24 h was taken to mean more TiCl4 was required. The original substrate 
265 gave several products in the imine formation procedure, which required chromatography to 
separate. However, the unpurified mixture reacted to produce the desired phenanthridinium 
products cleanly, so the imines were not purified following work up. More electron rich ketones 
gave cleaner conversion to the imine, while electron poor ketones cyclised rapidly following imine 
formation to produce a mixture. As the overlapping signals in the 1H NMR spectrum often 
obsfuscated important aromatic peaks, reaction completion was confirmed by loss of starting 
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material peaks, including movement of H4/H6 (Section 7.5, Figure 41). The diastereotopic CH2-1 
peaks at 3.0 - 3.5 ppm were also considered a useful indicator. 
 
Scheme 114 - Imine formation outline. 
 
Figure 50 - The imine precursors targets. 
 
The work up procedure developed with experience, as the quantity of TiO2 produced in 
quenching, the residual hexylamine and the vulnerability of the product to hydrolysis made 
identification of the correct procedure challenging.  
 
The conversion of acetophenone 329 to imine 363 did not proceed well and there were large 
quantities of SM present after work up, but it is not known if this represents incomplete 
conversion or facile hydrolysis.  
 
Overall the imines 353 - 362 formed from hexylamine could be prepared efficiently using TiCl4, but 
the TiCl4 solutions have short shelf lives, and the moisture sensitivity makes a usually routine 
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transformation the most technically demanding of the route. Although effective in the previous 
synthesis, TiCl4 has limited functional group tolerance, so the range of amines that could be used 
was explored briefly. Bulky cyclohexylmethylamine reacted with benzophenone 265 to give imine 
364 (Scheme 114). Similarly, the azido functionality in amine 342 was tolerated and the imine 365 
formed easily (Scheme 115). On the other hand imine formation with amines 336 - 341, 343 and 
344 failed when TiCl4 was used as the Lewis acid. A range of other conditions including MgSO4, 
PhMe/TsOH, BF3.OEt2, Ti(O
iPr)4 and CH(OEt)3 were then investigated. However, all were 
unsuccessful. 
 
Scheme 115 - Synthesis of cyclohexylmethylimine 364. 
 
Scheme 116 - Synthesis of azidohexylimine 365. 
 
Attempts were also then made to form the imine with an aza-Wittig reaction using alkyl azides 
340 and 343 with PPh3 or PBu3 and benzophenone 265 (Scheme 117). Following a trial with 
benzophenone 265, azide 343 and PPh3 in THF in the microwave at 100 °C, the iminophosphorane 
product of the Staudinger reaction was identified by a signal at 3.08 ppm, which was a dt (J = 18.3, 
7.4 Hz) and is consistent with literature values for the methylene unit of Ph3P=NCH2.
336 This was 
observed in the presence of benzophenone 265, showing the iminophosphoranes generated to be 
insufficiently reactive with the ketone to produce imine 287. 
 
Scheme 117 - Outline of the attempted aza-Wittig reactions. 
  
Chapter 8: Methodology exemplification 124 
 
8.4 Cyclisation 
8.4.1 Solvent free thermal cyclisation 
With the crude imines 287 and 353 - 365 in hand, the limits of the cyclisation procedure were 
established. The procedure developed for the preparation of the superoxide probe precursor 288 
involved heating under an inert atmosphere in a kugelrohr apparatus at atmospheric pressure. At 
the beginning of the reaction the imine is loaded as a solution in chloroform, which quickly 
evaporates leaving a layer of imine on the hot glass surface. 
 
The utility of these conditions were tested using the substrates believed to be most electronically 
and sterically demanding, methoxybenzophenone imine 361 and 3’’-methylbenzophenone imine 
362, respectively. The conjugation of methoxy group in imine 361 disfavours reaction para to this 
group. This is demonstrated by considering the contribution of minor resonance form 366, which 
displays the increase in electron density at C2’’ in exaggerated fashion (Scheme 118). 
Unsurprisingly the reaction is slower than with the benzophenone imine 287, However, forcing 
conditions (2 h 45 min at 100 ˚C, then 3 h at 125 ˚C) were successful and gave the 
phenanthridinium 304 in a 3:1 ratio over an impurity. Chromatography using 2% MeOH, 1% NEt3 
in DCM gave the N-hexylphenanthridinium 304 in a yield of 47% over two steps from the 
benzophenone 366. The 1H NMR spectrum of the impurity displayed a pattern for the aromatic 
protons that is characteristic of a phenanthridinium salt and so it was assumed to be elimination 
product 367.  
 
Scheme 118 - The cyclisation of 5’’-methoxybenzophenone imine 361, with the contributing 
resonance form 366, and suspected elimination product phenanthridinium 367. 
 
When imine formation was tested with sterically challenging 3’’-methylbenzophenone 332 two 
products resulted, with the expected benzophenone imine 362 favoured 3:1 over a related 
fluorinated compound which did not show inequivalent protons at CH2N. Initial heating (100 ˚C, 1 
h) in the kugelrohr increased the ratio of imine 362 to the unidentified side product of imine 
formation, but did not give significant conversion to the N-alkylphenanthridinium salt. When the 
reaction temperature was increased to 150 ˚C for 2 h 30 min, cyclisation and elimination of the N-
alkyl side chain occurred together to give phenanthridine 368, and this elimination was driven to 
completion by heating for 3 h at 200 ˚C (Scheme 119). A small quantity was purified for 
characterisation purposes. 
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Scheme 119 - The steric hindrance to cyclisation of 3’’-methylbenzophenone imine 362, as shown 
by the red arcs. 
8.4.2 Microwave-assisted cyclisations to give phenanthridinium salts in aprotic 
solvents 
It was clear that the method of cyclisation was not appropriate for imine 362 and had to be 
improved. Furthermore, solid material heats unevenly and chars, and this would be problematic 
for many of the the imines 353-365 as they would not be liquid at 100 ˚C given that most of the 
benzophenones melted at a higher temperature than this. It was also thought that other 
researchers would be more likely to make use of a more conventional procedure.  
 
Consequently, microwave heating in a range of solvents was tested. 1 mg/mL solutions of imine 
287 were heated in sealed tubes at 100 °C for 1 h using a 50 W microwave. No protic solvents 
were investigated because most of these are moderately nucleophilic and may compete with the 
desired reaction. The reactions in acetone and in toluene gave side products. Reactions in 
dichloromethane and THF did not go to completion, but the THF mixture contained only starting 
imine and product. The reaction in MeCN gave complete conversion, but had traces of side 
product, so the procedure was optimised to 2 h in THF at 100 °C. It is not surprising that reaction 
in the most polar solvent gave fastest conversion since the conjectured transition state (SNAr) is 
more polar than the ground state. 
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8.4.3 Optimisation of individual cyclisations and results 
With the start point for optimisation chosen, 20 mg portions of benzophenone imines were 
weighed by difference (due to the oily or foam-like nature of the imines) into 1 mL solvent and 
sonicated into solution or suspension. Small variations in molar concentration are unimportant 
considering the high dilution and intramolecular reaction. Following microwave heating the 
solvent was removed under vacuum, then a sample taken up in deuterated solvent and approx. 
0.05 mL d-TFA added. Conditions were assessed based on conversion as observed by 1H NMR 
spectroscopy, with final conditions then applied to the conversion of 100 mg in 5 mL of solvent.  
 
The work up procedure used for the scaled up microwave conditions involved removing the 
reaction solvent under reduced pressure and re-dissolving the residue in dry Et2O, then 
precipitating the phenanthridinium salt with excess ethereal HCl. Difficulties achieving reasonable 
spectra were common features of the phenanthridinium work, due to broad aromatic peaks 
attributed to aggregation effects such as π stacking, so the solvent used for the definitive spectra 
vary with the substrate. The conditions for the final cyclisations and the combined yields over 
imine formation and cyclisation steps are summarised in Table 3. 
 
Scheme 120 - Imine formation/cyclisation overview. 
Table 3 - Imine formation/cyclisation combined yield - conditions refer to cyclisation.  
no R1 R2 Y R3 R4 R5 R6 X Solv. T (˚C) t (h) % 
288 H tBu C H C6H13 Ph NO2 F THF 100 2 85 
299 H H C H C6H13 Ph NO2 F THF 100 2 84 
300 H Br C H C6H13 Ph NO2 F THF 100 2 100 
301 H H N H C6H13 Ph NO2 F THF 100 0.5 98 
302 NO2 H C H C6H13 Ph NO2 Cl THF 100 0.5 86 
303 OMe NO2 C H C6H13 Ph NO2 F THF 100 2 74 
304 OMe H C H C6H13 Ph NO2 F - 100* 2 47 
305 H NO2 C H C6H13 Ph NO2 F - -# - 97 
306 H NO2 C H C6H13 Me NO2 F - -# - 100Ϯ 
307 H H C H C6H13 Ph H F MeCN 110 1.5 68 
308 H H C Me C6H13 Ph NO2 F MeCN 110 10 79 
309 H tBu H H C7H13 Ph NO2 F MeCN 110 1.5 75 
310 H H C H C6H12N3 Ph H F MeCN 110 1.5 78 
* Original kugelrohr conditions.  
# Cyclisation complete on work up of imine formation.  
Ϯ Compound isolated as enamine 
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Upon scale up of the test cyclisation in THF at 100 °C for 2 h imine 287 gave good conversion to 
phenanthridinium 288. Cyclisations to electronically similar 8-nitrophenanthridiniums 299 and 
300 gave good yields under these conditions, with the variation in the yield dictated mostly by the 
imine formation step. 
 
The 2’’-fluoro-3’’-azabenzophenone imine 353 gave rapid reaction; most of the material cyclised 
during work up, with 30 min of microwave heating ensuring complete conversion. Ascertaining 
the nature of this compound posed a quandary; isolation of the double chloride salt was 
envisaged on addition of HCl. No sign of this species was observed by mass spectrometry 
suggesting that the final isolated form is the single salt. Chlorobenzophenone imine 358 rapidly 
cyclised to give phenanthridinium 302, despite the poorer chloride leaving group. This salt proved 
hygroscopic and required additional drying, resulting in a small loss in yield. 
 
The cyclisation to 2-methoxy-3-nitro phenanthridinium 303 proceeded in good yield under the 
THF/100 ˚C conditions. This is consistent with the summation of the Hammett parameters.288 Even 
though the methoxy group is electron-donating and directly conjugated to the site of nucleophilic 
attack, the inductive withdrawing effect of the meta NO2 group dominates. No impurities were 
observed so the lower yield is probably the result of losses on handling and drying. In the absence 
of the electron withdrawing group, the electron-donation of the methoxy dominates and the 
reaction is demanding. An attempt was also made to replace the kugelrohr method for synthesis 
of C2-OMe substrate 304, but similar conversion was achieved under microwave heating. 
 
Both the dinitroacetophenone 324 and analogous 3,8-dinitrobenzophenone 328 gave quantitative 
conversion to product without an explicit cyclisation step; for dinitroacetophenone 324 the 
neutral product enamine 369 is easier to isolate, although the expected phenanthridinium 306 is 
formed in acid (Scheme 121). 
 
Scheme 121 - Enamine 369 is isolated from imine formation, but reversibly forms 
phenanthridinium 306 on acidification. 
 
Cyclisation of imine 356 derived from benzophenone 327 to phenanthridinium 307 with 
unsubstituted A and C rings demonstrated the unsuitability of using THF at 100 ˚C for less 
activated substrates. Longer reaction times in this solvent resulted in decomposition. Testing at 
an increased temperature of 110 ˚C in THF and MeCN revealed the MeCN to be superior for 
slower cyclisations. High conversion was observed, with a 97% yield over the cyclisation step.  
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Following the earlier failure to form 4-methylphenanthridinium 308 by heating imine 362 formed 
from benzophenone 332 under the solvent-less conditions, this substrate was re-investigated 
under microwave conditions. No product was observed at 100 ˚C in THF, but increasing the 
temperature to 125 ˚C did give sluggish conversion and decomposition. Using MeCN as the 
solvent at 110 °C provided a breakthrough, converting the majority of the imine 362 into 4-
methylphenanthridinium 308 in 1 h. Increasing the temperature to 120 ˚C produced impurities, 
and longer reaction times at 110 °C gave a mixture of the starting imine 362, 4-
methylphenanthridinium 308 and phenanthridine 368. Driving the reaction to completion (14 h, 
MeCN, 110 ˚C) proved detrimental; more of phenanthridine 368 was observed (see Scheme 119, 
Section 8.4.1). Iterative testing showed that 10 h at 110 ˚C in MeCN gave the best ratio of product 
to starting imine 362 and phenanthridine 308. Purification on an ion exchange column gave the 4-
methylphenanthridinium 308 in a high yield. 
 
By contrast the other sterically challenging substrate N-cyclohexylmethyl imine 364 cyclised with 
relative alacrity in MeCN at 110 °C. The alternative of using THF at 100 ˚C was sluggish compared 
to the N-hexyl derivative 287, and significant impurities were generated. Loading the crude 
mixture from the MeCN reaction onto SiO2 and subsequent washing with DCM allowed impurities 
to be removed while the acidic silica prevented hydrolysis of the phenanthridinium salt 309. 
Addition of 0.5% NEt3 to DCM then allowed rapid elution of the open form, which was cyclised 
with HCl to give the phenanthridinium chloride in good yield. Azido-phenanthridinium 310 
required similar chromatographic purification due to decomposition of the imine 365 derived 
from the benzophenone 327 (perhaps via a process analogous to the Schmidt rearrangement). 
The incorporation of an azido group and would allow functionalization via the Huisgen 
cycloadddition.  
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8.5 Further modifications of phenanthridinium products 
The synthesis of 3-bromophenanthridinium 300 offered the possibility of synthesising a DNA 
targeting H2O2 probe 370 based on the group’s previous work.
95 Conceptually the hydrolysis of a 
boronic ester 370 would give a small group in plane with the ring and capable of H bonding, 
mimicking the 3-NH2 group important to intercalation. Reaction with H2O2 at DNA could be 
monitored by fluorescence (Scheme 122). The empty orbital of the boron may well quench the 
fluorescence of the phenanthridinium probe 371, but even if it did not formation of the phenol 
would give a considerable Stokes shift, allowing ratiometric measurement. 
 
Scheme 122 - The hydrolysis of boronic ester 370 to potential DNA-localised hydrogen peroxide 
probe 371, and reaction with hydrogen peroxide to form 3-hydroxyphenanthridinium 372. 
 
The bromophenanthridinium salt 300 was reduced using an Iron/acid procedure under mild 
conditions at 40 ˚C (Scheme 123), to give 8-aminophenanthridinium 373, a versatile precursor due 
to the aryl bromide functionality. 
 
Scheme 123 - Iron reduction of the 3-bromophenanthridinium 300. 
 
Trial Miyaura borylation reactions were unsuccessful; in dioxane solubility proved low. Reaction in 
DMSO gave difficulties in recovery of the material. Given time and thorough screening of 
conditions, testing of alternative procedures,337 and investigation of options such as protecting 
the aniline or borylation before cyclisation, it is anticipated that synthesis of hydrogen peroxide 
probe 370 should be achievable. 
 
Small scale reduction of 3-azaphenanthridinium 301 gave a 60% yield of the 8-amino-3-
azaphenanthridinium 374 (Scheme 124), identified by 1H NMR spectroscopy (Figure 51).  
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Scheme 124 - Small scale reduction of azaphenanthridinium 301. 
 
Figure 51 - Comparison between pre and post reduction material.  
 
The overall upfield shift is consistent with the nitro reduction, but the most characteristic change 
is the large upfield shift of H7 (red), which is particularly pronounced in 8-amino substrates, and is 
mirrored in the 13C spectrum. Time constraints did not allow this reaction to be repeated and 
further characterisation data to be acquired. 
 
 Enamine 369 was reduced under similar conditions to the aza-phenanthridinium 301, then the 
mixture was acidified so that the phenanthridinium partitioned into the aqueous layer. 
Neutralising the aqueous layer, and then reducing the mixture in a two-phase system of water 
and CHCl3 using NaBH4 led to isolation of dihydrophenanthridine 375 in low yield (Scheme 125). In 
CDCl3 the reduced form proved stable for several days. 
a) 1H NMR spectrum of 8-nitro compound 301. 
b) 1H NMR spectrum of 8-amino compound 374. 
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Scheme 125 - Enamine reduction. The product is isolated in the reduced form due to NaBH4 in the 
work up. 
 
In addition to modifying the products of the cyclisation, some more thought was given to the 
mechanism. In the original plan an SNAr mechanism had been assumed to operate, and some 
features of this mechanism are now described in greater detail. 
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8.6 Nucleophilic aromatic substitution mechanism 
Nucleophilic aromatic substitution (SNAr) is a reasonably well understood process, with the 
accepted mechanism shown in Figure 52. The nucleophile 377 approaches the aromatic 
electrophile and attacks the δ+ carbon attached to the ‘X’ group, breaking the aromaticity of the 
ring system 376. This forms species 378, which is the first transition state. The formation of TS1 is 
usually (but not invariably)338 the rate determining step. A conjugated electron withdrawing group 
is generally considered necessary339 except perhaps in the presence of a very powerful 
nucleophile340 or perhaps with the aid of an alternate single electron transfer (SET) mechanism.343 
This withdrawing group stabilises the formally anionic ring system, and the capacity of this group 
to stabilise charge will strongly affect TS1. The degree of polarisation of C-X and the capacity of 
the leaving group to stabilise the anion will also contribute, as does the nucleophilicity of the 
attacking group.341 Intermediate 379, known as the Meisenheimer complex, is formed with a full 
bond to both nucleophile and leaving group. These have pyramidal geometry at C1 and in some 
cases can be isolated as stable salts.342 A further (usually) lower energy barrier exists to TS2, 380, 
which represents the dissociation of the leaving group as an anion, allowing the complex to re-
aromatise and give aromatic product 381. 
 
Figure 52 - Generic SNAr reaction coordinate diagram. 
 
That nucleophilic attack as the rate limiting step is an inversion of the order normally encountered 
in both SN1 and SN2 mechanisms, and as such the leaving group characteristics which favour these 
(such as weak C-X bonding) do not apply. The greater polarisation and charge stabilisation of TS1 
offered by fluorine means that it is favoured over Cl as a leaving group in SNAr (kF/kCl may be as 
high as 1300), although it is probably poorer with regard to the actual leaving step TS2.343 
Complicating this simplistic picture is the importance of solvent and hydrogen bonding, 
particularly with amine nucleophiles, with ortho-nitro groups increasing reactivity through 
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hydrogen bonding with the nucleophile in TS1.344 In some cases specific solvent hydrogen bonding 
effects may also be relevant.345 
 
The addition of hydrogen bonding and additional solvent molecules does produce a more 
complex picture of SNAr, and these systems are less understood. One particular situation outlined 
in Figure 53 arises where amine nucleophiles are used in the presence of a weak base and 
formation of TS2 is rate-limiting. In this case general base catalysis is observed (Figure 53).345,346 
Nucleophilic attack from the amine 382 on arene 376 generates an ammonium species 384. Both 
the ammonium and hydrogen bonding interaction with the departing nucleophile will stabilise 
383 and 384, so deprotonation is required to increase electron density at the pyramidal carbon 
and proceed to the rate determining TS2. The involvement of multiple molecules of amine in a 
cyclic arrangement with the zwitterionic Meisenheimer complex is suggested by Isanbor and 
Babatunde346 with George and coworkers also implicating an additional molecule of ethanolamine 
in Meisenheimer complex decomposition in SNAr reactions on fluoronitrobenzenes.
347 
 
Figure 53 - TS2 limited, base catalysed SNAr. 
 
Both models shown (Figure 52 and Figure 53) feature a Meisenheimer complex, and theoretical 
studies consistently find this intermediate in a variety of conditions.341,345,347,348,349 A few 
exceptions exist, with a brief communication350 by Iwata and coworkers implicating a concerted 
process through a transition state equivalent to TS2 in Scheme 126 in the formation of the minor 
para regioisomer in reaction of ammonia with a polyfluorobenzene. 
 
Scheme 126 - Calculations by Iwata and co-workers suggest that formation of para isomer 389 is 
concerted.350 
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 Goryunov et al were able to take advantage of the favourable formation of Si-F bond in a leaving 
group to give concerted reaction between Me3SiPMe2 and polyfluoroarenes (Scheme 127).
351  
 
Scheme 127 - Typical example of the concerted SNAr conditions given by Goryunov et al.
351 
 
Some calculations support the idea of concerted displacement in particular circumstances, for 
non-first row leaving groups,352 with the observation that Meisenheimer complexes formed from 
iodoarenes are unstable,348 and that gas phase calculations suggest heavier halides require 
multiple withdrawing groups to form Meisenheimer complexes.353 It should be noted that even 
relatively favourable SNAr processes often require considerable heating; reaction of 2,4-
dichloropyridine with aqueous ammonia requires heating to 150-175 °C. As pyridine provides a 
level of activation analogous to a nitro substituent,343 the theoretical reactivity of weakly 
activated aryl bromides and iodides is probably unimportant as reaction is unlikely to occur; at 
least when using aryl fluorides or favourable, activated substrates a Meisenheimer complex 
should be assumed. 
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8.7 The mechanism of imine cyclisation: a computational study 
8.7.1 Mechanistic uncertainty 
Originally envisaged as an SNAr, another mechanistic pathway is hypothetically possible for the 
cyclisation shown; 6π electrocyclisation.354  
 
Scheme 128 - Literature 6π electrocyclisation example.354 
 
Curly-arrow representations of both mechanisms results in resonance structures of the 
Meisenheimer complex (Figure 54), illustrating the similarity of the pathways. The fundamental 
difference is the orbitals involved; SNAr originating from the imine lone pair, electrocyclisation 
from the C=N π bond. This difference has repercussions for the transition state geometry but 
cannot be convincingly distinguished experimentally. Dr Hans Senn investigated the reaction 
computationally to ascertain the correct mechanism, and provided all of the data and much of the 
interpretation for the following section. 
 
Figure 54 - Suggested SNAr (top) and electrocyclisation (bottom) mechanisms give rise to the same 
Meisenheimer complex-like structure 395 according to a curly arrow model. 
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8.7.2 The calculated pathway and energy values 
The N-alkyl chain was modelled as an ethyl group to reduce the complexity of the calculations. 
Structures 397a-h for a number of structural analogues (Table 4) were calculated using DFT 
modelling, with possible intermediates identified. With the exception of c, d and h these 
analogues had substituents on the A and C rings that matched compounds synthesised. The 
pathway considered involved conversion of the imine 396 into Meisenheimer complex 398 via 
transition state 397. The Meisenheimer complex then collapses to a close ion pair 399, which can 
then dissociate to solvent separated ion pair 401 or recombine to give the adduct of 400 of 
counterion addition to the iminium ion. The last structure is analogous to the pseudobase 
discussed in Section 4.3, Scheme 35. 
 
Scheme 129 - The species and pathway identified by DFT calculations.355 
Table 4 - The range of substrates investigated in the computational study 
Substrate X R1 R2 R3 
a F H H H 
b F H H NO2 
c F H NO2 H 
d F NO2 H H 
e F OMe H H 
f F H NO2 NO2 
g F OMe H NO2 
h Cl H H H 
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The pathway identified was shown to be an SNAr process (Scheme 129) based on transition state 
geometry, but with a twist. The Meisenheimer complex 398 is unstable and dissociates 
spontaneously into ion pair 399. Depending on the interplay of ion solvation enthalpy and C-X 
bond strength, the ion pair 399 can separate to form a solvent separated ion pair 401 (an entropic 
rather than enthalpically favoured process), or form an unusual C6-X adduct 400.  
 
Table 5 - DFT calculation results. The N5-C4a and C4a-X distances refer to TS 397, and are 
numbered as would be normal for the product phenanthridinium salts 401. 
 ΔG / (kJ mol–1) d‡ / Å 
396 TS 397 399 401 400 N5–C4a C4a–X 
a 103 –65 –81 –79 1.85 1.40 
b 98 –57 –74 –84 1.88 1.39 
c 93 –60 –72 –93 1.87 1.39 
d 72 -52 -71 -89 1.96 1.37 
e 115 –70 –90 –78 1.84 1.41 
f 90 –51 –59 –88 1.88 1.39 
g 112 –61 –77 –76 1.87 1.40 
h 120 –126 –133 [b] 1.88 1.87 
avac
[c] 112 80[d] 440 –80 1.81 1.39 
[a] Calculated at M06-2X/def2-TZVP+ level in polarizable continuum MeCN (εr = 22.5) for T = 383 
K, p = 320 kPa. [b] The 6-chlorophenanthridine 400g is not a stable minimum, but dissociates into 
the ion pair 399g during structure optimization. [c] Calculated in vacuum. [d] Energy of 398avac. In 
vacuum, the ion pair 399avac is not stable, but collapses to 398avac. 
Although the mechanistic pathway is consistent over the substrates, the stability of the solvent 
separated ion pair 401 versus halide adduct 400, transition state energy and bond lengths vary 
(Table 5). For those substrates synthesised activation energies (90 - 112 kJmol-1) correlate well to 
the reaction conditions. Figure 55 shows a reaction coordinate diagram based on the calculated 
values for f.  
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Figure 55 - A Reaction coordinate diagram for cyclisation of benzophenone imine 396f to phenanthridinium salt 401f, based on DFT calculations. 
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The calculated structures of 396-401 will now be considered in order and related to the 
experimental observations, and the task of distinguishing between the electrocyclisation and 
SNAr mechanisms. 
8.7.3 The Calculated Conformations of Imines 396a-h 
 
Figure 56 - Calculated conformation of 396a. 
 
The calculated conformation of the imine 396a corresponds well with the 1H NMR data (Figure 
56). The orientation of the phenyl ring face on to the C-ring is consistent with the upfield 1H NMR 
shift of H6 (8.1 ppm vs 8.3 ppm for H4). The electrophilic fluoroarene A ring is out of plane of the 
C ring by -54˚ in 396a, which limits conjugation between the rings and in more substituted 
analogues, reduces the effect that groups on one ring have on the other. Considerable steric 
congestion suggests a high barrier to rotation about the N- CH2 bond, demonstrated by the 
inequivalent methylene protons. Comparing Hirschfeld charges for a and h show the C-Cl to be 
less polarised revealing a less δ+ C2”. Thus, the more electronegative halogen atom lowers σ*CX, so 
that the aryl fluoride is more reactive. 
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8.7.4 The Calculated Structure of Transition State 397a 
 
Figure 57 - Calculated transition state structure (TS) 397a. 
 
The TS structure 397a represents an ‘early’ transition state as it is closer in structure to 396a than 
product phenanthridinium 401a, with the electrophilic A ring still -37˚ out of plane of the C ring 
(Figure 57). A shorter N-C4a distance suggests the vacuum transition state 397avac is later. The key 
feature is that the lone pair of N5 points at C4a at 125˚ from the ring plane of ring A (numbering 
see Scheme 129), which is consistent with the SNAr mechanism and inconsistent with an 
electrocyclisation. This will be discussed in more detail in Section 8.7.7. The F is shifted out of 
plane of the A ring by 36˚ giving pyramidal geometry, and the C-F bond lengthened due to loss of 
conjugation, although the ‘early’ nature of the TS is underlined by the average C4a-F bond length 
of around 1.39 Å for transition state structures 397a-h being equivalent to a full sp3 C-F bond.356 
The nearby C=C bond is lengthened from 1.39 Å to 1.42 Å, but C=N is almost unchanged (1.28 Å 
from 1.27 Å), which is again consistent with the SNAr mechanism and inconsistent with an 
electrocyclisation. Nitro groups on the electrophilic A ring have a stronger effect than those on 
the C ring even if meta to F (397b vs 397c, Table 5), consistent with their strong inductive 
effect.357 Comparing 397d and 397f shows the extent of the TS stabilisation provided by 
resonance from nitro groups on the different rings, with the long N5-C4a bond length in 397d 
suggesting this stabilisation allows an especially early TS. These results show the extent to which 
the biphenyl torsion angle reduces the effect of conjugated groups from the C ring on the TS 
energy. 
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8.7.5 The Calculated Structure of ion pairs 399a and 401a 
 
Figure 58 - The ion close and solvent separated ion pairs 399a and 401a. 
 
The structure shown (Figure 58) represents both ion pairs, 399a and 401a. These are stabilised by 
aromaticity across the A, B and C phenanthridinium rings, providing a planar structure (Figure 58). 
Separation of the close ion pair 399 to give solvent separated ion pair 401 is enthalpically 
disfavoured; however the entropic contribution from dissociating the ions is large enough to 
favour ion pair separation in solution. The conformation shows the C6-phenyl ring to be at an 
angle of close to 90˚ from the plane of the phenanthridinium, is characteristic of these salts. This 
conformation is consistent with the 1H NMR spectra of the product chloride salt 307, where H2’’ 
and H6’’ are upfield of H3’’ and H5’’. This is due to the loss of conjugation and mesomeric 
interaction with the electron poor phenanthridinium caused by the lack of orbital overlap 
between the respective π systems of the phenanthridinium and the phenyl ring in the 
conformation shown. In contrast to the transition state 397, the product 401 is destabilised by 
electron poor substituents. The position of electron donating or withdrawing substituents appears 
to have less influence on the energies of these planar, conjugated species than in 397 or 400. 
8.7.6 The Calculated Structure of fluoride pseudo-base 400a 
 
 
Figure 59 - Unexpected halide intermediate 400a.  
 
Halide addition at C6 of the ion pair 399 gives an adduct analogous to the pseudobases proposed 
in Section 4.3, Scheme 35. This unusual C6-halide adduct (Figure 59) is enthalpically favoured, and 
in some cases this preference overcomes the entropic drive for solvent separed ion pair 401. This 
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tends to occur where electron withdrawing substituents destabilise the phenanthridinium and 
make C6 more δ+. Phenanthridinium substituents are very influential; dinitrophenanthridinium 
fluoride adduct 400f is quite strongly favoured compared to solvent separated ion pair 401f (-29 
kJmol-1). In comparison the 2-methoxy phenanthridinium fluoride adduct 400e is less favoured 
than the solvent separated ion pair 401e (+ 12 kJmol-1). The pseudobase species neutralises 
charge and relieves the strain caused by the clashing 5 and 6 substituents, but the most important 
stabilising element is C-F bond strength. Chloride adduct 400g is unstable and dissociates to 399g. 
The solvation of the Cl- anion is weaker than the equivalent solvation of F-, however the difference 
between the strength of the C-Cl bond and a C-F bond in the halide adduct more than offsets the 
differences in anion solvation energy. During the synthesis a chloride counter ion is added on 
work up, so the the isolation of solely the ion pair product 401 is consistent with the results of 
these calculations. In addition, the chloride anion is added to the work up as HCl, which forms the 
much weaker acid HF. The relatively weak acidity of HF is a reflection of the favourability of the H-
F bonds, and the enthalpic gain from generating this relatively low energy side product would also 
favour the formation of the solvent separated ion pair 401. 
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8.7.7 Natural Bond Orbital analysis: 
The pyramidal geometry and the bond lengths of transition state 397 leave little doubt this is a 
SNAr type process. Further evidence was acquired through Natural Bond Orbital analysis, 
producing a model with localised orbitals rather molecular orbitals. This is displayed in Figure 60. 
 
Figure 60 - Imine lone pair (nN) interacting with π
* and σ* orbitals.358 
 
Both of the interactions shown in Figure 60 are highly favourable; donation of 0.4e from the lone 
pair to the π* (C4=C4a) aryl antibonding orbital is the largest interaction. This is clear in Figure 60 
from the degree of overlap. Donation primarily to the aryl π* orbital denotes an SNAr mechanism. 
The donation to the C4a-F antibonding σ* orbital is also significant, and weaker when X = Cl than 
when X = F. None of the π C=N affiliated orbitals have significant overlap with the electrophilic A 
ring. The transition state represents formation of the C4a-N5 bond and is essentially a 
Meisenheimer complex, with no intermediates between this and close ion pair 399. The reaction 
is therefore concerted, which represents a considerable mechanistic novelty, with extant studies 
showing unstable Meisenheimer complexes doing so only where additional stabilisation of F- 
reduces the barrier to the C-F bond breaking.351,359 
 
The relative energies of the calculated transition states 397a-g correspond well with the 
experimental conditions for these cyclisations. The SNAr mechanism and calculated structures 
perhaps hint at why 3’’-methylbenzophenone imine 362 was more difficult to cyclise than N-
methylcyclohexane imine derivative 364 - SNAr allows for the R substituent of the imine to be 
directed away from the reaction site in a way impossible in 6π electrocyclisation, and for a C3 
methyl substituent in either mechanism. 
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Chapter 9: A novel mitochondria-targeted probe for superoxide 
9.1 Testing of the 8-amino-3-tbutyl-6-phenyldihydrophenanthridine probe 
Testing of the precursor 293 to superoxide probe 294 was carried out by Dr Murphy's group at the 
MRC in Cambridge. Following the procedure developed in Glasgow, Angela Logan reduced the 
phenanthridinium 293 with NaBH4 in Et2O-water so that the product dihydrophenanthridine 294 
partitioned into the Et2O layer. Separation of layers and removal of Et2O gave a single product by 
HPLC. Dissolving the dihydrophenanthridine in EtOH, diluting with buffer and then reaction with 
superoxide generated from xanthine from xanthine oxidase360 gave no oxidation products. 
Neither phenanthridinium 293 nor hydroxyphenanthridinium 402 were produced. 
 
Scheme 130 - The reaction of model probe 293 with superoxide, with the expected substitution 
shown in red, the redox active iminium in orange and the tBu group which prevents intercalation 
in green. 
 
Based on the work of collaborators136 it was believed that the regiochemistry of superoxide 
reaction would give the 9-OH compound 402. On consulting the literature it was apparent that 
the regiochemistry of the superoxide reaction was disputed and attack at the C-2 was proposed 
by some authors.129 A detailed description of this issue and the assignment of phenanthridinium 
salts generally is provided in Chapter 10, but the potential site of reactivity at C-2 was blocked in 
dihydrophenanthridine 294. 
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9.2 A new probe design 
Having considered the available literature (Chapter 10) it was decided that a new probe design 
should allow reaction at 2 and 9 positions, while preferably being electronically similar to 
MitoSOX and preventing intercalation. We envisaged that aniline alkylation with a bulky group 
such as tBu would achieve this. The N-tBu analogue was discounted as it might block both sites 
and would have low stability in acid; a robust molecule would allow easy handling and increase 
the variety of conditions available for work up and purification. It was desirable to have an 
electronic rich substrate to improve the challenging alkylation. The small tweak of inserting a CH2 
into the design (using neopentyl groups) gave a much more robust molecule (Figure 61), while 
decreasing the steric hindrance to reaction at C2. 
 
Figure 61 - The improved targeted superoxide probe 404, MitoBNH and its phenanthridinium 
precursor 403 are shown. Potential substitution sites are shown in red, the targeting group in 
blue, the bulky neopentyl groups in green and the redox active iminium site in orange. 
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9.3 Synthesis of the model phenanthridinium 
Prior difficulties had emphasised the difficulty of N-alkylation of electron-poor phenanthridines 
and purification of their phosphonium analogues. The model untargeted bisneopentylethidium 
(BNE) analogue 405 was synthesised as a model compound (Scheme 131). 
 
Scheme 131 - Synthesis of a model neopentyl ethidium superoxide probe 406. 
 
Reductive amination was investigated for alkylation of 3,8-diaminophenanthridine 133 using Pd/C 
and H2 according to a literature procedure.
361 Imine π bonds are weaker than comparable 
carbonyls and undergo reversible iminium formation, allowing their reduction where Pd/H2 alone 
is usually insufficient for carbonyl reduction.362 Less than 10% conversion was observed. Instead 
the TFA/acetoxyborohydride procedure used previously for used in synthesis of secondary aniline 
241 (Section 6.5.1) was applied to 3,8-diaminophenanthridine 133, giving quantitative conversion 
to neopentyl derivative 405. Alkylation with EtOTf followed by chromatography gave ethidium 
derivative 406 in 50% yield. The key feature here is that the N-alkylamino groups at C-3 and C-8 
are strongly electron-donating making the N-alkylation of the phenanthridine using it favourable, 
but the neopentyl groups discourage alkylation of the pendant amines. Purification via 
recrystallisation in IPA also gives ethidium derivative 406, which is intensely purple. 
 
Although synthesised to test conditions, phenanthridinium 406 has potential uses as a non-
intercalating ethidium analogue. The oxidised version can be detected easily by mass 
spectrometry so the corresponding dihydrophenanthridine could function as an untargeted probe 
for ROS which react with phenanthridiniums in a characteristic fashion, such as nitric oxide. It is 
anticipated that the group will investigate the utility of this compound in future. 
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9.4 Synthesis of MitoBNH 
Given previous difficulties with the phosphonium compound 142, the triflate 408 of 1-
bromohexan-1-ol 407 was selected as the alkylating agent of choice and synthesised (Scheme 
132) using the same procedure as for triflates 142 and 146.  
  
Scheme 132 - Synthesis of bromohexyltriflate 408. 
 
The synthesis of the final probe is shown below (Scheme 133). Dry Et2O was chosen for the 
alkylation reaction as experience suggested that the phenanthridinium cationic products would 
precipitate. Alkylation of bisneopentylphenanthridine 405 worked, giving bisneopentylhexidium 
alkyl bromide 409. Unfortunately the material proved partially soluble in Et2O and so 
chromatography was necessary but insufficient for complete purification, giving 90 - 95% purity 
on a small scale. On the expectation that the dication produced by replacement of the bromide 
with phosphonium would result in phenanthridinium 403 being insoluble in PhMe or Et2O, less 
pure bromide 409 was used in the scaled up addition to form the phosphonium salt 403. 
Chromatography, ion exchange and precipitation did not give complete purification and so HPLC 
was employed to isolate the phenanthridinium 403, giving a disappointing yield. 
 
Scheme 133 - Synthesis of MitoBNH precursor 403. 
 
The d-15 phosphonium analogue 410 (Figure 62) was required as an internal standard for mass 
spectrometry calibration, and was synthesised on a smaller scale via the same route but using d15-
PPh3. This compound was isolated (4%) by HPLC, but a small of excess methanesulfonic acid was 
present following ion exchange and the material was contaminated on washing. 
 
Figure 62 - The deuterated mass spectrometry standard 410. 
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Chapter 10: Assignment of the proton NMR of phenanthridinium salts 
10.1 Why spectral assignment is important 
Review of the literature associated with MitoSOX 56 suggests some confusion exists as to the 
regiochemistry of superoxide addition. Chang363 names the product as the 2-
hydroxyphenanthridinium 57 while displaying the 9-hydroxy analogue 58 (Figure 63). The original 
literature suggests attack at the 2-position, and some spectral evidence has been offered for this 
conclusion by Zhao et al.129 The site of addition critically affects the synthesis of the MS standards 
and the design of analogues of MitoSOX. 
 
Figure 63 - MitoSOX and potential oxidation products. 
 
The issue was therefore re-examined. A paper by Beckman and co-workers136 compares the COSY 
correlation spectrum obtained from MitoSOX 56 to the spectrum of the superoxide oxidation 
product. The COSY of the superoxide addition product allows assignment of one spin system 
unambiguously, which is either H1-H2-H4 for product 58 or H10-H9-H7 for product 57 depending 
on the regiochemistry of addition (Table 6). 
 
Table 6 - The potential assignments of the 1,2,4 spin system identified by COSY. All other aromatic 
peaks are within a 7.6 - 8.0 ppm range. 
δ (ppm) Multiplicity Assignment: 
  57 58 
6.2 d H7 H4 
7.4 s H4 H7 
7.5 dd H9 H2 
8.4 d H10 H1 
 
It is then stated that the signal from either H2 or H9 of dihydrophenanthridine 56 has been lost 
and that definitive assignment of the regiochemistry is limited by the impossibility of 
distinguishing the A and C ring systems. As H9 was believed to be the more reactive position, the 
superoxide product was identified as 9-hydroxyphenanthridinium 58. Although logical within the 
scope of the work presented the more illuminating comparison of the addition product to the 
generic oxidation product 411 is missed; these systems are more electronically comparable. It was 
anticipated that if A and C rings were distinguished in a more definitive fashion then the 
regiochemistry of superoxide addition could likewise be ascertained by comparison with literature 
data.  
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10.2 Assignment of 3,8-dinitrophenanthridinium salt 305 
The steps used to assign phenanthridinium ring protons are detailed below alongside some 
commentary on the electronic features of phenanthridinium salts as inferred from the NMR 
spectroscopy data. The trends and assignments observed are in agreement with the detailed 
study presented by Leudkte et al.180 
 
Figure 64 - Numbering of 3,8-dinitrophenanthridinium 305. 
 
Phenanthridinium salts show characteristic NMR features which aid assignment of the protons of 
the A and C rings. 1H NMR shifts are variable depending on conditions, but the order of the peaks 
is consistent. An assignment of 3,8-dinitrophenanthridinium 305 (Figure 64) illustrates these 
(Figure 65). 
 
Figure 65 - 1H NMR spectra in CD3OD, assigned with the aid of the 2D spectra presented in Figure 
66 - Figure 68. 
 
The H7 proton signal is important in assignment of the C ring spin system, and as a result key to 
differentiating the A and C spin systems. This is because it displays a large upfield shift relative to 
other phenanthridinium signals. The presence of an 8-amino moiety exaggerates this shift in other 
compounds, which may be as far upfield as 6.0 ppm in more electron rich phenanthridinium salts 
than 3,8-dinitrophenanthridinium 305. One explanation for this behaviour is that the 6-Ph ring sits 
at an angle close to 90˚ to the plane of the phenanthridinium heterocycle, allowing the ring π 
system to shield H7.   
H1 H10 H4 
H9 H2 
H7 
H4’’ 
H3’’/H5’’ 
H2’’/H6’’ 
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The assignment of H7 itself can in the case of phenanthridinium 305 be confirmed by HMBC 
correlation to a quaternary 13C peak at 168 ppm, which is too far downfield to credibly represent 
any position but C6, and which correlates further to H2’’/H6’’ itself (Figure 66). 
 
Figure 66 – HMBC of dinitrophenanthridinium 305 in CD3OD. The H7 – C6 and C6 – H2’’/H6’’ 
correlations are highlighted. f1 corresponds to the 1D 13C spectrum, while f2 corresponds to the 
1D 1H NMR spectrum. 
 
Having identified H7, the attached carbon C7 can be identified from HSQC (Figure 67). There are a 
few distinctive features worthy of comment. Firstly, as demonstrated in Figure 67, many of the 
phenanthridinium 1H NMR shifts suggest very electronically distinct protons, yet the 13C NMR 
spectra suggest the attached carbons are fairly similar electronically. The strong downfield shift of 
H1/H10 is a recurring feature of the phenanthridinium core regardless of substitution pattern, 
and can probably be attributed to the influence of the neighbouring A/C ring π system through 
space. Similarly, the upfield shift of the C4 in the 13C NMR is characteristic. Indeed in more 
electron rich examples this may be below 100 ppm, giving values rarely seen in aromatic systems 
in the absence of metallic substituents or the heavy atom effect. 
 
Figure 67 – HSQC of dinitrophenanthridinium 1 in CD3OD. 
 
H7 H2’’/H6’’ 
H7 H4 H2’’/H6’’ 
Chapter 10: Assignment of the proton NMR of phenanthridinium salts 151 
 
Having distinguished H7 from H4, COSY spectra can then be used to link the other signals to these 
and hence differentiate the large ortho d of H1 from that of H10 and the dd of H2 from that of H9 
by following the correlations around the ring systems (Figure 68). 
 
Figure 68 – COSY spectrum of 3,8-dinitrophenanthridinium 305 in CD3OD. The assignment of H9 
and H10 from H7 is illustrated. 
 
Following analysis of the 2D spectra shown the A and C ring systems can therefore be 
unambiguously differentiated. In practice COSY correlation spectroscopy is usually sufficient as 
the position of H7 and H4 are often readily apparent. Similarly, placement of H1 relative to H10 
and H2 relative to H9 are general, excepting where the electronic effect of a substituent exerts a 
disproportionate influence on one or the other ring system. 
  
H10 
H9 
H7 
Chapter 10: Assignment of the proton NMR of phenanthridinium salts 152 
 
10.3 The assignment of 3,8-diaminophenanthridinium salt 406 
It was desirable that the 1H NMR of the phenanthridinium precursor 403 to the final superoxide 
probe be described as thoroughly and accurately as possible in order to provide an analogue for 
identifying the superoxide reaction product with final probe 404 and any other potential side 
products. For this neopentylethidium 406 (Table 7) was employed as a model because the ring 
system is extremely similar to that of the phenanthridinium precursor to the final probe, and was 
characterised by COSY, HMBC and HSQC correlation spectroscopy. In addition to the correlations 
already described HMBC correlations from the CH2-1’ triplet at around 4.5 ppm to H4 allowed the 
identity of H4 to be assigned. Accordingly the identity of H7, already acknowledged within the 
literature for electronically similar systems,180,364 was established unambiguously. The 1H (Figure 
69) and 13C NMR assignments are presented below (Table 7). 
 
Table 7 - Structure and 13C assignment of bisneopentylethidium 406. 
Pos. ppm  
C1 124.17 
 
C1a 117.43 
C2 117.30 
C3 152.30 
C4 98.30 
C4a 134.80 
C6 157.40 
C7a 124.73 
C7 105.50 
C8 147.64 
C9 128.15 
C10 122.06 
C10a 128.99 
C11 49.49 
C12 14.48 
 
 
Figure 69 - Assigned 1H NMR spectrum of bisneopentylethidium 406. 
 
One unusual feature of this spectrum is the two neat 1H t observed for the amines, probably due 
to steric hindrance slowing exchange. The 2 ppm shift difference illustrates the difference in 
H1 H10 
H9 
H7 
H11 
3-NHR 8-NHR 
H2 
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electronics between the A and C ring systems. With H7 identified, re-examination of both 
Beckman136 and Zhao’s129 2D NMR data demonstrate that attack occurs in the 2 position, and the 
correct structure of the product is phenanthridinium 57. 
10.4 General features of the 1H NMR spectra of phenanthridinium salts 
10.4.1 Orientation of the C6-Ph ring 
The conformation adopted by the C6-Ph group relative to the phenanthridinium unit is reflected 
in both 1H and 13C NMR spectra, in the unusual order of the signals. In a ring system conjugated to 
an electron poor iminium substituent such as a phenanthridinium core, it is reasonable to expect 
the ortho (H2’’/H6’’) and para (H4’’) signals to have similar chemical shifts and both to be 
downfield of the meta protons (H3’’/H5’’) due to the mesomeric contribution of the electron poor 
substituent. Instead H4’’ is the most downfield shifted signal, followed by H3’’/H5’’, with the 
ortho H2’’/H6’’ signals invariably displaying the lowest chemical shift of these phenyl group 
protons, because the phenyl group is twisted out of conjugation (Figure 70). This is consistent 
with the unconjugated phenanthridinium core influencing these shifts in a predominantly 
inductive fashion. 
 
Figure 70 - Poor p orbital overlap from the C6-phenyl to the phenanthridinium core. 
10.4.2 Assigning protons of an unsubstituted A ring 
Substrates which do not display the ABX (3,8 substitution) patterns provided additional 
challenges, making distinguishing H1/H4 and H2/H3 difficult. NOESY correlations allow these 
signals to be distinguished by correlating H1/H10 and H4/CH2-1’. 
10.5 Substituent Effects 
The existence of strong substituent effects can disrupt the established order of peaks; these are 
consistent with the known donating or withdrawing capability of the groups in question. A few 
substrates with difficult to interpret electronic influences are discussed in the following pages.  
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10.5.1 Assigning H1 and H4 of 2-Methoxy-3,8-dinitro-5-(hex-1’-yl)-6-
phenylphenanthridinium chloride 303 
One exotic example is the 2-methoxy-3-nitrophenanthridinium 303. In the absence of 
substituents H1 would be the more downfield signal, however 2-OMe and 3-NO2 move the H1 and 
H4 peaks upfield and downfield respectively. Basing an assignment on the balance of two 
unquantified, competing, and variable effects is dubious, so NOESY correlation spectroscopy was 
used to acquire a definitive answer. 
 
 
 
 
 
 
 
 
 
 
Figure 71 - NOESY spectrum in CDCl3, with ‘real’ correlations (negative signals) to other protons in 
blue. The observed correlations are shown on the structure. 
 
The correlation from H10 (9.2 ppm d, ortho coupling) and 2-OMe (4.2 ppm, s) identify H1 as the 
4th signal from the left (approx. 8.5 ppm), and correlation from CH2-1’ (4.7 ppm) gives additional 
confirmation by identifying H4. Correlation between H2’’/H6’’and CH2-1’ is also visible. 
  
OMe 
CH2-1’ 
H1 H4 H2’’/H6’’ H10 
Chapter 10: Assignment of the proton NMR of phenanthridinium salts 155 
 
10.5.2 Assigning H1 and H3 of 4-aza-5-(hex-1’-yl)-6-phenyl-8-nitrophenanthridinium 
chloride 301 
The pyridine ring system in 4-azaphenanthridinium 301 means many of the previously identified 
patterns would not necessarily be expected to apply. If it is assumed that the chemical shift 
patterns observed in simple pyridines is replicated, H3 would be shifted up to 1 ppm downfield 
relative to H1 before the influence of the larger conjugated system is considered.365 H1 itself 
would be expected still to display a downfield shift. The rationale for this observation is unlikely to 
be abolished by a change in the nature of the ring aromatic system, although the magnitude of 
the shift may vary. Again, even if numbers could be placed on these two effects a simple additive 
approach does not necessarily account for larger changes to the heterocycle electronics induced 
by the pyridine. NOESY correlation spectroscopy allowed these protons to be identified. 
 
Figure 72 - NOESY of 4-azaphenanthridinium 301 in CD3OD with ‘real’ correlations (negative 
signals) to other protons in blue. The observed correlations are shown on the structure. 
 
H10 is readily identified (9.4 ppm, d, ortho coupling) and gives a correlation to H1, more than 0.3 
ppm downfield of H3. As expected H2 is shifted upfield (1.2 ppm from H1), and is upfield even of 
H7. This is supported by the 1H NMR spectrum coupling pattern as relatively small ortho couplings 
of 4 - 6 Hz are common from the position (H3) adjacent to the nitrogen of the pyridine (shown by 
the red arrow in Figure 72). 
 
 
 
  
H10 
H1 H3 H2 
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10.5.3 Coalescence of 3-tertbutyl-5-(cyclohexylmethylamino)-6-phenyl-8-
nitrophenanthridinium chloride 
 
Figure 73 - Fluxional behaviour on the 1H NMR timescale based on slow rotation around N5-CH-1’ 
resulting in slow interconversion of H’1A and H’1B is observed for phenanthridinium 309. 
 
Hindered phenanthridinium 309 showed distinctive fluxional behaviour, due to slow rotation 
around N5-C1’. CH2-1’ was variably present as two broad singlets H’1A and H’1B (Figure 74) or 
absent in room temperature spectra, a result of rotation interchanging the position of these 
protons on a timescale close to that of the NMR relaxation. The signal was resolved by increasing 
the temperature, resulting in coalescence (Figure 74). The 13C spectra also showed an unusually 
broad aromatic signal believed to represent C2’’/C6’’ - higher temperatures (70 ˚C in d6-DMSO) 
producing an acceptable spectra. 
 
Figure 74 - 1H spectra of phenanthridinium 309 in CD3OD from RT to 50 ˚C with the appearance of 
CH2-1’ highlighted.  
 
 
 
 
 
 
 
RT 
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40 ˚C 
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Chapter 11: A targeted and ratiometric fluorescent calcium sensor 
11.1 Calcium and the mitochondria 
11.1.1 Why is calcium relevant? 
As with many components within the cell, the mitochondria orchestrate a number of other 
processes in addition to their vital role in providing energy for cellular processes. Of particular 
interest and discussed here is the role of the mitochondria in calcium signalling. The calcium 
dication is responsible for the regulation of a remarkable variety of cellular and extra-cellular 
processes. Calcium is the single most abundant metal in many animals; in humans it is responsible 
for bone structure, muscle contraction (including heartbeat), regulation of ATP synthesis in some 
cells and signalling for a vast number of different processes, possibly including cell mitosis.366 
Signals may be local, through the cell or indeed between cells. Concentration curves over the 
timespan of a signal can assume different shapes and the lifetime of a signal itself can vary greatly 
depending on the process; exocytosis can be triggered in microseconds but transcription may take 
minutes or even hours.367 Calcium signalling is therefore a topic of considerable depth and 
discussion here is limited to two specific contexts: the role of mitochondria in calcium signalling 
and the importance of such signalling in smooth muscle contraction. 
 
The specific functions of mitochondria in ion handling in general and calcium signalling specifically 
is a result of the chemiosmotic potential and resulting charge gradient across the inner 
mitochondrial membrane creating conditions different from those experienced elsewhere in the 
cell. Mitochondria have been identified as crucial elements in calcium signalling control in nearly 
all cell types.368 The formation of ATP and control of calcium ion concentration are intrinsically 
linked, with calcium ions being maintained in steep concentration excesses in organelles such as 
the endoplasmic reticulum and Golgi apparatus via ATP powered calcium pumps.369,370 
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11.1.2 Calcium regulation within the mitochondria 
A concise (if simplified) summary of calcium regulation within the mitochondria is illustrated in 
Figure 75 and is interpreted as follows; a sodium proton exchanger pumps out sodium ions, 
driven by proton influx due to the chemiosmotic potential. This sodium can then re-enter via an 
exchanger coupled to calcium efflux. This calcium removal is balanced by a uniporter transporting 
calcium ions into the mitochondria.371,372,373 Within the matrix the calcium is present in at least 
two forms: free calcium, often referred to as [Ca2+]m, and as an insoluble phosphate salt (believed 
to be either hydroxyapatite or tricalcium phosphate).371 The phosphate ions are transferred to the 
matrix in the form of phosphoric acid. The solubility of this salt is strongly pH dependent and 
addition of a protonophore leads to acidification and dramatic rises in [Ca2+]m.
374 The formation of 
this salt acts as a buffer on matrix calcium ion concentration. 
 
Figure 75 - Illustration of calcium homeostatis regulation within the mitochondria. Reproduced 
from Szabadkai and Duchen, 2008.368 
 
The contributions of the antiports and buffering is shown in Figure 76. Calcium ion matrix [Ca2+]m 
concentration can rise in a linear fashion at low concentration, acting as a messenger to stimulate 
enzymes such as NADH dehydrogenases and the Kreb’s cycle, increasing ATP output.3,375 Since 
extramitochondrial calcium rises as a result of many processes which consume ATP, this calcium 
feedback mechanism is regulating metabolism. Above this concentration range phosphate 
buffering ensues, and is so effective that a 50 fold increase in total matrix calcium causes an 
increase of [Ca2+]m of less than 50%.
376 Calcium efflux within this range is dependent on phosphate 
concentration and pH rather than calcium concentration, as shown by the relatively flat activity of 
the antiport. The uniporter by contrast increases in activity as a 3.5 power of extramitochondrial 
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concentration ([Ca2+]e), combining with the buffering to allow the mitochondria to control the 
local cytosol calcium concentration ([Ca2+]c), maintaining a concentration known as the ‘set point’, 
with a value of 0.78 M under normal conditions.371 
 
Figure 76 - Free matrix calcium concentrations as a function of extramitochondrial calcium 
concentration, compared to the relative activity of known regulation mechanisms as a function of 
extramitochondrial calcium concentration. 
 
In the 3rd ‘overload’ phase the buffering capacity of the phosphate salts is exceeded, leading to 
linear rises in [Ca2+]m. When this occurs calcium is released alongside low molecular weight ions 
and compounds, and additional solute enters, causing swelling and rupturing of the membrane. 
This is known as the permeability transition and has been investigated as a possible trigger for cell 
death via release of cytochrome c and other proteins with similar effects, through opening of a 
non-selective pore in both mitochondrial membranes.368 Loss of calcium homeostasis is an 
important step in cell death.371 This includes apoptotic death as well as necrotic (traumatic) 
destruction of cells. There is some evidence that in some cases even within the cell death process 
the majority of mitochondria continue to function in order to provide the energy for the 
programmed cell death.377  
 
An interesting example of Ca2+ mediated cell death occurs where glutamate has accumulated in 
response to anoxia or ischemia. In this case depolarising mitochondria to prevent uptake of 
calcium in the mitochondria has been shown to protect neurons.42 In this case the relationship 
between the cytosolic calcium ion concentration [Ca2+]c and cell death is not obvious, since similar 
concentrations from other sources do not trigger cell death. There is some evidence that the 
specific entry point for calcium in this case (NMDA gated channels) results in higher localised 
concentrations near receptors which cause nitrous oxide production (NO), which combines with 
the calcium concentration to trigger depolarisation and cell death.378 This highlights the 
importance of transient and local Ca2+ concentration variations, and the interactions of 
mitochondria and other organelles are vital in these events. Mitochondria also support calcium 
ion signalling by allowing the generation of microdomains of differing calcium ion concentration. 
This involves both active uptake and calcium release and the provision of ATP allowing other 
organelles to modulate their calcium uptake. Examples of direct involvement include the 
reduction of calcium ion concentration following depolarisation in signalling, which is achieved 
through the sodium/calcium exchange at the inner mitochondrial membrane.368  
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11.2 Calcium signalling in the sarcoplasmic reticulum of smooth muscle 
11.2.1 Smooth muscle 
As a tissue where energy consumption and the associated metabolic rate are directly tied to 
function and vary accordingly, muscle is of particular interest in the study of metabolism. Three 
types of muscle exist, and these are different at the cellular level: skeletal, cardiac and smooth 
muscle. Both skeletal and cardiac muscle produce short, powerful contractions (albeit repetitively 
in the case of cardiac muscle), by contrast smooth muscle produces a longer, sustained 
contraction. We have no conscious control over smooth muscle contraction, which respond to 
autonomic nervous signals and local stimuli, and are flexible, with a fusiform shape. This 
dependence on local stimulus and different mode of action allows smooth muscle to perform 
different roles, such as lining most blood vessels (not large arteries) and regulating their diameter 
to maintain pressure or contracting rhythmically in a peristaltic fashion to force matter through 
the digestive tract. Smooth muscle also plays an important structural role, helping to maintain the 
positioning and shape of internal organs. Calcium concentration plays an important role in muscle 
contraction through ‘excitation contraction coupling’, and so variation in patterns of contraction 
are likely to be reflected in the pattern of calcium signalling,379 in which a specialised organelle 
called the sarcoplasmic reticulum is heavily involved. 
11.2.2 Calcium signalling and the sarcoplasmic reticulum 
Both the sarcoplasmic reticulum, which is a type of endoplasmic reticulum found in smooth 
muscle, and the endoplasmic reticulum are in general strongly associated with mitochondria. 
There are two types of endoplasmic reticulum (rough and smooth) and their combined roles 
include numerous functions including synthesis of membranes, lipids, steroids and proteins and 
detoxification of drugs in addition to calcium storage and signalling functions. Calcium related 
interaction between mitochondria and the endoplasmic reticulum is believed to have an 
important role in stress related cell death.368 The sarcoplasmic reticulum is a more specialised 
organelle, with a primary role in calcium storage and signalling and is found in muscle tissue, with 
calcium release being a major component of the ‘excitation contraction coupling’ which 
stimulates muscle contraction.380 The calcium gradient is maintained via active transport381 (Ca2+-
ATPase enzymes such as SERCA) which requires a constant supply of ATP; for this reason 
mitochondria are often found close to the sarcoplasmic reticulum,368 and release ATP at specific 
sites, generating local high concentrations of ATP.382 In these regions the calcium releasing 
channels from both organelles are directly linked.383 Calcium concentrations also control the 
shape and position of mitochondria, for example causing migration of mitochondria onto the 
surface of the endoplasmic reticulum.384 Although present in all muscle, the role of the 
sarcoplasmic reticulum may vary somewhat between muscle cell types. 
 
Referring to the diagram shown (Figure 77), the interplay of calcium and the sarcoplasmic 
reticulum in smooth muscle contraction can be described as follows. The sarcoplasmic reticulum 
uses active transport to contribute to calcium regulation by removing it from the surrounding 
cytoplasm (1), which allows muscle relaxation (2). Calcium signals are then stimulated, modified 
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or amplified by this calcium being released in response to stimuli (3). The excitability of the 
membrane to further stimulus is then modified via calcium sensitive channels for other ions (4), 
and calcium released directly to extrusion pumps in the plasma membrane (5). The sarcoplasmic 
reticulum interacts strongly with mitochondria in smooth muscle (99.4% of mitochondria is within 
30 nm of the sarcoplasmic reticulum, with 82% totally surrounded by it),385 producing various 
microdomains of different calcium ion concentration and exchanging calcium with the 
mitochondria depending on the situation (6). 
 
Figure 77 - Calcium and the sarcoplasmic reticulum in smooth muscle contraction.
386
 
 
The proximity of the mitochondria and the release points for calcium ions in the sarcoplasmic 
reticulum leads to the mitochondrial calcium transporter taking up calcium ions much faster than 
would normally be expected, due to high local concentrations.386 It has been suggested that by 
decreasing feedback from the calcium sensors in the sarcoplasmic reticulum stimulating the 
release the calcium efflux is maximised. Release channels include IP3R and RyR receptors, which 
release calcium ions in response to messenger concentration and in a fashion mediated by a 
number of other factors. IP3R features a channel activated by binding of inositol triphosphate and 
mediated in activity by calcium ion concentration, providing a feedback mechanism,385 and are 
also found outside of the sarcoplasmic reticulum. IP3R channels are not randomly distributed but 
are clustered in groups across the sarcoplasmic reticulum, allowing various local concentrations to 
exist in a cell on a transient basis. The RyR (ryanodine sensitive release) channels are much larger 
and bind less specifically, being activated and deactivated directly by calcium binding in the 
protein. As a result the channel is stimulated by micromolar concentrations of calcium ions but 
deactivated at millimolar concentrations.387 The channel exists in a few different isoforms, with 
different calcium sensitivity, with RyR1 and RyR2 possibly aggregating together.388 Of these, RyR1 
is the more sensitive, possibly amplifying the calcium signal until RyR2 is activated, leading to a 
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large calcium efflux known as a ‘spark’. A third RyR3 is far more evenly distributed and may be an 
inhibitor389 under normal physiological conditions, although it can function as a release channel in 
the correct circumstances.390 
11.2.3 Calcium induced calcium release in smooth muscle contraction 
The collection of positive feedback mechanisms referred to as ‘calcium induced calcium release’ 
(CICR) are important in numerous cell types. They are believed to be involved in smooth muscle 
contraction, although the contribution from different Ca2+ sources probably varies somewhat. 
Various permutations are set out in Jaggar et al390 and discussed in a review by Berridge.391 An 
outline of the mechanisms involved is illustrated in Figure 78 as follows. (1) An external 
messenger such as acetylcholine activates a membrane receptor releasing the signalling molecule 
inositol triphosphate (labelled InsP3 in Figure 78) into the cytosol. (2) Synchronously through 
various mechanisms high extra-cellular Ca2+ leaks into the cytoplasm, reducing membrane 
polarisation and increasing [Ca2+]c, which is sequestered into the sarcoplasmic reticulum (3). The 
InsP3 channel IP3R precipitates a Ca
2+ ‘spark’, (4), which is then amplified by positive feedback 
cycles from both IP3R and RyR channels (5). Increasing Ca
2+ results in contraction of the muscle 
(6), with SERCA and the functionally analogous PMCA pumping Ca2+ into the SR and extracellular 
space respectively (7). Local increases in Ca2+ also activate potassium channels, which 
hyperpolarise the cell to prevent further excitation in a negative feedback mechanism limiting 
contraction (8). In some cells Ca2+ may also activate chloride channels which depolarise the cell 
and allow further Ca2+ accumulation from the extracellular space (9). It should be noted that while 
these mechanisms are all known to exist in some form, their relative importance or even 
involvement is variable and not well understood.392,393,394,395 
 
Figure 78 - Calcium induced contraction in smooth muscle. ©2008 The Author. Journal 
compilation. ©2008 The Physiological Society391 
 
In some cells it is possible that the final chloride induced Ca2+ influx initiates contraction, however 
it is not clear that global (full cytoplasm) increase in calcium ion concentration is required to open 
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chloride channels, with both major ion channel types able to generate substantial local increases 
in calcium ion concentration. These local increases allow for selective activation of calcium 
sensors based on a number of factors. Because loss of the high local concentration is rapid due to 
diffusion, selective activation of receptors with high association constants over slower receptors 
with comparable dissociation constants is possible. The localised nature of these sparks also 
allows spatial resolution.395 
 
 The interaction of mitochondria and the sarcoplasmic reticulum is expressed through various 
channels in carefully defined positions themselves modulated by several variables. Localised 
microdomains selectively activate and in turn activate further receptors and organelles. These are 
based on the selectivity of receptors which can be modulated up or down by both calcium ion 
concentration and other factors. Coupling this to the potential for receptors to be selectively 
activated based on association constant and calcium signalling within cells clearly constitutes an 
immensely complicated system. This is only very roughly elucidated here and varies considerably 
between cell types. The remarkable control and regulation of calcium within the smooth muscle 
cell allows a single species to act as a messenger selectively for a huge variety of processes and 
highlights the challenges and potential of designing sensors for such a system. 
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11.3 Design of a ratiometric intracellular ion probe 
11.3.1 Probe design features 
With the importance of probes for calcium ions clear, there is some potential for combining a 
mitochondria-targeting group with a calcium ion sensor in the same way as targeting DNP 
decouplers is potentially useful. However, with calcium ions involved in so many ion channels, 
organelles and individual signalling pathways there is also great utility in other targeting 
strategies. For this reason the synthesis of a fluorescent calcium sensor which can be easily 
conjugated to various targeting groups was planned. The fluorophore and binding groups are 
based on extant probes396,397 modified to allow easy attachment of different targeting groups 
(Scheme 134).  
 
Scheme 134 - Ion sensor target divided roughly into components; the ionophore (red), 
fluorophore (green) and targeting handle (purple). 
 
Sensor precursor 412 has an azide for attachment to different targeting groups by click 
chemistry.398 It is based on the benzofuran fluorophore Fura red due to the large stokes shift on 
Ca2+ observed with this fluorophore, which allows ratiometric imaging.399 This is attached through 
a conjugated system to a polydentate (octacoordinate) calcium chelator. Binding to calcium 
changes the bond angles from the coordinating groups to the tertiary amine, removing these from 
conjugation and changing the electronic properties of the ion sensor. Through conjugation this 
electronic change is passed to the fluorophore (Scheme 134), and here a difference in electronics 
translates to different excitation and fluorescence wavelengths.  
 
The chelating section of the molecule is based on Tsein’s 1,2-bis(o-aminophenoxy)ethane-
N,N,N',N'-tetraacetic acid (BAPTA) Ca2+ sensors396 as used in the Fura type indicators,73 although 
with the important addition of a nitro group on one ring. The reasoning for this is the dramatic 
increase in dissociation constant observed upon addition of an electron withdrawing substituent 
to Fluo-4.400 The intention is that the probe should have high selectivity but relatively low affinity 
to achieve a large dynamic reporting range and image specifically high local, transient Ca2+ 
concentrations. The probe is also ratiometric, due to the different absorption wavelength 
exhibited by chelating and non-chelating fura indicators. 
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11.3.2 Planned forward synthesis 
The modular synthesis illustrated below shares many common features with other syntheses of 
BAPTA type probes, in particular that of Grynkiewicz, Poenie and Tsein.396  
 
Scheme 135 - Intended forward synthesis. 
 
The two core rings A and B form the basis of the fluorophore and the binding modulating group 
respectively and are constructed by applying well established chemistry to hydroquinone 414 
through a series of protection, nitration, and deprotection then linked by alkylation with 
nitroarene 415 to form BAPTA precursor 416. Reduction of the nitro groups in this precrusor is 
followed by alkylation to add the chelating arms, followed by formylation of the more electron-
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rich ring and deprotection to give aldehyde 417. The placement of the last nitration step is 
restricted to quite late in the synthesis due to electronics, in particular the need for the 
formylation of ring B to deactivate this ring and improve nitration selectivity for ring A. Alkylation 
of aldehyde 417 with an aldehyde surrogate and condensatory cyclisation to give fura red 
precursor 418, with further condensation to connect thiohydantoin 419 forming ring C. Hydrolysis 
of the ester groups to give calcium sensor 412 as a tetra-acid would then complete then initial 
synthesis. An appropriate attachment point for the targeting group is also simultaneously 
attached with the thiohydantoin. There are a range of options for this group, with the typical 
example being an azido group as a precursor to copper-catalysed Huisgen cycloaddition.398 
11.4 Synthesis of a ratiometric Ca2+ ion sensor 
11.4.1 Synthesis and linking of phenol components 
The synthesis of the phenolic components (Scheme 136) and formation of the BAPTA skeleton 
were all carried out on large scale, allowing purification via non-chromatographic techniques such 
as crystallisation. 
 
Scheme 136 - BAPTA skeleton construction 
 
Benzyl protection of hydroquinone 414 to give dibenzylated phenol 420 works with benzyl 
chloride or bromide, although mechanical stirring proved necessary due to the viscosity of the 
suspension. The ethanol used was distilled from KOH prior to use due to the observation of a 
brown residue in a small scale trial which was attributed to additives in this solvent. 
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The benzyl ether 420 is sufficiently electron rich for nitration using nitric and acetic acid with 
modest heating to give nitroarene 421. This approach is considerably milder than more common 
nitric/sulphuric acid mixes as the rate equation for such an electron rich ring system would be 
zeroth order with respect to the aromatic component. The rate is dependent only on nitronium 
ion formation and this species is immediately consumed. Consequently the mixture is less 
oxidising. This may be important in avoiding oxidation to a quinone-type structure.331 The acetic 
acid also serves to moderate the acidity of nitric acid. 
 
Deprotection to give phenol 422 using TFA and chloroform proved slow, unreliable and difficult to 
purify. An alternative was investigated which made use of the ortho-nitro group to chelate a 
strong Lewis acid with an adjacent ether and so promote the deprotection of the phenol in this 
position through complex 424 (Scheme 137). The result is benzyl chloride and the aluminium 
phenoxide 425, which subsequently hydrolyses in acidic solution to the desired phenol product. 
 
Scheme 137 - Lewis acid catalysed deprotection. 
 
The conditions used are modified from a literature procedure;401 an initial small scale trial showed 
that the reaction worked well and gave good conversion. On scale up concentration was 
increased and the temperature was lowered to compensate for the change in heat loss 
characteristics of the exothermic reaction with the increased scale and concentration. The 
starting material was completely consumed and selectivity for the phenol 422 is about 5:1 over 
alternate phenolic products. The yield was limited by the repeated recrystallisation needed to 
remove side products, which had similar solubilities to the product. 
 
The bromide 415 was synthesised in moderate yield by reacting phenol 423 with dibromoethane 
in DMF, with similar conditions then used to link bromide 415 to phenol 422 to give biaryl 416. 
The initial attempt at this reaction contained dibromoethane and dimer 426 was isolated as a 
byproduct (Scheme 138).  
 
Scheme 138 – Small quantities of dimer 426 resulted from leftover dibromoethane in the coupling 
of nitroarenes 415 and 422. 
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Removal of leftover dibromoethane on scale up by distillation under reduced pressure from the 
product 415 allowed the subsequent coupling to form 416 to proceed quantitatively. 
 
Material generated from the large scale early synthesis was then transformed over a number of 
steps to the fluorophore precursor (Scheme 139). These steps proved more problematic and 
required more development. 
 
Scheme 139 - Continuation of the synthesis towards the fluorophore 
 
The reduction of the dinitro precursor 416 is complicated by the need to preserve the benzyl 
ether. Several conditions were evaluated in search of a replacement for hydrogenation over the 
Pt/C, reagent which was used in the synthesis of Tsein’s original ion sensor396 due to the expense 
of using this reagent on a large scale. Sodium dithionite402 in THF was tested, but no reaction was 
observed. Palladium on carbon with ammonium formate as a hydrogen source was also tested 
because it was hoped the reactivity of the nitro and benzyl groups would be sufficiently different 
as to allow reduction of the nitro group without deprotection. Small scale experiments quickly 
showed that complete reduction without deprotection was impossible under the conditions used. 
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As an alternative, iron in aqueous acid is a well-established reagent for reduction of nitroarenes. 
Initial tests in ethanol based on procedures previously used within the group403 proved 
unsuccessful, but replacement of the ethanol with an acetone/water mix404 gave clean conversion 
to dianiline 427 and acceptable yields after the solvent ratio was modified to better suit the 
substrate 416. 
 
The ‘arms’ of the molecule were then attached to dianiline 427, which is a potentially problematic 
reaction due to the need to ensure complete reaction and thus avoid difficult to remove 
impurities without risking generation of quaternary ammonium salts. Some variability in yields 
was seen in earlier attempts at this reaction, which may be explained by the subsequent 
observation that product 428 is somewhat sensitive to moderate heat and possibly prolonged 
exposure to light. Use of a large excess of reagents and careful drying of all reagents used allowed 
for eventual quantitative conversion to tetra-ester 428. 
 
Formylation was achieved with the Vilsmeier-Haack reaction,405 for which the mechanism is 
shown below (Scheme 140). 
 
Scheme 140 - The Vilsmeier-Haack formylation mechanism. 
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First the Vilsmeier reagent 433 is generated through nucleophilic attack by the oxygen atom of 
DMF 431 on the phosphorus atom, which subsequently loses a chloride. The resulting iminium 
phosphoryl chloride 432 is attacked by the chloride to form the iminium chloride 433, aided by 
the energetically favourable formation of the strong phosphorus-oxygen double bond. Once 
formed the reagent undergoes nucleophilic attack from the more electron rich aromatic ring of 
tetraester 428. The regiochemistry of addition is controlled by the ortho and para directing amino 
group and benzyl ether on the A ring, which both donate most strongly to the same positions. 
Since the position ortho to the amino group is sterically crowded selective reaction para to this 
group is favourable. The amine then ejects the chloride to reform the iminium structure 435, and 
a hydrogen ion is readily lost from the site of reaction due to the lower energy of the resulting 
aromatic system. The iminium ion 435 is hydrolysed in aqueous work up to give the desired 
aldehyde 429. 
 
In Tsein’s synthesis the major alternative formylation site on the B ring is blocked by a methyl 
group absent in our target, so formylation of the tetraester compound 428 required optimisation 
of conditions. Variation of conditions and equivalents showed that it was possible to formylate in 
only the desired position using additional equivalents of POCl3 for a short period of time 
(monitored by TLC), giving aldehyde 429 in high yield. 
 
Deprotection of benzyl ether 429 proved difficult; initially transfer hydrogenation with ammonium 
formate appeared effective, but proved unreliable on a larger scale and lead to decomposition. 
This was attributed to the acidic ammonium and an alternative hydrogen source was investigated, 
1,4-cyclohexadiene, but no reaction was observed. 
 
Lewis acids were also investigated, starting with a procedure using magnesium bromide and 
reputed to be quite specific for benzyl groups next to an aldehyde in a similar manner to the 
earlier aluminium trichloride deprotection.406 However benzyl ether 429 showed poor solubility in 
the specific solvent system used for this reaction, and no reaction was observed. Aluminium 
trichloride gave deprotection but other phenolic side products. The ability of this reagent to 
generate HCl(aq) in the presence of moisture and potentially cleave ether links meant that 
generation of impurities was difficult to control. Nevertheless some material was brought through 
with this system. 
 
Replacing the earlier transfer hydrogenation procedures with hydrogen gas and using a purer 
batch of starting material and a rigorous freeze/thaw degassing procedure prior to saturating the 
solvent with H2(g) gave phenol 430 in good yield. 
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11.4.2 Nitration: addition of the binding modulating group 
 
Scheme 141 - Attempted nitration of the B ring. 
 
The addition of a nitro group para to the amino group on ring B, which was on the less substituted 
ring system was a vital part of the initial design of the synthesis, but the exact position of the step 
in the synthesis is somewhat flexible. Since literature precedent for nitration at this stage exists 
the procedure was tested.407 
 
Given the earlier experience with acidic reagents for the deprotection, it was not surprising to 
observe considerable decomposition of the starting material when heated in a nitric acid/acetic 
acid mixture. Compared to the literature synthesis this reaction was of small scale, and so 
controlling the equivalents of nitric acid was problematic. Following this result the nitration step 
was postponed to later in the synthesis. 
11.4.3 Thiohydantoin heterocycle synthesis 
 
Scheme 142 - Synthesis of the thiohydantoin heterocycle 419. 
 
The thiohydantoin coupling partner 419 for later in the sequence was completed (Scheme 142), 
beginning from 1,7-dibromoheptane 436 and following a literature route to the amine408 438 in 
which the diazo compound 437 is formed by reaction with sodium azide in water. Although most 
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literature routes make use of DMF to improve mixing this proved unnecessary. This was followed 
by Staudinger reduction of one azido group featuring a biphasic Et2O/aqueous acid system. The 
amine formed is protonated and thus dragged into the acidic aqueous layer, preventing over-
reduction.  
 
Scheme 143 – Mechanism of the Staudinger reduction. 
 
The Staudinger reaction mechanism (Scheme 143) has been investigated computationally in the 
literature.409,410 These studies suggest the phosphine nucleophile attacks the α nitrogen atom of 
the azide 437 on the same side as the γ nitrogen atom with the attached R group to give a cis 
phosphazide due to stabilising interactions between the phosphine and the γ nitrogen atom. The 
resulting triphenylphosphonium salt 441 is subsequently attacked by the γ negative nitrogen 
atom to form a 4-membered intermediate 442,409 which decomposes, extruding N2 to give the 
iminophosphorane. It is noted409,410 that the energies of these transition states and intermediates 
are very close in the pathway and the reaction may be concerted in some cases. The resulting 
iminophosphorane can then undergo hydrolysis to give the amine 438.  
 
The isothiocyanate 439 was then formed in good yield by gradual addition of thiophosgene to a 
stirring mixture of mono azide 438. It was hoped that reaction with glycine methyl ester 
hydrochloride would lead directly to closed ring system 419,411 but instead the open chain 
compound 440 was isolated. Different ring closing strategies were attempted, with stirring in 
DCM with SiO2 proving unsuccessful, and p-toluenesulfonic acid in toluene giving lower yields 
than the aqueous acid/EtOH system shown in the scheme. The desired heterocycle was then 
isolated in good yield by recrystallisation. The completed heterocycle was used by Dr Stuart 
Caldwell and Laura Martin to make the intended fluorophore in advancing the calcium sensor 
synthesis and a separate project, respectively. 
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11.4.4 Benzofuran formation 
 
Scheme 144 - Routes investigated towards formation of the benzofuran. 
 
Following the decision to delay nitration, benzofuran formation was instead attempted. The 
combination of the diethyl acetal alkylating agent and the subsequent acid catalysed 
condensation are well precedented in literature.412 However, this is often a low yielding reaction. 
Initial alkylation proved difficult, perhaps due to thermal decomposition of the starting material 
430. A slower reaction at lower temperature appeared to yield some product 444 as part of a 
complex mixture, identified by a set of symmetrical multiplets at 3.9-3.6 ppm and a t at 4.8 ppm 
in the 1H NMR spectrum (CDCl3). Cyclisation was attempted both by stirring in acetic acid and 
using HCl(aq)/MeOH, but niether gave any of the desired product 446. Consequently, this route to 
the benzofuran product 446 was abandoned. 
 
Failure of the cyclisation represented a considerable difficulty; the substrate 430 is unsuitable for 
adaptation to a route mimicking the synthesis of related ion sensors. An alternative strategy of 
allylation to give allyl ether 445 then dihydroxylation and oxidative cleavage was investigated 
(Scheme 144). The first step was attempted on small scale (0.07 mmol) and the correct product 
was identified as part of a mixture due to the distinctive allyl signals (Figure 79), with the HC-HD 
geminal coupling of very similar size to the J4 coupling between HA and HC and HD giving the 
appearance of a dq structure, consistent with literature examples.413 The yield was estimated by 
1H NMR to be around 44%. No further work was carried out on this route. 
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Figure 79 - Characteristics signals in partial 1H NMR spectrum of tetraester 445 indicating the 
presence of an allyl group. 
11.4.5 Further work 
Work on the above route was halted at this point as Dr Stuart Caldwell pursued an alternative 
route, before eventually building on the route outlined to complete the synthesis of the final 
probe with a KDEL peptide sequence for retention in the sarcoplasmic reticulum attached (Figure 
80). 
 
Figure 80 - A sarcoplasmic reticulum targeted ratiometric calcium probe. 
 
The structure and route are mostly as previously described, with the exception of the heterocycle 
where a shorter chain has been utilised to aid purification. 
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Chapter 12: Thesis summary and future work 
12.1 Summary 
Synthesis of a photoactivated uncoupler 7-I was completed (Figure 81) and subsequently used by 
collaborators to demonstrate mitochondria uptake. The probe was then shown to allow selective 
uncoupling of mitochondria on UV stimulation. 
 
Figure 81 - MitophotoDNP iodide salt 
 
The synthesis of a ratiometric, targetable calcium sensor was completed up to intermediate 430 
(9 steps), alongside a thiohydantoin heterocycle 419 synthesised in 5 steps (Figure 82). A co-
worker has subsequently completed the probe synthesis based on this route, with the resulting 
probe shows good binding and optical responses in testing. 
 
Figure 82 - The BAPTA intermediate 430 and thiohydantoin heterocycle 419. 
 
Numerous routes to 5,6-disubstituted phenanthridinium salts were investigated towards the 
synthesis of a mitochondrially targeted superoxide probe and hydroxylated standards. In the 
course of this work a novel cyclisation was developed based on intramolecular SNAr giving access 
to 9-benzyloxyphenanthridinium salt 126.  
 
Scheme 145 - Novel cyclisation to 9-OH phenanthridine 126. 
 
Rapid and high-yielding access to 5,6-disubstituted phenanthridinium salts 289 and 299-310 was 
then achieved through forming benzophenones 265, 324-333 via Suzuki coupling and converting 
these to imines with the alkylamine. The nitrogen atom of the imine then undergoes cyclisation 
onto the aryl fluoride in an intramolecular SNAr upon heating. This transformation was shown to 
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have good steric and electronic tolerance in the synthesis of 13 phenanthridinium analogues with 
6 structural diversification points (Scheme 146). Subsequent DFT calculations by a colleague 
showed this reaction proceeds in a concerted fashion and as such represents a considerable 
mechanistic novelty. 
 
Scheme 146 - Precursors 448 and 449 allow access to benzophenones 265 and 324 - 333. The 
imine formation and cyclisation by intramolecular SNAr gives the 5,6-disubstituted 
phenanthridinium salts 289 and 299 - 310 in high yield. 
 
Efforts towards a new probe for mitochondrial superoxide led to the synthesis of 3-tertbutyl-
dihydrophenanthridine 294, which does not intercalate into DNA upon oxidation. This concept 
was refined and lead to the development of neopentyl ethidium 406 and the targeted analogue 
MitoBNH 404 and its deuterated analogue 410.  
 
Figure 83 - The non DNA-intercalating probes synthesised. 
12.2 Future work 
With regard to MitoPhotoDNP 7 and the ratiometric Ca2+ sensor it is hoped these will be 
appropriately utilised by collaborators, and the designs could be used to deliver alternative 
payloads or target different organelles, respectively.  
 
The cyclisation to the 9-benzyloxyphenanthridinium 126 may provide rapid access to substituted 
6-phenylphenanthridines, if higher yields and milder conditions could be achieved. The key to 
improving this reaction is likely to be found in reducing the imine isomerisation energy, and to 
this end an N-coordinating additive may prove helpful.  
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Numerous diversifications and expansions may be possible on the fruitful imine SNAr cyclisation. 
The C6 functionalisation opportunities offered by the enamine 369 may be worthy of 
investigation, allowing additional flexibility in decorating these important heterocycles. Many 
analogues are likely to be accessible via the methodology developed, including C6 unsubstituted 
variants. Improving or replacing the TiCl4 imine formation would be desirable, especially if the aza-
Wittig reaction could be made to work with a less stabilised phosphine or without the C6 
substituent in order to consolidate the imine formation step into the cyclisation procedure. 
Replacing the alkylamine with hydrazine or hydroxylamine may allow low temperature cyclisation 
due to the α effect, and the products may give interesting optical and particularly photolytic 
properties.  
 
Most obviously, the methodology will be utilised to access further probe systems, and to this end 
work is ongoing within the group to complete the DNA targeted H2O2 probe 371. 
 
Some further work is required to re-synthesise the MitoBNH deuterated standard, and then 
access the 2-hydroxymitoBNH controls. It is hoped that when these are available collaborators will 
be able to use these probes for accurate in vivo quantification of superoxide. The 
neopentylethidium model 406 is independently of interest, with the intention being to make a 
deuterated standard and use the combination for quantifying superoxide more generally. 
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Chapter 13: Experimental 
1H NMR were obtained using Bucker-ACS 60 spectrometers operating at 500 and 400 MHz 
respectively, 13C NMR spectra at 126 and 101 MHz accordingly. All coupling constants are 
recorded in Hz and reported uncorrected. DEPT was used to assign C, CH, CH2 and CH3. 2D 
techniques including COSY, HSQC, HMBC, NOESY and 19F equivalents and decoupled protons were 
used to aid assignment. The 19F spectra for trifluoroboronate salt 266 was corrected using 
CF3CO2H as an external standard. EI and CI mass spectra were obtained using the (M Station) JEOL 
JMS-700 spectrometer. Some ESI spectra were collected on a Bruker MicroTOF-Q in Glasgow, 
others by an LTQ Orbitrap XL by the National Mass Spectrometry Service Centre in Swansea. IR 
Spectra were obtained with a Shimadzu FTIR 8400S. Alumina for chromatography was deactivated 
by saturation with deionised water followed by drying at 150 C for 72 h. Ethanol for the synthesis 
of 1,4-bis(benzyloxy)-2-nitrobenzene was distilled from KOH. Acetone was dried by stirring with 4 
angstrom molecular sieves or distilled from CuSO4. All dry triethylamine was distilled from CaH2 
and stored over KOH. Dry solvents Hexylamine was distilled from CaH2 and stored over KOH. 
Pyridine was distilled from CaH2. All glassware for reactions involving anhydrous conditions was 
dried in an oven at 250 °C or flame dried under vacuum, with dry solvents collected from a 
Puresolv solvent purification system. A CEM Explorer PSL set to a maximum power of 50W, 
maximum ramp time of 20 min (never reached) and a 15 atm pressure cut off was used for the 
microwave reactions. All NEt3 was distilled from CaH2 and stored over KOH. Pyridine was distilled 
from CaH2. Allyl bromide was distilled MgSO4 in a dark environment and kept covered in storage 
to protect from light. NaI used was previously dried by heating under vacuum at 100 °C for 6 h. 
 
5-(Hydroxy-2-nitrobenzyl)methanol 22 
 
NaBH4 (2.38 g, 62.9 mmol, 1.90 eq.) was added over 45 min to a stirred solution of 5-hydroxy-2-
nitrobenzaldehyde (5.06 g, 33.0 mmol, 1.00 eq.) in MeOH (100 mL) at 0 C under argon. After 17 h 
the reaction was quenched into H2O. MeOH was removed and the aqueous concentrated under 
reduced pressure, leaving a yellow solid. This was partitioned between Et2O and 0.5 M HCl(aq), 
then the aqueous re-extracted with Et2O (x 3). The combined organic extracts were dried (MgSO4) 
and filtered, then the solvent was removed under reduced pressure and the solid dried under 
high vacuum to give benzylic alcohol 22 as a solid (4.68 g, 91%). H (400 MHz, CD3OD): 8.08 (1H, d, 
J = 9.0 Hz, H3), 7.26 (1H, s, H6), 6.78 (1H, dd, J = 8.9, 2.4 Hz, H4), 4.94 (2H, s, CH2OH). In 
agreement with values from Caroline Quin’s thesis.414 
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4-Iodobut-1-yltriphenylphosphonium iodide 24 
 
Triphenylphosphine (9.18 g, 35.0 mmol, 1.00 eq.) was dissolved in dry PhMe (40 mL). This was 
added slowly to a stirred solution of 1,4-diiodobutane (5.0 mL, 38 mmol, 1.1 eq.) in dry PhMe (160 
mL) under argon which was then heated to 100 C in the dark for 4 h. A white solid was formed 
which was then vacuum filtered and washed with Et2O then hot PhMe and dried under vacuum to 
give the phosphonium salt 24 as a powder (15.4 g, 26.9 mmol, 77%). H (400 MHz, CDCl3): 7.92 - 
7.78 (9H, m, +PPh3), 7.74 - 7.68 (6H, m, 
+PPh3), 3.90 - 3.80 (2H, m, CH2CH2
+PPh3), 3.35 (2H, t, J = 6.1 
Hz, ICH2CH2), 2.24 (2H, quintet, J = 6.6 Hz, ICH2CH2CH2), 1.83 (2H, sextet, J = 7.8 Hz, 
CH2CH2CH2
+PPh3). C (CDCl3, 100 MHz): 135.25 (d, J = 3.0 Hz, CH), 133.65 (d, J = 10.1 Hz, CH), 
130.61 (d, J = 12.6 Hz, CH), 117.68 (d, J = 86.2 Hz, C), 32.58 (d, J = 17.0 Hz, CH2), 23.16 (d, J = 3.6 
Hz, CH2), 21.85 (d, J = 51.4 Hz, CH2), 7.29 (CH2). IR (ATR cm
-1): 2890 (CH), 2859 (CH), 1588 (CAr=CAr), 
1484 (CAr=CAr), 1433 (P-Ph). MS (NSI
+): 445 (M+, 100%), 289 (M+ –HI –H2 –C2H4).  
 
{4-[3’-(Hydroxymethyl)-4’-nitrophenoxy]butyl}triphenylphosphonium iodide 25-I 
 
Phenol 22 (1.18 g, 7.21 mmol, 1.00 eq.), phosphonium salt 24 (2.49 g, 4.35 mmol, 0.60 eq.), and 
Cs2CO3 (1.48 g, 4.53 mmol, 0.63 eq.) were stirred and heated under reflux and argon in dry MeCN 
(20.0 mL) for 72 h. After cooling DCM was added, then the solution decanted off. The residual 
solvent was removed under reduced pressure, and the material dissolved in DCM and washed 
with 1 M NaOH(aq). The aqueous washings were extracted with DCM (x 2). The combined organics 
were then dried (MgSO4), then filtered and the solvent removed to give phosphonium salt 25-I as 
a yellow foam (2.57 g, 97%). H (400 MHz, CDCl3): 8.03 (1H, d, J = 9.1 Hz, H5’), 7.81 - 7.75 (9H, m, 
+PPh3), 7.71 - 7.65 (6H, m, 
+PPh3), 7.48 (1H, d, J = 2.8 Hz, H2’), 6.73 (1H, dd, J = 9.1, 2.8 Hz, H6’), 
4.70 (2H, s, CH2OH), 4.29 (2H, t, J = 6.1 Hz, OCH2CH2), 3.75 - 3.65 (2H, m, CH2CH2
+PPh3), 2.19 (2H, 
quintet, J = 6.6 Hz, OCH2CH2CH2), 1.85 (2H, sextet, J = 7.8 Hz, CH2CH2CH2
+PPh3). C (CDCl3, 100 
MHz): 163.12 (C), 142.71 (C), 139.45 (C), 135.27 (d, J = 2.9 Hz, CH), 133.66 (d, J = 10.0 Hz, CH), 
130.63 (d, J = 12.6 Hz, CH), 127.35 (CH),117.80 (d, J = 86.2 Hz, C), 113.60 (CH), 67.21 (CH2), 61.66 
(CH2), 29.03 (d, J = 16.7 Hz, CH2), 22.33 (d, J = 51.3 Hz, CH2), 18.95 (d, J = 3.8 Hz, CH2). IR (ATR cm
-
1): 3320 (OH), 3053 (CAr-H), 2932 (CH), 2864 (CH), 1613 (CAr=CAr), 1584 (CAr=CAr), 1576 (CAr=CAr), 
1506 (NO2), 1433 (P-Ph). MS (FAB/NOBA), m/z: 486 [M
+ (phosphonium cation), 100%], 317 
(C22H22P
+, 83), 262.1 (+PPh3, 53). HRMS: 486.1834. C29H29O4NP requires 486.1829. 
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{4-[3-(2”,4”-dinitrophenoxymethyl)-4’nitrophenoxy]butyl}triphenylphosphonium iodide 7-I 
 
Benzylic alcohol 25-I (712 mg, 1.16 mmol, 1.00 eq.), 1-fluoro-2,4-dinitrobenzene 26 (0.60 mL, 5.0 
mmol, 4.3 eq.) were combined and stirred in dry acetone (15.0 mL) under argon. Dry 
triethylamine (0.40 mL, 2.9 mmol, 2.5 eq.) was then added and the mixture heated to 45 C for 72 
h in the dark. The solvent was removed under reduced pressure and the material dissolved in 
DCM and washed with 0.5 M NaOH(aq) (x 3). The DCM layer was then dried (MgSO4), filtered and 
the solvent removed under reduced pressure. The material was then dissolved in minimal DCM 
and precipitated with addition of Et2O (x 2), then this process repeated to give a brown foam (706 
mg). Column chromatography on 244 mg of this material using gradient elution [MeCN - EtOAc 
(10:3 - 10.1), then MeCN – MeOH (20:1 - 1:1)] on deactivated alumina gave the DNP derivative 7-I 
as a yellow foam (13 mg, 5%). H (400 MHz, CDCl3): 8.87 (1H, d, J = 2.8 Hz, H3”), 8.52 (1H, d, J = 
9.3, 2.8 Hz, H5”), 8.27 (1H, d, J = 9.2 Hz, H6”), 7.94 - 7.84 (6H, m, +PPh3), 7.82 - 7.76 (3H, m, 
+PPh3), 
7.74 - 7.65 (6H, m, +PPh3), 7.58 (1H, d, J = 2.7 Hz, H2’), 7.50 (1H, d, J = 9.3 Hz, H5’), 7.06 (1H, dd, J = 
9.1, 2.8 Hz, H6’), 5.79 (2H, s, CH2OAr”), 4.37 (2H, t, J = 6.2 Hz, OCH2CH2), 4.15 - 4.00 (2H, m, 
CH2CH2
+PPh3), 2.28 (2H, quintet, J = 6.8 Hz, OCH2CH2CH2), 1.96 - 1.85 (2H, m, CH2CH2CH2
+PPh3). C 
(CDCl3, 100 MHz): 163.93 (C), 156.00 (C), 140.57 (C), 139.07 (C), 138.45 (C), 135.00 (d, J = 3.0 Hz, 
CH), 133.72 (d, J = 10.0 Hz, CH), 130.44 (d, J = 12.5 Hz, CH), 129.85 (CH), 128.43 (CH), 122.42 (CH), 
118.30 (d, J = 85.9 Hz, C), 115.30 (CH), 114.50 (CH), 114.07 (CH), 69.41 (CH2), 68.02 (CH2), 29.07 (d, 
J = 17.0, CH2), 21.95 (d, J = 50.5 Hz, CH2), 19.18 (d, J = 4.0 Hz, CH2). IR (NaCl, DCM cm
-1): 3054 (CAr-
H), 2987 (CH), 2924 (CH), 2854 (CH), 1606 (CAr=CAr), 1519 (CAr=CAr), 1438 (P-Ph). MS (NSI
+): 652 [M+ 
(phosphonium cation), 100%]. HRMS: 652.1834. C35H31O8N3P requires 652.1843.  
 
4-Bromobut-1-yltriphenylphosphonium bromide 28 
 
A stirred mixture of triphenylphosphine (2.73 g, 10.4 mmol, 1.00 eq.) and 1,4-dibromobutane 
(1.50 mL, 12.6 mmol, 1.21 eq.) in dry PhMe (35 mL) was then heated to reflux under argon for 72 
h. The mixture was allowed to cool and filtered. The solid collected was washed with Et2O and hot 
PhMe, then dissolved in MeOH. The solvent was removed under reduced pressure to give solid 28 
(4.30 g, 100%). H (400 MHz, CDCl3): 7.91 - 7.85 (6H, m, 
+PPh3), 7.83 - 7.77 (3H, m, 
+PPh3), 7.74 - 
7.68 (6H, m, +PPh3) 4.02 - 3.94 (2H, m, CH2CH2
+PPh3), 3.59 (2H, t, J = 5.9 Hz, BrCH2CH2), 2.33 (2H, 
quintet, J = 6.5 Hz, BrCH2CH2CH2), 1.86 (2H, sextet, J = 7.8 Hz, CH2CH2CH2
+PPh3). Compound is 
commercially available.415 
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{4-[3’-(Hydroxymethyl)-4’-nitrophenoxy]butyl}triphenylphosphonium bromide 25-Br 
 
Phenol 22 (829 mg, 5.08 mmol, 1.00 eq.), phosphonium salt 28 (1.81 g, 4.50 mmol, 0.89 eq.), and 
Cs2CO3 (1.48 g, 4.53 mmol, 0.89 eq.) were stirred under reflux and argon in dry MeCN (20.0 mL) 
for 72 h. The mixture was partitioned between H2O and EtOAc, then the aqueous was re-
extracted with EtOAc (x 4). The mixture was then dried (MgSO4) and the solvent removed under 
reduced pressure. The material was then dissolved in minimal DCM and precipitated with Et2O. 
Repeating this process gave triphenylphosphonium salt 25-Br (706 mg, 28%) which was used 
without further purification. 
 
{4-[3’-(Hydroxymethyl)-4’-nitrophenoxy]butyl}triphenylphosphonium tetraphenylborate 25-
BPh4 
 
Benzylic alcohol 25-Br (706 mg, 1.26 mmol, 1.00 eq.) and NaBPh4 (450 mg, 1.31 mmol, 1.04 eq.) 
were dissolved in a biphasic mixture of DCM (50 mL) and H2O (50 mL). The layers were separated 
then the DCM layer was partitioned with H2O. The organic layer was dried (MgSO4), filtered and 
the solvent removed under reduced pressure. The sample was dissolved in minimal DCM and 
precipitated with MeOH, giving salt 25- BPh4 (574 mg, 55%) as a brown foam sufficiently pure for 
the next step. H (400 MHz, CDCl3): 8.14 (1H, d, J = 9.1 Hz, H5’), 7.46 - 7.23 (23H, m, Ph4B
–, +PPh3), 
7.11 (1H, d J = 2.7 Hz, H2’), 6.98 - 6.86 (8H, m, Ph4B
–), 6.82 - 6.74 (4H, m, Ph4B
–), 6.70 (1H, dd, J = 
9.1, 2.8 Hz, H6’), 5.02 (2H, s, CH2OH), 3.76 (2H, t, J = 5.4 Hz, OCH2CH2), 2.12 - 2.00 (2H, m, 
CH2CH2
+PPh3), 1.65 - 1.35 (4H, m, OCH2CH2CH2CH2
+PPh3). 
 
{4-[3’-(2”,4”-Dinitrophenoxymethyl)-4’nitrophenoxy]butyl}triphenylphosphonium 
tetraphenylborate 7-BPh4 
 
A stirred mixture of benzylic alcohol 25-BPh4 (574 mg, 0.71 mmol, 1.00 eq.), 1-fluoro-2,4-
dinitrobenzene 26 (0.5 mL, 4.0 mmol, 5.6 eq.) and dry NEt3 (0.15 mL, 1.1 mmol, 1.5 eq.) in dry 
acetone (10.0 mL) under argon was heated to 45 C for 72 h in the dark. The solvent was removed 
under reduced pressure and the material dissolved in DCM and washed with 0.2 M NaOH(aq) (x 3). 
The DCM layer was then dried (MgSO4), filtered and the solvent removed under reduced pressure. 
The material was redissolved in minimal DCM and precipitated with excess MeOH. The residual 
solution was decanted off and the solid dried under vacuum. Following column chromatography 
[SiO2, dry loaded with DCM, EtOAc/MeOH (10:1)] the solvent mix was allowed to partially 
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evaporate over 4 days, resulting in formation of needle shaped brown crystals (104 mg, 15%) of 
probe 7-BPh4. H (400 MHz, CDCl3): 8.86 (1H, d, J = 2.9 Hz, H3’’), 8.59 (1H, dd, J = 9.3, 2.9 Hz, H5’’), 
8.29 (1H, d, J = 9.2 Hz, H6’’), 7.94 - 7.87 (3H, m, +PPh3), 7.86 - 7.72 (13H, 
+PPh3, H5’), 7.34 (1H, d, J = 
2.6 Hz, H2’), 7.22 - 7.16 (8H, m, Ph4B
–), 7.13 (1H, dd, J = 9.2, 2.8 Hz, H6’) 6.93 (8H, t J = 6.9 Hz, 
Ph4B
–), 6.80 (4H, t J = 6.9 Hz, Ph4B
–), 5.88 (2H, s, CH2OAr’’), 4.23 (2H, t, J = 6.0 Hz, OCH2CH2), 3.74 - 
3.61 (2H, m, CH2CH2
+PPh3), 1.98 (2H, quintet, J = 6.4 Hz, OCH2CH2CH2), 1.76 (2H, sextet, J = 7.6 Hz, 
CH2CH2CH2
+PPh3). MS (NSI
+): 652 [M+ (phosphonium cation), 100%]. HRMS: 652.1836. C35H31O8N3P 
requires 652.1843. MS (NSI––): 319 [M– (tetraphenyl borate anion), 100%]. HRMS: 319.1664. 
C24H20B requires 319.1664. 
 
4-Bromomethyltriphenylphosphonium bromide 30 
 
 A solution of triphenylphosphine (307 mg, 1.17 mmol, 1.00 eq.) in dry PhMe (2.0 mL) which was 
added slowly to a stirring solution of ,’-dibromoxylene 29 (616 mg, 2.34 mmol, 2.00 eq.) in dry 
PhMe (10.0 mL) at 100 C under and argon. After 20 h the mixture was allowed to cool and the 
precipitate was collected and washed with Et2O and hot PhMe. After drying under vacuum salt 30 
was collected as a solid (379 mg, 63%). H (400 MHz, CDCl3): 7.82 - 7.71 (9H, m, 
+PPh3), 7.69 - 7.60 
(6H, m, +PPh3), 7.18 - 7.08 (4H, m, H2,3,5,6), 5.50 (2H, d, J = 14.2 Hz, ArCH2
+PPh3), 4.40 (2H, s, 
ArCH2Br). Data matches previous spectra by Stephen McQuaker.
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2-Benzoyl-5-(benzyloxy)phenol 123 
 
2,4-dihydroxybenzophenone 122 (5.00 g, 23.4 mmol, 1.00 eq.), KI (5.84 g, 35.2 mmol, 1.50 eq.) 
and NaHCO3 (3.05 g, 36.3 mmol, 1.55 eq.) were combined and stirred under argon in dry MeCN 
(30 mL). Benzyl chloride (3.3 mL, 29 mmol, 1.2 eq.) was added, followed by additional dry MeCN 
(30 mL). The reaction mixture was then heated under reflux and argon for 48 h. The contents of 
the flask were washed out with additional DCM, and the solvent removed from all the material. 
The solid was then washed with DCM and the organic extracts dried (MgSO4) then filtered and the 
solvent removed under reduced pressure to give benzyl ether 123 (6.74 g, 95%). A small portion 
was crystallised for analysis (acetone/water), giving needles. H (400 MHz, CDCl3): 12.68 (1H, s, 
PhOH), 7.64 (2H, d, J = 7.6 Hz, H2’, H6’), 7.60 - 7.46 (4H, m, H3, H3’, H4’, H5’), 7.46 - 7.32 (5H, m, 
Ph), 6.61 (1H, d, J = 2.5 Hz, H6), 6.49 (1H, dd, J = 9.0, 2.4, H4), 5.13 (2H, s, OCH2Ph). C (100 MHz, 
CDCl3): 200.04 (C), 166.27 (C), 165.29 (C), 138.26 (C), 135.85 (C), 135.32 (CH), 131.48 (CH), 128.85 
(CH), 128.73 (CH), 128.34 (CH), 128.30 (CH), 127.54 (CH), 113.33 (C), 107.89 (CH), 102.12 (CH), 
70.29 (CH2). IR (ATR cm
-1): 3032 (CAr-H), 2091, 1643 (C=O), 1597 (CAr=CAr), 1505 (CAr=CAr), 1342 (Ph- 
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OH). MS (EI+): 304 (M+, 95%), 91 (C7H7
+
, 100). HRMS: 304.1098. C20H16O3 requires 304.1099. MP: 
118 °C. 
 
2-Benzoyl-5-benzyloxy-4-nitrophenol 124 
 
Phenol 123 (1.04 g, 3.41 mmol, 1.00 eq.) was suspended stirring in AcOH (6.6 mL) under argon, 
then HNO3(aq) (0.42 mL, 6.6 mmol, 1.9 eq., 70%) was added dropwise. After 4 h 30 min stirring 
under argon the reaction mixture was heated to 50 ˚C and developed a red colour. After a further 
17 h the mixture was poured into water, then extracted with chloroform (x 2) and the combined 
organics dried by azeotrope in PhMe and the solvent removed under reduced pressure. A mixture 
of 4-nitro and 6-nitro compounds (4.2:1) resulted, from which dropwise addition of water to the 
compound dissolved in acetone caused precipitation to give 4-nitrophenol 124 (517 mg, 45%). H 
(400 MHz, CDCl3): 12.95 (1H, s, PhOH), 8.39 (1H, s, H3), 7.69 - 7.65 (2H, m, H2’, H6’), 7.65 - 7.62 
(1H, m, H4’), 7.55 (2H, t, J = 7.5 Hz, H3’, H5’), 7.49 (2H, d, J = 7.3 Hz, H2’‘, H6’‘), 7.42 (2H, t, J = 7.1 
Hz, H3’‘, H4’‘, H6’‘), 6.70 (1H, s, H6), 5.27 (2H, s, O CH2Ph). 
13C NMR (101 MHz, CDCl3) δ 199.60, 
168.65, 158.57, 136.71, 134.49, 132.95, 132.72, 132.04, 128.99, 128.86, 128.65, 128.56, 126.97, 
111.70, 102.89, 71.54. Data matches previous characterisation by Susan Macintyre.173 
 
2’-Benzoyl-5’-benzyloxy-4’-nitrophenyl 4-methylbenzene-1-sulfonate 125 
 
Nitrophenol 124 (2.01 g, 5.73 mmol, 1.00 eq.) and para-methylbenzenesulfonyl chloride (1.42 g, 
7.47 mmol, 1.30 eq.) were combined stirring in dry pyridine (10.0 mL), then any residual solid 
washed in with additional dry pyridine (23.0 mL). The reaction mixture was then stirred at RT for 
17 h. The solvent was removed under reduced pressure, and the solids dissolved in DCM and 
washed with water (x 2), then the solvent was removed from the collected organics which were 
then dried by azeotrope in PhMe. Tosylate 125 was isolated (2.86 g, 99%). H (400 MHz, CDCl3): 
7.98 (1H, s, H3’), 7.61 - 7.53 (3H, m, H2’‘, H4’‘, H6’‘), 7.53 - 7.38 (9H, m, H2, H6, H3’‘, H5’‘, 
OCH2Ph), 7.29 (1H, s, H6’), 7.14 (2H, d, J = 8.1 Hz, H3, H5), 5.31 (2H, s, OCH2Ph), 2.36 (3H, s, 
CH3Ar). c (100 MHz, CDCl3): 190.36 (C), 154.43 (C), 150.49 (C), 146.21 (C), 136.18 (C), 134.28 (C), 
133.61 (CH), 131.12 (C), 129.95 (CH), 129.90 (CH), 128.94 (CH), 128.73 (CH), 128.50 (CH), 128.43 
(CH), 128.33 (CH), 127.28 (CH), 124.98 (C), 110.48 (CH), 71.92 (CH2), 21.73 (CH3). Data matches 
previous characterisation by Susan Macintyre.173 
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9-(Benzyloxy)-8-nitro-6-phenylphenanthridin-3-amine 127 
 
Tosylate 125 (303 mg, 0.60 mmol, 1.00 eq.) was combined with 1,3-phenylenediamine (408 mg, 
3.77 mmol, 6.29 eq.) and p-toluenesulfonic acid (96 mg, 0.50 mmol, 0.84 eq.) in PhMe (30 mL) 
within a dean stark apparatus, and heated under reflux stirring under argon for 120 h. The 
material was then filtered, and the filter cake washed with organic solvents (MeOH x 3, DCM, x 1), 
isolating the salt form 126 (130 mg, 28%), which was then washed with 7M NaOH(aq) to give 
phenanthridine 127 as a red solid for characterisation purposes. H (400 MHz, d6-DMSO): 7.94 
(1H, s, H7), 7.69 - 7.62 (3H, m, H2’, H4’, H6’), 7.59 (1H, s, H10), 7.53 (2H, d, J = 7.9 Hz, H2’‘, H6’‘), 
7.48 - 7.41 (4H, m, H3’, H5’, H3’’, H5’’), 7.38 - 7.33 (1H, t, J = 7.4 Hz, H4’‘), 7.30 (1H, d, J = 9.3 Hz, 
H1), 7.0 (1H, dd, J = 9.3, 2.2 Hz, H2), 6.93 (1H, d, J = 2.2 Hz, H4), 6.52 (2H, d, br, D2O, NH2), 5.46 
(2H, s, OCH2Ph). c (100 MHz, d6-DMSO): 153.03 (C), 150.55 (C), 152.52 (C), 150.05 (C), 148.22 (C), 
137.89 (C), 136.02 (C), 134.32 (C), 130.05 (CH), 128.87 (CH), 128.71 (CH), 128.53 (CH), 128.05 (CH), 
128.01 (CH), 127.29 (CH), 125.53 (CH), 121.06 (CH), 118.45 (C), 115.92 (C), 109.05 (CH), 102.58 
(CH), 102.53 (CH), 70.38 (CH2). IR (ATR cm
-1): 3341 (NH), 3171 (NH), 1636 (C=N), 1597 (CAr=CAr), 
1528 (NO2). MS (FAB): 422.4 [(M+H)
+, 100%], 329.2 [(M – C6H7N)
+, 73], 307.2 [(M –C7H7 – NO2 + 
Na)+, 74]. HRMS: 422.1501. C26H19N3O3 requires 422.1505. MP (as tosylate salt): 245 - 248 °C. 
 
3,8-Bis(carbobenzylamino)-6-phenylphenanthridine 138 
 
3,8-Diamino-6-phenylphenanthridine 133 (108 mg, 0.378 mmol, 1.00 eq.) was dissolved in THF 
(2.0 mL) and cooled to 0 ˚C stirring under argon. NaHCO3 (84 mg, 1.0 mmol, 2.6 eq.) was added 
followed by dropwise addition of benzyl chloroformate (3.0 mL, 21 mmol, 2.3 eq.), after which the 
mixture was allowed to warm to RT and stirred under argon for 72 h. The mixture was quenched 
into water then extracted with Et2O (x 2). The organic layer was washed repeatedly with water 
then dried (MgSO4), filtered and the solvent removed under reduced pressure. Column 
chromatography [SiO2, dry loaded in THF, Pet. ether/EtOAc (1:1)] gave phenanthridine 138 as a 
solid (172 mg, 82%). Rf = 0.64 in Pet. ether/EtOAc (1:1). 
1H NMR (500 MHz, CDCl3) δ 8.45 (d, J = 9.1 
Hz, H10), 8.37 (d, J = 9.0 Hz, H1), 8.01 (1H, d, br, J = 8.3 Hz, H9), 7.98 (1H, d, J = 2.2 Hz, H4), 7.92 
(1H, d, br, J = 8.7 Hz, H2), 7.87 (1H, d, J = 2.2 Hz, H7) 7.65 (2H, dd, J = 7.8, 1.5 Hz, H2’’, H6’’), 7.50 - 
7.43 (3H, m, H3’’, H4’’, H5’’), 7.41 (2H, dd, J = 7.8, 1.3 Hz, H2’’’, H6’’’), 7.39 - 7.29 (8H, m, H3’’’, 
H4’’’, H5’’’, Ph’), 7.13 (2H, s, br, NH), 5.23 (2H, s, 8-NHCO2CH2), 5.19 (2H, s, 3-NHCO2CH2). 
13C NMR 
(126 MHz, CDCl3) δ 161.28 (C), 153.31 (C), 143.83 (C), 139.39 (C), 138.05 (C), 136.39 (C), 135.94 
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(C), 135.83 (C), 129.57 (CH), 129.44 (C), 128.82 (CH), 128.64 (CH), 128.62 (CH), 128.41 (CH), 128.28 
(CH), 125.22 (C), 123.06 (CH), 122.62 (CH), 119.64 (CH), 119.10 (CH), 117.90 (CH), 116.80 (CH), 
67.22 (CH2). IR (ATR cm
-1): 3294 (N-H), 3059 (CAr-H), 3034 (CAr-H), 1703 (C=O), 1622 (C=N), 1587 
(CAr=CAr), 1547 1587 (CAr=CAr), 1517 (CAr=CAr), 1056 (C-O). MS (NSI
+): 1107 [(2M+H)+, 33%], 554 
[(M+H)+, 100]. HRMS: 554.2066. C35H28N3O4 requires 554.2076. MP: 93 - 95 ˚C. 
 
3,8-Bis(carbomethoxyamino)-6-phenylphenanthridine 139 
 
3,8-Diamino-6-phenylphenanthridine 133 (510 mg, 1.79 mmol, 1.00 eq.) in dry pyridine (3.0 mL) 
was cooled to 0 ˚C stirring under argon. Methyl chloroformate (0.55 mL, 7.1 mmol, 4.0 eq.) was 
added dropwise then the mixture heated to RT and stirred under argon for 20 h. The mixture was 
filtered, washed with water then the solid filtered and washed with MeOH. The solvent was 
removed under reduced pressure then the solid residue washed with 1 M NaOH(aq), filtered and 
acidified with 1 M HCl(aq) then dissolved in MeOH and the solvent removed under reduced 
pressure. The solid was dried by azeotrope with PhMe to give methylcarbamate 139 as the orange 
hydrochloride salt (649 mg, 83%). For analysis a sample (21 mg) of the salt was loaded onto a 
strata WCX ion exchange resin in MeOH and washed with further MeOH, then eluted with 7 M 
NH3/MeOH solution and removing the solvent under reduced pressure (19 mg, quant.). 
1H NMR 
(500 MHz, CD3OD) δ 8.48 (1H, d, J = 8.9 Hz, H10), 8.40 (1H, d, J = 8.9 Hz, H1), 8.12 (1H, d, J = 2.2 
Hz, H4), 8.07 (1H, d, J = 1.7 Hz, H7), 7.88 (1H, dd, J = 8.9, 1.7 Hz, H9), 7.74 (1H, dd, J = 8.9, 2.0 Hz, 
H2), 7.67 - 7.62 (2H, m, H2’, H6’), 7.60 - 7.54 (3H, m, H3’, H4’, H5’), 3.80 (3H, s, 8-NHCO2CH3), 3.73 
(3H, s, 3-NHCO2CH3). 
13C NMR (126 MHz, CD3OD) δ 161.49 (C), 154.94 (C), 154.91 (C), 142.90 (C), 
139.18 (C), 139.07 (C), 137.64 (C), 129.35 (CH), 128.90 (C), 128.58 (CH), 128.02 (CH), 124.81 (C), 
123.01 (CH), 122.45 (CH), 122.17 (CH), 119.20 (CH), 119.09 (CH), 115.96 (CH), 51.24 (CH3). IR (ATR 
cm-1, as HCl salt): 3221 (N-H), 3056 (CAr-H), 2954 (C-H), 1729 (C=O), 1701 (C=O), 1622 (C=N), 1586 
(CAr=CAr), 1575 (CAr=CAr), 1525 (CAr=CAr), 1071 (C-O). MS (NSI
+): 1204 [(3M+H)+, 9%], 803 [(2M+H)+, 
49], 402 [(M+H)+, 100]. HRMS: 402.1446. C23H20N3O4 requires 402.1448. MP (as HCl salt): 
Decomposition above 325 ˚C. 
 
3,8-Bis(carboethoxyamino)-6-phenylphenanthridine 140 
 
3,8-Diamino-6-phenylphenanthridine 133 (4.05 g, 14.2 mmol, 1.00 eq.) was dissolved in THF (112 
mL) and cooled to – 11 ˚C stirring under argon. NaHCO3 (2.92 g, 34.8 mmol, 2.45 eq.) was added 
followed by dropwise addition of ethyl chloroformate (3.3 mL, 35 mmol, 2.4 eq.), after which the 
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mixture was stirred for 3 h then allowed to warm to RT and stirred under argon for 44 h. The 
mixture was quenched into MeOH then the solvent removed under reduced pressure. The residue 
was partitioned between ETOAc and 1 M NH3(aq), and the organic layer washed with water (x 3) 
and concentrated under reduced pressure, then 1 M HCl(aq) was added and the mixture cooled to 
~5 ˚C for 16 h. The mixture was filtered and washed with EtOAc, then the filter cake dissolved in 
DCM/MeOH/1 M NH3(aq) and the solvent removed under reduced pressure. The residue was 
dissolved in EtOAc and washed with water (x 2), dried (MgSO4), filtered and the solvent removed 
under reduced pressure, giving bisethyl carbamate 140 as a yellow solid (5.82 g, 95%). 1H NMR 
(400 MHz, DMSO) 1H NMR (400 MHz, DMSO) δ 10.02 (1H, s, br, 8-NHCO2Et), 9.98 (1H, s, 3-
NHCO2Et), 8.73 (1H, d, J = 9.1 Hz, H10), 8.63 (1H, d, J = 9.1 Hz, H1), 8.31 (1H, d, br, J = 1.6 Hz, H4), 
8.22 (1H, d, J = 2.1 Hz, H7), 7.96 (1H, dd, J = 9.0, 2.0 Hz, H9), 7.81 (1H, dd, J = 8.9, 2.2 Hz, H2), 7.74 
- 7.67 (2H, m, H2’, H6’), 7.65 - 7.53 (3H, m, H3’, H4’, H5’), 4.19 (2H, q, J = 7.1 Hz, 8-NHCO2CH2CH3), 
4.11 (2H, q, J = 7.1 Hz, 3-NHCO2CH2CH3), 1.29 (3H, t, J = 7.1 Hz, 8-NHCO2CH2CH3), 1.22 (3H, t, J = 
7.1 Hz, 8-NHCO2CH2CH3). 
13C NMR (101 MHz, DMSO) δ 160.38 (C), 153.59 (C), 153.55 (C), 143.29 
(C), 139.51 (C), 139.28 (C), 137.89 (C), 129.54 (CH), 128.58 (CH), 128.20 (CH), 124.39 (C), 123.11 
(CH), 122.79 (CH), 122.70 (CH), 118.92 (CH), 118.46 (C), 116.44 (CH), 115.05 (CH), 60.35 (CH2), 
14.50 (CH3), 14.43 (CH3). IR (ATR cm
-1): 3293 (N-H), 2917 (C-H), 2852 (C-H), 1707 (C=O), 1620 
(C=N), 1590 (CAr=CAr), 1549 (CAr=CAr), 1522 (CAr=CAr), 1071 (C-O). MS (EI
+): 429 (M+., 70%), 383 (M+. 
– C2H5OH, 100), 336 [(M – H)
+ – 2C2H5OH, 80], 310 [(M – H)
+ – 2C2H5OH – CO, 63], 295 (37). HRMS: 
429.1688. C25H23O4N3 requires 429.1689. MP: 128 - 132 ˚C. This compound is known in 
literature.
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1,6-Hexanetrifluoromethanesulfonyl 142 
 
Triflic anhydride (10.0 g, 35.4 mmol, 1.00 eq.) was weighed under argon then dissolved in dry 
DCM (30 mL) and stirred at 0 ˚C under argon. Dry pyridine (2.8 mL, 35 mmol, 0.98 eq.) was added 
followed by 1,6-hexanediol 141 (1.70 mg, 14.4 mmol, 0.41 eq.). After stirring under argon at RT 
for 35 min the reaction mixture was quenched and washed with water (x 2) and the organic layer 
dried (MgSO4), filtered and the solvent removed under reduced pressure. The residue was 
redissolved in Et2O and filtered through a combination of SiO2 and MgSO4. Product 142 was 
isolated as an oil (3.44 g, 63%). H (400 MHz, CDCl3): 4.55 (4H, t, J = 6.28 Hz, CH2OTf), 1.94 - 1.79 
(4H, m, CH2CH2OTf), 1.55 - 1.48 (4H, m, CH2CH2CH2OTf) c (100 MHz, CDCl3): 118.64 (q, J = 254 Hz), 
29.04, 24.58. 1H NMR data agrees with literature.177 
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6-Trifluoromethylsulfonylhex-1-yltriphenylphosphonium trifluoromethylsulfonate 143 
 
Triflate 142 (197 mg, 0.515 mmol, 1.00 eq.) was dissolved in dry Et2O (2.6 mL) and stirred under 
argon. Triphenylphosphine (124 mg, 0.43 mmol, 0.83 eq., previously dried by azeotrope in PhMe) 
was added and the mixture stirred for 1 h. The solvent was then removed under reduced 
pressure. The resulting solid 143 (318 mg) was of > 90% estimated purity by 1H NMR. 1H NMR (500 
MHz, CDCl3) δ 7.91 - 7.61 (15H, m, PPh3), 4.61 - 4.52 (2H, m, CH2-6), 3.48 - 3.30 (2H, m, CH2-1), 
1.93 - 1.76 (2H, m, CH2-5), 1.75 - 1.32 (6H, m, CH2-2, CH2-3, CH2-4).The stability of this compound 
was too poor to collect further data. 
 
6-Benzyloxyhexan-1-ol 145 
 
1,6-Hexanediol 141 (49.34 g, 417.4 mmol, 7.075 eq.) was melted and dried by azeotrope with 
PhMe, which was removed under reduced pressure. Dry DMF (120 mL) was added and the 
reaction cooled to 0 ˚C stirring under argon. NaH (60% dispersion in mineral oil, 2.52 g, 63.0 
mmol, 1.07 eq.) was added portionwise, then after 30 min stirring followed by dropwise addition 
of benzyl bromide (7.0 mL, 59 mmol, 1.0 eq.). After 10 min stirring the mixture was heated to 60 
˚C for 48 h. The solvent was then removed under reduced pressure. Column chromatography 
[SiO2, loaded with Pet. ether, Pet. ether/Et2O (1:1)] gave alcohol 145 as an oil (11.71 g, 95%). Rf = 
0.11 Pet. ether/EtOAc (3:1). 1H NMR (400 MHz, CDCl3) δ 7.39 - 7.24 (5H, m, Ph), 4.50 (2H, s, 
CH2Ph), 3.64 (2H, t, J = 6.4 Hz, CH2OH), 3.47 (2H, t, J = 6.6 Hz, CH2OBn), 1.70 - 1.52 (4H, m, CH2-2, 
CH2-5), 1.47 - 1.33 (4H, m, CH2-3, CH2-4), 1.22 (1H, s, br, OH). 
13C NMR (126 MHz, CDCl3) δ 138.64, 
128.36, 127.64, 127.51, 72.89, 70.33, 62.97, 32.72, 29.72, 26.02, 25.58. Data is consistent with 
literature values.418 
 
6-Benzyloxyhex-1-yltrifluoromethanesulfonate 146 
 
Trifluoromethanesulfonic anhydride (10 g, 35 mmol, 1.3 eq.) was dissolved with stirring in dry 
DCM (55 mL) and cooled to 0 ˚C under argon. Addition of dry pyridine (2.8 mL, 35 mmol, 1.3 eq.) 
was followed by allowing the mixture to warm to RT and adding alcohol 145 (5.58 g, 26.8 mmol, 
1.00 eq.), then stirring for 2 h under argon. The mixture was diluted with DCM and washed with 
water (x 2). The washings were extracted with DCM and the combined organics dried (MgSO4), 
filtered, the solvent removed under reduced pressure and the residue washed through a small 
plug of SiO2 with dry Et2O, then the solvent removed under reduced pressure to give 
trifluoromethanesulfonyl 146 as a brown oil (7.15 g, 78%). 1H NMR (400 MHz, CDCl3) δ 7.39 - 7.27 
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(5H, m, Ph), 4.53 (2H, t, J = 6.5 Hz, CH2OSO2CF3), 4.50 (2H, s, OCH2Ph), 3.48 (2H, t, J = 6.4 Hz, 
CH2OBn), 1.83 (2H, quin., J = 6.9 Hz, CH2-2), 1.63 (2H, J = 6.8 Hz, CH2-5), 1.48 - 1.40 (4H, m, CH2-3, 
CH2-4). 
1H NMR matches literature values.
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3,8-Bis(carboethoxyamino)-5-(6’-benzyloxyhex-1’-yl)-6-phenylphenanthridinium 
trifluoromethanesulfonate 150 
 
Phenanthridine 140 (208 mg, 0.484 mmol, 1.00 eq.) and 2,6-ditertbutyl-4-methylpyridine (283 mg, 
1.38 mmol, 2.87 eq.) were combined under argon then trifluoromethanesulfonate 146 (704 mg, 
2.07 mmol, 4.31 eq.) was added as a solution in dry PhNO2 (3.0 mL). After 72 h stirring under 
argon the mixture was transferred to SiO2 in DCM and washed with additional DCM, followed by 
elution with DCM/MeOH (9:1). Repeated column chromatography [SiO2, loaded in DCM, 
DCM/MeOH gradient elution (33:1) - (3:2)] gave a soft yellow residue which was 2:1 
Phenanthridinium 150 to DCM by weight (26 mg, 7%). 1H NMR (400 MHz, CDCl3) δ 9.08 (1H, s, br, 
3-NHCO2Et), 8.55 (1H, d, br, J = 1.2 Hz, 8-NHCO2Et), 8.34 (1H, d, J = 9.4 Hz, H1), 8.31 (1H, s, br, H4), 
8.28 (1H, d, J = 9.3 Hz, H10), 8.13 (1H, dd, br, J = 9.2, 1.4 Hz, H2), 8.06 (1H, dd, J = 9.1, 2.1 Hz, H9), 
7.75 (1H, d, J = 1.8 Hz, H7), 7.72 - 7.62 (3H, m, H3’’, H4’’, H5’’), 7.38 (2H, dd, J = 7.5, 1.7 Hz, H2’’, 
H6’’), 7.29 - 7.13 (5H, m, OCH2Ph), 4.62 (2H, s, br, CH2-1’), 4.37 (2H, s, OCH2Ph), 4.11 (2H, q, J = 7.1 
Hz, 3-NHCO2CH2CH3), 4.02 (2H, q, J = 7.1 Hz, 8-NHCO2CH2CH3), 3.31 (2H, t, J = 6.4 Hz, CH2-6’), 1.83 
(2H, s, br, CH2-2’), 1.48 - 1.38 (2H, m, CH2-5’), 1.29 - 1.10 (4H, m, CH2-3’, CH2-4’), 1.23 (3H, t, J = 7.1 
Hz, 3-NHCO2CH2CH3), 1.14 (3H, t, J = 7.1 Hz, 8-NHCO2CH2CH3). 
13C NMR (126 MHz, CDCl3) δ 161.94 
(C), 154.07 (C), 153.58 (C), 143.36 (C), 140.03 (C), 138.63 (C), 133.92 (C), 131.83 (CH), 130.77 (C), 
130.59 (C), 130.39 (CH), 129.83 (CH), 128.27 (CH), 128.03 (CH), 127.54 (CH), 127.44 (CH), 127.39 
(CH), 125.02 (C), 124.38 (CH), 122.70 (CH), 120.89 (C), 120.67 (q, J = 320.3 Hz, CF3), 118.07 (CH), 
106.65 (CH), 72.87 (CH2), 70.03 (CH2), 61.61 (CH2), 61.51 (CH2), 54.79 (CH2), 29.53 (CH2), 29.24 
(CH2), 26.09 (CH2), 25.28 (CH2), 14.24 (CH3), 14.21 (CH3). IR (ATR cm
-1): 3259 (N-H), 2943 (C-H), 
2858 (C-H), 1727 (C=O), 1622 (C=N), 1596 (CAr=CAr), 1552 (CAr=CAr), 1519 (CAr=CAr). MS (NSI
+): 620 
[M+ (phenanthridinium cation), 100%]. HRMS: 620.3104. C38H42N3O5 requires 620.3119. MP: 73 - 
85 ˚C. 
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3,8-Bis(carboethoxyamino)-5-(1’-hexan-6-ol)-6-phenylphenanthridinium 
trifluoromethanesulfonate 151 
 
Phenanthridinium salt 150 (260 mg, 0.338 mmol, 1.00 eq.) was combined in MeOH (3.0 mL) with 
10% palladium on carbon (50 mg, 0.047 mmol, 0.14 eq.), then the solution frozen in N2(l), exposed 
to vacuum and then sealed and warmed to until the mixture melted. This process was repeated (x 
2), then H2(g) bubbled through the solution for 20 min and the reaction stirred at RT under H2(g) for 
20 h. The mixture was filtered through celite, eluting with DCM and MeOH, then dried (MgSO4), 
filtered and the solvent removed under reduced pressure. Column chromatography [SiO2, loaded 
in DCM followed by gradient elution DCM/MeOH (50:1) - (8:1)] gave alcohol 151 as a yellow foam 
(40 mg, 17%). Rf = 0.25 DCM/MeOH (17:3). 
1H NMR (400 MHz, DMSO) δ 10.57 (1H, s, br, 3-
NHCO2Et), 10.28 (1H, s, br, 8-NHCO2Et), 9.08 (1H, d, J = 9.4 Hz, H1), 9.02 (1H, d, J = 9.2 Hz, H10), 
8.68 (1H, s, br, H4), 8.26 (1H, dd, J = 9.3, 2.0 Hz, H2), 8.14 (1H, dd, J = 9.2, 1.9 Hz, H9), 7.86 - 7.73 
(6H, m, H7, Ph), 4.53 (2H, s, br, CH2-1’), 4.32 (1H, t, J = 5.1 Hz, OH), 4.26 (2H, q, J = 7.1 Hz, 3-
NHCO2CH2CH3), 4.09 (2H, q, J = 7.1 Hz, 8-NHCO2CH2CH3), 1.97 (2H, s, br, CH2-2’), 1.51 - 1.36 (2H, s, 
br, CH2-5’), 1.35 - 1.09 (4H, m, CH2-3’, CH2-4’), 1.32 (3H, t, J = 7.1 Hz, 3-NHCO2CH2CH3), 1.20 (3H, t, 
J = 7.1 Hz, 8-NHCO2CH2CH3). (ATR cm
-1): 3058 (CAr-H), 2939 (C-H), 2870 (C-H), 1729 (C=O), 1623 
(C=N), 1596 (CAr=CAr), 1553 (CAr=CAr), 1519 (CAr=CAr). MS (ESI
+): 530 [M+ (phenanthridinium cation), 
100%]. HRMS: 530.2664. C31H36N3O5 requires 530.2649. 
 
5-Nitro-2-(4’-nitrophenyl)aniline 157 
 
Biphenyl-2-ylamine 156 (13.8 g, 81.3 mmol, 1.00 eq.) was dissolved in concentrated H2SO4(aq) 
(98%, 170 mL) at 0 ˚C with mechanical stirring. After the initial heat from neutralisation had 
dissipated KNO3 (16.2 g, 161 mmol, 1.98 eq.) was added portion wise over 20 min. The mixture 
was then kept at 0 ˚C stirring for 4 h 30 min before being quenched slowly into ice water then 
basified with NaOH(aq) (7 M). The suspension formed was filtered. The filter cake was dissolved in 
acetone and solvent removed under reduced pressure. The solid was washed repeatedly with 
water to remove inorganic impurities, then transferred in acetone and dried by azeotrope in 
PhMe (x 3) before being dried under vacuum at 80 ˚C for 6 h. To give amine 157 as an orange solid 
(17.1 g, 84%). H (400 MHz, d6-DMSO): 8.33 (2H, d, J = 8.8 Hz, H3’, H5’), 7.76 (2H, d, J = 8.8 Hz, H2’, 
H6’), 7.65 (1H, d, J = 2.4 Hz, H6), 7.45 (1H, dd, J = 8.4, 2.4 Hz, H4), 7.29 (1H, d, J = 8.4 Hz, H3), 5.76 
(2H, s, NH2). c (400 MHz, d6-DMSO): 148.21 (C), 146.75 (C), 146.66 (C), 144.61 (C), 131.24 (CH), 
129.95 (CH), 129.03 (C), 123.95 (CH), 110.36 (CH), 109.03 (CH). IR (ATR cm-1): 3470 (NH), 3381 
(NH), 3106 (CAr-H), 3086 (CAr-H), 1632 (CAr=CAr), 1597 (CAr=CAr), 1501 (NO2), 1337 (NO2). MS (CI) 260 
[(M+H)+, 9%), 230, 200 [(M+H)+ – H2N2O2, 27], 113, (47), 85 (73), 71 (100). HRMS: 260.0672. 
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C12H10O4N3 requires 260.0671. MP: 199 - 205 ºC. Compound has been previously synthesised but 
limited data was reported.143 
 
N-[5’-Nitro-2’-(4’’-nitrophenyl)phenyl]benzamide 160 
 
Adapted from a literature procedure.185 Dry NEt3 (0.15 mL, 1.1 mmol, 1.1 eq.) was added to a 
solution of amine 157 (295 mg, 0.99 mmol, 1.00 eq.) in dry DCM (8.4 mL) stirring under argon, 
followed by dropwise addition of benzoyl chloride (180 µL, 1.55 mmol, 1.57 eq.). After 1 h stirring 
under argon the mixture was quenched into 0.5 M HCl(aq), then extracted into DCM and washed 
(0.5 M HCl(aq) x 1, 0.5 M NaOH(aq) x 2). The collected organic layer was dried (MgSO4), filtered, then 
the solvent removed under reduced pressure and the solid dried by azeotrope in PhMe and then 
further evaporated with CHCl3. The material was crystallised (acetone/water) to give the amide 
160 (267 mg, 74%) as a solid. H (400 MHz, d6-DMSO): 10.52 (1H, s, br, NHCO), 8.59 (1H, d, J = 2.4 
Hz, H6’), 8.41 (2H, d, J = 8.8 Hz, H3’’, H5’’), 8.36 (1H, dd, J = 8.6, 2.4, H4’), 7.94 - 7.88 (4H, m, H2’‘, 
H2, H6, H6’‘), 7.88 (1H, d, J = 8.6 Hz, H3’), 7.69 (1H, tt, J = 7.4 Hz, 1.3 Hz, H4) 7.64 - 7.56 (2H, m, 
H3, H5). c (400 MHz, d6-DMSO): 165.76 (C), 147.42 (C), 147.04 (C), 144.52 (C), 141.61 (C), 136.49 
(C), 133.79 (C), 131.89 CH), 131.71 (CH), 129.82 (CH), .128.44 (CH), 127.64 (CH), 123.63 (CH), 
121.98 (CH), 121.02 (CH). IR (ATR cm-1): 3214 (CON-H), 1645 (C=O), 1597 (CAr=CAr), 1510 (NO2), 
1341 (NO2). MP: 232 °C. MS (ESI
-): 362 [(M–H)–, 100]. HRMS: 362.0767. C19H12N3O5 requires 
362.0782.  
 
6-(Tetrahydropyran-2’-yloxy)hexan-1-ol 161 
 
Previously dried by azeotrope with PhMe, 1,6-hexanediol 141 (40.0 g, 338 mmol, 4.02 eq.) was 
melted at 60 ˚C stirring under argon. Addition of para toluenesulfonic acid monohydrate (3.0 g, 16 
mmol, 0.2 eq.) appeared to cause some precipitation, so the mixture was heated to 90 ˚C and 
allowed to cool back to 50 ˚C prior to addition of 3,4-dihydropyran (7.7 mL, 84 mmol, 1.0 eq.) and 
stirring for 72 h at this temperature under argon. The reaction mixture was washed repeatedly 
with water then the solvent removed under reduced pressure. Column chromatography [SiO2, 
Pet. ether/EtOAc (1:1)] gave the alcohol 161 as an oil (10.3 g, 61%). Pet. ether/EtOAc (1:1) Rf = 
0.39. H (400 MHz, CDCl3): 4.57 (1H, dd, J = 4.5, 2.8 Hz, H2’), 3.86 (1H, ddd, J = 11.1, 7.3, 3.6 Hz, 
H6’ax), 3.78 - 3.69 (1H, m, CH
AHBOTHP), 3.68 - 3.61 (2H, m, CH2OH), 3.54 - 3.47 (1H, m, H6’eq), 3.39 
(1H, m, CHAHBOTHP), 1.89 - 1.76 (1H, m, H3’) 1.76 - 1.67 (1H, m), 1.67 - 1.47 (8H, m, CH2), 1.47 - 
1.34 (4H, m, CH2), 1.28 (1H, s, br, OH). 
1H NMR data agrees with literature.420 
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2- (6’-Iodohex-1’-yloxy)tetrahydropyran 162 
 
Triphenylphosphine (2.62 g, 10.0 mmol, 2.13 eq.) and imidazole (664 mg, 9.75 mmol, 2.07 eq.) 
were dried by azeotrope in PhMe then dissolved in dry DCM (30 mL). Iodine (2.55 g, 9.96 mmol, 
2.12 eq.) was added at 0 ˚C to the stirring solution. After 15 min the mixture was warmed to RT 
and alcohol 161 (950 mg, 4.70 mmol, 1.00 eq.) was added dropwise in DCM (1.0 mL). The mixture 
was then stirred under argon for 4 h, then quenched into water and extracted in DCM. The 
solvent was removed under reduced pressure. Column chromatography [SiO2, Pet. ether/EtOAc 
(19:1)] gave iodide 162 as an oil (620 mg, 42%). Rf = 0.58 Pet. ether/EtOAc (19:1). H (400 MHz, 
CDCl3): 4.57 (1H, dd, J = 4.4, 2.8 Hz, H1), 3.92 - 3.81 (1H, ddd, J = 11.0, 7.3, 3.4 Hz, H6ax), 3.74 (1H, 
dt, J = 9.6, 6.7 Hz, CHAHBOTHP), 3.54 - 3.47 (1H, m, H6eq), 3.39 (1H, dt, J = 9.6, 6.5 Hz, CH
AHBOTHP), 
3.19 (2H, t, J = 7.1 Hz, CH2I), 1.90 - 1.78 (3H, m, CH2CH2I, 1 of CH2) 1.76 - 1.67 (1H, m, 1 of CH2), 
1.66 - 1.48 (6H, m, 3 x CH2), 1.48 - 1.35 (4H, m, 2 x CH2). C (100 MHz, CDCl3): 98.80, 67.31, 62.29, 
33.37, 30.67, 30.22, 29.43, 25.40, 25.14, 19.60, 6.97. 1H and 13C NMR match literature data.421 
 
6-(Tetrahydropyran-2’-yloxy)hexanal 164 
 
Oxalyl chloride (10.0 mL, 120 mmol, 2.9 eq.) was added at –78˚C to DCM (160 mL) stirring under 
argon. After 10 min DMSO (8.5 mL, 120 mmol, 2.9 eq.) was syringed into the mixture which was 
then stirred for a further 40 min. Alcohol 161 (8.3 g, 41 mmol, 1.0 eq.) was then added as a DCM 
solution (80 mL) and the reaction allowed to stir at −78 ˚C under argon for 2 h. NEt3 (30.0 mL, 215 
mmol, 5.24 eq.) was then added and the reaction allowed to warm to RT overnight. The mixture 
was washed with 0.5 M HCl(aq), which was back extracted with DCM. The combined organics were 
washed with water, then dried (MgSO4), filtered and the solvent removed under reduced 
pressure. The residue was washed through SiO2 with Et2O, then dried (MgSO4), filtered and the 
solvent removed under reduced pressure, giving aldehyde 164 as an oil (7.7 g, 93%). (400 MHz, 
CDCl3): 9.77 (1H, t, J = 1.7 Hz, C(O)H), 4.60 - 4.54 (1H, m, H2’), 3.92 - 3.81 (1H, m, H6’), 3.80 - 3.69 
(1H, m, CHAHBOTHP) 3.58 - 3.45 (1H, m, H6’), 3.43 - 3.35 (1H, m, CHAHBOTHP), 2.45 (2H, td, J = 7.3, 
1.8 Hz, CH2C=O), 1.9 - 1.3 (12H, m, CH2). Data consistent with literature.
422 
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Methyl 5-{[5’-nitro-2’-(4’‘-nitrophenyl)phenyl]carbamoyl}pentanoate 172 
 
6-Methoxy-6-oxohexanoic acid 171 (1.0 mL, 5.8 mmol, 2.0 eq.) was dissolved in SOCl2 (3.0 mL, 
41.2 mmol, 7.1 eq.) and heated stirring under reflux and argon for 13 h. The SOCl2 was then 
removed under reduced pressure. Some of this material (1.0 g, 5.6 mmol, 1.9 eq.) was dissolved in 
dry DCM (3.0 mL) and added dropwise to a stirring solution of amine 157 (772 mg, 2.98 mmol, 
1.00 eq.) in dry DCM (30 mL) under argon. After 17 h stirring the mixture was quenched into 
water, then the layers separated and the organic layer washed with 0.5 M HCl(aq) (x 1) and 0.5 M 
NaOH(aq) (x 2), then dried (MgSO4) and filtered. The solvent was evaporated off at atmospheric 
pressure then traces removed under vacuum. The mixture was then dry loaded onto celite in 
DCM. Column chromatography [SiO2, Pet. ether/EtOAc, gradient elution (7:3 to 3:7)] gave 1.02 g 
(86%) gave amide as a solid 172. H (400 MHz, CDCl3): 9.10 (1H, d, J= 1.8 Hz, H6’) 8.40 (2H, d, J = 
8.8, H3’’, H5’’), 8.09 (1H, dd, J = 8.4, 2.3 Hz, H4’) 7.76 (2H, d, J = 8.8 Hz, H2’’, H6’’), 7.43 (1H, d, J = 
8.4 Hz, H3’), 7.24 (1H, s, br, NHCO), 3.65 (3H, s, CO2CH3), 2.33 (2H, t, J = 7.0 Hz, CH2CO2Me) 2.28 
(2H, t, J = 6.9 Hz, CH2CONH), 1.72 - 1.59 (4H, m, NCOCH2CH2CH2CH2CO2Me). C (100 MHz, CDCl3): 
173.83 (C), 170.99 (C), 148.46 (C), 148.16 (C), 143.05 (C), 136.45 (C), 135.68 (C), 130.70 (CH), 
130.06 (CH), 124.59 (CH), 119.54 (CH), 118.03 (CH), 51.66 (CH3), 36.96 (CH2), 33.42 (CH2), 24.59 
(CH2), 24.01 (CH2). IR (ATR cm
-1): 3225 (NH2), 3086 (CAr-H), 2940 (C-H), 2862 (C-H), 1728 (C=O), 
1651 (C=O), 1597 (CAr=CAr), 1528 (CAr=CAr), 1505 (NO2), 1335 (NO2). MS (FAB/NOBA): 402 [(M+H)
+, 
62%], 370 [(M+H)+ – MeOH, 13], 154 (100). HRMS (FAB): 402.1298 requires 402.1301 C19H20O7N3. 
MP: 154 - 156 °C. 
 
Methyl 5-N-{[5’-nitro-2’-(4’‘-nitrophenyl)phenyl]carbamoyl}pentanoic acid 173 
 
Ester 172 (199 mg, 0.50 mmol, 1.00 eq.) was suspended in ethanol (2.5 mL) and 7 M KOH(aq) was 
added (0.25 mL, 1.8 mmol, 3.5 eq.). The solution was then stirred for 17 h at RT under argon and 
quenched into water. The mixture was extracted with Et2O and EtOAc (x 2). The aqueous layer 
was acidified with 0.5 M HCl(aq) and the precipitate filtered off. After drying the solid was dissolved 
in acetone then dried (MgSO4) and filtered. After removal of solvent under reduced pressure the 
product 173 was collected as a beige solid (147 mg, 77%).H (400 MHz, CD3OD): 8.50 (1H, d, J = 2.3 
Hz, H6’), 8.35 (2H, d, J = 8.8 Hz, H3’’, H5’’), 8.20 (1H, dd, J = 8.5, 2.3 Hz, H4’), 7.67 (2H, d, J = 8.8 Hz, 
H2’’, H6’’), 7.63 (1H, d, J = 8.5 Hz, H3’), 2.30 (2H, t, J = 7.1 Hz, CH2CO2H), 2.27 (2H, t, J = 7.1 Hz, 
CH2CONH), 1.66 - 1.49 (4H, m, CH2CH2CH2CH2). c IR (ATR cm
-1): 3233 (NH), 3086 (CAr-H), 3032 (CAr-
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H), 2940 (C-H), 2870 (C-H), 1705 (C=O), 1659 (C=O), 1597 (CAr=CAr), 1528 (CAr=CAr), 1505 (NO2), 
1335 (NO2). MP: 187 °C. Used without further analysis. 
 
6-{[5’-Nitro-2'-(4’‘-nitrophenyl)phenyl]amino}hexan-1-ol 174 
 
BH3-THF (24.6 mL of a 1 M solution, 24.6 mmol, 4.01 eq.) was added dropwise to a stirred solution 
of carboxylic acid 173 (2.38 g, 6.14 mmol, 1.00 eq.) in dry THF (30 mL) under argon. The mixture 
was then heated to reflux for 2 h. On cooling the solution was quenched into MeOH and filtered 
through MgSO4 eluting with DCM and CHCl3. The solvent was then removed under reduced 
pressure and the material dried by azeotrope with PhMe. Column chromatography [SiO2, Pet. 
ether/EtOAc (1:1)] and drying under high vacuum gave 174 as a red solid (1.53 g, 69%). Rf = 0.41 in 
Pet. ether. ether/EtOAc (1:1). H (400 MHz, CDCl3): 8.36 (2H, d, J = 8.8 Hz, H3’’, H5’’), 7.61 (2H, d, J 
= 8.8 Hz, H2’’, H6’’), 7.63 - 7.60 (1H, m, H4’), 7.50 (1H, d, J = 2.2 Hz, H6’), 7.18 (1H, d, J = 8.2 Hz, 
H3’), 3.95 (1H, t, D2O ex., J = 5.1 Hz, NHR), 3.65 (2H, td, J = 6.4, 5.3 Hz, CH2OH), 3.18 (2H, td, J = 
7.1, 5.4 Hz, CH2NHR), 1.65 - 1.52 (4H, m, CH2CH2NH, CH2CH2OH), 1.45 - 1.35 (4H, m, CH2CH2CH2-
CH2), 8.36 (1H, t, J = 5.3 Hz, OH). c (400 MHz, CDCl3): 149.47 (C), 147.72 (C), 145.84 (C), 144.37 
(C), 130.53 (CH), 130.52 (C), 130.00 (CH), 124.57 (CH), 117.70 (CH), 104.97 (CH), 62.75 (CH2), 43.77 
(CH2), 32.53 (CH2), 28.89 (CH2), 26.85 (CH2), 25.46 (CH2). IR (ATR cm
-1): 3626 (OH), 3356 (NH), 3109 
(CAr-H), 2932 (C-H), 2862 (C-H), 1597 (CAr=CAr), 1512 (NO2), 1335 (NO2). MS (FAB): 360 [(M+H)
+, 
100%], 154 (44). HRMS (FAB): 360.1560. C18H22O5N requires 360.1559. MP: 75 - 76 °C. 
 
6’-{[5’’-Nitro-2'’-(4’‘’-nitrophenyl)phenyl]amino}hexan-1’-yl benzoate 175 
 
Alcohol 174 (542 mg, 1.51 mmol, 1.00 eq.) was dissolved in dry DCM (22 mL) stirring under argon. 
Dry NEt3 (0.25 mL, 1.8 mmol, 1.2 eq.) was added, followed by benzoyl chloride (160 µL, 1.38 
mmol, 0.914 eq.). The mixture was stirred for 20 h at RT under argon, then quenched into 1 M 
NaOH(aq) and extracted with DCM. The organic layer was washed with 1 M HCl(aq) and 1 M 
NaOH(aq), dried (MgSO4), filtered and the solvent removed under reduced pressure. Column 
chromatography [SiO2, loaded in minimal DCM, gradient elution with Pet. ether/EtOAc (4:1) - 
(1:1)] gave ester 175 as an orange solid (572 mg, 89%). Rf = 0.8 in Pet. ether/EtOAc (1:1). 
1H NMR 
(500 MHz, CDCl3) δ 8.37 (2H, d, J = 8.9 Hz, H3’’’, H5’’’), 8.04 (dd, J = 8.4, 1.3 Hz, H2, H6), 7.66 - 7.60 
(3H, m, H4’’, H2’’’, H6’’’), 7.57 (1H, tt, J = 7.4, 1.4 Hz, H4), 7.52 (1H, d, J = 2.2 Hz, H6’’), 7.45 (2H, 
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dd, J = 7.9, 7.5 Hz, H3, H5), 7.20 (1H, d, J = 8.2 Hz, H3’’), 4.34 (2H, t, J = 6.6 Hz, CH2-1’), 3.97 (1H, t, 
J = 5.2 Hz, NH), 3.21 (2H, dt, J = 5.5, 7.1 Hz, CH2-6’), 1.86 - 1.76 (2H, quin., J = 6.6 Hz, CH2-2’), 1.69 - 
1.61 (2H, quin., J = 7.3 Hz, CH2-5’), 1.56 - 1.41 (4H, m, CH2-3’, CH2-4’). 
13C NMR (126 MHz, CDCl3) δ 
166.61 (C), 149.44 (C), 147.70 (C), 145.79 (C), 144.32 (C), 132.91 (CH), 130.54 (CH), 130.34 (C), 
129.97 (CH), 129.49 (CH), 128.36 (CH), 124.56 (CH), 111.72 (CH), 104.95 (CH), 64.66 (CH2), 43.74 
(CH2), 28.87 (CH2), 28.61 (CH2), 26.66 (CH2), 25.68 (CH2). IR (ATR cm
-1): 3405 (N-H), 2952 (C-H), 
2936 (C-H), 2927 (C-H), 2857 (C-H), 1706 (C=O), 1614 (CAr=CAr), 1600 (CAr=CAr), 1585 (CAr=CAr), 1516 
(NO2), 1344 (NO2). MS (NSI
+): 949 [(2M+Na)+, 16%], 502 [(M+K)+, 29], 486 [(M+Na)+, 65], 464 
[(M+H)+, 100]. HRMS: 464.1814. C25H26N3O6 requires 465.1848. MP: 83 - 85˚ C. 
 
6-{[5’-nitro-2'-(4’‘-nitrophenyl)phenyl]amino}hexan-1-yl trifluoroethanoate 180 
 
Alcohol 174 (49 mg, 0.13 mmol, 1.0 eq.) and benzaldehyde (30 µL, 0.29 mmol, 2.2 eq.) were 
combined in TFA (0.3 mL) then sealed in an argon flushed tube and heated to 120 ˚C for 2 days, 
then 125 ˚C for a further 3 days. The solvent was then removed under reduced pressure. Column 
chromatography gave trifluoroacetic ester 180 as a brown oil (13 mg, 21%). 1H NMR (500 MHz, 
CDCl3) δ 8.38 (2H, d, J = 8.9 Hz, H3’’, H5’’), 7.67 - 7.60 (3H, m, H2’’, H6’’, H4’), 7.52 (1H, d, J = 2.2 
Hz, H6’), 7.21 (1H, d, J = 8.2 Hz, H3’), 4.37 (2H, t, J = 6.6 Hz, CH2-1), 3.97 (1H, s, NH), 3.21 (2H, t, J = 
7.1 Hz, CH2-6), 1.83 - 1.74 (2H, m, CH2-2), 1.68 - 1.60 (2H, m, CH2-5), 1.50 - 1.39 (4H, m, CH2-3,4). 
13C NMR (126 MHz, CDCl3) δ 157.52 (q, J = 42.2 Hz, C), 149.44 (C), 147.72 (C), 145.73 (C), 144.30 
(C), 130.57 (CH), 129.97 (CH), 124.55 (CH), 114.50 (q, J = 285.6 Hz, CF3), 111.80 (CH), 104.94 (CH), 
67.91 (CH2), 43.71 (CH2), 28.83 (CH2), 28.01 (CH2), 26.54 (CH2), 25.29 (CH2). IR (ATR cm
-1): 2934 (C-
H), 2856 (C-H), 1784 (C=O), 1722, 1614 (CAr=CAr), 1597 (CAr=CAr), 1517 (NO2), 1341 (NO2). MS 
(APCI+): 456 [(M+H)+, 100%], 356 [(M+H)+ – CF3CO2H], 260 [(M+H)
+ – CF3CO2H – C7H12]. HRMS: 
456.1369. C20H21F3N3O6 requires 456.1377. 
 
2-Iodo-5-nitrobenzophenone 218 
 
2-amino-5-nitrobenzophenone 217 (15.0 g, 42.5 mmol, 1.00 eq.) was dissolved in DMSO (300 mL). 
H2SO4(aq) (30%, 300mL) was added to the stirring mixture at 0 ˚C over 5 min and the mixture 
stirred at this temperature for 30 min. A 3.7 M solution of NaNO2(aq) (70 mL, 260 mmol, 6.1 eq.) 
was added dropwise and the mixture stirred for 3 h at 0 ˚C. KI(aq) was added dropwise as an 5.6 M 
solution (90 mL, 500 mmol, 12 eq.) and the mixture allowed to warm to RT and stir for 48 h. The 
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reaction mixture was then diluted (H2O) and extracted with EtOAc. The combined organics were 
washed sequentially with saturated NaHCO3(aq), saturated NaS2O3(aq) and water before drying 
(MgSO4), filtering and removal of solvent under reduced pressure. This gave benzophenone 218 
as a yellow solid (21.4 g, 98%). 1H NMR (500 MHz, CDCl3) δ 8.16 (1H, d, J = 8.6 Hz, H3), 8.12 (1H, d, 
J = 2.6 Hz, H6), 8.02 (1H, dd, J = 8.6, 2.7 Hz, H4), 7.82 - 7.78 (2H, dd, J = 8.4, 1.3 Hz, H2’, H6’), 7.68 
(1H, ddt, J = 7.8, 7.0, 1.3 Hz, H4), 7.52 (2H, t, J = 7.8 Hz, H3’, H5’). 13C NMR (126 MHz, CDCl3) δ 
195.10 (C), 147.88 (C), 146.04 (C), 141.28 (CH), 134.71 (CH), 134.65 (C), 130.60 (CH), 129.21 (CH), 
125.32 (CH), 123.00 (CH), 100.81 (C). Consistent with literature data.255 
 
2-(4’’-Methoxybenzene)-5-nitrobenzophenone 220 
 
Benzophenone 218 (101 mg, 0.286 mmol, 1.00 eq.), 4-methoxyphenylboronic acid 219 (68 mg, 
0.45 mmol, 1.5 eq.), NaHCO3 (83 mg, 0.99 mmol, 3.4 eq.), PhMe (2.8 mL) and MeOH (0.3 mL) were 
combined and under argon and frozen with N2(l), then placed under vacuum and melted. This 
process was repeated twice, then Pd(PPh3)4 was added (34 mg, 0.030 mmol, 0.10 eq.) and the 
mixture heated to 90 ˚C stirring under argon for 16 h. The mixture was partitioned between Et2O 
and water, then the aqueous further extracted with Et2O and the combined organics dried 
(MgSO4), filtered and the solvent removed under reduced pressure. Column chromatography 
[SiO2, Pet. ether/EtOAc (7:1)] gave the coupled biaryl 220 as a thick yellow oil (41 mg, 43%). Rf = 
0.24, Pet. ether/EtOAc (7:1). 1H NMR (400 MHz, CDCl3) δ 8.39 (1H, dd, J = 8.5, 2.4 Hz, H4), 8.35 
(1H, d, J = 2.3 Hz, H6), 7.64 (3H, apparent d, J = 8.6 Hz, H3, H2’, H6’), 7.48 (1H, tt, J = 7.5, 1.3 Hz, 
H4’), 7.33 (1H, t, J = 7.8 Hz, H3’, H5’), 7.22 (2H, d, J = 8.8 Hz, H2’’, H6’’), 6.78 (2H, d, J = 8.8 Hz, H3’’, 
H5’’), 3.74 (3H, s, OCH3). 
13C NMR (101 MHz, CDCl3) δ 196.50 (C), 160.20 (C), 147.08 (C), 146.50 
(C), 139.82 (C), 136.34 (C), 133.78 (CH), 131.11 (CH), 130.47 (C), 130.32 (CH), 130.00 (CH), 128.63 
(CH), 124.99 (CH), 124.02 (CH), 114.35 (CH), 55.40 (CH3). (ATR cm
-1): 3065 (CAr-H), 2961 (C-H), 
2934 (C-H), 2837 (C-H), 1663 (C=O), 1604 (CAr=CAr), 1579 (CAr=CAr), 1516 (NO2), 1342 (NO2). MS 
(CI+): 334 [(M+H)+, 100%], 304 [(M+H)+ – OCH3, 62]. HRMS: 334.1081. C20H16O4N requires 
334.1079. 
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3-Nitrobenzophenone 228 
 
Iodobenzophenone 218 (107 mg, 0.300 mmol, 1.00 eq.), trifluoroborate salt 285 (70 mg, 0.35 
mmol, 1.2 eq.), PEPPSI-iPr catalyst (4.0 mg, 0.0059 mmol, 0.02 eq.) and K2CO3 (124 mg, 0.900 
mmol, 3.00 eq.) were combined under argon then the flask evacuated and refilled with argon (x 
2). EtOH (degassed with argon, 4 mL) was added and the mixture stirred under reflux and argon 
for 18 h. The mixture was then diluted with Et2O and filtered through celite then dried (MgSO4), 
filtered and the solvent removed under reduced pressure. Nitrobenzophenone 228 was estimated 
to be 65% of the crude by 1H NMR; a sample was separated from the residue, which included 
dimer 229, by HPLC [C12, gradient elution; MeOH/0.1% HCO2H(aq) (60:40) for 8 min, then gradient 
to (95:5) by 30 min.] for characterisation purposes. RT = 19.2 min. Rf = 0.24 in Pet. ether/EtOAc 
(5:1). 1H NMR (500 MHz, CDCl3) δ 8.66 - 8.59 (1H, m, H2), 8.48 - 8.42 (1H, m, H6), 8.15 (1H, dd, J = 
7.7, 1.0 Hz, H4), 7.84 - 7.78 (2H, m, H2’, H6’), 7.71 (1H, t, J = 7.9 Hz, H5), 7.67 (1H, t, J = 7.5 Hz, 
H4’), 7.54 (2H, t, J = 7.8 Hz, H3’, H5’). 13C NMR (126 MHz, CDCl3) δ 194.30 (C), 148.27 (C), 139.25 
(C), 136.44 (C), 135.56 (CH), 133.51 (CH), 130.16 (CH), 129.78 (CH), 128.89 (CH), 126.86 (CH), 
124.87 (CH). MS (EI+): 227 (M+., 65%), 105 (C6H5CO
+, 100). HRMS: 227.0584. C13H9O3N requires 
227.0582. Consistent with literature data.257 
 
t: 0.1% HCO2H (%): MeOH (%): Flow (mL): RT (min): 
0 40 60 15.0 228 19.24 
8 40 60 15.0 229 27.29 
30 5 95 15.0  
50 5 95 15.0  
55 50 50 15.0  
58 50 50 1.0  
 
2,2’-Dibenzoyl-4,4’-dinitrobiphenyl 229 
 
Iodobenzophenone 218 (1.00 g, 2.83 mmol, 1.12 eq.), PEPPSI-iPr catalyst (96 mg, 0.14 mmol, 0.05 
eq.) and arylboronic acid 316 (510 mg, 2.53 mmol, 1.00 eq.) were divided evenly between two 
microwave tubes (10.0 mL) under argon. The tubes were opened to vacuum, then refilled with 
argon. This process was repeated twice then N,N-diisopropylethylamine (1.45 mL, 8.32 mmol, 
3.29 eq.) and degassed ethanol (10.0 mL) were split between the tubes. Each tube was heated to 
125 ˚C for 10 min. After cooling the mixtures were combined and partitioned between DCM and 1 
M HCl(aq) then the aqueous layer extracted (DCM x 2). The combined organics were dried (MgSO4), 
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filtered and the solvent removed under reduced pressure. Column chromatography [SiO2, Pet. 
Ether/EtOAc (15:1), after drying loading onto celite] gave dimer 229 as a yellow solid (24 mg, 2%). 
1H NMR (500 MHz, CDCl3) δ 8.36 (2H, dd, J = 8.5, 2.4 Hz, H5, H5’), 8.27 (2H, d, J = 2.3 Hz, H3, H3’), 
7.64 (4H, dd, J = 8.4, 1.2 Hz, H2’’, H6’’), 7.61 (2H, d, J = 8.5 Hz, H6, H6’), 7.40 (2H, tt, J = 7.5, 1.3 Hz, 
H4’’), 7.31 (4H, dd, J = 8.2, 7.5 Hz, H3’’, H5’’). 13C NMR (126 MHz, CDCl3) δ 194.35 (C), 146.83 (C), 
145.02 (C), 139.09 (C), 135.64 (C), 133.98 (CH), 132.41 (CH), 130.31 (CH), 128.57 (CH), 125.01 (CH), 
124.22 (CH). (ATR cm-1): 1667 (C=O), 1597 (CAr=CAr), 1526 (NO2), 1346 (NO2). MS (APCI
+): 453 
[(M+H)+, 100%]. HRMS: 453.1086. C26H17N2O6 requires 453.1081. 
 
6-Benzyloxyhexen-1-al 231 
 
Alcohol 145 (11.5 g, 55.0 mmol, 1.00 eq.) was dissolved in DCM (550 mL) and cooled to 0 ˚C then 
KBr (1.30 g, 10.9 mmol, 0.198 eq.) added, followed by TEMPO (88 mg, 0.56 mmol, 0.010 eq.) and 
a combination of NaOCl(aq) (assumed 4%, 100 mL, 56.9 mmol, 1.03 eq.) and NaHCO3(aq) (140 mL, 
160 mmol, 2.91 eq.). The mixture was stirred for 2 h, then additional NaOCl(aq) (23.0 mL, 13.1 
mmol, 0.238 eq.) was added. The mixture was stirred for 2 h with addition of NaOCl(aq) (9.0 mL, 
5.12 mmol, 0.0936 eq. in total), then the biphasic mixture separated and the aqueous extracted 
with DCM. The combined organics were dried (MgSO4), filtered and the solvent removed under 
reduced pressure to give aldehyde 231 as an oil (11.05 g, 97%). 1H NMR (400 MHz, CDCl3) δ 9.79 
(1H, t, J = 1.8 Hz, CH2CHO), 7.40 - 7.30 (5H, m, Ph), 4.52 (2H, s, OCH2Ph), 3.50 (2H, t, J = 6.5 Hz, 
CH2-5), 2.46 (2H, td, J = 7.4, 1.7 Hz, CH2-1), 1.74 - 1.60 (4H, m, CH2-2, CH2-4), 1.50 - 1.39 (2H, m, 
CH2-3). 
13C NMR (126 MHz, CDCl3) δ 202.83 (CH), 138.67 (C), 128.51 (CH), 127.77 (CH), 127.68 
(CH), 73.08 (CH2), 70.16 (CH2), 43.98 (CH2), 29.65 (CH2), 25.97 (CH2), 22.03 (CH2). Consistent with 
literature data.423 
 
6-Benzyloxy-1-bromohexane 232 
 
Alcohol 145 (1.50 g, 7.17 mmol, 1.00 eq.) was dissolved in dry DCM (26 mL) with stirring under 
argon and cooled to 0 ˚C. CBr4 (3.05 g, 9.18 mmol, 1.28 eq.) and PPh3 (2.44 g, 9.30 mmol, 1.30 eq.) 
were added successively, then the mixture stirred under argon for 20 min before being allowed to 
warm to RT and stir for a further 17 h. The mixture was washed with brine and water, dried 
(MgSO4), filtered and the solvent removed under reduced pressure. Column chromatography 
[SiO2, Pet. ether/Et2O (99:1)] followed by vacuum distillation to remove CHBr3 gave alkyl bromide 
232 as an oil (1.76 g, 91%). 1H NMR (500 MHz, CDCl3) δ 7.37 - 7.26 (5H, m, Ph), 4.50 (2H, s, 
OCH2Ph), 3.47 (2H, t, J = 6.5 Hz, CH2-6), 3.40 (2H, t, J = 6.8 Hz, CH2-1), 1.86 (2H, tt, J = 6.9, 6.8 Hz, 
CH2-5), 1.63 (2H, tt, J = 7.0, 7.0 Hz, CH2-2), 1.50 - 1.36 (4H, m, CH2-3, CH2-4). 
13C NMR (126 MHz, 
CDCl3) δ 138.74 (C), 128.51 (CH), 127.78 (CH), 127.67 (CH), 73.07 (CH2), 70.34 (CH2), 34.05 (CH2), 
32.90 (CH2), 29.73 (CH2), 28.15 (CH2), 25.57 (CH2). Data is consistent with literature.
424 
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2-Nitro-4-tertbutylbromobenzene 239 
 
A solution of HNO3(aq) (1.0 mL, 16 mmol, 1.4 eq.) in H2SO4(aq) (98%, 2mL) was added to stirring 4-
tertbutylbenzene at 0 ˚C. The mixture was allowed to gradually warm to RT and stirred under 
argon for 14 h. The reaction mixture was then partitioned with Pet. ether, and the aqueous re-
extracted with Pet. ether. The combined organics were washed with brine then dried (MgSO4), 
filtered and the solvent removed under reduced pressure to give nitroarene 239 as a yellow oil 
(2.82 g, 95%). 1H NMR (400 MHz, CDCl3) δ 7.83 (1H, d, J = 2.4 Hz, H3), 7.64 (1H, d, J = 8.5 Hz, H6), 
7.48 – 7.42 (1H, dd, J = 8.5, 2.4 Hz, 1H), 1.34 [9H, s, C(CH3)3]. Consistent with literature data.
270 
 
2-Amino-4-tertbutylbromobenzene 240 
 
Bromobenzene 239 (3.5 g, 14 mmol, 1.0 eq.) was dissolved in a mixture of AcOH (60 mL) and EtOH 
(60 mL), and iron fillings (4.06 g, 72.6 mmol, 5.34 eq.) added, then the mixture stirred and heated 
to 100 ˚C for 2 h under argon. The mixture was cooled then basified with NaOH(aq) (7 M) and 
extracted with EtOAc (x 2). The combined organics were washed with brine then dried (MgSO4), 
filtered and the solvent removed under reduced pressure. The brown oil was dried by azeotrope 
with PhMe then dissolved in Pet. ether and dry loaded onto SiO2, washed with pet. ether and 
eluted with Et2O, then dried (MgSO4), before filtering and removal of the solvent under reduced 
pressure, giving aniline 240 as a red oil (2.80 g, 91%). 1H NMR (400 MHz, CDCl3) δ 7.31 (1H, d, J = 
8.4 Hz, H6), 6.79 (1H, d, J = 2.3 Hz, H3), 6.66 (1H, dd, J = 8.4, 2.3 Hz, H5), 4.02 (2H, s, br, NH2), 1.27 
[9H, s, C(CH3)3]. 
13C NMR (101 MHz, CDCl3) δ 151.97 (C), 143.59 (C), 132.10 (CH), 117.17 (CH), 
113.27 (CH), 106.41 (C), 34.56 (C), 31.31 (CH3). Consistent with literature data.
425 
 
2-(6’-Benzyloxyhexylamino)-tertbutylbromobenzene 241 
 
Aniline 240 (6.0 g, 26 mmol, 1.0 eq., dried by azeotrope with PhMe) was cooled to –15 ˚C under 
argon then dry TFA (34 mL) added and the material agitated and warmed until the material 
dissolved, then cooled to –15 ˚C. NaBH(OAc)3 (12.0 g, 56.6 mmol, 2.18 eq.) was added and the 
mixture stirred for 30 min, then aldehyde 231 (10.1 g, 48.6 mmol, 1.87 eq., dried by azeotrope 
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with PhMe) was added portion wise as a solution in dry DCM (135 mL). After 20 min the mixture 
was quenched into NaOH(aq) (7 M) and extracted with DCM (x 2), then the combined organics 
dried (MgSO4), filtered and the solvent removed under reduced pressure. Column 
chromatography [SiO2, Pet. ether/Et2O (20:1)] gave secondary amine 241 as an orange oil (7.86 g, 
72%). Rf = 0.30 in Pet. ether/Et2O (10:1). 
1H NMR (500 MHz, CDCl3) δ 7.36 - 7.26 (5H, m, Ph’’), 7.31 
(1H, d, J = 8.5 Hz, H6), 6.64 (1H, d, J = 2.2 Hz, H3), 6.59 (1H, dd, J = 8.3, 2.3 Hz, H5), 4.51 (2H, s, 
OCH2Ph), 4.18 (1H, t, J = 5.0 Hz, NH), 3.48 (2H, t, J = 6.5 Hz, CH2-6’), 3.16 (2H, dt, J = 7.0, 5.3 Hz, 
CH2-1’), 1.75 - 1.61 (4H, m, CH2-2’, CH2-5’), 1.48 - 1.41 (4H, m, CH2-3’, CH2-4’), 1.29 [9H, s, C(CH3)3]. 
13C NMR (126 MHz, CDCl3) δ 151.87 (C), 144.60 (C), 138.68 (C), 131.69 (CH), 128.36 (CH), 127.64 
(CH), 127.51 (CH), 114.92 (CH), 108.69 (CH), 106.69 (C), 72.94 (CH2), 70.30 (CH2), 43.84 (CH2), 
34.73 (C), 31.32 (CH3), 29.73 (CH2), 29.31 (CH2), 27.02 (CH2), 26.07 (CH2). (ATR cm
-1): 3408 (N-H), 
2933 (C-H), 2854 (C-H), 1588 (CAr=CAr), 1511 (CAr=CAr). MS (CI
+): 420 [(81BrM+H)+, 96%], 418 
[(79BrM+H)+, 100]. HRMS: 420.1711 and 418.1748. C23H33ON
81Br and C23H33ON
79Br require 
420.1728 and 418.1746 respectively. 
 
2-[N-(6’-benzyloxyhexylamino)-tert-butylcarbamate]-4-tert-butylbromobenzene 245 
 
Aniline 241 (5.425 g, 12.79 mmol, 1.000 eq.) and di-tert-butyl dicarbonate (5.66 g, 25.9 mmol, 
2.02 eq.) were combined in dry THF (65 mL) at 0 ˚C under stirring under argon. Lithium 
hexamethyldisilazide (1.0 M in THF, 20.0 mL, 20 mmol, 1.6 eq.) was added over 10 min, then the 
mixture was allowed to warm to RT and stirred for 3 h. The reaction was cooled back to 0 ˚C and 
additional Lithium hexamethyldisilazide (5.0 mL, 5.0 mmol, 0.4 eq.) and di-tert-butyl dicarbonate 
(3.0 g, 14 mmol, 1.1 eq.) added, then the reaction allowed to warm to RT and stirred under argon 
for 17 h. The solvent was removed under reduced pressure, then the residue triturated with 
warm Et2O and filtered. The combined organics were washed with NaHCO3(aq) and brine, then 
dried (MgSO4), filtered and the solvent removed under reduced pressure. Hexamethylsilazide was 
distilled out of the product under high vacuum at 50 ˚C. Column chromatography [SiO2, Pet. 
ether/Et2O gradient from (20:1) - (10:1), using ceric ammonium molybdate solution to visualise 
residual hexamethyldisilazide] gave carbamate 245 as a pink oil (5.42 g, 82%). Rf = 0.17 in Pet. 
ether/Et2O (5:1). 
1H NMR (400 MHz, CDCl3) δ 7.54 - 7.45 (1H, m, H6), 7.37 - 7.26 (5H, m, Ph), 7.22 - 
7.11 (2H, m, H5, H3), 4.51 - 4.46 (2H, m, OCH2Ph), 3.81 - 3.63 (1H, m, CH2-1’A), 3.50 - 3.40 (2H, m, 
CH2-6’), 3.34 - 3.21 (1H, m, CH2-1’B), 1.67 - 1.46 (8H, m, CH2-2’, CH2-3’, CH2-4’, CH2-5’), 1.43 - 1.24 
[18H, m, C(CH3)3 x 2]. Spectrum is complex due to the appearance of atropisomers on an NMR 
timescale - limited coalescence seen at 90 ˚C. 13C NMR (101 MHz, DMSO, recorded at 90 ˚C) δ 
153.39, 151.32, 148.46, 140.71, 138.85, 132.31, 127.95, 127.69, 127.13, 127.01, 125.45, 119.61, 
83.62, 79.01, 71.96, 69.69, 34.11, 30.76, 29.14, 27.92, 27.26, 26.15, 25.41. (ATR cm-1): 2967 (C-H), 
2936 (C-H), 2862 (C-H), 1697 (C=O). MS (CI+): 520 [(81BrM+H)+, 17%], 518 [(79BrM+H)+, 18], 464 
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[(81BrM+H)+ – C(CH3)3, 100], 462 [(
79BrM+H)+ – C(CH3)3, 100], 420 [(
81BrM+H)+ – C(CH3)3 – CO2, 30], 
418 [(79BrM+H)+ – C(CH3)3 – CO2, 32], 382 [(M–H)
+ – Br – C(CH3)3, 22]. HRMS: 520.2263 and 
518.2258. C28H41O3N
81Br and C28H41O3N
79Br require 520.2285 and 518.2270. 
 
2-[N-(6’-benzyloxyhexylamino)-tert-butylcarbamate]-4-tert-butylbenzene 248 
 
Bromobenzene 245 (96 mg, 0.19 mmol, 1.00 eq.) was dissolved in dry THF (1.0 mL) under argon 
and the stirring solution cooled to –78 ˚C. nButyllithium (2.5 M in hexane, 90 µL, 0.23 mmol, 1.2 
eq.) was added and the mixture stirred under argon for 1 h. MeOH (0.3 mL) was added then the 
mixture partitioned between Et2O and water then the organic layer dried (MgSO4), filtered and 
the solvent removed under reduced pressure. Column chromatography [SiO2, Pet. ether/Et2O 
(5:1)] gave carbamate 248 as an oil (61 mg, 75%). Rf = 0.43 in Pet. ether/Et2O (2:1). 
1H NMR (500 
MHz, CDCl3) δ 7.29 - 7.13 (7H, m, Ph, H1, H3), 7.10 (1H, s, br, H5), 6.91 (1H, d, J = 7.3 Hz, H6), 4.42 
(2H, s, OCH2Ph), 3.54 (2H, apparent t, J = 7.5 Hz, CH2-6’), 3.38 (2H, t, J = 6.6 Hz, CH2-1’), 1.57 - 1.44 
(4H, m, CH2-2’, CH2-5’), 1.41 - 1.19 [22H, m, CH2-3’, CH2-4’, C(CH3)3 x 2]. MS (EI
+): 439 (M+., 20%), 
339 (M+. – .CO2 – 
.C4H8, 90), 248 ((M
+. – .CO2 – 
.C4H8 – 
.C7H7, 51), 161 (PhN
+H2C5H9, 100). HRMS: 
439.3090. C28H41O3N requires 439.3086. 
 
2-(5’-bromopentanamide)-tertbutylbromobenzene 255 
 
5-Bromopentanoic acid 253 (900 mg, 4.97 mmol, 1.13 eq.) was dissolved in SOCl2 and heated to 
reflux stirring under argon for 70 h. The SOCl2 was removed by distillation then the residue 
dissolved in dry THF (10 mL). The mixture was cooled to 0 ˚C then a solution of bromoaniline 240 
(1.0 g, 4.4 mmol, 1.0 eq.) in dry THF (30 mL) was added. The mixture was allowed to warm 
gradually to RT and stirred under argon for 17 h. The mixture was then quenched into NaHCO3(aq) 
and extracted into Et2O. The organic layer was washed with NaHCO3(aq), brine and water then 
dried (MgSO4), filtered and the solvent removed under reduced pressure. Column 
chromatography [SiO2, dry loaded onto celite with Et2O, Pet. ether/Et2O (10:1)] to give amide 255 
as an oil (621 mg, 36%). Rf = 0.08 Pet. ether/Et2O (5:1). 
1H NMR (500 MHz, CDCl3) δ 8.43 (1H, s, br, 
H3), 7.58 (1H, s, br, NH), 7.43 (1H, d, J = 8.5 Hz, H6), 7.01 (1H, dd, J = 8.5, 2.2 Hz, H5), 3.45 (2H, t, J 
= 6.5 Hz, CH2-5’), 2.48 (2H, t, J = 7.1 Hz, CH2-2’), 2.04 - 1.84 (4H, m, CH2-3’, CH2-3’), 1.31 [9H, s, 
C(CH3)3]. 
13C NMR (126 MHz, CDCl3) δ 170.61 (C), 152.20 (C), 135.27 (C), 131.65 (CH), 122.65 (CH), 
119.54 (CH), 110.24 (C), 36.86 (CH2), 35.01 (C), 33.15 (CH2), 32.09 (CH2), 31.31 (CH3), 24.04 (CH2). 
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(ATR cm-1): 3279 (N-H), 2961 (C-H), 2907 (C-H), 2868 (C-H), 1667 (C=O), 1574 (CAr=CAr), 1518 
(CAr=CAr). 
 
5-[(2-Bromo-5-tert-butylbenzene)carbamoyl]butyltriphenylphosphonium bromide 256 
 
Bromide 255 (543 mg, 1.39 mmol, 1.00 eq.) was dried by azeotrope with PhMe then dissolved in 
dry MeCN (3.0 mL) and transferred into triphenylphosphine (dried by azeotrope with PhMe, 720 
mg, 2.75 mmol, 1.98 eq.) under argon, then additional dry MeCN (2.0 mL) added and the mixture 
stirred under reflux and argon for 64 h. The mixture was cooled, the solvent removed under 
reduced pressure and the residue dissolved in DCM and precipitated by addition to Et2O, then the 
solvent decanted off and the process repeated. The residue was loaded onto SiO2 in DCM and 
washed with further DCM, then eluted with DCM/MeOH, dried (MgSO4), filtered and the solvent 
removed under educed pressure, giving triphenylphosphonium bromide 256 as a white solid (700 
mg, 77%). 1H NMR (500 MHz, CDCl3) δ 8.89 (1H, s, NH), 7.91 - 7.58 (16H, m, PPh3, H6’), 7.36 (1H, d, 
J = 8.4 Hz, H3’), 6.98 (1H, dd, J = 8.4, 2.2 Hz, H4’), 3.87 - 3.76 (2H, m, CH2-1), 2.86 (2H, t, J = 6.6 Hz, 
CH2-4), 2.10 (2H, quin., J = 6.5 Hz, CH2-2), 1.85 - 1.74 (2H, m, CH2-3), 1.24 [9H, s, C(CH3)3]. 
13C NMR 
(126 MHz, CDCl3) δ 171.52 (C), 151.16 (C), 135.59 (C), 135.00 (d, J = 3.0 Hz, CH), 133.73 (d, J = 10.0 
Hz, CH), 131.82 (CH), 130.48 (d, J = 12.6 Hz, CH), 123.37 (CH), 122.61 (CH), 118.21 (d, J = 86.0 Hz, 
CP), 113.85 (C), 35.31 (CH2), 34.66 (C), 31.19 (CH3), 25.92 (d, J = 16.9 Hz, CH2), 22.58 (d, J = 50.5 Hz, 
CH2), 21.45 (d, J = 4.0 Hz, CH2). (ATR cm
-1): 2963 (C-H), 2870 (C-H), 1674 (C=O), 1574 (CAr=CAr), 
1520 (CAr=CAr). MS (NSI
+): 574 [81BrM+ (phosphonium cation), 100%], 572 [79Br M+ (phosphonium 
cation), 97]. HRMS: 574.1682 and 572.1705. C33H36
81BrNOP and C33H36
79BrNOP require 574.1693 
and 572.1712 respectively. MP: 91 - 95 ˚C. 
 
6-Benzyloxyhexanoic acid 259 
 
Based on the procedure of Lermer et al,426 ε-capralactone 258 (5.0 mL, 45 mmol, 1.0 eq.) was 
dissolved stirring in dry PhMe (120 mL) under argon, then KOH (12.5 g, 223 mmol, 4.95 eq.) and 
benzyl bromide (26.5 mL, 223 mmol, 4.95 eq.) added and the mixture heated under reflux for 48 
h. After cooling the mixture was diluted and partitioned between Et2O and water, then the 
aqueous further extracted with Et2O (x 2). The solvent was removed from the combined organics 
under reduced pressure, then PhMe (15 mL) and NaOH(aq) (5.0 M, 45 mL, 225 mmol, 5.0 eq.) 
added and the mixture heated with stirring under reflux for 18 h. After cooling the mixture was 
partitioned with Et2O and water, then the aqueous further extracted with Et2O (x 3), acidified with 
a mixture of 1 M H2SO4(aq) and ice then extracted with DCM (x 3). The chlorinated extracts were 
combined, dried (MgSO4), filtered and the solvent removed under reduced pressure to give acid 
259 as a yellow oil (9.46 g, 95%). 1H NMR (400 MHz, CDCl3) δ 7.45 - 7.10 (5H, m, Ph), 4.55 - 4.45 
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(2H, m, OCH2Ph), 3.54 - 3.44 (2H, m, CH2-6), 2.43 - 2.32 (2H, m, CH2-2), 1.75 - 1.59 (4H, m, CH2-3, 
CH2-5), 1.52 - 1.39 (2H, m, CH2-4). 
13C NMR (101 MHz, CDCl3) δ 178.68 (C), 138.69 (C), 128.51 (CH), 
127.78 (CH), 127.67 (CH), 73.07 (CH2), 70.21 (CH2), 33.87 (CH2), 29.54 (CH2), 25.87 (CH2), 24.65 
(CH2). Data consistent with literature values.
426 
 
2-Fluoro-5-tert-butylphenyliodide 273 
 
2-fluorophenyliodide 269 (260 µL, 2.23 mmol, 1.00 eq.) and tert-butyl chloride (372 µL, 0.338 
mmol, 1.47 eq.) were combined and cooled to 0 ˚C stirring under argon. AlCl3 (9 mg, 0.07 mmol, 
0.03 eq.) was added, then the mixture stirred for 15 min and quenched into ice water, then 
combined with Na2S2O3(aq) and shaken until colourless then extracted with DCM (x 2). The organics 
were washed with brine, dried (MgSO4), filtered and the solvent removed under reduced 
pressure, giving aryl iodide 273 as an oil (610 mg, 98%). 1H NMR (400 MHz, CDCl3) δ 7.71 (1H, dd, J 
= 6.0, 2.4 Hz, H6), 7.31 (1H, ddd, J = 8.7, 4.8, 2.4 Hz, H4), 6.98 (1H, dd, J = 8.6, 7.8 Hz, H3), 1.29 
[9H, s, C(CH3)3]. 
13C NMR (126 MHz, CDCl3) δ 159.80 (d, J = 243.5 Hz, CF), 149.05 (d, J = 3.5 Hz, C), 
136.37 (d, J = 1.2 Hz, CH), 127.20 (d, J = 6.9 Hz, CH), 115.04 (d, J = 23.3 Hz, CH), 81.08 (d, J = 24.9 
Hz, C), 34.44 (C), 31.48 (CH3). 
19F NMR (377 MHz, CDCl3) δ −99.20 - −99.25 (m). (ATR cm
-1): 2963 
(C-H), 2907 (C-H), 2870 (C-H), 1493 (CAr=CAr). MS (EI
+): 278 (M+., 98%), 263 (M+. – .CH3, 100), 235 
(M+. –.CH3 x 3, 35), 136 (C9H9F
+., 39). HRMS: 277.9965. C10H12FI requires 277.9968. 
 
2-Bromo-5-tert-butylphenyldiazonium tetrafluoroborate 274 
 
2-amino-4-tert-butylbromobenzene 240 (976 mg, 4.28 mmol, 1.00 eq.) was added dropwise to a 
stirring solution of HBF4(aq) (48%, 5.0 mL, 38 mmol, 8.9 eq.). After 30 min the mixture was cooled 
to 0 ˚C then NaNO2(aq) (5.1 M, 2.0 mL, 10 mmol, 2.4 eq.) was added dropwise. After 30 min stirring 
the mixture was shaken then allowed to warm to RT and stirred for 2 h. Precipitation with Et2O 
followed by vacuum filtration, washing with HBF4(aq) then drying under vacuum gave the 
diazonium salt 274 as a beige solid (719 mg, 51%). 1H NMR (400 MHz, d6-DMSO) δ 8.94 (1H, d, J = 
1.9 Hz, H6), 8.25 (1H, dd, J = 8.8, 2.3 Hz, H4), 8.22 (1H, d, J = 8.6 Hz, H3), 1.33 [9H, s, C(CH3)3]. The 
very low solubility and probable explosive nature of this compound hindered further 
characterisation. 
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2-Fluoro-4-tert-butylphenylbromide 275 
 
NOBF4 (313 mg, 2.70 mmol, 1.32 eq.) was dissolved in stirring, dry DCM (10.0 mL), at 0 ˚C under 
argon. After 30 min 2-Amino-4-tertbutylphenylbromide 240 (471 mg, 2.04 mmol, 1.00 eq.) was 
added dropwise and the mixture allowed to warm to RT under argon for 13 h. PhMe (10.0 mL) 
was added then the DCM removed carefully under vacuum. The suspension was heated to reflux 
for 2 h stirring under argon, then cooled and the solvent removed under reduced pressure. 
Column chromatography (SiO2, Pet. ether) gave aryl fluoride 275 as an oil (341 mg, 72%). 
1H NMR 
(500 MHz, CDCl3) δ 7.46 (1H, apparent t, J = 7.9 Hz, H6), 7.16 (1H, dd, J = 10.9, 2.2 Hz, H3), 7.06 
(1H, dd, J = 8.4, 2.1 Hz, H5), 1.32 [9H, s, C(CH3)3]. 
13C NMR (126 MHz, CDCl3) δ 159.01 (d, J = 245.9 
Hz, CF), 153.49 (d, J = 5.9 Hz, C), 132.95 (CH), 122.49 (d, J = 3.2 Hz, CH), 113.94 (d, J = 22.4 Hz, CH), 
105.51 (d, J = 20.8 Hz, C), 34.88 (d, J = 1.4 Hz, C) 31.21 (CH3). 
19F NMR (470 MHz, CDCl3) δ −108.22 
(dd, 10.8, 7.4 Hz). Max(ATR)cm
-1: 2963 (C-H), 2870, (C-H), 1566 (CAr=CAr), 1481, 1404 (C-F). MS 
(EI+): 232 (81BrM+., 22%), 230 (79BrM+., 22%), 217 [(81BrM+H)+ – .CH3, 77], 215 [(
79BrM+H)+ – .CH3, 
77], 84 (100). HRMS: 232.0078 and 230.0110. C10H12
81BrF requires 232.0086, C10H12
79BrF requires 
230.0106. 
 
Potassium 2-Fluorophenyltrifluoroborate 285 
 
2-Fluorophenylbromide 268 (0.62 mL, 5.7 mmol, 1.0 eq.) was dissolved stirring in dry THF (15.0 
mL) under argon and cooled to –77 ˚C. nbutyllithium (2.5 M in hexane, 2.50 mL, 6.25 mmol, 1.10 
eq.) was added over 20 min, then the mixture stirred for 65 min. Triisopropxyborate (2.65 mL, 
11.5 mmol, 2.01 eq.) was added and the mixture stirred for a further 30 min before warming to 
RT and stirring for a further 30 min. The mixture was poured into KHF2(aq) (0.85 M, 30.0 mL, 25.5 
mmol, 4.48 eq.) and stirred for 17 h under argon. The solvent was removed under reduced 
pressure, triturated with Et2O and filtered. The filter cake was dissolved in acetone then dried 
(MgSO4), filtered and the solvent removed under reduced pressure. Crystallisation from acetone 
gave trilfuoroborate salt 285 as a solid (317, 28%). 1H NMR (400 MHz, DMSO) δ 7.34 (1H, t, J = 5.3 
Hz, H6), 7.11 - 7.03 (1H, m, H4), 6.91 (1H, td, J = 7.2, 0.7 Hz, H5), 6.79 (1H, t, J = 8.6 Hz, H3). 13C 
NMR (126 MHz, DMSO) δ 165.60 (dd, J = 239.0, 0.8 Hz, CF), 134.08 (dq, J = 13.4, 2.6 Hz, CH), 
127.06 (d, J = 8.0 Hz, CH), 122.35 (d, J = 2.4 Hz, CH), 113.59 (d, J = 25.9 Hz, CH). (ATR cm-1): 3078 
(CAr-H), 3057 (CAr-H), 1616 (CAr=CAr), 1566 (CAr=CAr). Data is consistent with literature values.
427 
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Potassium 2-Fluoro-4-tert-butylphenyltrifluoroboronate 266 
 
Aryl bromide 275 (5.88 g, 25.5 mmol, 1.00 eq.) was dissolved in dry THF (100 mL) and cooled to – 
77 ˚C. 1.6 M nbutyllithium (21.0 mL, 33.6 mmol, 1.32 eq.) was added to the stirring mixture 
dropwise over 50 min, then the mixture allowed to stir for 90 min. Triisopropylborate (12.0 mL, 
50.5 mmol, 1.98 eq.) was added dropwise over 10 min and the mixture allowed to warm to RT 
and stir for 14 h. The mixture was quenched into a KHF2 (10.0 g, 128 mmol, 5.0 eq.) solution 
[MeOH/H2O (1:1)] and allowed to stir for 55 h then the solvent removed under reduced pressure. 
The residue was dissolved in acetone and filtered, then the filtrate concentrated. Crystallisation 
from acetone gave Potassium trifluoroborate salt 266 (4.22 g, 64%). 1H NMR (500 MHz, Acetone) 
δ 7.45 (1H, apparent t, J = 7.3 Hz, H6), 7.03 (1H, ddd, J = 7.7, 1.7, 0.9 Hz, H5), 6.87 (1H, dd, J = 11.8, 
1.6 Hz, H3) [C(CH3)3]. 
13C NMR (126 MHz, Acetone) δ 168.23 (d, J = 235.0 Hz, CF), 152.83 (d, J = 7.2 
Hz, C), 135.87 (dq, J = 13.2, 2.6 Hz, CH), 121.19 (CH), 112.49 (d, J = 27.3 Hz, CH), 35.86 (d, J = 1.8 
Hz, C), 32.71 (CH3). 
19F NMR [470 MHz, (CD3)2CO] δ −107.63 - −107.79 (m), −137.84- −138.49 (m). 
Max(ATR)cm
-1: 2965 (C-H), 1624, 1551 (CAr=CAr), 1398. MS (NSI
–): 219 (M– (trifluoroborate anion), 
100%), 149 (M–−H3BF3, 59). HRMS: 219.0971. C10H12BF4 requires 219.0974. MP: > 250 ˚C. 
 
2-(2’’-Fluorophenyl)-5-nitrobenzophenone 286 
 
Iodobenzophenone 218 (1.29 g, 3.65 mmol, 1.00 eq.), PEPPSI-iPr catalyst (72 mg, 0.11 mmol, 0.03 
eq.) and arylboronic acid 314 (450 mg, 3.65 mmol, 1.00 eq.) were combined under argon and the 
reaction vessel was opened to vacuum, then refilled with argon. This process was repeated twice 
then N,N-diisopropylethylamine (1.90 mL, 10.9 mmol, 2.99 eq.) and degassed ethanol (18.0 mL) 
added. The mixture was heated to reflux stirring for 16 h. After cooling the mixture was filtered 
through celite eluting with DCM and the solvent removed under reduced pressure. After column 
chromatography [SiO2, Pet. ether/Et2O gradient (99:1) to (9:1)] the solvent was removed under 
reduced pressure and the material suspended in Pet. ether/Et2O (9:1) then sonicated. Ketone 286 
precipitated as an amorphous solid (570 mg, 49%). 1H NMR (400 MHz, CDCl3) δ 8.44 (1H, dd, J = 
8.4, 2.4 Hz, H4), 8.41 (1H, dd, J = 2.4, 0.5 Hz, H6), 7.71 - 7.67 (3H, m, H3, H2’, H6’), 7.52 (1H, ddt, J 
= 8.0, 6.9, 1.3 Hz, H4’), 7.40 - 7.35 (2H, m, H3’, H5’), 7.30 - 7.23 (2H, m, H4’’, H6’’), 7.11 (1H, td, J = 
7,8, 1.1 Hz, H5’’), 6.95 (1H, ddd, J = 10.2, 8.9, 1.0 Hz, m, H3’’). 13C NMR (101 MHz, CDCl3) δ 195.11 
(d, J = 1.1 Hz, C), 158.91 (d, J = 247.8 Hz, CF), 147.18 (C), 141.69 (C), 140.57 (d, J = 1.0 Hz, C), 
136.19 (C), 133.68 (CH), 132.53 (d, J = 1.4 Hz, CH), 131.18 (d, J = 2.6 Hz, CH), 130.99 (d, J = 8.3 Hz, 
CH), 129.99 (CH), 128.58 (CH), 126.05 (d, J = 14.8 Hz, C), 125.09 (CH), 124.60 (d, J = 3.7 Hz, CH), 
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124.15 (CH), 115.90 (d, J = 21.8 Hz, CH). 19F NMR (377 MHz, CDCl3) δ −115.11 - −115.20 (m). 
Max(ATR)cm
-1: 3067 (CAr-H), 1667 (C=O), 1597 (CAr=CAr), 1582 (CAr=CAr), 1522 (NO2), 1348 (NO2). MS 
(EI+): 321 (M+., 39), 227 (M+. – C6H5F, 37), 105 (PhCO
+, 100), 77 (Ph+, 39). MP: 108 - 110 ˚C. HRMS: 
321.0807. C19H12O3NF requires 321.0801. 
 
2-(2’’-Fluoro-4’’-tert-butylphenyl)-5-nitrobenzophenone 265 
 
Iodobenzophenone 218 (431 mg, 1.22 mmol, 1.00 eq.), PEPPSI-iPr catalyst (51 mg, 0.08 mmol, 
0.06 eq.) and potassium trifluoroborate salt 266 (353 mg, 1.37 mmol, 1.12 eq.) were combined 
under argon then the reaction vessel was opened to vacuum, then refilled with argon. This 
process was repeated twice then N,N-diisopropylethylamine (0.74 mL, 4.2 mmol, 3.4 eq.) and 
degassed ethanol (10.0 mL) added. The mixture was heated to reflux stirring for 4 h. After cooling 
the mixture was partitioned between Et2O and H2O, then the aqueous re-extracted with Et2O. The 
combined organics were washed with brine, then dried (MgSO4), filtered through celite eluting 
with Et2O and the solvent removed under reduced pressure. Column chromatography [SiO2, Pet. 
Ether/EtOAc (8:1), loaded in CHCl3] gave ketone 265 as a pale straw coloured oil (357 mg, 78%). Rf 
= 0.26 in Pet. ether/EtOAc (5:1). 1H NMR (500 MHz, CDCl3) δ 8.44 - 8.39 (2H, m, H4, H6), 7.67 (3H, 
d, br, J = 7.8 Hz, H3, H2’, H6’), 7.49 (1H, apparent t, J = 7.4 Hz, H4’), 7.35 (2H, apparent t, J = 7.7 
Hz, H3’, H5’), 7.18 (1H, apparent t, J = 8.1 Hz, H6’’), 7.11 (1H, dd, J = 8.1, 1.8 Hz, H5’’), 6.92 (1H, dd, 
J = 12.4, 1.7 Hz, H3’’), 1.23 [9H, s, C(CH3)3]. 
13C NMR (126 MHz, CDCl3) δ 195.21 (d, J = 1.1 Hz, C), 
158.66 (d, J = 246.7 Hz, CF), 155.27 (d, J = 6.9 Hz, C), 146.85 (C), 141.83 (C), 140.31 (C), 136.24 (C), 
133.31 (CH), 132.33 (d, J = 1.2 Hz, CH), 130.55 (d, J = 3.1 Hz, CH), 129.79 (CH), 128.33 (CH), 124.98 
(CH), 124.11 (CH), 122.73 (d, J = 15.5 Hz, C), 121.43 (d, J = 3.0 Hz, CH), 112.80 (d, J = 22.4 Hz, CH), 
34.82 (d, J = 1.4 Hz, C), 30.94 (CH3). 
19F NMR (470 MHz, CDCl3) δ −115.57 - −115.66 (m). 
Max(ATR)cm
-1: 2964 (CH), 1670 (C=O), 1606 (CAr=CAr), 1582 (CAr=CAr), 1523 (NO2), 1349 (NO2). MS 
(EI+): 377 (M+., 64%), 362 (M+. – .CH3, 100). HRMS (EI
+): 377.1426. C23H20FNO3 requires M
+. 
377.1427. 
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N-hexyl imine of 2-(2’’-Fluoro-4’’-tertbutylphenyl)-5-nitrophenyl(phenyl)benzophenone 287 
 
Benzophenone 265 (1.01 g, 2.66 mmol, 1.00 eq.) and dry hexylamine (2.45 mL, 18.6 mmol, 6.97 
eq.) were combined stirring under argon at 0 ˚C in dry PhMe (20.0 mL) then titanium tetrachloride 
(0.44 mL, 4.0 mmol, 1.5 eq.) was added over 5 min. The reaction was allowed to warm to RT and 
allowed to stir for 17 h. The mixture was quenched into H2O, with the residue washed out with 
Et2O. The layers were separated and the aqueous was then extracted (Et2O, x 2) then the 
combined organics washed (brine) and dried (MgSO4), then filtered and the solvent removed 
under reduced pressure. The imine 287 was purified by chromatography [SiO2, Pet. ether/Et2O 
(20:1)] and isolated as a solid (665 mg, 54%). Rf = 0.26 Pet. Ether/Et2O (20:1). 
1H NMR (500 MHz, 
CDCl3) δ 8.34 (1H, dd, J = 8.5, 2.4 Hz, H4), 8.09 (1H, d, J = 2.4 Hz, H6), 7.67 (1H, dd, J = 8.5, 1.8 Hz, 
H3), 7.52 - 7.44 (2H, m, H2’, H6’), 7.34 (1H, tt, J = 7.3, 1.3 Hz, H4’), 7.31 - 7.24 (2H, m, H3’, H5’), 
7.02 (1H, dd, J = 12.4, 1.7 Hz, H3’’), 6.98 (1H, dd, J = 8.1, 1.8 Hz, H5’’), 6.94 (1H, apparent t, J = 8.0 
Hz, H6’’), 3.26 - 3.18 (1H,m, H1A’’’), 3.08 (1H, ddd, J = 13.6, 7.8, 5.7 Hz, H1B’’’), 1.63 - 1.53 (1H, m, 
H2A’’’), 1.45 - 1.33 (1H, m, H2B’’’), 1.32 - 1.15 (15H, m, H3’’’, H4’’’, H5’’’, tBu), 0.85 [3H, t, J = 7.1 
Hz, C(CH3)3]. 
13C NMR (126 MHz, CDCl3) δ 164.11 (C), 159.13 (d, J = 247.1 Hz, CF), 155.28 (d, J = 6.8 
Hz, C), 147.26 (C), 141.92 (C), 139.50 (C), 138.16 (C), 132.48 (d, J = 2.6 Hz, CH), 130.13 (CH), 129.94 
(d, J = 2.9 Hz, CH), 128.29 (CH), 128.15 (CH), 124.05 (CH), 123.36 (CH), 122.72 (d, J = 14.6 Hz, C), 
121.20 (d, J = 3.1 Hz, CH), 113.12 (d, J = 22.5 Hz, CH), 54.39 (CH2), 34.97 (d, J = 1.4 Hz, C). 31.80 
(CH2), 31.14 (CH3), 30.93 (CH2), 27.29 (CH2), 22.72 (CH2), 14.19 (CH3). 
19F NMR (377 MHz, CDCl3) δ 
−116.01 (dd, J = 12.4, 7.8 Hz). Max(ATR)cm
-1: 2958 (C-H), 2932 (C-H), 2859 (C-H), 1624 (C=N), 1578 
(CAr=CAr), 1524 (NO2), 1346 (NO2). MS (EI
+): 460 (M+., 7%), 441 (C29H33N2O2
+., 7), 403 (C25H24FN2O2
+, 
22), 84 (C6H12
+., 100). HRMS: 460.2527. C29H33FN2O2 requires 460.2526. MP: decomp. 
 
3-tert-Butyl-6-phenyl-8-nitrophenanthridine 290 
 
Imine 287 (10 mg, 0.02 mmol, 1.0 eq.) was heated to 200 ˚C stirring in dry nitrobenzene (1.0 mL) 
for 1 h, then cooled and the solvent removed under reduced pressure. The resulting mixture was 
dissolved in MeOH and HCl(aq) (1 M, approx. 1:1), and the solvents removed under reduced 
pressure. The salt was loaded onto a Strata SCX ion exchange column, then washed with 
additional MeOH. The material was then eluted with 7 M NH3 in MeOH, and the solvent removed 
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under reduced pressure to give traces of phenanthridine 290 (2 mg, 26%). 1H NMR (500 MHz, 
CDCl3) δ 9.01 (1H, d, J = 2.3 Hz, H7), 8.81 (1H, d, J = 9.1 Hz, H10), 8.63 (1H, dd, J = 9.1, 2.4 Hz, H9), 
8.58 (1H, d, J = 8.7 Hz, H1), 8.30 (1H, d, J = 2.0 Hz, H4), 7.86 (1H, dd, J = 8.7, 2.1 Hz, H2), 7.77 - 7.73 
(2H, m, H2’, H6’), 7.65 - 7.57 (3H, m, H3’, H4’, H5’), 1.48 [s, 9H, C(CH3)3]. 
13C NMR (126 MHz, CDCl3) 
δ 161.51 (C), 155.02 (C), 145.97 (C), 145.23 (C), 138.70 (C), 137.58 (C), 129.84 (CH), 129.60 (CH), 
129.07 (CH), 126.93 (CH), 126.46 (CH), 125.21 (CH), 124.52 (C), 124.29 (CH), 124.02 (CH), 122.65 
(CH), 120.24 (C), 35.48 (C), 31.40 (CH3). Max(ATR)cm
-1: 2965 (C-H), 1616 (C=N), 1589 (CAr=CAr), 
1537 (CAr=CAr), 1516 (NO2), 1341 (NO2). MS (EI
+): 356 (M+., 59%), 341 (M+. – .CH3, 100), 326 (M
+. – 
C2H6, 49), 311 [(M
+. – .NO2, 60], 295 (M
+. – CH4, 
.HNO2, 34). HRMS: 356.1526. C23H20N2O2 requires 
356.1525. 
 
3-tert-Butyl-5-(hex-1’-yl)-6-phenyl-8-nitrophenanthridinium chloride 288 
 
Benzophenone 265 (500 mg, 1.33 mmol, 1.00 eq.) and dry hexylamine (1.05 mL, 9.31 mmol, 7.00 
eq.) were combined stirring under argon at 0 ˚C in dry PhMe (5.0 mL) then a 1 M solution of 
titanium tetrachloride in dry PhMe (2.00 mL, 2.00 mmol, 1.50 eq.) was added over 5 min. The 
reaction was allowed to warm to RT and allowed to stir for 40 h. The mixture was quenched into 1 
M K2CO3(aq) then filtered through celite and extracted into DCM (x 3). The combined organics were 
acidified (0.55 M HCl(aq)). The acidic aqueous extracts were further extracted (DCM, x 2), then the 
organic extracts recombined and basified in 1 M K2CO3(aq). The organic layers were dried (MgSO4), 
then filtered and the solvent removed under reduced pressure. From the crude yield of 623 mg of 
extremely viscous brown oil, a portion (100 mg, 0.22 mmol, 1.00 eq.) was weighed by difference 
onto a spatula and sonicated into a microwave tube (10 mL) containing dry THF (5.0 mL). The tube 
was filled with argon and sealed then heated to 100 ˚C for 2 h. After cooling the material was 
transferred to a round bottom flask with DCM and the solvent removed under reduced pressure. 
The residue was dissolved in dry Et2O then precipitated with 2 M ethereal HCl (1.00 mL, 2.00 
mmol, 9.09 eq.). The precipitate was allowed to settle, then the bulk of the solvent syringed out 
and the remainder removed under reduced pressure, isolating the phenanthridinium chloride 288 
as a brown foam (87 mg, 85%). 1H NMR (400 MHz, 0.75 mL CD3CN + 0.05 mL CF3CO2D) δ 8.96 (d, J 
= 9.2 Hz, H10), 8.86 (1H, d, J = 9.1 Hz, H1), 8.71 (1H, dd, J = 9.2, 2.3 Hz, H9), 8.16 - 8.05 (3H, m, H2, 
H4, H7), 7.72 - 7.67 (1H, m, H4’’), 7.67 - 7.61 (2H, m, H3’’, H5’’), 7.51 - 7.46 (2H, m, H2’’, H6’’), 4.68 
- 4.56 (2H, m, CH2-1’), 1.85 – 1.76 (2H, m, CH2-2’’), 1.34 [s, 9H, C(CH3)3], 1.20 - 1.09 (2H, m, CH2-3’), 
1.00 (4H, m, CH2-4’, CH2-5’), 0.63 (3H, t, J = 7.0 Hz, CH3-6’). 
13C NMR (126 MHz, 0.75 mL CD3CN + 
0.05 mL CF3CO2D) δ 164.32 (C), 158.62 (C), 147.28 (C), 138.16 (C), 134.94 (C), 132.03 (CH), 129.95 
(CH), 129.68 (CH), 129.62 (CH), 128.22 (CH), 127.91 (CH), 125.60 (CH), 125.38 (C), 125.19 (CH), 
123.51 (C), 117.03 (CH), 116.30 (C), 55.26 (CH2), 35.86 (C), 30.33 (CH2), 29.89 (CH3), 28.82 (CH2), 
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25.66 (CH2), 21.79 (CH2), 12.84 (CH3) . Max(ATR)cm
-1: 2956 (CAr-H), 2927 (CAr-H), 2870 (CAr-H), 1620 
(C=N), 1588 (CAr=CAr), 1539 (CAr=CAr), 1342 (NO2). MS (ESI
+): 441 [M+ (phenanthridinium cation), 
100%]. HRMS: 441.2516. C29H33N2O2 requires 441.2537. 
 
3-tert-Butyl-5-(hex-1’-yl)-6-phenyl-8-aminophenanthridinium chloride 293 
 
Benzophenone 265 (500 mg, 1.33 mmol, 1.00 eq.) and dry hexylamine (1.23 mL, 9.31 mmol, 7.16 
eq.) were combined stirring under argon at 0 ˚C in dry DCM (10.0 mL) then titanium tetrachloride 
(0.22 mL, 2.0 mmol, 1.5 eq.) was added over 5 min. The reaction was allowed to warm to RT and 
allowed to stir for 15 h. The remaining mixture was quenched into H2O and partitioned with DCM 
then the aqueous layer was re-extracted (DCM x 2). The combined organics were washed with 
brine and dried by filtration through a hydrophobic frit, then the solvent removed under reduced 
pressure. The residue was dissolved in dry CHCl3 and transferred to a kugelrohr bulb. The CHCl3 
was evaporated at atmospheric pressure and the oil allowed to heat at 100 ˚C under argon for 
110 min. The oil was then dissolved in CHCl3 and TFA (10:1), which were removed under reduced 
pressure to give the cyclised nitro product. This was dissolved in TFA (18.0 mL) and 10% Pd/C (349 
mg, 0.33 mmol, 0.25 eq.) added, then the mixture stirred while a balloon of H2(g) was used to 
degas the solution. The mixture was allowed to stir for 2 h at RT under a H2(g) atmosphere, then 
concentrated. The residue was diluted and neutralised by addition of DCM and K2CO3 respectively, 
then filtered through a combination of celite and K2CO3 with additional DCM. The material was 
purified by chromatography (SiO2, loaded and washed with DCM, then eluted with DCM/MeOH). 
The counterion was then exchanged to mesylate on an Amberlite IR-401 column, giving the final 
salt 293 as a red foam (315 mg, 47%). 1H NMR (500 MHz, CDCl3) δ 8.60 (1H, d, J = 9.0 Hz, H1), 8.43 
(1H, d, J = 9.1 Hz, H10), 8.03 (1H, d, J = 1.4 Hz, H4), 7.96 (1H, dd, J = 8.8, 1.5 Hz, H2), 7.84 (1H, dd, J 
= 8.9, 1.7 Hz, H9), 7.76 - 7.68 (3H, m, H3’’, H4’’, H5’’), 7.47 - 7.41 (2H , m, H2’’, H6’’), 6.34 (1H, d, J 
= 2.2 Hz, H7), 5.43 (2H, s, br, NH2), 4.80 - 4.60 (2H, m, br, CH2-1’), 2.59 (3H, s, O3SCH3), 1.96 - 1.79 
(2H, m, br, CH2-2’), 1.46 [9H, s, C(CH3)3], 1.32 - 1.10 (6H, m, CH2-3’, CH2-4’, CH2-5’), 0.79 (3H, t, J = 
7.0 Hz, CH2-6’). 
13C NMR (126 MHz, CDCl3) δ 160.63 (C), 153.78 (C), 150.31 (C), 131.65 (CH), 131.61 
(C), 131.29 (C), 129.97 (CH), 129.40 (CH), 128.67 (CH), 128.16 (CH), 127.03 (C), 126.32 (C), 125.03 
(C), 123.60 (CH), 123.51 (CH), 115.13 (CH), 110.53 (CH), 54.30 (CH2), 39.46 (CH3), 35.80 (C), 31.15 
(CH3), 30.89 (CH2), 29.72 (CH2), 26.28 (CH2), 22.27 (CH2), 13.84 (CH3). Max(ATR)cm
-1: 3333 (NH), 
3210 (NH), 2959 (C-H), 2932 (C-H), 2866 (C-H), 1609 (C=N). MS (NSI+): 411 [M+ (phenanthridinium 
cation), 100%], 327 [(M+H)+ – C6H12, 25]. HRMS: 411.2803. C29H35N2 requires 411.2795.  
 
 
 
Chapter 13: Experimental 209 
 
2-Fluoro-4-nitrophenyl-4,4,5,5-tetramethyl-1,3,2-dioxoborolane 315 
 
Aryl bromide 319 (1.88 g, 8.55 mmol, 1.00 eq.), bis(pinacolato)diboron (2.24 g, 8.82 mmol, 1.03 
eq.), anhydrous potassium acetate (2.71 g, 27.6 mmol, 3.23 eq.) and (dppf)PdCl2.DCM (150 mg, 
0.18 mmol, 2 mol%) were combined and opened to vacuum, then refilled with argon. The cycle 
was repeated (x 2) then dry 1,4-dioxane (65 mL) added and the reaction heated to 100 ˚C and 
stirred under argon for 3 h. The mixture was filtered through celite, dried (MgSO4), filtered and 
the solvent removed under reduced pressure. Column chromatography [SiO2, gradient from Pet. 
ether to Pet. ether/EtOAc (6.7:1)] gave impure boronate ester (2.01 g), of which a portion (1.81 g) 
was chromatographed again [SiO2, gradient from Pet. ether to Pet. ether/EtOAc (6.7:1)] to give 
boronate ester 315 as a solid (1.27 g, 61%). 1H NMR (500 MHz, CDCl3) δ 8.00 (1H, dd, J = 8.2, 2.0 
Hz, H5), 7.92 (1H, dd, J = 8.2, 5.8 Hz, H6), 7.88 (1H, dd, J = 8.7, 2.0 Hz, H3), 1.38 (12H, s, CH3 x 4). 
13C NMR (101 MHz, CDCl3) δ 166.69 (d, J = 255.5 Hz, CF), 150.99 (d, J = 9.2 Hz, C), 137.82 (d, J = 8.5 
Hz, CH), 118.42 (d, J = 3.6 Hz, CH), 110.93 (d, J = 29.4 Hz, CH), 84.84 (C), 24.88 (CH3).
 19F NMR (377 
MHz, CDCl3) δ −98.70 (dd, J = 8.6, 5.8 Hz). Max(ATR)cm
-1: 2978 (C-H), 2932 (C-H), 1611 (CAr=CAr), 
1524 (NO2), 1341 (NO2). MS (APCI
+): 268 [(M+H)+, 100%]. HRMS: 268.1149. C12H16BFNO4 requires 
268.1151. MP: 73 - 77 ˚C. 
 
Potassium 2-fluoro-4-nitrophenyltrifluoroborate 320 
 
Bromide 319 (2.00 g, 9.09 mmol, 1.00 eq.), bis(pinacolato)diboron (2.58 g, 10.1 mmol, 1.12 eq.), 
dry KOAc (2.78 g, 28.3 mmol, 3.12 eq.) and (dppf)PdCl2.DCM (150 mg, 0.184 mmol, 0.0202 eq.) 
were placed under vacuum then the vessel refilled with argon. This process was repeated (x 2), 
then dry 1,4-dioxane (65 mL) was added and the mixture heated with stirring under argon to 100 
˚C for 6 h, with dry NEt3 (0.20 mL, 1.4 mmol, 0.16 eq.) added at 60 ˚C. After cooling to 50 ˚C the 
mixture was vacuum filtered through celite and MgSO4 eluting with CHCl3, then the solvent 
removed from the filtrate under reduced pressure. The residue was dissolved in MeOH/water 
(1:1) then KHF2 added (16 g, 205 mmol, 22.5 eq.) and the solution stirred for 20 h. The mixture 
was concentrated under reduced pressure and the residue dissolved in acetone and filtered. The 
filtrate was concentrated, and the potassium trifluoroborate salt 320 crystallised from hot 
acetone as a beige solid (367 mg, 16%). 1H NMR (500 MHz, Acetone) δ 7.82 (1H, ddd, J = 8.1, 2.1, 
0.7 Hz, H5), 7.72 (1H, apparent t, br, J = 6.3 Hz, H6), 7.62 (1H, dd, J = 8.6, 1.8 Hz, H3). 13C NMR (101 
MHz, DMSO) δ 164.79 (d, J = 243.7 Hz, CF), 146.93 (d, J = 9.2 Hz, C), 134.85 (dq, J = 13.9, 2.6 Hz, 
CH), 117.67 (d, J = 2.8 Hz, CH), 109.11 (d, J = 31.7 Hz, CH). (ATR cm-1): 1528 (NO2), 1360 (NO2). MS 
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(NSI–): 208 [M– (trifluoroborate anion)]. HRMS: 208.0195. C6H3BF4NO2 requires 208.0198. MP: > 
250 ˚C. 
 
2-Bromo-5-nitroacetophenone 321 
 
2-Bromoacetophenone 323 (2.00 g, 10.1 mmol, 1.00 eq.) was added to a solution of KNO3 (1.26 g, 
12.5 mmol, 1.23 eq.) in H2SO4(aq) (10 mL) stirring at 0 ˚C. The mixture was allowed to stir warming 
to RT for 70 min, and was then quenched (H2O) and extracted with DCM (x 2). The combined 
organics were dried (MgSO4), filtered and the solvent removed under reduced pressure. Column 
chromatography [SiO2, Pet. ether/EtOAc (7:1)] gave nitroacetophenone 321 as a solid (1.34 g, 
55%). Rf = 0.34 in Pet. ether/EtOAc (7:1). 
1H NMR (500 MHz, CDCl3) δ 8.28 (1H, d, J = 2.7 Hz, H6), 
8.12 (1H, dd, J = 8.7, 2.7 Hz, H4), 7.82 (1H, d, J = 8.7 Hz, H3), 2.67 (3H, s, COCH3). 
13C NMR (101 
MHz, CDCl3) δ 198.87 (C), 147.06 (C), 142.39 (C), 135.27 (CH), 126.22 (C), 125.98 (CH), 123.83 (CH), 
30.19 (CH3). Max(ATR)cm
-1: 3095 (CAr-H), 3073 (CAr-H), 1709 (C=O), 1604 (CAr=CAr), 1568 (CAr=CAr), 
1523 (NO2), 1355 (NO2). MS (EI
+): 245 (81BrM+., 22%), 243 (79BrM+., 26), 230 [(81BrM+H) – .CH3, 82], 
228 [(79BrM+H) – .CH3, 100], 184 [(
81BrM.+H) – .CH3 – 
.NO2, 24], 182 [(
79BrM.+H) – .CH3 – 
.NO2, 26]. 
HRMS: 244.9514. C8H6
81BrNO3 requires 244.9511. MP: 85 - 87 ˚C. 
 
2-(2’-Fluoro-4’-nitrophenyl)-5-nitroacetophenone 324 
 
Bromoacetophenone 321 (1.00 g, 4.10 mmol, 1.00 eq.), PEPPSI-iPr catalyst (140 mg, 0.21 mmol, 
0.05 eq.) and arylboronic acid 315 (1.13 g, 4.22 mmol, 1.03 eq.) were divided evenly between two 
microwave tubes (10 mL) under argon. The tubes were opened to vacuum, then refilled with 
argon. This process was repeated twice then N,N-diisopropylethylamine (2.00 mL, 11.4 mmol, 
2.79 eq.) and degassed ethanol (10.0 mL) were split between the tubes. Each tube was heated to 
125 ˚C for 10 min. After cooling the mixtures were filtered through celite eluting with DCM and 
the solvent removed under reduced pressure. The residue was redissolved then partitioned 
(DCM/1 M HCl(aq)) then the aqueous layer extracted (DCM x 2). The combined organics were dried 
(MgSO4), filtered and the solvent removed under reduced pressure. Additional boronic acid (200 
mg, 0.75 mmol, 0.18 eq.), N,N-diisopropylethylamine (1.00 mL, 5.74 mmol, 1.40 eq.), PEPPSI-iPr 
catalyst (50 mg, 0.07 mmol, 0.02 eq.) and ethanol (10.0 mL) was added and the mixture divided 
then the previous processes repeated. Column chromatography [SiO2, Pet. Ether/ EtOAc (5:1)] 
gave ketone 324 as a solid (499 mg, 40%). Rf = 0.23 in Pet. Ether/ EtOAc (5:1). 
1H NMR (500 MHz, 
CDCl3) δ 8.65 (1H, d, J = 2.3 Hz, H6), 8.46 (1H, dd, J = 8.4, 2.3 Hz, H4), 8.17 (1H, dd, J = 8.4, 1.9 Hz, 
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H5’), 7.99 (1H, dd, J = 9.5, 2.2 Hz, H3’), 7.56 (1H, d, J = 8.4 Hz, H3), 7.51 (dd, J = 8.2, 7.4 Hz, H6’), 
2.62 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 198.04 (d, J = 0.6 Hz, C), 158.38 (d, J = 251.0 Hz, CF), 
148.90 (d, J = 8.7 Hz, C), 148.12 (C), 139.95 (C), 138.97 (C), 134.19 (d, J = 16.0 Hz, C), 132.89 (CH), 
131.01 (d, J = 3.3 Hz, CH), 126.41 (CH), 123.64 (CH), 120.03 (d, J = 3.7 Hz, CH), 111.65 (d, J = 27.4 
Hz, CH), 28.44 (CH3). 
19F NMR (470 MHz, CDCl3) δ −111.05 (dd, J = 9.6, 7.2 Hz). Max(ATR)cm
-1: 3111 
(CAr-H), 3078, (CAr-H), 3057 (CAr-H), 1699 (C=O), 1609 (CAr=CAr), 1580 (CAr=CAr), 1510 (NO2), 1346 
(NO2). MS (EI
+): 304 (M+., 62%), 289 (M+. – .CH3, 100), 285 (M
+. – .F 9), 243 (M+. – F. – CH2CO, 22) 
213 (C14H10FO
+, 15). HRMS: 304.0491. C14H9FN2O5 requires 304.0495. MP: 123 - 124 ˚C. 
 
2-(2’’-Fluoro-3’’-pyridyl)-5-nitrobenzophenone 325 
 
Iodobenzophenone 218 (1.00 g, 2.83 mmol, 1.00 eq.), PEPPSI-iPr catalyst (100 mg, 0.15 mmol, 
0.05 eq.) and arylboronic acid 312 (400 mg, 2.84 mmol, 1.00 eq.) were divided evenly between 
two microwave tubes (10 mL) under argon. The tubes were then opened to vacuum, then refilled 
with argon. This process was repeated twice then N,N-diisopropylethylamine (1.46 mL, 8.38 
mmol, 2.96 eq.) and degassed ethanol (10 mL) were split between the tubes. Each tube was 
heated to 125 ˚C for 1 h in a microwave. After cooling the mixtures were combined and filtered 
through celite with DCM and the solvent removed under reduced pressure. The residue was 
partitioned between DCM and 1 M HCl(aq) then the aqueous layer extracted (DCM x 2). The 
combined organics were dried (MgSO4), filtered and the solvent removed under reduced 
pressure. Column chromatography [SiO2, Pet. Ether/EtOAc gradient from (7:1) to (5:1)]. The 
benzophenone 325 was isolated as a solid (480 mg, 53%). Rf = 0.14 in Pet ether/EtOAc (5:1). 
1H 
NMR (400 MHz, CDCl3) δ 8.46 (1H, dd, J = 8.4, 2.4 Hz, H4), 8.42 (1H, d, J = 2.2 Hz, H6), 8.15 (1H, 
ddd, J = 4.9, 1.9, 1.2 Hz, H4’’), 7.77 - 7.65 (4H, m, H3, H6’’, H2’, H6’), 7.56 (1H, ddt, J = 8.0, 6.8, 1.3 
Hz, H4’), 7.45 - 7.38 (2H, m, H3’, H5’), 7.20 (1H, ddd, J = 7.4, 4.9, 1.8 Hz, H5’’). 13C NMR (101 MHz, 
CDCl3) δ 194.67 (C), 159.30 (d, J = 238.7 Hz, CF), 148.26 (d, J = 14.8 Hz, CH), 147.43 (C), 141.47 (d, J 
= 3.5 Hz, CH), 140.45 (C), 139.85 (d, J = 4.5 Hz, C), 135.85 (C), 134.05 (CH), 132.44 (d, J = 0.8 Hz, 
CH), 129.99 (CH), 128.80 (CH), 125.35 (CH), 124.29 (CH), 121.73 (d, J = 4.4 Hz, CH), 121.01 (d, J = 
30.4 Hz, C). 19F NMR (377 MHz, CDCl3) δ −68.76 (d, J = 9.5 Hz). Max(ATR)cm
-1: 3069 (CAr-H), 3062 
(CAr-H), 1668 (C=O), 1607 (CAr=CAr), 1583 (CAr=CAr), 1523 (NO2), 1351 (NO2). MS (EI
+): 322 (M+., 
100%), 245 (M+ – Ph, 20), 121 (C6H3NO2
+., 40), 105 (PhCO+, 87), 77 (Ph+, 37). HRMS: 322.0750. 
C18H11O3N2F requires 322.0754. MP: 125 -127 ˚C. 
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2-(2’’-Fluoro-4’’-bromophenyl)-5-nitrobenzophenone 326 
 
Iodobenzophenone 218 (1.45 g, 4.11 mmol, 1.00 eq.), PEPPSI-iPr catalyst (94 mg, 0.14 mmol, 0.03 
eq.) and arylboronic acid 313 (1.00 g, 4.57 mmol, 1.11 eq.) were combined under argon and the 
reaction vessel was opened to vacuum, then refilled with argon. This process was repeated twice 
then N,N-diisopropylethylamine (2.4 mL, 14 mmol, 3.4 eq.) and degassed ethanol (40 mL) added. 
The mixture was heated to reflux stirring for 22 h. After cooling the mixture was filtered through 
celite eluting with DCM and the solvent removed under reduced pressure. The residue was 
partitioned between DCM and 1 M HCl(aq) then the aqueous layer further extracted (DCM x 2). The 
combined organics were dried (MgSO4), filtered and the solvent removed under reduced 
pressure. Column chromatography [SiO2, Pet. ether/EtOAc (15:1)]. Gave ketone 326 as a yellow 
solid (896 mg, 55%). Rf = 0.32 in Pet. ether/EtOAc (5:1). 
1H NMR (400 MHz, CDCl3) δ 8.43 (1H, dd, J 
= 8.4, 2.4 Hz, H4), 8.39 (1H, d, J = 2.3 Hz, H6), 7.75 - 7.68 (2H, m, H2’, H6’), 7.65 (1H, d, J = 8.4 Hz, 
H3), 7.57 (1H, ddt, J = 8.0, 7.0, 1.3 Hz, H4’), 7.41 (2H, t, J = 7.7 Hz, H3’, H5’), 7.28 (1H, dd, J = 8.3, 
1.6 Hz, H5’’), 7.19 - 7.12 (2H, m, H3’’, H6’’). 13C NMR (101 MHz, CDCl3) δ 194.82 (d, J = 0.7 Hz, C), 
158.56 (d, J = 252.3 Hz, CF), 147.20 (C), 140.69 (C), 140.36 (C), 135.94 (C), 133.96 (CH), 132.42 (d, J 
= 0.6 Hz, CH), 132.02 (d, J = 3.3 Hz, CH), 130.06 (CH), 128.74 (CH), 128.07 (d, J = 3.7 Hz, CH), 
125.29 (CH), 125.21 (d, J = 15.1 Hz, C), 124.21 (CH), 123.64 (d, J = 9.5 Hz, C), 119.62 (d, J = 25.1 Hz, 
CH). 19F NMR (470 MHz, CDCl3) δ −112.25 (apparent t, J =  8.7 Hz). Max(ATR)cm
-1: 3088 (CAr-H), 
3071 (CAr-H), 1668 (C=O), 1605 (CAr=CAr), 1582 (CAr=CAr), 1524 (NO2), 1350 (NO2). MS (EI
+): 401 
(81BrM+., 26%) 399 (79BrM+., 30), 353 (M+. – NO2
., 30), 105 (PhCO+, 100), 77 (Ph+, 34). HRMS: 
398.9902 and 400.9877. C19H11O3NBrF requires 398.9906 and 400.9888. MP: 101 -105 ˚C. 
 
2-(2’’-Fluorophenyl)-benzophenone 327 
 
Iodobenzophenone 218 (1.41 g, 4.57 mmol, 1.00 eq.), PEPPSI-iPr catalyst (76 mg, 0.11 mmol, 0.03 
eq.) and arylboronic acid 314 (563 mg, 4.55 mmol, 1.00 eq.) were combined under argon and the 
reaction vessel was opened to vacuum, then refilled with argon. This process was repeated twice 
then N,N-diisopropylethylamine (1.91 mL, 11.0 mmol, 2.75 eq.) and degassed ethanol (18.0 mL) 
added. The mixture was heated to reflux stirring for 16 h. After cooling the mixture was filtered 
through celite eluting with DCM and the solvent removed under reduced pressure. The residue 
was taken up in Et2O then dried (MgSO4), filtered and the solvent removed under reduced 
pressure. Column chromatography [SiO2, Pet. ether/EtOAc (12:1)] gave ketone 327 as a clear oil 
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(958 mg, 76%). Rf = 0.24 Pet. ether/EtOAc (12:1). 
1H NMR (500 MHz, CDCl3) δ 7.71 - 7.67 (2H, m, 
H2’, H6’), 7.62 - 7.55 (2H, m, H6, H4), 7.51 - 7.47 (2H, m, H3, H5), 7.43 (1H, ddt, J = 7.9, 6.8, 1.3 Hz, 
H4’), 7.35 - 7.29 (2H, t, J = 7.7 Hz, H3’, H5’), 7.24 (apparent td, J = 7.6, 1.8 Hz, H6’’), 7.17 - 7.13 (1H, 
m, H4’’), 7.05 (1H, apparent td, J = 7.5, 1.3 Hz, H5’’), 6.88 (1H, ddd, J = 10.1, 8.4, 1.2 Hz, H3’’). 13C 
NMR (101 MHz, CDCl3) δ 197.70 (d, J = 1.1 Hz, C), 159.20 (d, J = 246.3 Hz, CF), 139.34 (d, J = 0.8 Hz, 
C), 137.49 (C), 135.39 (C), 132.83 (CH), 131.60 (d, J = 3.2 Hz, CH), 131.24 (d, J = 1.2 Hz, CH), 130.65 
(CH), 130.06 (CH), 129.59 (d, J = 8.1 Hz, CH), 129.32 (CH), 128.17 (CH), 128.10 (d, J = 15.1 Hz, C), 
127.66 (CH), 124.19 (d, J = 3.7 Hz, CH), 115.53 (d, J = 22.3 Hz, CH). 19F NMR (470 MHz, CDCl3) δ 
−115.75 (ddd, J = 10.0, 7.7, 5.2 Hz). Max(ATR)cm
-1: 3061 (CAr-H), 3030 (CAr-H), 1663 (C=O), 1595 
(CAr=CAr), 1582 (CAr=CAr), 1501 (CAr=CAr). MS (EI
+): 276 (M+., 89%), 257 (M+ – F., 38), 199 (M
+. – Ph., 
100), 170 (C12H10O
+., 62). HRMS: 276.0946. C19H13OF requires 276.0950. 
 
2-(2’’-Fluoro-4’’-nitrophenyl)-5-nitrobenzophenone 328 
 
Iodobenzophenone 218 (995 mg, 2.82 mmol, 1.00 eq.), PEPPSI-iPr catalyst (105 mg, 0.15 mmol, 
0.05 eq.) and arylboronate 315 (706 mg, 2.64 mmol, 0.94 eq.) were divided evenly into three 
microwave tubes (10 mL) and each reaction vessel was opened to vacuum, then refilled with 
argon. This process was repeated twice then N,N-diisopropylethylamine (1.56 mL, 8.96 mmol, 
3.18 eq.) and degassed ethanol (15.0 mL) divided between them. Each tube was sealed and 
heated to 100 ˚C for 30 min in a microwave. After cooling the material was combined in DCM and 
filtered through a celite/K2CO3 mixture and the solvent removed from the filtrate under reduced 
pressure. The material was dry loaded onto celite in DCM then column chromatography [SiO2, 
Pet. Ether/DCM, (1:1)] gave ketone 328 as a solid (962 mg, 99%). Rf = 0.14 DCM/Pet. ether (6:4). 
1H NMR (500 MHz, CDCl3) δ 8.50 (1H, dd, J = 8.4, 2.4 Hz, H4), 8.44 (1H, d, J = 2.3 Hz, H6), 8.07 (1H, 
dd, J = 8.4, 2.1 Hz, H5’’), 7.87 (1H, dd, J = 9.4, 2.2 Hz, H3’’), 7.74 (2H, d, J = 8.5 Hz, H2’, H6’), 7.69 
(d, J = 8.4 Hz, H3), 7.63 - 7.58 (1H, tt, J = 7.5, 1.2 Hz, H4’), 7.52 (1H, dd, J = 8.4, 7.4 Hz, H6’’), 7.46 
(2H, m, H3’, H5’). 13C NMR (126 MHz, CDCl3) δ 194.07 (d, J = 1.1 Hz, C), 158.42 (d, J = 252.3 Hz, CF), 
148.95 (d, J = 8.6 Hz, C), 147.76 (C), 140.49 (d, J = 0.9 Hz, C), 139.37 (C), 135.77 (C), 134.02 (CH), 
132.86 (d, J = 15.6 Hz, C), 132.22 (d, J = 1.3 Hz, CH), 131.74 (d, J = 3.2 Hz, CH), 129.92 (CH), 128.74 
(CH), 125.30 (CH), 124.24 (CH), 119.47 (d, J = 3.8 Hz, CH), 111.62 (d, J = 27.4 Hz, CH). 19F NMR (470 
MHz, CDCl3) δ −110.18 (dd, J = 9.3, 7.7 Hz). Max(ATR)cm
-1: 3090 (CAr-H), 1667 (C=O), 1597 (CAr=CAr), 
1522 (NO2), 1346 (NO2). MS (CI
+): 367 [(M+H)+, 100%], 228 [(PhCOC6H4NO2+H)
+
, 92]. HRMS: 
367.0722. C19H12O5NF requires 367.0730. MP: 143 -144 ˚C. 
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2-(2’-Fluorophenyl)acetophenone 329 
 
Bromoacetophenone 323 (800 mg, 4.02 mmol, 1.00 eq.), PEPPSI-iPr catalyst (136 mg, 0.20 mmol, 
0.05 eq.) and aryl boronic acid 314 (562 mg, 4.02 mmol, 1.00 eq.) were divided evenly between 
two microwave tubes (10 mL) under argon. The tubes were opened to vacuum, then refilled with 
argon. This process was repeated twice then N,N-diisopropylethylamine (2.10 mL, 15.6 mmol, 
3.88 eq.) and degassed ethanol (12.0 mL) were split between the tubes. Each tube was heated to 
125 ˚C for 1 h. After cooling the mixtures were filtered through celite with DCM and the solvent 
removed under reduced pressure. The residue was redissolved then partitioned (DCM/1 M HCl(aq)) 
then the aqueous layer extracted (DCM x 2). The combined organics were dried (MgSO4), filtered 
and the solvent removed under reduced pressure. Column chromatography [SiO2, Pet. 
Ether/EtOAc (15:1)] gave ketone 329 as a clear oil (725 mg, 84%). Rf = 0.32 in 7:1 Pet. Ether/ 
EtOAc. 1H NMR (400 MHz, CDCl3) δ 7.69 (1H, ddd, J = 7.6, 1.4, 0.5 Hz, H6), 7.55 (1H, td, J = 7.5, 1.4 
Hz, H4), 7.46 (1H, td, J = 7.6, 1.3 Hz, H5), 7.40 - 7.31 (2H, m, H3, H4’), 7.29 (1H, dd, J = 7.6, 1.8 Hz, 
H6’), 7.22 (td, J = 7.5, 1.2 Hz, H5’), 7.15 - 7.08 (1H, m, H3’). 13C NMR (101 MHz, CDCl3) δ 202.17 (C), 
159.27 (d, J = 245.8 Hz, CF), 140.28 (C), 134.36 (C), 131.48 (CH), 131.17 (CH), 131.12 (d, J = 3.3 Hz, 
CH), 129.72 (d, J = 8.1 Hz, CH), 128.72 (d, J = 15.5 Hz, C), 128.39 (CH), 128.08 (d, J = 2.0 Hz, CH), 
124.52 (d, J = 3.6 Hz, CH), 115.64 (d, J = 22.3 Hz, CH), 29.14 (CH3). 
19F NMR (377 MHz, CDCl3) δ 
−116.23 - −116.33 (m). Max(ATR)cm
-1: 3063 (CAr-H), 1688 (C=O), 1595 (CAr=CAr), 1568 (CAr=CAr), 
1499 (CAr=CAr). MS (EI
+): 214 (M+., 57%), 199 (C13H8FO
+, 100), 170 (C12H10O
+., 42). HRMS: 214.0791. 
C14H11FO requires 214.0794.
 
 
2-(2’’-Chloro-5’’-nitrophenyl)-5-nitrobenzophenone 330 
 
Iodobenzophenone 218 (1.00 g, 2.83 mmol, 1.12 eq.), PEPPSI-iPr catalyst (96 mg, 0.14 mmol, 0.05 
eq.) and arylboronic acid 316 (510 mg, 2.53 mmol, 1.00 eq.) were divided evenly between two 
microwave tubes (10.0 mL) under argon. The tubes were opened to vacuum, then refilled with 
argon. This process was repeated twice then N,N-diisopropylethylamine (1.45 mL, 8.32 mmol, 
3.29 eq.) and degassed ethanol (10.0 mL) were split between the tubes. Each tube was heated to 
125 ˚C for 10 min. After cooling the mixtures were combined and partitioned between DCM and 1 
M HCl(aq) then the aqueous layer extracted (DCM x 2). The combined organics were dried (MgSO4), 
filtered and the solvent removed under reduced pressure. Column chromatography [SiO2, Pet. 
Ether/EtOAc (15:1), after drying loading onto celite]. Ketone 330 was isolated as a solid (540 mg, 
56%). 1H NMR (500 MHz, CDCl3) δ 8.50 (1H, dd, J = 8.4, 2.4 Hz, H4), 8.48 (1H, d, J = 2.3 Hz, H6), 
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8.16 (1H, d, J = 2.6 Hz, H6’’), 8.13 (1H, dd, J = 8.7, 2.7 Hz, H4’’), 7.72 (2H, dd, J = 8.5, 1.4 Hz, H2’, 
H6’), 7.64 (1H, dd, J = 8.4, 0.5 Hz, H3), 7.59 (1H, ddt, J = 7.8, 7.1, 1.3 Hz, H4’), 7.52 (1H, d, J = 8.7 
Hz, H3’’), 7.37 (2H, t, br, J = 7.9 Hz, H3’, H5’). 13C NMR (126 MHz, CDCl3) δ 194.03 (C), 147.63 (C), 
146.45 (C), 143.25 (C), 140.09 (C), 139.32 (C), 138.79 (C), 135.84 (C), 134.11 (CH), 132.60 (CH), 
130.80 (CH), 130.15 (CH), 128.89 (CH), 126.11 (CH), 125.66 (CH), 124.75 (CH), 124.62 (CH). 
Max(ATR)cm
-1: 3057 (CAr-H), 1670 (C=O), 1597 (CAr=CAr), 1574 (CAr=CAr), 1530 (NO2), 1348 (NO2). MS 
(EI+): 385 [(37ClM+H)+, 35%], 383 [(35ClM+H)+, 100]. HRMS: 385.0416 and 383.0432. C19H11 ClN2O5 
requires 385.0413 and 383.0435. MP: 115 - 116 ˚C. 
 
2-(2’’-Fluoro-3’’-methylphenyl)-5-nitrobenzophenone 332 
 
Iodobenzophenone 218 (688 mg, 1.95 mmol, 1.00 eq.), PEPPSI-iPr catalyst (41 mg, 0.06 mmol, 
0.03 eq.) and arylboronic acid 318 (300 mg, 1.95 mmol, 1.00 eq.) were combined under argon 
then the reaction vessel was opened to vacuum, then refilled with argon. This process was 
repeated twice then N,N-diisopropylethylamine (1.02 mL, 5.85 mmol, 3.00 eq.) and degassed 
ethanol (12.0 mL) added. The mixture was heated to reflux stirring for 22 h. After cooling the 
mixture was filtered through celite eluting with DCM and the solvent removed under reduced 
pressure. The material was the redissolved in Et2O, dried with MgSO4 and ethereal HCl (2 M) 
added to precipitate the diisopropylethylamine as a salt, which was then removed by filtration. 
The solvent was then removed from the filtrate under reduced pressure and the solid 
recrystallised from CHCl3 and washed with CHCl3 to give ketone 332 as a brown solid (430 mg, 
66%). Rf = 0.29 [SiO2, Pet. ether/EtOAc (9:1)]. 
1H NMR (500 MHz, CDCl3) δ 8.42 (1H, dd, J = 6.2, 2.4 
Hz, H4), 8.41 (1H, d, J = 2.5 Hz, H6), 7.69 - 7.64 (3H, m, H3, H2’, H6’), 7.50 (1H, ddt, J = 7.9, 7.0, 1.3 
Hz, H4’), 7.35 (2H, apparent t, J = 8.0 Hz, H3’, H5’), 7.10 - 7.02 (2H, m, H4’’, H6’’), 6.97 (1H 
apparent t, J = 7.5 Hz, H5’’), 2.14 (3H, d, J = 2.2 Hz, CH3). 
13C NMR (126 MHz, CDCl3) δ 195.24 (C), 
157.34 (d, J = 246.3 Hz, CF), 147.08 (C), 142.13 (C), 140.46 (C), 136.27 (C), 133.53 (CH), 132.49 
(CH), 132.45 CH), 129.87 (CH), 128.58 (d, J = 2.5 Hz, CH), 128.44 (CH), 125.71 (d, J = 15.7 Hz, C), 
125.40 (d, J = 17.7 Hz, C) , 125.03 (CH), 124.18 (CH), 124.07 (d, J = 4.3 Hz, CH), 14.56 (d, J = 4.3 Hz, 
CH3). 
19F NMR (377 MHz, CDCl3) δ −119.51 (apparent td, J = 6.9, 2.2 Hz). Max(ATR)cm
-1: 1670 
(C=O), 1597 (C=CAr), 1582 (C=CAr), 1524 (NO2), 1348 (NO2). MS (EI
+): 335 (M+., 97%), 320 (M+. – .CH3, 
55), 258 (M+. – Ph., 43), 183 (C13H8F
+., 42), 105 (PhCO+, 85), 86 (100). HRMS (EI+): 335.0954. 
C20H14FNO3 requires M
+. 335.0958. MP: 140 - 145 ˚C. 
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2-(2’’-Fluoro-5’’-methoxyphenyl)-5-nitrobenzophenone 333 
 
Iodobenzophenone 333 (625 mg, 1.77 mmol, 1.00 eq.), PEPPSI-iPr catalyst (36 mg, 0.05 mmol, 
0.03 eq.) and arylboronic acid 317 (301 mg, 1.77 mmol, 1.00 eq.) were combined under argon 
then the reaction vessel was opened to vacuum, then refilled with argon. This process was 
repeated twice then N,N-diisopropylethylamine (0.93 mL, 5.3 mmol, 3.0 eq.) and degassed 
ethanol (12.0 mL) added. The mixture was heated to reflux stirring for 22 h. After cooling the 
mixture was filtered through celite eluting with DCM and the solvent removed under reduced 
pressure. The material was the redissolved in Et2O, dried with MgSO4 and ethereal HCl (2 M) 
added to precipitate the diisopropylethylamine as a salt, which was then removed by filtration. 
The solvent was then removed from the filtrate under reduced pressure and the solid 
recrystallised from CHCl3 then washed with CHCl3 to give ketone 333 as a brown solid (517 mg, 
83%). Rf = 0.20 [Pet. ether/EtOAc (9:1)]. 
1H NMR (500 MHz, CDCl3) δ 8.43 (1H, dd, J = 8.4, 2.4 Hz, 
H4), 8.40 (1H, d, J = 2.3 Hz, H6), 7.70 (3H, apparent t, J = 8.7 Hz, H3, H2’, H6’), 7.53 (1H, tt, J = 7.4, 
1.3 Hz, H4’), 7.39 (2H, apparent t, J = 7.8 Hz, H3’, H5’), 6.89 - 6.84 (1H, m, H3’’), 6.78 - 6.74 (2H, m, 
H4’’, H6’’), 3.72 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 195.13 (C), 155.80 (d, J = 2.0 Hz, C), 153.25 (d, 
J = 240.3 Hz, CF), 147.13 (C), 141.66 (C), 140.54 (C), 136.14 (C), 133.74 (CH), 132.46 (d, J = 1.0 Hz, 
CH), 130.00 (CH), 128.60 (CH), 126.32 (d, J = 16.5 Hz, C),125.12 (CH), 124.10 (CH), 116.58 (d, J = 
23.9 Hz, CH), 116.13 (d, J = 8.0 Hz, CH), 115.70 (d, J = 2.5 Hz, CH), 55.93 (CH3). 
19F NMR (377 MHz, 
CDCl3) δ −126.33 (dt, J = 9.6, 4.8 Hz). Max(ATR)cm
-1: 2951 (CH), 2934 (CH), 2845 (CH), 1672 (C=O), 
1595 (C=CAr), 1578 (C=CAr), 1518 (C=CAr), 1499 (NO2), 1346 (NO2). MS (EI
+): 351 (M+., 90%), 279 (M+. 
– NO2 – C2H2,
 30), 274 (M+. – Ph., 25), 227 (PhCOC6H4NO2
+., 25), 167,149 (O2NC6H3CO
+., 100) 105 
(PhCO+, 97), 77 (Ph+, 45). HRMS: 351.0902. C20H14O4NF requires 351.0907. MP: 100 - 102 ˚C. 
 
2-(2’’-Fluoro-4’’-nitro-5’’-methoxyphenyl)-5-nitrobenzophenone 334 
 
Benzophenone 218 (749 mg, 2.13 mmol, 1.00 eq.), acetic anhydride (20 mL) and DCM (10.0 mL) 
were combined and cooled to 0 ˚C. Concentrated nitric acid (2.0 mL, 44 mmol, 21 eq.) was added 
and the mixture allowed to stir for 2 h then quenched into NaOH(aq) (1 M) and extracted (DCM, x 
2). The organic layer was dried (MgSO4), filtered and the solvent removed under reduced 
pressure. The residue was then dissolved in minimal hot EtOAc and precipitated by addition of 
pet. ether, then left to settle (12 h). The solvent was decanted off and the solid triturated with hot 
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EtOAc. Nitrated benzophenone 334 was isolated as a brown solid (604 mg, 72%). 1H NMR (400 
MHz, CDCl3) δ 8.48 (1H, dd, J = 8.4, 2.4 Hz, H4), 8.42 (1H, d, J = 2.3 Hz, H6), 7.76 - 7.68 (3H, m, H3, 
H2’, H6’), 7.60 (1H, ddt, J = 8.0, 7.0, 1.3 Hz, H4’), 7.55 (1H, d, J = 8.8 Hz, H3’’), 7.49 - 7.41 (2H, m, 
H3’, H5’), 7.00 (1H, d, J = 5.9 Hz, H6’’), 3.89 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 194.56 (C), 151.45 
(d, J = 244.8 Hz, CF), 149.60 (d, J = 2.7 Hz, C), 147.75 (C), 140.75 (C), 139.48 (d, J = 0.9 Hz, C), 
139.06 (d, J = 8.1 Hz, C), 135.78 (C), 134.37 (CH), 132.33 (d, J = 1.3 Hz, CH), 132.01 (d, J = 16.7 Hz, 
C), 130.09 (CH), 128.98 (CH), 125.40 (CH), 124.18 (CH), 116.20 (d, J = 2.5 Hz, CH), 113.66 (d, J = 
28.3 Hz, CH), 57.29 (CH3). 
19F NMR (377 MHz, CDCl3) δ −122.91 (dd, J = 8.8, 6.0 Hz). Max(ATR)cm
-1: 
3069 (CAr-H), 1668 (C=O), 1595 (CAr=CAr), 1522 (NO2), 1346 (NO2). MS (EI
+): 396 (M+., 100%), 105 
(PhCO+, 59), 77 (Ph+, 31). HRMS: 396.0751. C20H13O6N2F requires 396.0758. MP: 143 - 144 ˚C. 
 
2-(2’’-Fluoro-4’’-nitro-5’’-methoxy-6’’-nitrophenyl)-5-nitrobenzophenone 335 
 
Benzophenone 218 (100 mg, 0.284 mmol, 1.00 eq.) was dissolved in MeCN (2.0 mL) and stirred 
under argon and cooled to – 42 ˚C. NO2BF4 was added (approx. 2 eq.) and the reaction warmed to 
0 ˚C then stirred for 10 min. The mixture was quenched into water then extracted with DCM. The 
organic layer was dried (MgSO4), filtered and the solvent removed under reduced pressure. 
1H 
NMR showed the major product to be the double nitrated benzophenone 335, and a 
characterisation sample was acquired by column chromatography [SiO2, Pet. ether/EtOAc (7:1)]. 
Rf = 0.20 in Pet. ether/EtOAc (7:1). 
1H NMR (400 MHz, CDCl3) δ 8.50 (1H, dd, J = 8.3, 2.3 Hz, H4), 
8.47 (1H, dd, J = 2.3, 0.5 Hz, H6), 7.86 (1H, d, J = 8.0 Hz, H3’’), 7.75 (2H, dd, J = 8.4, 1.3 Hz, H2’, 
H6’), 7.68 (1H, ddt, J = 7.9, 7.0, 1.4 Hz, H4’), 7.64 (1H, dd, J = 8.3, 0.5 Hz, H3), 7.56 - 7.50 (2H, t, J = 
7.7 Hz, H3’, H5’), 4.00 (3H, s, OCH3). 
13C NMR (101 MHz, CDCl3) δ 193.14 (C), 153.84 (d, J = 252.1 
Hz, CF), 148.23 (C), 146.39 (C), 143.27 (d, J = 8.6 Hz, C), 143.01 (d, J = 4.3 Hz, C), 139.75 (C), 135.53 
(C), 134.15 (CH), 133.82 (C), 132.14 (CH), 130.19 (CH), 128.89 (CH), 126.89 (C), 126.10 (CH), 125.43 
(CH), 114.45 (d, J = 28.2 Hz, CH), 65.32 (CH3). 
19F NMR (377 MHz, CDCl3) δ −110.49 (d, J = 8.0 Hz). 
(ATR cm-1): 3077 (CAr-H), 1668 (C=O), 1595 (CAr=CAr), 1528 (NO2), 1343 (NO2). MS (CI
+): 442 
[(M+H)+, 100%], 412 [(M+2H)+ – OCH3, 49]. HRMS: 442.0694. C20H13O8N3F requires 442.0687.  
 
4-Azidobutyltriphenylphosphonium iodide 345 
 
Phosphonium iodide 24 (955 mg, 1.67 mmol, 1.00 eq.) and NaN3 (404 mg, 6.22 mmol, 3.72 eq.) 
were dissolved in a combination of MeCN (3.5 mL) and water (0.9 mL) then stirred and heated to 
80 ˚C for 2 h. The mixture was then cooled and partitioned between DCM and water, then the 
aqueous re-extracted with DCM and the combined organics washed with brine then the solvent 
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removed under reduced pressure to give triphenylphosphonium salt 345 as a solid (820 mg, 
quant.). 1H NMR (400 MHz, CDCl3) δ 7.83 - 7.70 (9H, m, 
+PPh3), 7.70 - 7.60 (6H, m, 
+PPh3), 3.81 - 
3.68 (2H, m, CH2-1), 3.37 (2H, t, J = 6.2 Hz, CH2-4), 1.96 (2H, quin., J = 6.9 Hz, CH2-2), 1.75 - 1.62 
(2H, m, CH2-3). 
13C NMR (101 MHz, CDCl3) δ 135.28 (d, J = 3.1 Hz, CH), 133.83 (d, J = 10.0 Hz, CH), 
130.68 (d, J = 12.6 Hz, CH), 118.11 (d, J = 86.1 Hz, C), 50.71 (d, J = 1.2 Hz, CH2), 29.31 (d, J = 16.7 
Hz, CH2), 22.71 (d, J = 51.0 Hz, CH2), 19.96 (d, J = 3.9 Hz, CH2). (ATR cm
-1): 3075 (CAr-H), 3055 (CAr-
H), 2945 (CAr-H), 2936 (CAr-H), 2893 (CAr-H), 2868 (CAr-H), 2097 (N3), 1587 (CAr=CAr). MS (NSI
+) 289 
[M+ (phosphonium cation), 100%]. HRMS: 360.1627. C22H23N3P requires 360.1624. MP: 142 - 144 
˚C. 
 
4-Aminobutyltriphenylphosphonium iodide 339 
 
Phosphonium salt 345 (836 mg, 1.72 mmol, 1.00 eq.) and 10% Pd/C (220 mg, 0.207 mmol, 0.120 
eq.) were combined in MeOH (8.0 mL) and degassed by bubbling H2(g) through the solution. The 
mixture was then stirred under a H2(g) atmosphere for 14 h. The mixture was filtered through 
celite eluting with MeOH, then the solvent removed under reduced pressure. The residue was re-
dissolved in DCM then dried (MgSO4), filtered and the solvent removed under reduced pressure 
to give amine 339 as a solid (736 mg, 93%). 1H NMR (500 MHz, CDCl3) δ 7.88 - 7.57 (15H, m, 
+PPh3), 4.05 (2H, s, br, NH2), 3.74 - 3.58 (2H, m, CH2-1), 2.81 (2H, t, J = 6.7 Hz, CH2-4), 2.02 - 1.89 
(2H, m, CH2-2), 1.78 - 1.64 (2H, m, CH2-3). 
13C NMR (126 MHz, CDCl3) δ 135.07 (d, J = 2.8 Hz, CH), 
133.78 (d, J = 10.0 Hz, CH), 130.57 (d, J = 12.5 Hz, CH), 118.02 (d, J = 86.0 Hz, C), 39.97 (CH2), 31.14 
(CH2), 22.66 (d, J = 50.4 Hz, CH2), 20.06 (CH2). (ATR cm
-1): 3378 (N-H), 3051 (CAr-H), 3008 (CAr-H), 
2989 (CAr-H), 2867 (CAr-H), 1587 (CAr=CAr). MS (ESI
+): Matches data acquired by a colleague.416 
 
1-Azidohexane 343 
 
Bromohexane 346 (2.0 g, 12 mmol, 1.0 eq.) was dissolved in MeCN (25 mL), then NaN3 (2.35 g, 
36.2 mmol, 3.01 eq.) and water (6 mL) added and the reaction stirred under reflux for 17 h. The 
mixture was partitioned between brine and Et2O then the organic layer washed with water (x 3) 
and dried (MgSO4), filtered and the solvent removed under reduced pressure to give azide 343 as 
an oil (1.40 g, 92%). 1H NMR (500 MHz, CDCl3) δ 3.26 (2H, t, J = 7.0 Hz, CH2-1), 1.60 (2H, quin., J = 
7.2 Hz, CH2-2), 1.45 - 1.27 (6H, m, CH2-3, CH2-4, CH2-5), 0.91 (3H, t, J = 7.0 Hz, CH2-6). 
13C NMR (126 
MHz, CDCl3) δ 51.75 (CH2), 31.51 (CH2), 29.01 (CH2), 26.58 (CH2), 22.65 (CH2), 14.04 (CH3). 
Consistent with literature data.428 
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1,6-Diazidohexane 349 
 
1,6-Dibromohexane 347 (1.90 mL, 12.4 mmol, 1.00 eq.) was added to a stirring solution of NaN3 
(4.96 g, 76.3 mmol, 6.15 eq.) in water (50 mL) and heated to reflux for 68 h. After cooling the 
mixture was extracted with Et2O (x 2), and the combined organic extracts dried (MgSO4), filtered 
and the solvent removed under reduced pressure. Azide 349 was isolated as a clear oil (2.10 g, 
quant.). 1H NMR (500 MHz, CDCl3) δ 3.28 (4H, t, J = 6.9 Hz, CH2-1, CH2-6), 1.67 - 1.57 (4H, m, CH2-2, 
CH2-5), 1.46 - 1.38 (4H, m, CH2-3, CH2-4). 
13C NMR (126 MHz, CDCl3) δ 51.55 (CH2), 28.92 (CH2), 
26.49 (CH2). Consistent with literature data.
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6-Azidohexyltriphenylphosphonium Iodide 348 
 
Triphenylphosphonium iodide 348 (100 mg, 0.167 mmol, 1.00 eq.) and NaN3 (45 mg, 0.69 mmol, 
4.2 eq.) were combined in a mixture of MeCN (0.5 mL) and water (0.1 mL) and heated to 80 ˚C 
with stirring for 2 h. The mixture was partitioned with water and CHCl3 then the organic layer 
dried (MgSO4), filtered and the solvent removed under reduced pressure, giving azide 340 as a 
solid (89 mg, quant.). 1H NMR (500 MHz, CDCl3) δ 7.92 - 7.54 (15H, m, 
+PPh3), 3.66 - 3.50 (2H, m, 
CH2-1), 3.17 (2H, t, J = 6.8 Hz, CH2-6), 1.72 - 1.53 (4H, m, CH2-2, CH2-5), 1.52 - 1.41 (2H, m, CH2-4), 
1.38 - 1.28 (2H, m, CH2-3). 
13C NMR (126 MHz, CDCl3) δ 135.11 (d, J = 3.0 Hz, CH), 133.54 (d, J = 
10.0 Hz, CH), 130.52 (d, J = 12.6 Hz, CH), 117.90 (d, J = 86.0 Hz, C), 51.16 (CH2), 29.75 (d, J = 16.0 
Hz, CH2), 28.33 (CH2), 26.10 (CH2), 22.96 (d, J = 50.4 Hz, CH2), 22.39 (d, J = 4.3 Hz, CH2). (ATR cm
-1): 
3053 (CAr-H), 2936 (C-H), 2859 (C-H), 2091 (N3), 1587 (CAr=CAr). Matches data acquired by a 
colleague.416  
 
1-Azido-6-aminohexane 342 
 
1,6-Diazidohexane 349 (7.47 g, 44.4 mmol, 1.00 eq.) was dissolved in Et2O (150 mL), and 
combined with 1 M HCl(aq) (150 mL). Triphenylphosphine (13.2 g, 50.3 mmol, 1.13 eq.) was added 
and the mixture stirred for 24 h. The layers were then separated and the aqueous basified with 7 
M NaOH(aq) and extracted with Et2O (x 2). The combined organics were dried (MgSO4), then 
filtered and the solvent removed under reduced pressure to give amine 342 as a clear oil (4.74 g, 
75%). 1H NMR (500 MHz, CDCl3) δ 3.26 (2H, t, J = 6.9 Hz, CH2-1), 2.70 (2H, t, J = 6.9 Hz, CH2-6), 1.67 
– 1.56 (2H, apparent quin. J = 7.1 Hz, CH2-2), 1.46 (2H, quin., J = 7.0 Hz, CH2-5), 1.42 – 1.32 (4H, m, 
CH2-3, CH2-4), 1.15 (2H, s, br, NH2). 
13C NMR (126 MHz, CDCl3) δ 51.64 (CH2), 42.29 (CH2), 33.86 
(CH2), 29.00 (CH2), 26.79 (CH2), 26.61 (CH2). Consistent with literature data.
429 
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Aminohex-5-yne 341 
 
Phthalimide 350 (5.0 g, 22 mmol, 1.0 eq.) was dissolved in IPA (25 mL) and water (15 mL) then 
NaBH4 added (4.17 g, 110 mmol, 5.00 eq.) and the mixture stirred for 18 h. AcOH (100 mL) was 
then added and the mixture heated to 80 ˚C for 2 h. The material was loaded onto a previously 
acidified column of IR-120 resin (65 g), washed with water then eluted with NH3(aq). The aqueous 
was extracted into Et2O, then from the organic into 1 M HCl(aq) then the solvent removed under 
reduced pressure and the residue recrystallised from IPA to give amine 341 (300 mg, 14%). 1H 
NMR (500 MHz, CD3OD) δ 3.00 - 2.94 (2H, m, CH2-1), 2.31 - 2.25 (3H, m, CH2-2, CH2-6), 1.85 - 1.76 
(2H, m, CH2-3), 1.66 - 1.58 (2H, m, CH2-4). 
13C NMR (126 MHz, CD3OD) δ 84.00, 70.39, 40.34, 27.65, 
26.39, 18.56. Consistent with literature data.430 
 
4-Methyl-6-phenyl-8-nitrophenanthridine 368 
 
Imine 362 (100 mg, 0.24 mmol, 1.00 eq.) was weighed and sonicated into dry MeCN (5.0 mL) in a 
microwave tube (10 mL), which was sealed and heated to 110 ˚C in a microwave for 10 h. After 
cooling the solvent was removed under reduced pressure then the residue dissolved in dry Et2O 
and precipitated with 2 M ethereal HCl (1.00 mL, 2.00 mmol, 8.33 eq.). The solvent was removed 
under reduced pressure then the mixture dissolved in MeOH and loaded onto a Strata WCX ion 
exchange column. The column was washed with additional MeOH before elution with 
NaOAc/MeOH (15 mg/mL). The solvent was removed under reduced pressure and replaced with 
dry CHCl3 then the solution filtered and the solvent removed under reduced pressure. The 
product 368 was sequentially recrystallised from MeOH and dry CHCl3, then isolated as a white 
solid (8 mg, 11%). 1H NMR (500 MHz, CDCl3) δ 9.11 (1H, d, J = 2.3 Hz, H7), 8.83 (1H, d, J = 9.1 Hz, 
H10), 8.61 (1H, dd, J = 9.1, 2.4 Hz, H9), 8.50 (1H, d, J = 8.1 Hz, H1), 7.86 - 7.79 (2H, m, H2’, H6’), 
7.75 (1H, d, J = 7.0 Hz, H3), 7.69 - 7.57 (4H, m, H2, H3’, H4’, H5’), 2.90 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ 159.49 (C), 146.08 (C), 143.93 (C), 139.05 (C), 138.06 (C), 131.74 (CH), 130.35 (CH), 
129.54 (CH), 128.87 (CH), 127.61 (CH), 124.98 (CH), 124.51 (CH), 124.23 (C), 123.89 (CH), 122.31 
(C), 120.66 (CH), 18.51 (CH3). Max(ATR)cm
-1: 2918 (CAr-H), 1614 (C=N), 1602 (CAr=CAr), 1590 
(CAr=CAr), 1571 (CAr=CAr), 1531 (NO2), 1336 (NO2). MS (APCI): 315 ([M+H]
+, 100%). HRMS: 315.1129. 
C20H14N2O2 requires 315.1128. MP: 242 -243 ˚C. 
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5-(Hex-1’-yl)-6-phenyl-8-nitrophenanthridinium chloride 299 
 
Benzophenone 286 (253 mg, 0.79 mmol, 1.00 eq.) and dry hexylamine (0.73 mL, 5.5 mmol, 7.0 
eq.) were combined stirring under argon at 0 ˚C in dry PhMe (3.0 mL) then 1 M titanium 
tetrachloride in dry PhMe (1.18 mL, 1.18 mmol, 1.49 eq.) was added over 5 min. The reaction was 
allowed to warm to RT and allowed to stir for 72 h. The mixture was quenched into brine then 
filtered and extracted into Et2O (x 1) and DCM (x 2). The combined organics were dried (MgSO4), 
then filtered and the solvent removed under reduced pressure. From the crude yield of 272 mg of 
extremely viscous brown oil, a portion (101 mg, 0.25 mmol, 1.00 eq.) was weighed by difference 
onto a spatula and sonicated into a microwave tube (10 mL) containing dry THF (5.0 mL). The tube 
was filled with argon and sealed then heated in a microwave to 100 ˚C for 2 h. The solution was 
filtered and the residue eluted with CHCl3 and MeOH, then the solvent removed under reduced 
pressure, then the residue triturated with pet. ether, which was filtered. The residue and filter 
cake were recombined in CHCl3 and the solvent removed under reduced pressure. The residue 
was then redissolved in dry Et2O and precipitated with ethereal HCl (1.00 mL, 2.00 mmol, 7.69 
eq.), then allowed to settle for 15 h. The solid was partitioned between Et2O and 1 M NaOH(aq) 
then the aqueous re-extracted (Et2O x 1, CHCl3 x 2). The organic fractions were recombined, then 
ethereal HCl (1.00 mL, 2.00 mmol, 7.69 eq.) and PhMe were added and the solvent removed 
under reduced pressure, isolating the phenanthridinium chloride 299 as brown solid (103 mg, 
84%). 1H NMR (500 MHz, CD3CN + 0.05 mL CF3CO2D): 9.12 (1H, t, J = 9.0 Hz, H10), 9.07 (1H, d, J = 
7.9 Hz, H1), 8.87 (1H, d, J = 8.6 Hz, H9), 8.48 (1H, d, J = 8.3 Hz, H4), 8.26 (1H, s, H7), 8.21 (1H, 
apparent t, br, J = 7.2 Hz, H3), 8.14 (1H, apparent t, br, J = 7.1 Hz, H2), 7.83 (1H, t, J = 7.2 Hz, H4’’), 
7.77 (2H, t, J = 6.8 Hz, H3’’, H5’’), 7.63 (2H, d, J = 6.9 Hz, H2’’, H6’’), 4.71 (2H, s, br, CH2-1’), 2.00 - 
1.89 (2H, m, CH2-2’), 1.30 - 1.04 (6H, m, CH2-3’, CH2-4’, CH2-5’), 0.75 (3H, t, J = 6.9 Hz, CH2-6’). 
13C 
NMR (101 MHz, 0.75 mL CD3OD + 0.05 mL CF3CO2D) δ 166.13 (C), 149.03 (C), 140.13 (C), 136.62 
(C), 135.59 (CH), 133.53 (CH), 132.71 (CH), 131.58 (C), 131.45 (CH), 131.07 (CH), 130.03 (CH), 
129.10 (CH), 127.37 (C), 127.35 (CH), 127.31 (C), 127.04 (CH), 122.28 (CH), 57.07 (CH2), 31.94 
(CH2), 30.71 (CH2), 27.20 (CH2), 23.35 (CH2), 14.17 (CH3). Max(ATR)cm
-1: 3067 (CAr-H), 2953 (C-H), 
2926, (C-H), 2857 (C-H), 1620 (C=N), 1589 (CAr=CAr), 1537 (NO2), 1341 (NO2). MS (NSI
+): 385 [M+ 
(phenanthridinium cation), 100%], 301 (M+ – C6H10, 15). HRMS: 385.1916. C25H25N2O2
+
 requires 
385.1911. MP: 190 - 192 ˚C. 
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3-Bromo-5-(hex-1’-yl)-6-phenyl-8-nitrophenanthridinium chloride 300 
 
Benzophenone 326 (530 mg, 1.32 mmol, 1.00 eq.) and dry hexylamine (1.75 mL, 13.2 mmol, 10.0 
eq.) were combined stirring under argon at 0 ˚C in dry PhMe (5.0 mL) then 1 M titanium 
tetrachloride in dry PhMe (1.86 mL, 1.86 mmol, 1.41 eq.) was added. The reaction was allowed to 
warm to RT and allowed to stir for 15 h, at which point additional 1 M titanium tetrachloride in 
PhMe was added (0.50 mL, 0.50 mmol, 0.38 eq.). After stirring for an additional 20 h the mixture 
was quenched into 1 M K2CO3(aq) then filtered and extracted into DCM (x 3). The combined 
organics were acidified (0.55 M HCl(aq)). The acidic aqueous extracts were further extracted (DCM, 
x 2), then the organic extracts recombined and basified in 1 M K2CO3(aq). The organic layers were 
dried (MgSO4), then filtered and the solvent removed under reduced pressure. From the crude 
yield of 656 mg of extremely viscous brown oil, a portion (102 mg, 0.20 mmol, 1.00 eq.) was 
weighed by difference onto a spatula and sonicated into a microwave tube (10 mL) containing dry 
THF (5.0 mL). The tube was filled with argon and sealed then heated in a microwave to 100 ˚C for 
2 h. After cooling the material was transferred to a round bottom flask with CHCl3 and the solvent 
removed under reduced pressure. The residue was dissolved in dry Et2O then precipitated with 2 
M ethereal HCl (1.00 mL, 2.00 mmol, 10.0 eq.). The precipitate was allowed to settle, then the 
bulk of the solvent syringed out and the remainder removed under reduced pressure, then the 
solid triturated with dry Et2O, CHCl3 and MeOH consecutively. The solvent was removed under 
reduced pressure, isolating the phenanthridinium chloride 300 was isolated as an off-white solid 
(103 mg, 100%). 1H NMR (400 MHz, CD3OD) δ 9.25 (1H, d, J = 9.2 Hz, H10), 9.09 (1H, d, J = 8.9 Hz, 
H1), 8.93 (1H, dd, J = 9.2, 2.2 Hz, H9), 8.79 (1H, d, J = 1.4 Hz, H4), 8.33 – 8.27 (2H, m, H2, H7), 7.85 
(1H, t, J = 7.5 Hz, H4’’), 7.79 (2H, t, J = 7.3 Hz, H3’’, H5’’), 7.68 (2H, d, J = 7.4 Hz, H2’’, H6’’), 4.87 - 
4.72 (2H, m, CH2-1’), 2.00 - 1.86 (2H, m, CH2-2’), 1.31 - 1.03 (6H, m, CH2-3’, CH2-4’, CH2-5’), 0.81 - 
0.72 (3H, t, J = 7.2 Hz, CH2-6’). 
13C NMR (126 MHz, 0.75 mL CD3OD + 0.05 mL CF3CO2D) δ 167.34 
(C), 149.26 (C), 139.82 (C), 137.15 (C), 136.11 (CH), 133.68 (CH), 131.89 (CH), 131.25 (C), 131.06 
(CH), 129.97 (C), 129.91 (CH), 129.29 (CH), 128.83 (CH), 127.30 (C), 127.02 (CH), 126.36 (C), 124.82 
(CH), 57.10 (CH2), 31.76 (CH2), 30.55 (CH2), 27.00 (CH2), 23.15 (CH2), 13.92 (CH3). Max(ATR)cm
-1: 
2955 (C-H), 2930 (C-H), 2857 (C-H), 1618 (C=N), 1603 (CAr=CAr), 1589 (CAr=CAr), 1533 (NO2), 1518 
(CAr=CAr), 1341 (NO2). MS (ESI
+): 465 [81BrM+ (phenanthridinium cation), 100%], 463 [79BrM+ 
(phenanthridinium cation), 98]. HRMS: 463.1011 and 465.0986. C25H24BrN2O2 requires 463.1016 
and 465.0996. MP: 160 - 165 ˚C. 
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4-Aza-5-(hex-1’-yl)-6-phenyl-8-nitrophenanthridinium chloride 301 
 
Benzophenone 325 (520 mg, 1.61 mmol, 1.00 eq.) and dry hexylamine (1.50 mL, 11.4 mmol, 7.05 
eq.) were combined stirring under argon at 0 ˚C in dry PhMe (5.0 mL) then 1 M titanium 
tetrachloride in dry PhMe (2.40 mL, 2.40 mmol, 1.49 eq.) was added over 5 min. The reaction was 
allowed to warm to RT and allowed to stir for 20 h. The mixture was quenched into H2O, then 
filtered through celite with DCM and partitioned between DCM and 1 M HCl(aq), then the aqueous 
layer was re-extracted (DCM x 2). The combined organics were washed with 1 M HCl(aq) then 
NaHCO3(aq) and dried (MgSO4) then filtered and the solvent removed under reduced pressure. 
From the crude yield of 631 mg of brown solid a portion (100 mg, 0.25 mmol, 1.00 eq.) was 
weighed by difference onto a spatula and sonicated into a microwave tube (10 mL) containing dry 
THF (5.0 mL). The tube was filled with argon and sealed then heated in a microwave to 100 ˚C for 
30 min then cooled and transferred to a round bottomed flask in dry CHCl3, then the solvent 
removed under reduced pressure. The residue was dissolved in dry Et2O then precipitated with 2 
M ethereal HCl (1.00 mL, 2.00 mmol, 8.13 eq.). The solvent was removed under reduced pressure, 
then the solid triturated with pet. ether and dried under reduced pressure. The salt 301 was 
isolated as a solid (106 mg, 98%). 1H NMR (400 MHz, CD3OD) δ 9.71 (1H, dd, J = 8.5, 1.7 Hz, H1), 
9.41 (1H, d, J = 9.1 Hz, H10), 9.38 (1H, dd, J = 4.4, 1.7 Hz, H3), 9.08 (1H, dd, J = 9.1, 2.3 Hz, H9), 
8.49 (1H, d, J = 2.0 Hz, H7), 8.28 (1H, dd, J = 8.4, 4.4 Hz, H2), 7.97 (1H, t, J = 7.4 Hz, H4’’), 7.91 (2H, 
t, J = 7.3 Hz, H3’’, H5’’), 7.85 - 7.79 (2H, d, J = 7.4 Hz, H2’’, H6’’), 5.12 - 5.02 (2H, m, CH2-1’), 2.08 - 
1.97 (2H, m, CH2-2’), 1.40 - 1.16 (6H, m, CH2-3’, CH2-4’, CH2-5’), 0.87 (3H, t, J = 7.1 Hz, CH2-6’). 
13C 
NMR (126 MHz, CDCl3) δ 167.29 (C), 153.69 (CH), 147.66 (C), 144.54 (C), 138.75 (C), 136.83 (CH), 
132.35 (CH), 130.23 (CH), 129.73 (CH), 129.62 (C), 128.77 (CH), 128.02 (CH), 127.77 (CH), 126.80 
(CH), 126.32 (C), 121.51 (C), 54.80 (CH2), 30.65 (CH2), 29.78 (CH2), 26.47 (CH2), 22.28 (CH2), 13.86 
(CH3). Max(ATR)cm
-1: 3064 (CAr-H), 2956 (C-H), 2931 (C-H), 2926 (C-H), 1623 (C=N), 1604 (CAr=CAr), 
1592 (CAr=CAr), 1538 (NO2), 1518 (CAr=CAr), 1343 (NO2). MS (ESI
+): 418 [M+ (phenanthridinium 
cation) + MeOH, 62%], 386 [M+ (phenanthridinium cation), 100], 302 [(M+ (phenanthridinium 
cation) – C6H12, 69). HRMS: 386.1857. C24H24N3O2
+ requires 386.1863. MP: 188 - 189 ˚C. 
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2,8-Dinitro-5-(hex-1’-yl)-6-phenylphenanthridinium chloride 302 
 
Benzophenone 330 (300 mg, 0.78 mmol, 1.00 eq.) and dry hexylamine (0.60 mL, 4.6 mmol, 5.9 
eq.) were combined stirring under argon at 0 ˚C in dry PhMe (3.0 mL) then 1 M titanium 
tetrachloride in dry PhMe (0.98 mL, 0.98 mmol, 1.3 eq.) was added over 5 min. The reaction was 
allowed to warm to RT and allowed to stir for 20 h. A sample (0.1 mL) was quenched into H2O, 
partitioned between DCM and water and the organic separated and the solvent removed under 
reduced pressure. Proton NMR confirmed the reaction was complete. The remaining mixture was 
quenched into H2O, then filtered through celite with DCM and partitioned between DCM and 1 M 
HCl(aq), then the aqueous layer was re-extracted (DCM x 2). The combined organics were washed 
with 1 M HCl(aq) then NaHCO3(aq) and dried (MgSO4) then filtered and the solvent removed under 
reduced pressure. From the crude yield of 336 mg of brown solid a portion (100 mg, 0.21 mmol, 
1.00 eq.) was weighed by difference onto a spatula and sonicated into a microwave tube (10 mL) 
containing dry THF (5.0 mL). The tube was filled with argon and sealed then heated in a 
microwave to 100 ˚C for 30 min then cooled and transferred to a round bottomed flask in dry 
CHCl3, then the solvent removed under reduced pressure. The residue was dissolved in dry Et2O 
then precipitated with 2 M ethereal HCl (1.00 mL, 2.00 mmol, 9.35 eq.). The solvent was removed 
under reduced pressure. The solid was dissolved in DCM, dried (MgSO4) and filtered, then the 
solvent removed under reduced pressure. The salt 302 was isolated as a solid (91 mg, 86%). 1H 
NMR [500 MHz, CD3CN/CF3CO2D (10:1)] δ 9.82 (1H, d, J = 2.3 Hz, H1), 9.27 (1H, d, J = 9.1 Hz, H10), 
8.95 (1H, dd, J = 9.1, 2.2 Hz, H9), 8.84 (1H, dd, J = 9.5, 2.2 Hz, H3), 8.66 (1H, d, J = 9.5 Hz, H4), 8.29 
(1H, d, J = 2.2 Hz, H7), 7.86 (1H, t, J = 7.5 Hz, H4’’), 7.79 (2H, t, J = 7.5 Hz, H3’’, H5’’), 7.63 (2H, d, J = 
7.3 Hz, H2’’, H6’’), 4.79 - 4.66 (2H, m, CH2-1’), 1.99 - 1.88 (2H, m, CH2-2’), 1.30 - 1.03 (6H, m, CH2-
3’, CH2-4’, CH2-5’), 0.75 (3H, t, J = 7.2 Hz, CH2-6’). 
13C NMR [126 MHz, CD3CN/CF3CO2D (10:1)] δ 
167.94 (C), 148.39 (C), 148.15 (C), 138.14 (C), 137.68 (C), 132.56 (CH), 131.23 (CH), 129.83 (CH), 
129.38 (C), 128.56 (CH), 128.09 (CH), 127.42 (CH), 126.64 (C), 126.35 (C), 126.25 (CH), 123.34 (CH), 
121.76 (CH), 56.45 (CH2), 30.31 (CH2), 28.88 (CH2), 25.61 (CH2), 21.89 (CH2), 12.99 (CH3). 
Max(ATR)cm
-1: 3099 (CAr-H), 2957 (C-H), 2927 (C-H), 2857 (C-H), 1601 (C=N), 1578 (CAr=CAr), 1526 
(NO2), 1494 (NO2), 1342 (NO2), 1326 (NO2). MS (NSI
+): 430 [M+ (phenanthridinium cation), 100%]. 
HRMS: 430.1752. C25H24N3O4
+ requires 430.1761. MP: 260 - 263 ˚C. 
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2-Methoxy-3,8-dinitro-5-(hex-1’-yl)-6-phenylphenanthridinium chloride 303 
 
Benzophenone 334 (501 mg, 1.26 mmol, 1.00 eq.) and dry hexylamine (1.17 mL, 8.86 mmol, 7.03 
eq.) were combined stirring under argon at 0 ˚C in dry PhMe (5.0 mL) then a 1 M solution of 
titanium tetrachloride in dry PhMe (1.90 mL, 1.90 mmol, 1.51 eq.) was added over 5 min. The 
reaction was allowed to warm to RT and allowed to stir for 40 h. The mixture was quenched into 
H2O, filtered through celite with DCM and partitioned between DCM and 0.5 M HCl(aq), then the 
aqueous layer was re-extracted (DCM x 2). The combined organics were dried (MgSO4) then 
filtered and the solvent removed under reduced pressure. From the crude yield of 572 mg of 
brown solid a portion (100 mg, 0.21 mmol, 1.00 eq.) was was weighed by difference onto a 
spatula and sonicated into a microwave tube (10 mL) containing dry THF (5.0 mL). The tube was 
filled with argon and sealed then heated in a microwave to 100 ˚C for 2 h. The solvent was 
removed under reduced pressure, then the residue dissolved in dry Et2O and precipitated with 2 
M ethereal HCl (1.00 mL, 2.00 mmol, 9.52 eq.). The precipitate was allowed to settle, then the 
bulk of the solvent syringed out and the process repeated. After the remaining solvent was 
removed under reduced pressure the phenanthridinium salt 303 was isolated as a powder (80 mg, 
74%). 1H NMR (400 MHz, 0.75 mL CD3CN + 0.05 mL CF3CO2D) δ 9.31 (1H, d, J = 9.2 Hz, H10), 9.02 
(1H, dd, J = 9.2, 2.2 Hz, H9), 8.90 (1H, s, H4), 8.64 (1H, s, H1), 8.36 (1H, d, J = 2.2 Hz, H7), 7.94 (1H, 
t, J = 7.5 Hz, H4’’), 7.87 (2H, t, J = 7.3 Hz, H3’’, H5’’), 7.71 (2H, d, J = 7.1 Hz, H2’’, H6’’), 4.79 - 4.71 
(2H, m, CH2-1’), 4.36 (3H, s, OCH3), 2.06 - 1.91 (2H, m, CH2-2’), 1.39 - 1.10 (6H, m, CH2-3’, CH2-4’, 
CH2-5’), 0.84 (3H, t, J = 7.1 Hz, CH2-6’). 
13C NMR (126 MHz, 0.75 mL DMSO + 0.05 mL CF3CO2D) δ 
163.79 (C), 151.64 (C), 147.82 (C), 143.26 (C), 136.31 (C), 131.79 (CH), 129.70 (C), 129.63 (CH), 
129.28 (CH), 129.06 (C), 128.44 (C), 128.36 (CH), 127.13 (CH), 127.06 (CH), 126.81 (C), 117.75 (CH), 
109.21 (CH), 58.14 (CH3), 55.44 (CH2), 29.90 (CH2), 28.53 (CH2), 25.19 (CH2), 21.47 (CH2), 13.16 
(CH3). Max(ATR)cm
-1: 3018 (CAr-H), 2954 (C-H), 2922 (C-H), 2917 (C-H), 2853 (C-H), 1621 (C=N), 
1595 (CAr=CAr), 1537 (NO2), 1521 (CAr=CAr), 1501 (CAr=CAr), 1350 (NO2). MS (ESI
+): 460 [M+ 
(phenanthridinium cation), 100%]. HRMS: 460.1846. C26H26N3O5
+ requires 460.1867. MP: 195 - 198 
˚C. 
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2- Methoxy-5-(hex-1’-yl)-6-phenyl-8-nitrophenanthridinium trifluoroacetate 304 
 
Benzophenone 333 (102 mg, 0.29 mmol, 1.00 eq.) and dry hexylamine (0.27 mL, 2.0 mmol, 7.1 
eq.) were combined stirring under argon at 0 ˚C in dry PhMe (1.0 mL) then titanium tetrachloride 
(0.42 mL, 0.4 mmol, 1.5 eq.) was added. The reaction was allowed to warm to RT and allowed to 
stir for 20 h. The mixture was quenched into H2O and extracted into diethyl ether (x 2). The 
combined organics were dried (MgSO4), then filtered and the solvent removed under reduced 
pressure. The crude yield of 114 mg was transferred in dry CHCl3 into a kugelrohr bulb and the 
chloroform distilled out, then the oil heated at 100 ˚C for 2 h 45 min, then at 125 ˚C for 3 h. TFA 
was added then evaporated off under reduced pressure. The mixture was partitioned from a 
water/TFA mixture with DCM (x 3), and CHCl3 (x 3). The organics were combined and the solvent 
removed under reduced pressure. Following column chromatography [SiO2, loaded and washed in 
DCM then eluted with DCM/MeOH/NEt3 (97:2:1)]. The solvent was removed under reduced 
pressure and replaced with CHCl3 then the compound dried (MgSO4). The mixture was filtered, 
then TFA was added then and the solvent removed under reduced pressure. The 
phenanthridinium trifluoroacetate 304 was isolated as brown oil (70 mg, 47%). 1H NMR (500 MHz, 
CDCl3) δ 9.08 (1H, d, J = 9.1 Hz, H10), 8.77 (1H, dd, J = 9.1, 2.1 Hz, H9), 8.39 (1H, d, J = 9.6 Hz, H4), 
8.34 (1H, d, J = 2.2 Hz, H7), 8.27 (1H, d, J = 2.5 Hz, H1), 7.86 - 7.82 (1H, m, H4’’), 7.78 (2H, t, J = 7.8 
Hz, H3’’, H5’’), 7.74 (1H, dd, J = 9.6, 2.6 Hz, H3), 7.65 (2H, d, J = 7.7 Hz, H2’’, H6’’), 4.94 - 4.79 (2H, 
m, CH2-1’), 4.10 (3H, s, OCH3), 1.93 (2H, quin, J = 7.9 Hz, CH2-2’), 1.34 - 1.08 (6H, m, CH2-3’, CH2-4’, 
CH2-5’), 0.81 (3H, t, J = 7.2 Hz, CH2-6’). 
13C NMR (126 MHz, CDCl3) δ 161.75 (C), 160.61 (C), 147.64 
(C), 137.85 (C), 132.43 (CH), 130.11 (C), 129.73 (C), 129.57 (CH), 128.84 (CH), 128.05 (C), 127.74 
(CH), 126.39 (CH), 125.70 (C), 124.60 (CH), 122.64 (CH), 106.64 (CH), 56.82 (CH3), 56.09 (CH2), 
30.76 (CH2), 30.05 (CH2), 26.19 (CH2), 22.26 (CH2), 13.74 (CH3). Max(ATR)cm
-1: 2958 (C-H), 2920 (C-
H), 2850 (C-H), 1777 (TFA), 1731 (TFA), 1614 (C=N), 1541 (CAr=CAr), 1592 (CAr=CAr), 1348 (NO2). MS 
(NSI+): 415 [M+ (phenanthridinium cation), 100%]. HRMS: 415.2005, C26H27N2O3
+ requires 
415.2016.  
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3,8-Dinitro-5-(hex-1’-yl)-6-phenylphenanthridinium chloride 305 
 
Benzophenone 328 (390 mg, 1.06 mmol, 1.00 eq.) and dry hexylamine (1.00 mL, 7.57 mmol, 7.14 
eq.) were combined stirring under argon at 0 ˚C in dry PhMe (5.5 mL) then a 1 M solution of 
titanium tetrachloride in dry PhMe (1.60 mL, 1.60 mmol, 1.51 eq.) was added over 5 min. The 
reaction was allowed to warm to RT and allowed to stir for 48 h. The mixture was quenched into 
H2O, and the resulting precipitate washed with Et2O, CHCl3, DCM, MeCN and MeOH and the 
organics combined and washed with brine and extracted DCM (x 1), Et2O (x 1), and CHCl3 (x 4). The 
combined organics were dried (MgSO4) then filtered and the solvent removed under reduced 
pressure. From the crude yield of 504 mg of brown solid a portion (100 mg, 0.22 mmol, 1.00 eq.) 
was transferred to a round bottom flask with DCM and the solvent removed under reduced 
pressure. The residue was dissolved in dry Et2O then precipitated with 2 M ethereal HCl (1.00 mL, 
2.00 mmol, 9.09 eq.). The precipitate was allowed to settle, then the bulk of the solvent syringed 
out and the remainder removed under reduced pressure, isolating the phenanthridinium chloride 
305 as a powder (95 mg, 97%). 1H NMR (500 MHz, CD3OD) δ 9.58 (1H, d, J = 9.2 Hz, H1), 9.52 (1H, 
d, J = 9.1 Hz, H10), 9.44 (1H, d, J = 1.9 Hz, H4), 9.15 (1H, dd, J = 9.1, 2.3 Hz, H9), 9.01 (1H, dd, J = 
9.1, 1.9 Hz, H2), 8.49 (1H, d, J = 2.2 Hz, H7), 8.01 (1H, t, J = 7.5 Hz, H4’’), 7.96 (2H, t, J = 7.5 Hz, 
H3’’, H5’’), 7.86 (2H, d, J = 7.8 Hz, H2’’, H6’’), 5.10 - 4.99 (2H, m, CH2-1’), 2.20 - 2.08 (2H, m, CH2-
2’), 1.49 - 1.40 (2H, m, CH2-3’), 1.36 - 1.23 (4H, m, CH2-4’, CH2-5’), 0.92 (3H, t, J = 7.1 Hz, CH2-6’). 
13C NMR (126 MHz, CD3OD) δ 170.05 (C), 152.37 (C), 150.81 (C), 139.67 (C), 137.15 (C), 134.72 
(CH), 133.09 (CH), 132.01 (C), 131.97 (CH), 131.93 (C), 130.41 (CH), 130.32 (CH), 130.17 (CH), 
129.44 (C), 128.82 (CH), 126.82 (CH), 118.76 (CH), 58.12 (CH2), 32.68 (CH2), 31.39 (CH2), 27.95 
(CH2), 24.16 (CH2), 15.01 (CH3). Max(ATR)cm
-1: 2955 (C-H), 2928 (C-H), 2859 (C-H), 1618 (C=N), 
1591 (CAr=CAr), 1537 (CAr=CAr), 1518 (NO2), 1343 (NO2). MS (NSI
+): 430 [M+ (phenanthridinium 
cation), 100%]. HRMS: 430.1754. C25H24N3O4 requires 430.1761. MP: 189 ˚C. 
 
3,8-Dinitro-5-(hex-1’-yl)-6-methylene-5-hydrophenanthridine 369 
 
Benzophenone 324 (426 mg, 1.40 mmol, 1.00 eq.) and dry hexylamine (1.45 mL, 11.0 mmol, 7.58 
eq.) were combined stirring under argon at 0 ˚C in dry PhMe (5.0 mL) then a 1 M solution of 
Chapter 13: Experimental 228 
 
titanium tetrachloride in dry PhMe (2.70 mL, 2.70 mmol, 1.93 eq.) was added over 5 min. The 
reaction was allowed to warm to RT and allowed to stir for 19 h. The mixture was quenched into 
H2O, then filtered through celite with DCM and partitioned between DCM and 1 M HCl(aq), then 
the aqueous layer was re-extracted (DCM x 2). The combined organics were washed with 1 M 
HCl(aq) then NaHCO3(aq) and dried (MgSO4) then filtered and the solvent removed under reduced 
pressure. The enamine 369 was isolated as a purple solid (523 mg, quant.). 1H NMR (400 MHz, 
CDCl3) δ 8.62 (1H, d, J = 2.3 Hz, H7), 8.22 (1H, dd, J = 8.9, 2.3 Hz, H9), 8.03 (1H, d, J = 8.9 Hz, H10), 
7.96 (1H, d, J = 8.7 Hz, H1), 7.74 (1H, dd, J = 8.7, 2.2 Hz, H2), 7.69 (1H, d, J = 2.1 Hz, H4), 4.96 (1H, 
d, J = 3.1 Hz, NC=CHtrans), 4.39 (1H, d, J = 3.2 Hz, NC=CHcis), 3.83 - 3.69 (2H, m, CH2-1’), 1.83 (2H, 
quint., J = 7.8 Hz, CH2-2’), 1.56 - 1.47 (2H, m, CH2-3’), 1.47 - 1.36 (4H, m, CH2-4’, CH2-5’), 0.95 (3H, 
t, J = 7.1 Hz, CH2-6’). 
13C NMR (101 MHz, CDCl3) δ 149.91 (C), 148.41 (C), 142.18 (C), 141.83 (C), 
133.65 (C), 132.01 (C), 125.05 (CH), 124.37 (CH), 123.72 (C), 123.54 (CH), 120.68 (CH), 113.94 (CH), 
108.01 (CH), 86.80 (CH2), 48.23 (CH2), 31.50 (CH2), 26.69 (CH2), 24.43 (CH2), 22.75 (CH2), 14.11 
(CH3). Max(ATR)cm
-1: 2957 (C-H), 2926 (C-H), 2856 (C-H), 1603 (CAr=CAr), 1578 (CAr=CAr), 1520 
(NO2), 1339 (NO2). MS (APCI
+): 368 [(M+H)+, 100). HRMS: 368.1603. C20H22N3O4
+ requires 
368.1605. MP: 169 - 171 ˚C. 
 
5-(Hex-1’-yl)-6-phenylphenanthridinium chloride 307 
 
Benzophenone 327 (594 mg, 2.15 mmol, 1.00 eq.) and dry hexylamine (2.00 mL, 15.1 mmol, 7.04 
eq.) were combined stirring under argon at 0 ˚C in dry PhMe (5.0 mL) then titanium tetrachloride 
(0.35 mL, 3.2 mmol, 1.5 eq.) was added over 5 min. The reaction was allowed to warm to RT and 
allowed to stir for 72 h. The mixture was quenched into brine, and extracted with diethyl ether (x 
1), EtOAc (x 1) and DCM (x 5). The combined organics were dried (MgSO4) then filtered and the 
solvent removed under reduced pressure. From the crude yield of 537 mg of brown oil a portion 
(100 mg, 0.28 mmol, 1.00 eq.) was weighed by difference onto a spatula and sonicated into a 
microwave tube (10 mL) containing dry MeCN (5.0 mL). The tube was filled with argon and sealed 
then heated in a microwave to 110 ˚C for 90 min. After cooling the material was transferred to a 
round bottom flask with DCM and the solvent removed under reduced pressure. The residue was 
dissolved in dry Et2O then precipitated with 2 M ethereal HCl (1.00 mL, 2.00 mmol, 7.14 eq.) The 
precipitate was allowed to settle, then the bulk of the solvent syringed out and the remainder 
removed under reduced pressure, isolating the phenanthridinium salt 307 as a white solid (102 
mg, 68%). 1H NMR (500 MHz, 0.75 mL CD3CN + 0.05 mL CF3CO2D) δ 9.01 (1H, d, J = 7.6 Hz, H1), 
8.94 (1H, d, J = 8.1 Hz, H10), 8.40 (1H, d, J = 8.0 Hz, H4), 8.21 (1H, apparent t, J = 7.3 Hz, H9), 8.12 - 
8.00 (2H, m, H2, H3), 7.80 - 7.67 (4H, m, H8, H2’’, H3’’, H5’’), 7.61 - 7.50 (3H, m, H7, H2’’, H6’’), 
4.74 - 4.55 (2H, m, CH2-1’), 2.00 - 1.85 (2H, m, CH2-2’), 1.30 - 1.18 (2H, m, CH2-3’), 1.16 - 1.00 (m, 
CH2-4’, CH2-5’), 0.74 (3H, t, J = 7.0 Hz, CH2-6’). 
13C NMR (101 MHz, 0.75 mL CD3CN + 0.05 mL 
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CF3CO2D) δ 164.01 (C), 137.53 (CH), 135.04 (C), 133.91 (C), 132.91 (CH), 132.38 (CH), 131.46 (CH), 
130.79 (C), 130.48 (CH), 130.13 (CH), 129.43 (CH), 128.11 (CH), 126.37 (C), 125.74 (C), 124.68 (CH), 
122.83 (CH), 120.39 (CH), 54.86 (CH2), 30.31 (CH2), 28.97 (CH2), 25.64 (CH2), 21.83 (CH2), 12.85 
(CH3). Max(ATR)cm
-1: 3051 (CAr-H), 2953 (C-H), 2926 (C-H), 2861 (C-H), 1609 (C=N), 1584 (CAr=CAr), 
1574 (CAr=CAr). MS (NSI
+): 340 [M+ (phenanthridinium cation], 100%], 256 (M+ – C6H12, 52). HRMS: 
340.2058. C25H26N
+ requires 340.2060. MP: 194 - 195 ˚C. 
 
4- Methyl-5-(hex-1’-yl)-6-phenyl-8-nitrophenanthridinium chloride 308 
 
Benzophenone 332 (526 mg, 1.57 mmol, 1.00 eq.) and dry hexylamine (1.45 mL, 11.0 mmol, 7.01 
eq.) were combined stirring under argon at 0 ˚C in dry PhMe (5.0 mL) then titanium tetrachloride 
(0.26 mL, 2.4 mmol, 1.5 eq.) was added. The reaction was allowed to warm to RT and allowed to 
stir for 72 h. The mixture was quenched into brine then filtered and extracted into diethyl ether (x 
1) and DCM (x 2). The combined organics were dried (MgSO4), then filtered and the solvent 
removed under reduced pressure. From the crude yield of 695 mg of extremely viscous brown oil, 
a portion (100 mg, 0.24 mmol, 1.00 eq.) was weighed by difference onto a spatula and sonicated 
into a microwave tube (10 mL) containing dry MeCN (5.0 mL). The tube was filled with argon and 
sealed then heated in a microwave to 110 ˚C for 10 h. After cooling the material was transferred 
to a round bottom flask with DCM and the solvent removed under reduced pressure. The residue 
was dissolved in dry Et2O then precipitated with 2 M ethereal HCl (1.00 mL, 2.00 mmol, 8.33 eq.). 
The precipitate was allowed to settle, then the bulk of the solvent syringed out and the remainder 
removed under reduced pressure, then the residue loaded onto a Strata WCX column in MeOH, 
then the column washed with additional MeOH before elution with NaOAc/MeOH (15 mg/mL). 
The solvent was removed under reduced pressure and replaced with CHCl3 then the compound 
dried (MgSO4) and the solution filtered then the solvent removed under reduced pressure. The 
phenanthridinium chloride 308 was isolated as brown oil (77 mg, 79%). 1H NMR (500 MHz, 
CD3OD) δ 9.31 (1H, d, J = 9.2 Hz, H10), 9.10 (1H, dd, J = 7.6, 1.9 Hz, H1), 9.00 (1H, dd, J = 9.2, 2.3 
Hz, H9), 8.48 (1H, d, J = 2.3 Hz, H7), 8.14 - 8.06 (2H, m, H2, H3), 8.00 - 7.94 (1H, m, H4’’), 7.93 - 
7.85 (4H, m, H2’’, H3’’, H5’’, H6’’), 5.05 (2H, t, J = 6.9 Hz, CH2-1’), 3.07 (3H, s, ArCH3), 1.54 (2H, 
quintet, J = 7.7 Hz, CH2-2’), 1.08 - 1.00 (2H, m, CH2-3’), 0.99 - 0.84 (4H, m, CH2-4’, CH2-5’), 0.71 (3H, 
t, J = 7.2 Hz, CH2-6’). 
13C NMR (126 MHz, CD3OD) δ 169.05 (C), 148.88 (C), 140.64 (C), 139.63 (CH), 
137.15 (C), 134.20 (CH), 133.25 (C), 132.45 (C), 132.11 (CH), 131.72 (CH), 131.43 (CH), 131.07 (CH), 
129.26 (CH), 128.59 (C), 126.88 (CH), 126.82 (C), 125.11 (CH), 61.15 (CH2), 31.75 (CH2), 31.02 
(CH2), 26.66 (CH2), 24.53 (CH3), 23.02 (CH2), 14.00 (CH3). Max(ATR)cm
-1 (TFA salt): 2961 (C-H), 2930 
(C-H), 2862 (C-H), 1778 (TFA), 1732 (TFA), 1622 (C=N), 1586 (CAr=CAr), 1539 (CAr=CAr), 1348 (NO2). 
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MS (ESI+): 399 [M+ (phenanthridinium cation), 100%]. HRMS: 399.2050. C26H27N2O2
+ requires 
399.2067. 
 
3-tert-Butyl-5-(cyclohexylmethylamino)-6-phenyl-8-nitrophenanthridinium chloride 309 
 
 
Benzophenone 265 (360 mg, 0.95 mmol, 1.00 eq.) and cyclohexylmethylamine 336 (0.90 mL, 6.9 
mmol, 7.3 eq.) were combined stirring under argon at 0 ˚C in dry PhMe (5.0 mL) then a 1 M 
solution of titanium tetrachloride in dry PhMe (1.50 mL, 1.50 mmol, 1.50 eq.) was added over 5 
min. The reaction was allowed to warm to RT and allowed to stir for 20 h. The mixture was 
quenched into H2O, then filtered through celite with DCM and partitioned between DCM and 0.5 
M HCl(aq), then the aqueous layer was re-extracted (DCM x 2). The combined organics were 
washed with 1 M HCl(aq) then NaHCO3(aq) and dried (MgSO4) then filtered and the solvent removed 
under reduced pressure. From the crude yield of 445 mg of brown solid four portions (total of 80 
mg, 0.16 mmol, 1.00 eq.) were weighed by difference onto a spatula and sonicated into 
microwave tubes (10 mL) containing dry MeCN (1.0 mL). The tubes were filled with argon and 
sealed then heated in a microwave to 110 ˚C for 90 min then cooled and the solvent removed 
under reduced pressure. Following column chromatography of the combined residues [SiO2, 
loaded in and washed with DCM and eluted with DCM/NEt3 (200:1)] the combined organics were 
concentrated under reduced pressure then washed (1 M HCl(aq) x 2), and dried (MgSO4). After 
filtration 2 M ethereal HCl (1.00 mL, 2.00 mmol, 12.5 eq.) was added to the filtrate and the 
solvent removed under reduced pressure, to give phenanthridinium salt 309 as a brown solid (63 
mg, 75%). Rf = 0.21 in DCM/NEt3 (100:1). 
1H NMR (400 MHz, CD3OD, 50˚C) δ 9.32 (1H, d, J = 9.2 Hz, 
H10), 9.20 (1H, d, J = 8.8 Hz, H1), 8.99 (1H, dd, J = 9.2, 2.2 Hz, H9), 8.49 - 8.43 (2H, m, H4, H7), 8.37 
(1H, dd, J = 8.8, 1.4 Hz, H2), 7.94 (1H, t, J = 7.4 Hz, H4’’), 7.88 (2H, t, J = 7.3 Hz, H3’’, H5’’), 7.79 (2H, 
d, J = 7.0 Hz, H2’’, H6’’), 5.00 (2H, s, br, CH2-N), 2.08 (1H, m, CH2-1’), 1.73 - 1.49 (2H, m, CH2-2’A), 
1.59 [9H, s, C(CH3)], 1.40 - 0.82 (8H, m, CH2-2’B, CH2-4’, CH2-5’). 
13C NMR (126 MHz, DMSO, 70 ˚C) δ 
164.57 (C), 157.00 (C), 146.73 (C), 137.58 (C), 135.08 (C), 131.65 (CH), 129.94 (C), 129.49 (CH), 
129.31 (CH), 128.89 (CH), 128.82 (CH), 127.30 (CH), 125.55 (C), 125.31 (CH), 125.03 (CH), 123.00 
(C), 117.19 (CH), 59.46 (CH2), 38.29 (CH), 35.65 (C), 30.32 (CH3), 29.88 (CH2), 24.82 (CH2). 
Max(ATR)cm
-1: 2926 (C-H), 2853 (C-H), 1621 (C=N), 1587 (CAr=CAr), 1540 (CAr=CAr), 1343 (NO2). MS 
(ESI+): 453 [M+ (phenanthridinium cation), 100]. HRMS: 453.2523. C30H33N2O2
+ requires 453.2537.  
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5-(6’-Azidohex-1’-yl)-6-phenylphenanthridinium chloride 310 
 
Benzophenone 327 (414 mg, 1.49 mmol, 1.00 eq.) and 6-azidohex-1-ylamine (1.00 g, 7.86 mmol, 
5.28 eq.) were combined stirring under argon at 0 ˚C in dry PhMe (7.0 mL) then 1 M titanium 
tetrachloride in dry PhMe (1.70 mL, 1.70 mmol, 1.14 eq.) was added over 5 min. After 15 h a 
sample (0.1 mL) was quenched into H2O, partitioned between DCM and water and the organic 
separated and the solvent removed under reduced pressure. This process was repeated at 21 h, 
at which point the starting material was shown to be consumed by proton NMR. The mixture was 
quenched into water then filtered through celite with DCM, then partitioned between DCM and 1 
M HCl(aq). The aqueous was extracted with DCM (x 2) then the collected organics washed with 1 M 
HCl(aq), followed by NaHCO3(aq). The organic layers were dried (MgSO4), then filtered and the 
solvent removed under reduced pressure. From the crude yield of 571 mg of brown oil a portion 
(100 mg, 0.25 mmol, 1.00 eq.) was weighed by difference onto a spatula and sonicated into a 
microwave tube (10 mL) containing dry MeCN (5.0 mL). The tube was filled with argon and sealed 
then heated in a microwave to 110 ˚C for 90 min. After cooling the residue was dissolved in MeOH 
and loaded onto a Strata SCX ion exchange column and washed (MeOH) then eluted (15 mg/mL 
NaOAc in MeOH). The solution was partitioned between CHCl3 and 1 M HCl(aq), then the organic 
layer washed (1 M HCl(aq) x 2). The organic layer was dried (MgSO4), filtered and ethereal HCl (1.00 
mL, 2.00 mmol, 7.75 eq.) was added, then the solvent removed under reduced pressure. The 
phenanthridinium chloride 310 was isolated as a brown oil (79 mg, 78%). 1H NMR (400 MHz, 0.75 
mL CDCl3 + 0.05 mL CF3CO2D) δ 8.99 (1H, dd, J = 8.1, 1.7 Hz, H1), 8.93 (1H, d, J = 8.5 Hz, H10), 8.40 
(1H, d, J = 8.3 Hz, H4), 8.30 (1H, ddd, J = 8.5, 7.2, 1.5 Hz, H9), 8.20 - 8.11 (2H, m, H2, H3), 7.81 - 
7.67 (4H, m, H8, H3’’, H4’’, H5’’), 7.68 (1H, d, J = 7.7 Hz, H7), 7.60 - 7.53 (2H, m, H2’’, H6’’), 4.89 - 
4.79 (2H, m, CH2-1’), 3.26 (2H, t, J = 6.7 Hz, CH2-6’), 2.01 (2H, s, br, CH2-2’), 1.58 - 1.49 (2H, m, CH2-
3’), 1.42 - 1.23 (4H, m, CH2-4’, CH2-5’). 
13C NMR (101 MHz, 0.75 mL CDCl3 + 0.05 mL CF3CO2D) δ 
163.82 (C), 138.43 (CH), 135.27 (C), 133.35 (C), 133.21 (CH), 133.09 (CH), 132.37 (CH), 131.21 (CH), 
130.71 (CH), 130.05 (CH), 127.62 (CH), 126.38 (C), 125.10 (C), 124.83 (CH), 122.75 (CH), 119.35 
(CH), 54.47 (CH2), 51.02 (CH2), 29.75 (CH2), 28.06 (CH2), 25.84 (CH2), 25.62 (CH2). Max(ATR)cm
-1 (as 
TFA salt): 2928 (C-H), 2856 (C-H), 1779 (TFA), 1738 (TFA), 1622 (C=N), 1588 (CAr=CAr), 
1538(CAr=CAr). MS (NSI
+): 381 [M+ (phenanthridinium cation), 38%], 256 (M+ – C6H12, 100). HRMS: 
381.2073. C25H25N4
+ requires 381.2074.  
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3-Bromo-5-(hex-1’-yl)-6-phenyl-8-aminophenanthridinium chloride 373 
 
Nitrophenanthridinium 300 (250 mg, 0.50 mmol, 1.00 eq.) was dissolved in a 1:1 mixture of AcOH 
and EtOH (15.0 mL) then iron powder (346 mg, 6.20 mmol, 10.7 eq.) added and the mixture 
heated stirring to 40 ˚C for 90 min. The mixture was then poured into 1 M HCl(aq), and extracted 
with DCM (x 2). The combined organics were then washed with 1 M HCl(aq) and NaHCO3(aq) (x 2) 
sequentially, before drying (MgSO4), filtering and removing the solvent under reduced pressure. 
The amine 373 was isolated as a red powder (200 mg, 85%). 1H NMR (500 MHz, CDCl3) δ 8.57 (1H, 
d, J = 8.9 Hz, H1), 8.48 (1H, d, J = 8.6 Hz, H10), 8.24 (1H, s, H4), 7.98 (1H, d, J = 8.7 Hz, H2), 7.83 - 
7.68 (4H, m, H9, H3’’, H4’’, H5’’), 7.49 (2H, d, J = 6.8 Hz, H2’’, H6’’), 6.52 (1H, s, H7), 4.95 (2H, s, br, 
NH2), 4.63 (2H, t, J = 8.4 Hz, CH2-1’), 1.95 - 1.83 (2H, m, CH2-2’), 1.36 - 1.11 (6H, m, CH2-3’, CH2-4’, 
CH2-5’), 0.84 (3H, t, J = 7.2 Hz, CH2-6’). 
13C NMR (126 MHz, CDCl3) δ 162.20 (C), 151.19 (C), 133.51 
(CH), 132.28 (C), 131.91 (CH), 131.01 (C), 130.11 (CH), 129.92 (CH), 128.22 (CH), 127.55 (C), 126.08 
(C), 125.78 (C), 125.45 (CH), 123.85 (C), 123.55 (CH), 122.14 (CH), 111.20 (CH), 54.75 (CH2), 30.74 
(CH2), 29.67 (CH2), 26.26 (CH2), 22.34 (CH2), 13.91 (CH3). Max(ATR)cm
-1: 3277 (N-H), 3133 (N-H), 
2952 (C-H), 2929 (C-H), 2859 (C-H), 1609 (C=N), 1579 (CAr=CAr). MS (ESI
+): 435 [81BrM+ 
(phenanthridinium cation), 100%], 433 [79BrM+ (phenanthridinium cation], 100). HRMS: 435.1242, 
433.1255. C25H26
81BrN2 requires 435.1253, C25H26
79BrN2 requires 433.1274. MP: 153 - 157 ˚C. 
 
3,8-Diamino-5-(hex-1’-yl)-6-methyl-5,6-dihydrophenanthridine 375 
 
Enamine 369 (100 mg, 0.27 mmol, 1.00 eq.) was dissolved in a 1:1 mixture of AcOH and EtOH (4.0 
mL) then iron powder (151 mg, 2.71 mmol, 10.0 eq.) added and the mixture heated stirring to 60 
˚C for 1 h. The mixture was then poured into 1 M HCl(aq), then the acidity reduced with NaHCO3(aq). 
Excess NaBH4 was added and the aqueous extracted with CHCl3 which was then dried (MgSO4) 
and filtered, then the solvent removed under reduced pressure. The phenanthridine 375 was 
isolated as a solid (15 mg, 18%). 1H NMR (500 MHz, CDCl3) δ 7.41 (1H, d, J = 8.2 Hz, H10), 7.40 (1H, 
d, J = 8.1 Hz, H1), 6.62 (1H, dd, J = 8.3, 2.4 Hz, H9), 6.39 (1H, d, J = 2.4 Hz, H7), 6.15 (1H, dd, J = 8.1, 
2.2 Hz, H2), 6.03 (1H, d, J = 2.1 Hz, H4), 4.26 (1H, q, J = 6.5 Hz, H6), 3.60 (4H, s, br, NH2), 3.37 (1H, 
dt, J = 13.9, 7.0 Hz, CH2-1’A), 3.04 (1H, dt, J = 13.8, 7.7 Hz, CH2-1’B), 1.71 - 1.59 (2H, m, CH2-2’), 1.41 
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- 1.19 (6H, m, CH2-3’, CH2-4’, CH2-5’), 1.10 (3H, d, J = 6.5 Hz, C-6CH3), 0.88 (3H, t, J = 7.0 Hz, CH2-6’). 
13C NMR (101 MHz, CDCl3) δ 146.27 (C), 144.38 (C), 144.16 (C), 137.87 (C), 123.44 (CH), 122.89 
(CH), 122.60 (C), 114.93 (C), 114.74 (CH), 111.81 (CH), 104.81 (CH), 100.11 (CH), 58.31 (CH), 49.59 
(CH2), 31.86 (CH2), 28.00 (CH2), 27.13 (CH2), 22.80 (CH2), 18.57 (CH3), 14.21 (CH3). Max(ATR)cm
-1 
(oxidised form): 3453 (N-H), 3351 (N-H), 3215 (N-H), 2956 (C-H), 2922 (C-H), 2855 (C-H), 1610 
(C=N), 1495 (CAr=CAr). MS (ESI
+): 308 [M+ (phenanthridinium cation), 100%, 294 [(M+H)+ – CH4, 28]. 
HRMS: 308.2110. C20H26N3 requires 308.2121. 
 
3,8-Diamino(2,2-dimethylpropyl)-6-phenylphenanthridine 405 
 
3,8-Diamino-6-phenylphenanthridine 133 (650 mg, 2.28 mmol, 1.00 eq.) and NaBH(OAc)3 (1.45 g, 
6.83 mmol, 3.00 eq.) were mixed in TFA (0.81 mL, 11 mmol, 4.7 eq.). The mixture was cooled to 
−15 ˚C under argon with an IPA/CO2(s) bath. DCM (6.5 mL) was added and the mixture stirred. 2,2-
dimethylpropanal (0.54 mL, 5.0 mmol, 2.2 eq.) was then added by syringe and the mixture 
allowed to stir for 2 h, then the mixture was partitioned between DCM and H2O, then the aqueous 
extracted with DCM. The combined organic layers were washed with brine, then extracted with 
DCM and the organics combined and solvent removed under reduced pressure. The material was 
dissolved in Et2O and precipitated with excess ethereal HCl (2 M), then allowed to settle 
overnight. The solid was filtered, washed with Et2O and dissolved in DCM then washed with 
NaHCO3(aq). The aqueous was re-extracted with DCM, then the combined organics dried (MgSO4), 
filtered and the solvent removed under reduced pressure to give phenanthridine 405 as a foam 
(1.08 g, 99%). 1H NMR (CDCl3, 500 MHz): 8.28 (1H, d, J = 9.0 Hz, H10), 8.19 (1H, d, J = 8.9 Hz, H1), 
7.68 – 7.63 (2H, m, H2’’, H6’’), 7.53 – 7.43 (3H, m, H3’’, H4’’, H5’’), 7.26 (1H, d, J = 2.3 Hz, H4), 7.16 
(1H, dd, J = 8.9, 2.5 Hz, H9), 7.02 – 6.97 (2H, m, H7, H2), 3.91 (2H, s, br, 3-NHR, 8-NHR), 3.02 (2H, s, 
8-NHCH2), 2.87 (2H, s, 3-NHCH2), 1.00 [9H, s, 8-NHCH2C(CH3)3)], 0.96 [9H, s, 3-NHCH2C(CH3)3)]. 
13C 
NMR (126 MHz, CDCl3) δ 159.91 (C), 148.65 (C), 146.73 (C), 143.19 (C), 139.57 (C), 129.51 (CH), 
128.56 (CH), 128.25 (CH), 126.56 (C), 125.12 (C), 122.36 (CH), 121.94 (CH), 120.51 (CH), 117.04 
(CH), 116.17 (C), 107.43 (CH), 107.33 (CH), 55.88 (CH2), 55.84 (CH2), 32.04 (C), 31.97 (C), 27.58 
(CH3), 27.56 (CH3). IR (ATR cm
-1): 3424 (N-H), 3285 (N-H), 2953 (C-H), 2864 (C-H), 1620 (C=N), 1568 
(CAr=CAr), 1512 (CAr=CAr). MS (EI
+): 425 (M+., 72%), 368 [M+. –.C(CH3)3, 100]. HRMS: 425.2837. 
C29H35N3 requires 425.2831. 
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3,8-Diamino(2,2-dimethylpropyl)-5-N-ethyl-6-phenylphenanthridinium methanesulfonate 
406 
 
Phenanthridine 405 (100 mg, 0.23 mmol, 1.00 eq.) dissolved in Et2O (1.0 mL), then stirred under 
argon at RT. Ethyl triflate (34 μL, 0.26 mmol, 1.1 eq.) was added by syringe followed by a further 
0.2 mL Et2O. After 20 h stirring at RT the reaction was quenched into H2O, extracted with DCM (x 
2) then the organic layers dried (MgSO4), filtered and the solvent removed under reduced 
pressure. Column chromatography [SiO2, gradient from DCM/MeOH/NEt3 (200:2:1) to (100:2:1)] 
was followed by ion exchange to mesylate and salt 406 was isolated as purple foam (65 mg, 50%). 
1H NMR (CDCl3, 400 MHz): 8.24 (1H, d, J = 9.3 Hz, H1), 8.05 (1H, d, J = 9.3 Hz, H10), 7.89 (1H, s, 
H4), 7.78 - 7.64 (3H, m, H3’’, H4’’, H5’’), 7.48 (1H, dd, J = 9.2, 2.5 Hz, H9), 7.40 - 7.31 (3H, m, H2’’, 
H6’’, H2), 7.13 (1H, t, J = 6.0 Hz, NH), 5.97 (1H, d, J = 2.4 Hz, H7), 4.87-4.75 (3H, m, NCH2CH3, NH), 
3.12 (2H, d, J = 6.1 Hz NHCH2), 2.81 (3H, s, CH3SO3
−,) 2.65 (2H, d, J = 6.1 Hz, NHCH2), 1.52 (3H, t, J = 
7.1 Hz, NCH2CH3), 1.09 [9H, s, C(CH3)3], 0.86 [9H, s, C(CH3)3]. 
13C (101 MHz, CDCl3) δ 157.40 (C), 
152.30 (C), 147.64 (C), 134.79 (C), 132.08 (C), 131.07 (CH), 129.70 (CH), 128.99 (C), 128.15 (CH), 
128.03 (CH), 124.73 (C), 124.17 (CH), 122.06 (CH), 117.78 (CH), 117.43 (C), 105.05 (CH), 98.30 
(CH), 55.15 (CH2), 54.96 (CH2), 49.49 (CH2), 32.65 (C), 32.39 (C), 27.63 (CH3), 27.55 (CH3), 14.48 
(CH3). IR (ATR cm
-1): 3350 (N-H), 2957 (C-H), 2864 (C-H), 1622 (C=N), 1535 (CAr=CAr). MS (as CF3SO3
– 
salt, NSI+): 454 (M+, 100%). HRMS: 454.3211. C31H40N3 requires 454.3217. MS (as CF3SO3
– salt, NSI–
): 148 (CF3SO3
–, 100%). HRMS: 148.9530. CF3SO3 requires 148.9526. MP: Decomp > 180 ˚C. 
 
1-Bromohexyltrifluoromethanesulfonate 408 
 
1-Bromohexan-6-ol 407 (1.00 g, 5.52 mmol, 1.00 eq.) was added to a 0 ˚C stirring solution of dry 
DCM (5.0 mL), dry pyridine (0.4 mL, 6.1 mmol, 1.1 eq.) and triflic anhydride (1.02 mL, 6.08 mmol, 
1.10 eq.) under argon. After 90 min the mixture was quenched into DCM/H2O, then the organic 
washed (x 2) with H2O and dried (MgSO4) then filtered and the solvent removed under reduced 
pressure. The triflate 408 was isolated as a brown oil (1.318 g, 76%). δH (CDCl3, 400 MHz): 4.55 
(2H, t, J = 6.4 Hz, CH2OTf), 3.41 (2H, t, J = 6.6 Hz, CH2Br), 1.93 - 1.81 (4H, m, CH2CH2OTf, CH2CH2Br), 
1.57 - 1.42 (4H, m, CH2CH2CH2CH2). δc (CDCl3, 100 MHz): 119.02 (q, J = 319.7 Hz, CF3), 77.29 (CH2), 
33.66 (CH2), 32.69 (CH2), 29.47 (CH2), 27.76 (CH2), 24.71 (CH2). 
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3,8-Diaminoneopentyl-5(6’-bromohexyl)-6-phenylphenanthridinium triflate 409 
 
Triflate 408 (413 mg, 1.32 mmol, 1.02 eq) was dissolved in dry Et2O (6.6 mL) stirring under argon 
and cooled to −30 ˚C, then phenanthridine 405 (549 mg, 1.29 mmol, 1.00 eq.) was added and the 
mixture allowed to warm to RT then stirred for 17 h. The mixture was quenched into H2O and 
extracted into DCM, then dried (MgSO4), filtered and the solvent removed under reduced 
pressure. Column chromatography [SiO2, loaded in DCM, DCM/MeCN/NEt3, gradient from 
(100:7.5:1) to (100:15:2)]. The fractions were dried (MgSO4), filtered and the solvent was removed 
under reduced pressure. A mixture containing mostly the desired product 409 was obtained (450 
mg, 50%) and used directly without further purification. 
 
3,8-Diaminoneopentyl-5(6’-triphenylphosphoniohexyl)-6-phenylphenanthridinium mesylate 
403 
 
 
Bromophenanthridinium 409 (300 mg, 0.41 mmol, 1.00 eq.) was transferred to a flask in DCM 
which was then removed under reduced pressure. Triphenylphosphine was dried by azeotrope 
with PhMe, then added (1.07 g, 4.08 mmol, 10.0 eq.), followed by dry PhMe (6.0 mL). The 
reaction was heated to reflux for 15 h under argon stirring. The mixture was cooled to 70 ˚C then 
poured into PhMe. The residue was dissolved in CHCl3, then the solvent removed under reduced 
pressure. The material was converted to chloride with an anion exchange resin [loaded in MeOH, 
eluted with MeOH/H2O (1:1)]. Following column chromatography (SiO2, loaded with CHCl3, 
CHCl3/MeOH/NH3(aq) gradient from (100:15:1) to (100:25:2)] product fractions were combined, 
then the solvent removed under reduced pressure. The material was dissolved in CHCl3 and 
precipitated with Et2O and Pet. ether. The resulting mixture was purified using HPLC in 20 mg/10 
ml aliquots (9:1 H2O/MeCN). 
 
Column: C18 synergi Max-RP 10 μm 250 x 21.2 mm  RT: 48.5 min 
Time: (min) 0.1% TFA(aq): (%) MeCN: (%) Flow: (ml/min) 
0 90 10 15 
5 90 10 15 
60 20 80 15 
70 90 10 15 
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The clean fractions from the aliquots were combined and the solvent removed under reduced 
pressure. The counter ion was then exchanged (IRA 401 resin in mesylate form, loaded and eluted 
in 1:1 MeOH/H2O) to the mesylate form. The double salt 403 was isolated as a purple glass (38 
mg, 9%). δH (CDCl3, 500 MHz): 8.34 (1H, d, J = 9.6 Hz, H1), 8.21 (1H, d, J = 9.2 Hz, H10), 7.97 (1H, 
apparent s, H4), 7.80 - 7.62 (19H, m, H9, PPh3, H2’’, H4’’, H6’’), 7.34 - 7.30 (2H, m, H3’’, H5’’), 7.29 
(1H, J = 9.4 Hz, 1.7 Hz, H2), 7.11 (1H, t, J = 6.1 Hz, C3-NH), 5.96 (1H, d, J = 2.4 Hz, H7), 5.18 (1H, t, J 
= 6.2 Hz, C8-NH), 4.68 (2H, apparent s, broad, CH2-1’), 3.60 - 3.48 (2H, m, CH2-6’), 3.08 (2H, d, J = 
6.1 Hz, 3-NHCH2), 2.70 (6H, s, CH3SO3
-), 2.63 (2H, d, J = 6.1 Hz, 8-NHCH2), 1.83 (2H, apparent s, 
broad, CH2-3’), 1.65 - 1.44 (6H, m, CH2-3’, CH2-4’, CH2-5’), 1.01 [9H, s, 3-CH2C(CH3)], 0.83 [9H, s, 8-
CH2C(CH3)]. δc (CDCl3, 125 MHz): 157.52 (C), 152.91 (C), 148.40 (C), 135.29 (d, J = 2.7 Hz, CH), 
135.18 (C), 133.90 (d, J = 10.0 Hz, CH), 132.49 (C), 131.31 (CH), 130.78 (d, J = 12.6 Hz, CH), 129.97 
(CH), 129.32 (CH), 129.14 (C), 128.28 (CH), 124.92 (C), 124.53 (CH), 122.14 (CH), 118.74 (d, J = 86.1 
Hz, C), 117.43 (C), 116.32 (CH), 104.70 (CH), 100.06 (CH), 55.46 (CH2), 55.12 (CH2), 53.65 (CH2), 
39.95 (CH3), 33.10 (C), 32.87 (C), 29.44 (CH2), 29.30 (CH2), 28.01 (CH3), 27.95 (CH3), 25.04 (CH2), 
22.09 (d, J = 4.2 Hz, CH2) 21.53 (d, J = 50.9 Hz, CH2). Max(ATR)cm
-1: 3298 (NH), 3059 (CAr-H), 2949 
(C-H), 2936 (C-H), 2904 (CH), 2866 (C-H), 1618 (C=N), 1587 (CAr=CAr), 1541 (CAr=CAr), 1520 (CAr=CAr). 
MS (ESI+): 386 (M++, 100%). HRMS: 385.7332. C53H62N3P
2+ requires 385.7335. 
 
1,4-Bis(benzyloxy)benzene 420 
 
1,4-hydroquinone 414 (40.0 g, 363 mmol, 1.00 eq.) and benzyl chloride (101 mL, 878 mmol, 2.42 
eq.) were suspended in ethanol (268 mL). Ethanolic KOH (250 mL, 2.85 M) was added and the 
mixture stirred mechanically for 3 h under argon then allowed to stand for 3 days. The mixture 
was quenched in H2O and the off-white precipitate was filtered and crystallised in eight portions 
(14 g/500 mL) from boiling EtOH. The combined crystallisation leftovers were combined, then 
concentrated to give another crop of crystals. The combined solid was dried under vacuum to give 
ether 420 as needles (71.8 g, 68%). H (400 MHz, CDCl3): 7.45 - 7.28 (10H, m, OCH2Ph), 6.90 [4H, s, 
Ph(Obn)2], 5.01 (4H, s, OCH2Ph). 
13C NMR (101 MHz, CDCl3) δ 153.26 (C), 137.37 (C), 128.68 (CH), 
128.02 (CH), 127.60 (CH), 115.90 (CH), 70.74 (CH2). Consistent with literature data.
 431,396 
 
1,4-Bis(benzyloxy)-2-nitrobenzene 421 
 
Protected quinol 420 (65.0 g, 224 mmol, 1.00 eq.) was suspended in glacial acetic acid (240 mL) 
and a solution of nitric acid in glacial acetic acid (HNO3(aq) 70% aqueous solution, 17 mL, 270 
mmol, 1.2 eq. Made up to 75 mL with glacial acetic acid) was added to the mixture and 
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mechanically stirred for 2 h, then additional AcOH (300 mL) added and the reaction stirred at 50 
˚C for 18 h. The material was cooled to 0 - 5 ˚C for 4 h, then filtered. The filtrate was diluted (H2O) 
and further precipitate collected, then the remaining solution concentrated under reduced 
pressure and the process repeated. Remaining H2O and AcOH were removed by azeotrope with 
PhMe, which was then removed under reduced pressure. Nitro compound 421 was isolated as a 
yellow solid (73.2 g, 97%). H (400 MHz, CDCl3): 7.49 (1H, d, J = 3.0, H3), 7.46 - 7.30 (10H, m, 
OCH2Ph), 7.12 (1H, dd, J = 9.2, 3.1 Hz, H5), 7.05 (1H, d, J = 9.2 Hz, H6), 5.18 (2H, s, CH2), 5.05 (2H, 
s, CH2). 
13C NMR (101 MHz, CDCl3) δ 152.30 (C), 146.39 (C), 135.97 (C), 135.88 (C), 128.75 (CH), 
128.70 (CH), 128.37 (CH), 128.22 (CH), 127.59 (CH), 127.15 (CH), 121.54 (CH), 117.24 (CH), 111.18 
(CH), 72.10 (CH2), 70.94 (CH2). IR (ATR cm
-1): 1520 (NO2), 1497 (CAr=CAr), 1341 (NO2). MS (ESI
+): 358 
[(M+Na)+, 100]. HRMS: 358.1034. C20H17NNaO4 requires 358.1050. Compound known but not 
previously fully characterised.396 
 
4-Benzyloxy-2-nitrophenol 422 
 
Nitroaryl 421 (4.50 g, 13.4 mmol, 1.00 eq.) was dissolved in CHCl3 (65 mL) and stirred at 0 ˚C under 
argon. To the mixture a suspension of AlCl3 (2.07 g, 15.5 mmol, 1.16 eq.) in CHCl3 (10 mL) was 
added portionwise with additional CHCl3 (20 mL). The reaction was monitored by TLC and was 
complete after 15 min. The mixture was quenched into HCl(aq) (1 M) and extracted with DCM (x 3). 
The combined organics were dried (MgSO4), filtered and the solvent removed under reduced 
pressure. The residue was crystallised from boiling MeOH, then recrystallised from boiling MeOH 
with 5% H2O added. The resulting crystals were washed (H2O), then partitioned between H2O and 
DCM. The organic layer was separated and the solvent removed under reduced pressure, giving 
nitrophenol 422 as a solid (1.88 g, 57%). H (400 MHz, CDCl3): 10.36 (1H, s, ArOH), 7.61 (1H, d, J = 
3.1 Hz, H3), 7.46 - 7.33 (5H, m, OCH2Ph), 7.29 (1H, dd, J = 9.2, 3.1 Hz, H5), 7.10 (1H, d, J = 9.2 Hz, 
H6). 13C NMR (101 MHz, CDCl3) δ 151.64 (C), 150.20 (C), 135.86 (C), 132.97 (C), 128.76 (CH), 
128.42 (CH), 127.88 (CH), 127.65 (CH), 120.93 (CH), 107.19 (CH), 70.92 (CH2). IR (ATR cm
-1): 3231 
(O-H), 3123 (CAr-H), 3106 (CAr-H), 1584 (CAr=CAr), 1530 (NO2), 1501 (CAr=CAr), 1485 (CAr=CAr), 1316 
(NO2). MS (EI
+): 245 (M+, 18%), 91 (C7H7
+., 100). HRMS: 245.0696. C13H11O4N requires 245.0688. 
Compound known but not previously fully characterised.396 
 
1-(2-bromoethoxy)-2-nitrobenzene 415 
 
Following the method of Tsein and coworkers,396 2-nitrophenol 423 (3.99 g, 28.7 mmol, 1.00 eq.), 
1,2-dibromoethane (7.5 mL, 87 mmol, 3.0 eq.) and K2CO3 (4.36 g, 31.6 mmol, 1.10 eq.) were 
combined in DMF (6.0 mL) and stirred at 120 C for 3 h under argon. The precipitate was filtered 
off and washed with DCM and H2O. The filtrate layers were separated and the organics were 
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washed with 0.5 M NaOH(aq) and saturated brine solution. The organics were dried (MgSO4) and 
filtered, then the solvent was removed under reduced pressure to give the bromide 415 (4.53 g, 
65%) as a solid. H (400 MHz, CDCl3): 7.85 (1H, dd, J = 8.3, 1.7 Hz, H6), 7.55 (1H, ddd, J = 8.4, 7.5, 
1.7 Hz, H4), 7.12 - 7.06 (2H, m, H3, H5), 4.42 (2H, t, J = 6.5 Hz, OCH2CH2Br), 3.68 (2H, t, J = 6.5 Hz, 
OCH2CH2Br). This material is commercially available and 
1H NMR is consistent with literature 
data.432 
 
2-Nitro-1-[2’-(4’‘-benzyloxy-2’‘-nitrophenoxy)ethoxy]benzene 416 
 
Following the method of Tsein and coworkers396 1-(2-bromoethoxy)-2-nitrobenzene 415 (10.9 g, 
44.3 mmol, 1.47 eq.), nitrophenol 422 (7.0 g, 30 mmol, 1.0 eq.) and K2CO3 (3.0 g, 22 mmol, 0.7 eq.) 
were combined in dry DMF (17.0 mL) and stirred at 140 C for 2 h under argon, then allowed to 
stir at RT for 12 h. The material was heated to 50 C, and the precipitate was dissolved with 
dropwise addition of water. After 24 h stirring precipitate had formed and was collected by 
filtration. The material was then washed out in a mixture of acetone and hexane. The solvent was 
removed under reduced pressure and the compound dissolved in DCM then washed with water (x 
3) and 5% LiCl(aq) solution, then the solvent removed from the combined organics to give the ether 
416 in quantitative yield (12.4 g, quant.). H (400 MHz, CDCl3): 7.84 (1H, dd, J = 8.1, 1.7 Hz, H3), 
7.57 (1H, ddd, J = 8.5, 7.4, 1.7 Hz, H5), 7.47 - 7.32 (6H, m, OCH2Ph, H3’’), 7.23 - 7.19 (3H, m, H6, 
H5’’, H6’’), 7.12 - 7.05 (1H, m, H4), 5.07 (2H, s, OCH2Ph), 4.52 - 4.46 (4H, m, OCH2CH2O). C (CDCl3, 
100 MHz): 152.95 (C), 151.956 (C), 146.37 (C), 140.63 (C), 140.20 (C), 135.90 (C), 134.34 (CH), 
128.76 (CH), 128.38 (CH), 127.59 (CH), 125.68 (CH), 121.73 (CH), 121.24 (CH), 118.75 (CH), 115.61 
(CH), 111.04 (CH), 70.96 (CH2), 69.99 (CH2), 68.77 (CH2). IR (ATR cm
-1): 3094 (CH), 2960 (CH), 2929 
(CH), 2871 (CH), 1606 (CAr=CAr), 1518 (NO2), 1497 (CAr=CAr), 1487 (NO2), 1451 (CAr=CAr). MS (EI
+): 
(410 M+., 45%), 166 (O2NC6H4OCH2CH2
+, 38), 122 (C4H4NO2
+, 44), 91 (PhCH2
+, 100). HRMS: 
410.1114. C21H18N2O7 requires M
+. 410.1114. MP: 110 -111 °C. 
 
1-Nitro-2-[2’-(2’‘-nitrophenoxy)ethoxy]benzene 426 
 
Dimer 426 (321 mg, 4%) was isolated as a side product of an earlier synthesis of ether 416, and 
separated from ether 416 by column chromatography [SiO2, Pet. ether/EtOAc (5:2)]. H (400 MHz, 
d6-DMSO): 7.86 (2H, dd, J = 8.0, 1.7 Hz, H6, H3’‘), 7.66 (2H, ddd, J = 8.4, 7.5, 1.7 Hz, H4, H5’‘), 7.44 
(2H, J = 8.5, 1.0 Hz, H3, H6’‘), 7.15 (2H, m, H5, H4’‘), 4.54 (4H, s, OCH2). c (100 MHz, d6-DMSO): 
150.89 (C), 139.75 (C), 134.30 (CH), 124.83 (CH), 120.98 (CH), 115.55 (CH), 68.02 (CH2). IR (ATR cm
-
1): 2931 (C-H), 2878 (C-H), 1605 (CAr=CAr), 1512 (NO2), 1358 (NO2). MS (EI
+): 304 (M+ 28%), 166 
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(C8H8NO3
+, 63%), 122 (C6H4NO2
+, 100%). HRMS: 304.0698 requires 304.0695 C14H12O6N2. MP: 161 - 
164 °C. Consistent with literature data.433 
 
2-[2’-(2’‘-Aminophenoxy)ethoxy]-5-(benzyloxy)aniline 427 
 
Dinitro compound 416 (100 mg, 0.24 mmol, 1.00 eq.) was dissolved in acetone (4.0 mL) and 
added to a stirring solution of NH4HCO2 (123 mg, 1.95 mmol, 8.13 eq.) in deionised water (1.0 
mL). Iron filings (141 mg, 2.52 mmol, 10.5 eq.) were added and the reaction mixture was then 
stirred at 70 ˚C under argon for 17 h. The mixture was filtered through celite with acetone, then 
the solvent removed under reduced pressure. The residue was dissolved in DCM, then washed 
with brine and dried (MgSO4), filtered and the solvent removed under reduced pressure, giving 
diamine 427 as a solid (52 mg, 61%). H (400 MHz, CDCl3): 7.44 - 7.34 (4H, m, H2’’’, H3’’’, H5’’’, 
H6’’’) 7.33 - 7.27 (1H, m, H4’’’), 6.86 - 6.79 (2H, m, H4’’, H6’’), 6.77 (1H, d, J = 8.7 Hz, H6), 6.74 - 
6.68 (2H, m, H3’’, H5’’), 6.39, (1H, d, J = 2.9 Hz, H3), 6.30 (1H, dd, J = 8.7, 2.9 Hz, H5), 4.98 (2H, s, 
OCH2Ph), 4.35 - 4.27 (4H, m, OCH2CH2O), 3.83 (4H, s, NH2). C (100 MHz, CDCl3): 154.37 (C), 146.26 
(C), 140.85 (C), 138.24 (C), 137.47 (C), 136.89 (C), 128.52 (CH), 127.81 (CH), 127.43 (CH), 121.94 
(CH), 118.38 (CH), 115.36 (CH), 114.31 (CH), 112.66 (CH), 103.46 (CH), 103.10 (CH), 70.43 (CH2), 
68.64 (CH2), 67.64 (CH2). IR (ATR cm
-1): 3454 (NH), 3433 (NH), 3367 (NH), 3350 (NH), 3063 (CAr-H), 
3038 (CAr-H), 2959 (C-H), 2939 (C-H), 2886 (C-H), 1611 (CAr=CAr), 1601 (CAr=CAr), 1595 (CAr=CAr), 
1207 (C-O). MS (EI+): 350 (M+., 70%), 241 (M+ – C6H4NH2O, 9), 215 (C13H13NO2
+, 42), 214 
(C13H14NO2
+., 11), 136 (C8H9NO
+, 41), 91 (C7H7
+, 100). HRMS: 350.1629 requires 350.1630. MP: 146 
˚C. 
 
Ethyl-2-N-(2’’-{2’’’-[4’’’’-(benzyloxy)-2’’’’-N,N-(2’’’’’-ethoxy-2’’’’’-
oxoethyl)amino]phenoxy]ethoxy}phenyl)-N-(2’-ethoxy-2’-oxoethyl)amino]acetate 428 
 
Aniline 427 (1.80 g, 5.14 mmol, 1.00 eq.) was dried by azeotrope twice in PhMe then combined 
under argon with NaI (2.12 g, 14.1 mmol, 2.75 eq., dried under vacuum at 100 ˚C for 6 h) and 
proton sponge (also dried by azeotrope in PhMe, 7.50 g, 35.0 mmol, 6.81 eq.) dry MeCN (10.0 mL) 
and ethyl bromoacetate (5.00 mL, 46.3 mmol, 9.01 eq.) were added to the stirring mixture which 
was then heated under reflux for 24 h. The solvent was then removed under reduced pressure 
and the residue was dissolved in PhMe and filtered. The filtrate was washed 5 times with dilute 
HCl(aq), then the organics were then combined and the solvent removed under vacuum. 
Crystallisation (Pet. ether/EtOAc) gave the diammine tetraester 428 (4.00 g, quant.) as needles. H 
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(400 MHz, CDCl3): 7.45 - 7.34 (4H, m, H2’’’’’, H3’’’’’, H5’’’’’, H6’’’’’) 7.33 - 7.28 (1H, m, H4’’’’’), 6.93 - 
6.78 (4H, m, H3’‘, H4’‘, H5’‘ H6’‘), 6.76 (1H, d, J = 9.5 Hz, H6’‘‘‘), 6.50 - 6.44 (2H, m, H3’‘‘‘, H5’‘‘‘), 
4.97 (2H, s, OCH2Ph), 4.23 (4H, s, OCH2CH2O), 4.16 (4H, s, NCH2), 4.14 (4H, s, NCH2), 4.055 (4H, q, J 
= 7.2 Hz, CO2CH2), 4.053 (4H, q, J = 7.2 Hz, CO2CH2), 1.16 (6H, t, J = 7.1 Hz, CH2CH3), 1.15 (6H, t, J = 
7.1 Hz, CH2CH3). C (100 MHz, CDCl3): 171.60 (C), 171.42 (C), 153.61 (C), 150.32 (C), 144.73 (C), 
140.58 (C), 139.36 (C), 137.22 (C), 128.53 (CH), 127.89 (CH), 127.53 (CH), 122.13 (CH), 121.40 (CH), 
118.96 (CH), 114.43 (CH), 113.09 (CH), 107.22 (CH), 106.37 (CH), 70.45 (CH2), 67.81 (CH2), 67.11 
(CH2), 60.80 (CH2), 60.75 (CH2), 53.49 (CH2), 53.44 (CH2), 14.06 (CH3), 14.03 (CH3). IR (ATR cm
-1): 
2986 (C-H), 2932 (C-H), 1736 (C=O), 1598 (CAr=CAr), 1512 (CAr=CAr). MS (NSI): 717 [(M+Na
+), 52%], 
695 [(M+H)+, 100],. HRMS: 695.3173. C37H47O11N2 requires 695.3180. MP: 96 - 97 °C. 
 
Ethyl-2-[(2’’-{2’’’-[4’’’’-(benzyloxy)-2’’’’-[bis(2’’’’’-ethoxy-2’’’’’-oxoethyl)amino]5-
formylphenoxy]ethoxy}phenyl)(2’-ethoxy-2’-oxoethyl)amino]acetate 429 
 
Tetraester 428 (1.02 g, 1.28 mmol, 1.00 eq.) was dried by azeotrope twice in PhMe then dissolved 
in dry DMF (62 mL) and stirred under argon at 0 ˚C. Dry pyridine (1.56 mL, 19.0 mmol, 14.8 eq.) 
was added followed by slow addition of POCl3 (1.56 mL, 16.7 mmol, 13.4 eq.). After 30 min the 
reaction mixture was allowed to warm to RT, and the reaction was followed by TLC. After 1 h 10 
min the mixture was quenched into cold 1 M NaOH(aq). After vacuum filtration the filtrate was 
extracted with PhMe (x 3), which was then removed under reduced pressure. The sample was 
dissolved in DCM and precipitated with hexane, the solid collected and the process repeated, 
giving aldehyde 429 (700 mg, 77%) as an amorphous solid. H (400 MHz, CDCl3): 10.31 (1H, s, CHO) 
7.42 - 7.31 (5H, m, Ph), 7.29 (1H, s, H6’’’’), 6.93 - 6.79 (4H, m, H3’’, H4’’, H5’’ H6’’), 6.30 (1H, s, 
H3’’’’), 5.10 (2H, s, OCH2Ph), 4.27 - 4.20 (4H, m, OCH2CH2O), 4.18 (4H, s, NCH2), 4.14 (4H, s, NCH2), 
4.06 (4H, q, J = 7.1 Hz, CO2CH2), 4.03 (4H, q, J = 7.1 Hz, CO2CH2), 1.16 (6H, t, J = 7.2 Hz, CH2CH3), 
1.14 (6H, t, J = 7.1 Hz, CH2CH3). C (100 MHz, CDCl3): 187.49 (CH), 171.51 (C), 170.7051 (C), 157.34 
(C), 150.19 (C), 146.44 (C), 143.96 (C), 139.48 (C), 136.32 (C), 128.71 (CH), 128.24 (CH), 127.29 
(CH), 122.10 (CH), 121.66 (CH), 119.10 (CH), 117.98 (C), 113.32 (CH), 110.62 (CH), 102.67 (CH), 
71.10 (CH2), 67.61 (CH2), 66.90 (CH2), 61.22 (CH2), 60.76 (CH2), 53.86 (CH2), 53.50 (CH2), 14.07 
(CH3), 14.02 (CH3). IR (ATR cm
-1): 2975 (C-H), 2938 (C-H), 2928 (C-H), 2873 (C-H), 1745 (C=O), 1718 
(C=O), 1662, 1598 (CAr=CAr), 1517 (CAr=CAr), 1508 (CAr=CAr). MS (NSI): 1462 [(2M+NH4
+), 6%], 761 
[(M+K+), 3], 745 [(M+Na+), 60], 740 [(M+NH4
+), 45], 723 [(M+H+), 100]. HRMS: 723.3121 requires 
723.3129, C38H47O12N2. MP: 135 - 136 °C. 
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Ethyl-2-{[2’’-(2’’’-{2’’’’-[bis(2’’’’’-ethoxy-2’’’’’-oxoethyl)amino]-5’’’’-formyl-4’’’’-
hydroxyphenoxy}ethoxy)phenyl](2’-ethoxy-2’-oxoethyl)amino}acetate 430 
 
Aldehyde 429 (500 mg, 0.62 mmol, 1.00 eq.) was combined in acetic acid (6.0 mL) with palladium 
on carbon (10% loading by weight, 160 mg, 0.15 mmol, 0.24 eq.). After an initial 10 min flush with 
argon, the solution was frozen in N2(l) and the gas removed under vacuum. The mixture was then 
melted under H2(g), which was bubbled through the solution for 5 min. This procedure was 
repeated twice, then the mixture allowed to stir under H2(g) for 2 h 20 min. The mixture was then 
filtered through celite eluting with DCM then dried over (MgSO4) filtered and the solvent removed 
under reduced pressure. Azeotrope with PhMe then removal of the solvent under reduced 
pressure was used to remove AcOH. This gave the desired phenol 430 (387 mg, 87%) as a solid. H 
(400 MHz, CDCl3): 11.21 (1H, s, PhOH), 9.61 (1H, s, CHO), 6.92 (1H, s, H6’’’’), 6.94 - 6.82 (4H, m, 
H3’’, H4’’, H5’’ H6’’), 6.15 (1H, s, H3’’’’), 4.23 (4H, s, OCH2CH2O), 4.22 (4H, s, NCH2), 4.15 (4H, s, 
NCH2), 4.08 (4H, q, J = 7.1 Hz, CO2CH2), 4.08 (4H, q, J = 7.1 Hz, CO2CH2), 1.19 (6H, t, J = 7.2 Hz, 
CH2CH3), 1.16 (6H, t, J = 7.2 Hz, CH2CH3). C (100 MHz, CDCl3): 193.22 (CH), 171.49 (C), 170.37 (C), 
158.82 (C), 150.17 (C), 148.32 (C), 142.72 (C), 139.48 (C), 122.25 (CH), 121.78 (CH), 119.23 (CH), 
115.90 (CH), 113.38 (CH), 113.06 (C), 104.22 (CH), 68.23 (CH2), 66.92 (CH2), 61.34 (CH2), 60.78 
(CH2), 53.85 (CH2), 53.48 (CH2), 14.09 (CH3), 13.97 (CH3). IR (ATR cm
-1): 2977 (CAr-H), 2960 (CAr-H), 
2937 (CAr-H), 2908 (CAr-H), 2877 (CAr-H), 1739 (CO), 1630 (CO), 1507 (CAr=CAr). MS (NSI): 671 
[(M+K+), 5%], 655 [(M+Na+), 62], 650 [(M+NH4
+), 22], 633 [(M+H+), 100]. HRMS: 633.2652. (M+H)+ 
C31H41O12N2 requires 633.2659. MP: 78 - 80 °C.  
 
Ethyl-2-{[2’’-(2’’’-{2’’’’-[bis(2’’’’’-ethoxy-2’’’’’-oxoethyl)amino]-5’’’’-formyl-4’’’’-(prop-2’’’’’’-en-
1’’’’’’-yloxy)phenoxy}ethoxy)phenyl](2’-ethoxy-2’-oxoethyl)amino}acetate 445 
 
Phenol 430 (49 mg, 0.07 mmol, 1.0 eq.) was dried by azeotrope in PhMe and diluted in dry 
DMF(1.5 mL). This mixture was syringed into a dry vial containing a stirrer bar, K2CO3 (37 mg, 0.3 
mmol, 3.7 eq.) and tetrabutylammonium bromide (2 mg, 6 µmol, 0.09 eq.), all of which had 
previously been dried by azeotrope in PhMe. The mixture was cooled with stirring to 0 ˚C under 
argon in the dark. Allyl bromide (10 µL, 0.11 mmol, 1.5 eq.) was added and the mixture warmed 
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to RT and allowed to stir for 48 h. The mixture was then filtered eluting with DCM and the filtrate 
was washed with water, saturated brine solution and then NaHCO3(aq) (saturated), and dried 
(MgSO4). The mixture was filtered and the solvent removed under reduced pressure, to give 
phenol 445 impure (54 mg, estimate 44% purity from NMR). Data derived from the spectrum of 
the mixture. H (400 MHz, CDCl3): 10.30 (1H, s, CHO) 6.93 - 6.78 (5H, m, H3’’, H4’’, H5’’, H6’’, 
H6’’’’), 6.26 (1H, s, H3’’’’), 6.03 (1H, ddt, J = 17.3, 10.5, 5.2 Hz, OCH2CHCH2), 5.41 [1H, dq, J = 17.3, 
1.4 Hz, CH2CHCH(cis)H(trans)], 5.31 [1H, dq, J = 10.5, 1.4 Hz, CH2CHCH(cis)H(trans)], 4.56 (2H, dt, J = 5.2, 
1.5 Hz), 4.23 - 4.19 (8H, m, OCH2CH2O, NCH2), 4.14 (4H, m, NCH2), 4.07 (4H, q, J = 7.2 Hz, 
CO2CH2CH3), 4.04 (4H, q, J = 7.2 Hz), 1.16 (6H, t, J = 7.2 Hz, CH2CH3), 1.14(6H, t, J = 7.2 Hz, CH2CH3). 
MS (NSI): 711 ([M+Na+], 73%), 673 ([M+H+], 100). HRMS: 673.2964 requires 673.2972, 
C33H45O12N2. 
 
1,7-Diazoheptane 437 
 
1,7-dibromoheptane 436 (4.0 mL, 30 mmol, 1.0 eq.) and NaN3 (11.4 g, 176 mmol, 5.87 eq.) were 
combined in deionised water (130 mL) and stirred at reflux under argon for 13 h 40 min. The 
desired product was then extracted into DCM. This solution was dried (MgSO4), filtered, then the 
solvent removed under reduced pressure to give diazide 437 as an oil (4.5 g, 88%). H (400 MHz, 
CDCl3): 3.27 (4H, t, J = 6.9 Hz, N3CH2CH2), 1.65 - 1.56 (4H, m, N3CH2CH2), 1.45 - 1.31 (6H, m, 
N3CH2CH2CH2CH2CH2). C (400 MHz, CDCl3): 51.41 (CH2), 28.75 (CH2), 28.70 (CH2), 26.59 (CH2). IR 
(ATR cm-1): 2935 (C-H), 2876 (C-H), 2860 (C-H), 2091 (N3), 1464, 1456. MS (APCI
+): 183 [(M+H)+, 
16%), 155 [(M – HN2)
+, 100). HRMS: 183.1348. C7H15N6 requires 183.1353. Consistent with 
literature data.434 
 
7-Azidohept-1-amine 438 
 
1,7-diazoheptane 437 (4.5 g, 20 mmol, 1.0 eq.) was dissolved in Et2O (180 mL). Dilute HCl(aq) (1M, 
135 mL) was added, followed by triphenylphosphine (6.0 g, 23 mmol, 1.1 eq.). The reaction 
mixture was then allowed to stir for 36 h at RT under argon, then the aqueous layer extracted 
with Et2O (100 mL, x 4) and DCM (100 mL, x 3), with NaOH(aq) (7 M) used to basify the aqueous 
between extractions. The organic layers were combined and dried (MgSO4), then filtered and the 
solvent removed under reduced pressure to give amine 438 as an oil (2.98 g, 75%). H (400 MHz, 
CDCl3): 3.26 (2H, t, J = 6.9 Hz, N3CH2CH2), 2.69 (2H, t, J = 6.9 Hz, H2NCH2CH2), 1.66 - 1.54 (2H, m, 
N3CH2CH2), 1.50 - 1.26 (8H, m, 4 x CH2). C (400 MHz, CDCl3): 51.60 (CH2), 42.35 (CH2), 33.89 (CH2), 
28.93 (CH2), 26.89 (CH2), 26.84 (CH2). IR (ATR cm
-1): 2928 (C-H), 2855 (C-H), 2093 (N3), 1575, 1464, 
1456. MS (APCI+): 157 [(M+H)+, 100%). HRMS: 157.1444. C7H17N4 requires 157.1448. 
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1-Azido-7-isothiocyanatoheptane 439 
 
Azido compound 438 (2.8 g, 14 mmol, 1.0 eq.) and Ca2CO3 (2.9 g, 29 mmol, 2.1 eq.) were 
combined stirring under argon in DCM (62.2 mL) and deionised water (62.2 mL). Thiophosgene 
(1.6 mL, 22 mmol, 1.5 eq.) was then added slowly to the stirring mixture. After 1 h 30 min the 
reaction mixture was quenched into water, then extracted with DCM (100 mL, x 3), dried (MgSO4), 
then filtered and the solvent removed under reduced pressure to give product 439 (88%). H (400 
MHz, CDCl3): 3.52 (2H, t, J = 6.6 Hz, SCNCH2CH2), 3.27 (2H, t, J = 6.9 Hz, N3CH2CH2), 1.76 - 1.66 (2H, 
m, SCNCH2CH2), 1.66 - 1.56 (2H, m, N3CH2CH2), 1.50 - 1.31 (3 x CH2, 6H). C (400 MHz, CDCl3): 
204.39 (C), 51.38 (CH2), 45.01 (CH2), 29.85 (CH2), 28.73 (CH2), 28.38 (CH2), 26.53 (CH2), 26.46 (CH2). 
 
Methyl-2-{[(7-azidoheptyl)carbamothioyl]amino}acetate 440 
 
Isothiocyanate 439 (3.12 g, 15.8 mmol, 1.00 eq.) was combined in EtOAc (90 mL) with NEt3 (2.50 
mL, 17.7, 1.12 eq.) and glycine methyl ester hydrochloride (2.22 g, 17.7 mmol, 1.12 eq.) and 
heated stirring under reflux and argon. The reaction mixture was partitioned between DCM and 
water and the organic layer washed with water and brine solution then dried (MgSO4), filtered 
and the solvent removed under reduced pressure to give the product 440 (3.83 g, 85%), which 
was used without purification. 
 
1-(7-Azidoheptyl)thiohydantoin 419 
 
Carbamothioyl 440 (3.83 g, 14.7 mmol, 1.00 eq.) was refluxed stirring in a mixture of ethanol (190 
mL) and 0.5 M HCl(aq) (25.9 mL) heated under argon. The solvent was then removed under 
reduced pressure and the mixture partitioned between DCM and water, then extracted with DCM 
(3 x 100 mL). The combined organics were dried (MgSO4), then filtered and the solvent removed 
under reduced pressure. The material was then crystallised (Pet. ether/EtOAc) to give 
thiohydantoin 419 (2.58 g, 76%) as yellow needles. H (400 MHz, CDCl3): 4.06 (2H, d, J = 1.12 Hz, 
R(CO)NCH2CO), 3.81 (2H, t, J = 7.54 Hz, (CS)RNCH2), 3.26 (2H, t, J = 6.93 Hz, N3CH2CH2), 1.75 - 1.54 
(4H, m, N3CH2CH2, HNCH2CH2), 1.44 - 1.28 (6H, m, other CH2). C (100 MHz, CDCl3): 185.23 (C), 
171.38 (C), 51.41 (CH2), 48.30 (CH2), 41.32 (CH2), 28.73 (CH2), 28.64 (CH2), 27.40 (CH2), 26.54 (CH2). 
IR (ATR cm-1): 1740 (CO), 3177 (NH), 2933 (C-H), 2854 (C-H), 2090 (N3), 1538 (HNC), 1467, 1445 
(CH2), 1353 (HCN), 1273 (N3). MS (CI
+): 256 [(M+H)+, 100%]. HRMS: 256.1236 requires 256.1232, 
C10H18ON5S.MP: 66˚C 
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